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Abstract.
Introduction: One of the main objectives of prenatal diagnosis programmes is to ensure 
women make informed decisions about testing. As few studies have operationalised 
informed decision making, it is unclear whether or not this objective has been attained. 
However, evidence suggests that (a) insufficient information is provided to enable informed 
and autonomous decision making, and (b) women's knowledge of testing is often 
incomplete. It is unlikely, therefore, that all women make fully informed decisions.
Aims: To describe the conditions enabling informed decision making; to operationalise and 
assess the informed decision making process; to evaluate the efficacy of decision analysis 
to facilitate informed decision making; to describe the factors associated with prenatal 
diagnosis decisions.
Sample: Data from 128 prenatal diagnosis information giving consultations between a 
health professional and women receiving a screen positive triple test result were included 
for analysis.
Methods: Theoretical and integrative reviews summarising prior empirical research; 
observational designs assessing the decision making process; a randomised control trial 
design evaluating the decision analysis intervention. The following materials were piloted: a 
checklist of information provided; a coding frame of information utilised; a consent form; a 
questionnaire completed at two time points.
Results: Insufficient information about Down's syndrome and termination was provided by 
the health professional to enable informed decision making. As many women employed a 
‘screening out’ strategy to limit the information for assimilation, not all women made fully 
informed decisions. In the RCT (n = 106), 17 women chose no further testing. Compared 
with women receiving routine information, those allocated to the decision analysis 
consultation made more informed decisions, experienced less decisional conflict, were less 
falsely reassured and had longer consultations. Perceived social norm, expected-utility 
values and anxiety predicted women’s test decisions.
Discussion: Decision analysis consultations were associated with more informed decisions 
than routine care. However, additional empirical research is required to ascertain what 
aspects of the decision analytic technique were associated with the facilitation of informed 
decision making. Recommended changes to routine clinical practice and women’s role in 
the consultation will be dependent on these subsequent findings.
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11. Prenatal diagnosis and women’s decision making: 
a theoretical review.
This chapter provides an overview of the application of psychological theory to 
understanding informed decision making in the context of prenatal diagnosis for Down’s 
syndrome. The first section of the chapter describes the procedures offered during 
pregnancy to identify fetal abnormalities, summarises the findings from research 
exploring women’s experiences of prenatal testing for Down’s syndrome and outlines 
the objectives of prenatal diagnosis. The second part of the chapter focuses on some of 
the psychological models that have been used to explain individual’s health decisions. 
In particular, this section assesses the usefulness of these models in understanding, 
operationalising and facilitating informed decision making. The final section includes a 
theoretical review (Cooper, 1989) that integrates the empirical evidence from research 
carried out to explain women’s prenatal diagnostic test behaviour for Down’s syndrome 
and evaluates the extent to which this testing decision can be said to be informed.
1.1 Prenatal testing.
A number of procedures offered during pregnancy are described by the umbrella term 
'prenatal testing’. These procedures fall into three areas of testing: prenatal screening 
(section 1.1.1)] genetic testing (section 1.1.2); prenatal diagnosis (section 1.1.3). 
Prenatal diagnosis is only offered to a woman1 if the risks of having a baby with an 
abnormality are sufficient to warrant the use of such an invasive and risky procedure 
(Harper, 1992; Royal College of Obstetricians and Gynaecologists, 1993; Hewison,
1996). Women with a sufficient or increased risk of having a baby with an abnormality 
are identified and distinguished from those with ‘insufficient risk’, either following a 
screening test or as a result of carrier testing for a genetic disease. Although the offer of 
a procedure may depend on the results of a previous test, each choice a woman makes 
about a prenatal testing procedure is a discrete decision event (Shiloh, 1995). The 
following section briefly describes the types of procedures used to identify fetal 
abnormalities within each of these three prenatal testing contexts.
1.1.1 Screening tests.
Screening tests provide women with a risk figure that estimates their likelihood of 
having a baby with an abnormality. Arbitrary cut-off points are used to dichotomise the
1 Woman refers to the individual making the prenatal testing decision. For consistency, the term 
woman is employed when the literature refers to couples making the prenatal diagnosis decision.
2range of risk figures provided by the screening test into either a screen negative or 
screen positive test result. A screen negative result is sometimes referred to as a low 
risk, a screen positive as an increased or high risk. Prenatal screening tests provide a 
non-invasive method of segregating the population so that those with an increased or 
sufficient risk may be offered prenatal diagnosis. Although screening tests are referred 
to as non-invasive, there is an extensive literature describing an increase in 
psychological morbidity amongst pregnant women following their experience of 
undergoing prenatal screening (Berne-Fromell, Uddenberg and Kessler, 1983; Burton, 
Dillard and Clark, 1985; Tymstra, 1989; Green, 1990; Green, Statham and Snowden, 
1992; Marteau, 1992; Gregg, 1993; Marteau, Kidd, Michie, Cook, Johnston and Shaw, 
1993; Green, 1994; Thornton, Hewison, Lilford and Vail, 1995; Green and Statham, 
1996; Hewison, 1996; Michie, Smith, McClennan and Marteau, 1997). In addition, a 
large body of research has focused on factors associated with the uptake of prenatal 
screening procedures, including both women’s and health professionals’ understanding 
of and attitudes towards prenatal screening (Lippman-Hand and Cohen, 1980; Sikkink, 
1990; Green, Satham and Snowden, 1992; Marteau, 1992; Marteau, Johnston, Kidd, 
Michie and Cook, 1992; Marteau, Slack, Kidd and Shaw, 1992; Roelofsen, Kamerbeek, 
Tymstra, Beekhuis and Mantingh, 1993; Marteau, 1994a; Khalid, Price and Barrow, 
1994; Smith, Shaw and Marteau, 1994; Smith, Slack, Shaw and Marteau, 1994; 
Jorgensen, 1995; Thornton, Hewison, Lilford and Vail, 1995; Goel, Glazier, Holzapfel, 
Pugh and Summers, 1996; Hewison, 1996; Sullivan, 1996; Fairgrieve, 1997; Michie, 
Smith, McClennan and Marteau, 1997; Proud and Murphy-Black, 1997; Ryder, 1998). 
The issues of impact and uptake pertaining to screening procedures are not discussed 
further as they are outside the remit of a thesis focusing on prenatal diagnostic test 
decisions. However, as prenatal diagnosis is only offered to women with a sufficient risk 
of having a baby with an abnormality, three prenatal screening methods used to 
estimate the risk of fetal abnormality are described in more detail below.
Taking a medical history is the primary screening method used to identify some 
women at increased risk for fetal abnormalities (Royal College of Physicians, 1989; 
Gosden, Nicolaides and Whitting, 1994). A medical, reproductive and family history is 
routinely taken from all women attending their ‘booking-in visit’ at an antenatal clinic 
early in the pregnancy. For example, the following characteristics of women are 
associated with an increased risk of the baby having an abnormality: increased 
maternal age (35 years and over) is associated with an increase in the incidence of 
chromosomal abnormalities, in particular Down's syndrome; certain ethnic groups have 
a greater likelihood of inheriting specific genetic diseases such as Tay-Sachs in the
3Askenazi-Jewish population and cystic fibrosis amongst northern Europeans (Mueller 
and Young, 1995); having already had a baby with an abnormality may be associated 
with a recurrence risk in subsequent pregnancies; maternal diseases such as rubella 
and diabetes.
Biochemical or maternal serum screening is routinely offered in most antenatal 
departments (Green, 1994)2. Risk figures for neural tube defects and chromosomal 
abnormalities are calculated from a number of biochemical markers found in the 
woman’s blood or maternal serum (Wald and Cuckle, 1992; Aitken and Crossley, 1996). 
Whereas risk figures from the medical-history taking are associated with the enduring 
characteristics of a woman, risk figures calculated from serum screening are specific to 
the current pregnancy. The screening test for neural tube defects is sometimes referred 
to as maternal serum alpha-fetoprotein (MSAFP) and the tests for chromosomal 
abnormalities as maternal serum screening, the triple test or the Bart’s test. The 
biochemical tests provide more accurate risk estimates for the chromosomal 
abnormalities than figures based on maternal age (Wald and Cuckle, 1991). Although 
blood for the MSAFP is usually taken after 15 weeks gestation, the triple test can be 
performed after 13 weeks gestation (Aitken and Crossley, 1995). A screen positive triple 
test result falls between a 1:5-1:250 risk of having a baby with Down's syndrome, a 
screen negative result between 1:251-1:50 000 (Wald and Cuckle, 1992; Royal College 
of Obstetricians and Gynaecologists, 1993)3. Although the test is technically non- 
invasive and is often presented as a routine procedure (Madlon-Kay, Reif, Mersy and 
Luxenberg, 1992; Marteau, Slack, Kidd and Shaw, 1992; Gosden, Nicolaides and 
Whitting, 1994), guidelines suggest that women should make an informed choice to 
accept or decline maternal serum screening (Royal College of Obstetricians and 
Gynaecologists, 1993).
The ultrasound scan is routinely used within the ante-natal clinic to monitor the growth 
or development of the fetus (Campbell and Smith, 1984; Royal College of Physicians, 
1989; Wald and Cuckle, 1991; Whittle, 1995). A picture of the fetus, placenta and 
amniotic fluid surrounding the baby is built up by passing high-frequency sound waves 
through the woman’s abdomen (Gosden, Nicolaides and Whiting, 1994). Initially the
2 In theory, maternal serum screening is available to any pregnant woman. However, some 
health regions offer maternal serum screening to women over a certain age to reduce laboratory 
costs (Royal College of Obstetricians and Gynaecologists, 1993).
3 The risk level of 1: 250 was estimated to generate a 5% amniocentesis rate. This rate is similar 
to that generated from screening by maternal age and was considered a reasonable cut-off point 
(Royal College of Obstetricians and Gynaecologists, 1993). However, the cut-off point risk figure 
is based on medical and economic considerations and may vary between health regions.
4ultrasound scan is used to ensure that a pregnancy is viable, to ascertain the number of 
fetuses and to estimate the gestational age of the fetus (es). The ultrasound scan is also 
used to screen for fetal abnormalities at two time points: fetal nuchal translucency after 
thirteen weeks gestation (Nicolaides, Brizot and Snijders, 1994); structural abnormalities 
after sixteen weeks gestation (Campbell and Smith, 1984; Royal College of Physicians, 
1989; Wald and Cuckle, 1991; Green, 1994a; Chitty, 1995; Smith and Marteau, 1995; 
Whittle, 1995). In addition, the ultrasound scan is used as a diagnostic technique for 
some fetal abnormalities such as a cleft palate or heart defect (Royal College of 
Physicians, 1989; Wald and Cuckle, 1992; Chitty, 1995). However, the results of 
ultrasound screening provide only a risk figure for the likelihood of having a baby with 
Down's syndrome. The evidence suggests that, although the ultrasound scan is 
employed as both a screening and diagnostic technique, few women make an informed 
choice about whether or not to be scanned (Lippman, 1994; Chitty, 1995; Smith and 
Marteau, 1995; Proud and Murphy-Black, 1997).
1.1.2 Genetic tests.
Over the last thirty years, genes and genetic inheritance patterns have been implicated 
in the cause of a number of diseases to a greater or lesser extent (Mueller and Young, 
1995). Of particular relevance to this discussion are the disorders known as single gene 
diseases such as Huntington’s chorea, cystic fibrosis, Duchenne muscular dystrophy, 
Tay-Sachs, thalassaemia and sickle cell. For these diseases, a single gene is known to 
be the cause and manifestation of the disease in an individual. The disease information 
is coded within an individual’s genes and can only be passed on to others at conception 
of a fetus. Single gene diseases are either recessive or dominant. A recessive gene 
disease requires both genes within a gene pair to have the mutation associated with the 
disorder before the individual manifests the disease. An individual with one ‘disease 
gene’ is usually asymptomatic and is known as a carrier. A recessive gene disease can 
only be passed on to the fetus if both parents are carriers of the ‘disease gene’. If both 
parents are carriers of a recessive gene disorder then there is a 25% or 1:4 risk that the 
baby will inherit the disease. A dominant gene disease requires only one gene within a 
gene pair to have the mutation associated with the disorder before the individual 
manifests the disease, i.e. an individual with only one ‘disease gene’ will usually 
develop the disease. A dominant gene disease requires only one parent to have the 
gene for the disease to be passed on to the fetus. If one parent has the disease gene, 
then there is a 50% or 1:2 risk that the baby will inherit the disease. For a number of 
single gene disorders, ascertaining whether or not individuals carry the ‘disease gene’ 
requires an analysis of their blood or saliva. Although carrier testing is technically non-
5invasive, it is recommended that carrier testing should be undertaken before pregnancy 
(Royal College of Physicians, 1989) because testing may be associated with increased 
psychological morbidity (Royal College of Physicians, 1993; Bekker, Denniss, Modell, 
Bobrow and Marteau, 1994; Marteau and Anionwu, 1996). However, a number of single 
gene carrier testing programmes have been offered both before and during pregnancy 
(Watson, Mayall, Chappie, Harrington, Williams and Williamson, 1991; Marteau, 1992; 
Mennie, Gilfillan, Compton, Curtis, Liston, Pullen and Brock, 1992; Bekker, Modell, 
Dennis, Silver, Mathew, Bobrow and Marteau, 1993; Bekker, Dennis, Modell, Bobrow 
and Marteau, 1994; Meidzybrodzka, Hall, Mollison, Templeton, Russel, Dean, Kelly, 
Marteau and Haites, 1995; Hewison, 1996; Marteau and Anionwu, 1996). In essence, 
women at risk of having a baby with a genetic disease are considered to be of ‘sufficient 
risk’ to be offered a prenatal diagnostic test.
1.1.3 Diagnostic tests.
Three test procedures are offered during pregnancy to diagnose whether or not a baby 
has a fetal abnormality: amniocentesis; chorionic villus sampling; fetal blood sampling. 
All three procedures are invasive and use a ‘sampling needle’ to remove some tissue or 
liquor from the fetus in utero (Gosden, Nicolaides and Whiting, 1994). The procedures 
are usually performed transabdominally in conjunction with an ultrasound scan to guide 
the position of a needle (Royal College of Physicians, 1989; Gosden, Nicolaides and 
Whiting, 1994). An additional rate of miscarriage (spontaneous abortion) over and 
above the miscarriage rate quoted for routine pregnancies is associated with the 
diagnostic test procedures. In addition, women may experience tenderness or bruising 
as a consequence of the 'sampling needle’ insertion. The abnormalities identified by the 
tests, the techniques, the timing of test results and the risk of miscarriage associated 
with the procedure are described below.
Amniocentesis is usually performed after 14 weeks of pregnancy. A sampling needle is 
passed through the abdomen into the amniotic sac within the uterus (Gosden, 
Nicolaides and Whitting, 1994; Queenan, 1996). Between 10-20 ml of amniotic fluid are 
aspirated for analysis and test results obtained about 2-3 weeks later. The miscarriage 
risk figure associated with amniocentesis is between 0.5-1% (Royal College of 
Physicians, 1989). There is a small likelihood that the cells contained within the fluid 
may not culture or grow, requiring a repeat test to be carried out (Harper, 1992; Gosden, 
Nicolaides and Whitting, 1994). The following fetal abnormalities are diagnosed by 
amniocentesis: chromosomal disorders such as Down's syndrome, Edward’s syndrome
6and Turner's syndrome; single gene disorders such as cystic fibrosis, Duchenne 
muscular dystrophy and Huntington’s chorea; neural tube defects such as spina bifida.
Chorionic villus sampling is carried out after 10 weeks of pregnancy. Two needles are 
commonly required for this procedure: the first is passed through the abdomen into the 
uterus to penetrate the surface of the placenta; the second is passed through the first 
needle and is used to scrape some tissue from the placenta for analysis. The reported 
risk of miscarriage from chorionic villus sampling ranges between 1-4% (Royal College 
of Physicians, 1989). In addition, carrying out chorionic villus sampling before 10 weeks 
gestation is associated with an increased risk of fetal limb defects. A chorionic villus 
sampling culture is twice as likely as amniocentesis to need repeating because of the 
likelihood of mosaicism (Tolmie, 1995). Mosaicism refers to the presence of different 
numbers of chromosomes or complements of chromosomes in two or more cell lines 
from the same sample (Mueller and Young, 1995; Tolmie, 1995). Mosaicism may be a 
result of either a true in vivo difference in the arrangement of chromosomes in the fetus 
or a phenomenon of the prenatal diagnostic test procedure; chorionic villus sampling 
takes cells from outside the fetus that may result in the extraction of both maternal and 
fetal cells and mosaicism being identified (Harper, 1992; Gosden, Nicolaides and 
Whitting, 1994; Roberts and Rodeck, 1995; Mueller and Young, 1995; Tolmie, 1995). 
Chorionic villus sampling provides a diagnosis for the chromosomal and single gene 
disorders described under the explanation of amniocentesis. Although preliminary test 
results are obtained after 24 hours, information concerning the presence of mosaicism 
is only available three weeks after the test has been undertaken.
Fetal blood sampling involves inserting a sampling needle through the abdomen into 
the umbilical cord within the uterus to extract the baby’s blood. The procedure related 
risk of miscarriage is about 1-2% after nineteen weeks of pregnancy (Royal College of 
Physicians, 1989; Gosden, Nicolaides and Whitting, 1994; Roberts and Rodeck, 1995). 
Fetal blood sampling is commonly used to diagnose haemoglobin disorders and 
infections such as toxoplasmosis and rubella; it can also be used for the identification of 
chromosomal or single gene disorders. The test results are obtained between 1-2 days 
later. As fetal blood sampling is offered later in pregnancy, the majority of women 
having prenatal diagnosis will be offered the choice of amniocentesis or chorionic villus 
sampling (Ward, 1991; Williamson, Harris, Church, Fiddler and Rhind, 1996). For the 
purpose of this thesis, prenatal diagnosis refers to the offer of amniocentesis and 
chorionic villus sampling only.
71.1.4 Women’s experience of prenatal diagnosis for Down’s syndrome.
The focus of this thesis is to understand women’s informed decision making about 
whether to have or not have prenatal diagnosis following receipt of a screen positive 
triple test for Down’s syndrome. Down’s syndrome (trisomy 21) is a chromosomal 
abnormality occurring spontaneously in about 1 in 700 births (Wald and Cuckle, 1992; 
Mueller and Young, 1995). Down’s syndrome is the most common cause of mental 
retardation. The severity of Down’s syndrome varies by individual as illustrated by the 
IQ scores which have a range of values from 25 to 75 (Mueller and Young, 1995). 
Although life expectancy is generally good, there are a number of associated physical 
abnormalities, such as malformations of the heart, digestive system, eyes and ears, 
which may lead to premature death (Wald and Cuckle, 1992; Leeds Antenatal 
Screening Service, 1993; Barnes and Bryan, 1997). There is a strong association 
between advancing maternal age and the risk of having a baby with Down’s syndrome; 
between 35 and 45 years of age women’s risk of having a baby with Down’s syndrome 
increases from about 1:400 to 1:30 (Wald and Cuckle, 1992). The recurrence rate of 
having a second baby with Down's syndrome is related to maternal age and falls 
somewhere between a 0.5-1% risk (Wald and Cuckle, 1992; Mueller and Young, 1995). 
Until the early 1990s, maternal age was used as the screening test for Down’s syndrome 
with women over 35 years of age being offered prenatal diagnosis for Down’s syndrome 
(Royal College of Obstetricians and Gynaecologists, 1993). However, the development 
of a biochemical screening test for Down’s syndrome, the triple test, has meant that all 
pregnant women can be offered a screening test for Down’s syndrome regardless of 
maternal age (section 1.1.1). All women receiving a screen positive biochemical test 
result are now offered prenatal diagnosis.
The decision to have or not have a diagnostic test following receipt of a screen positive 
triple test result can be described as ‘risky’. The decision is ‘risky’ because women have 
to choose an alternative from two options, both with uncertain and negative 
consequences: to have no diagnostic test and continue the pregnancy, knowing the risk 
of having a baby with Down's syndrome; to have a diagnostic test and risk miscarrying a 
baby without Down's syndrome. Furthermore, a woman’s decision to have or not have a 
diagnostic test involves what are referred to as 'hot cognitions' (Abelson, 1963) i.e. 
cognitive processes about personal, affect-laden and important issues (Janis and Mann, 
1977). The consequences of the prenatal diagnostic test options are serious and some 
are irreversible: management of the 'increased risk’ information; birth of a healthy
8baby4; miscarriage of a healthy pregnancy; birth of a baby with Down’s syndrome; 
consideration of a termination of a pregnancy for Down’s syndrome. It is likely that the 
prenatal diagnostic test decision would result in women experiencing intense conflict 
during decision making (Janis and Mann, 1977). Decisional conflict or ambiguity (Eagly 
and Chaiken, 1993) is present in a decision which generates the simultaneous desire to 
accept and reject an option (Janis and Mann, 1977). Where both alternatives involve 
negative consequences or losses, such as the prenatal diagnosis decision, decisional 
conflict intensifies. Decisional conflict is expressed by hesitation, vacillation, feelings of 
uncertainty, and acute emotional affect such as anxiety (Janis and Mann, 1977; Mann, 
1992; Baron, 1994). The evidence to date suggests that women do find the prenatal 
diagnosis decision extremely distressing (Nielsen, 1981; Pauker and Pauker, 1987; 
Gregg, 1993). Women expressed concerns about having a baby with an abnormality, 
injuring the fetus following testing, interfering with nature, miscarrying the fetus, the pain 
of having a diagnostic procedure and waiting for test results (Nielsen, 1981; McGovern, 
Goldberg and Desnick, 1986; Sjorgen and Uddenberg, 1988; Green, Statham and 
Snowden, 1992; Burke and Kolker, 1993). In addition, anxiety levels measured before 
women have a diagnostic procedure tended to be extremely high, equivalent to those 
considered to be clinically abnormal (Beeson and Golbus, 1979; Burton, Dillard and 
Clark, 1985; Green, 1990; Marteau, Kidd, Cook, Michie, Johnston, Slack and Shaw,
1992). Although the majority of studies report that this high level of anxiety returned to 
levels considered normal for pregnant women upon receipt of a negative diagnostic test 
result (Burton, Dillard and Clark, 1985; Green, 1990; Marteau, Kidd, Cook, Michie, 
Johnson, Slack and Shaw, 1992), it is clear that women find the decision to have or not 
have prenatal diagnosis difficult and stressful.
1.1.5 Objectives of prenatal diagnosis.
The offer of testing during pregnancy is an aspect of preventive medicine. More 
specifically, secondary prevention - which aims to detect and cure disease at a stage 
before symptoms present in an attempt to reduce the morbidity and mortality associated 
with the disease (Royal College of Physicians, 1991; Marteau, 1994a) - Wilson (1965) 
developed a number of criteria to justify which diseases may be suitable targets for 
preventive medicine (from Ogden, 1996):
1. the disease must be sufficiently prevalent and/or sufficiently serious to make early 
detection appropriate;
4 The term ‘healthy’ is used for convenience to refer to a fetus, baby or child unaffected by the 
abnormality for which it was tested. Although it is likely most babies are born healthy, there are 
instances where the baby may have or develop a condition despite undergoing prenatal testing.
92. the disease must be sufficiently well defined to permit accurate diagnosis;
3. there must be a possibility that the disease remains undiagnosed in many cases so 
that rapid diagnosis is not inevitable without intervention;
4. there must be a beneficial outcome from early diagnosis in terms of disease 
treatment;
5. there must be a screening test which has good sensitivity and specificity and a 
reasonable positive predictive value in the population to be screened.
There are some concerns about the use of these criteria to justify targeting some 
diseases and omitting others from the realm of preventive medicine. For example, a 
screening programme for a disease may be introduced because the technology is 
available to test for it rather than because it is ‘sufficiently serious’. Equally, ‘sufficiently 
serious’ is a subjective evaluation of a disease state which may be susceptible to the 
attitudes of the professionals implementing the technology rather than populations’ 
attitudes towards the disease (see Rose, 1992). It is beyond the remit of this thesis to 
explore these concerns in relation to the current diseases or abnormalities targeted 
within the context of prenatal testing. However, an issue particularly pertinent to the 
prenatal testing domain is that of ensuring that testing is associated with more benefits 
than costs. Undergoing testing in pregnancy is a voluntary behaviour of women who are 
essentially well. As previously described, the experience of undergoing prenatal 
diagnosis for Down’s syndrome is associated with increased psychological morbidity 
and a consequence of testing may be to miscarry a healthy pregnancy. Of the number 
of women that accept the offer of prenatal screening, about 5% (Haddow, 1996) are 
offered a diagnostic test. About 2-4% of those offered prenatal diagnosis receive a 
diagnosis of Down’s syndrome (Royal College of Obstetricians and Gynaecologists, 
1993; Piggott, Wilkinson and Bennett, 1994). Once Down’s syndrome has been 
identified there is no treatment to cure it. The ‘treatment’ offered to women at this stage 
is to terminate the pregnancy (therapeutic abortion). If women accept treatment, the 
current pregnancy is terminated and the birth of a baby with Down’s syndrome is 
prevented; if treatment is declined, women have gained information about the health 
status of their baby during the second trimester of pregnancy, so enabling them to 
prepare for the birth of a baby with Down's syndrome. Taking into account the affect 
associated with making the prenatal diagnosis decision, the increased risk of 
miscarrying a healthy pregnancy and the likelihood of having to terminate a current 
pregnancy, it appears that, at least in the short term, prenatal testing may engender 
more harm than good. In an attempt to minimise these iatrogenic consequences, the 
Royal College of Physicians (1989) developed the following guidelines for health
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professionals to consider when offering prenatal diagnosis. The objectives of prenatal 
diagnosis are:
• to allow the widest possible range of informed choice to women and couples at risk 
of having children with an abnormality;
• to provide reassurance and reduce the level of anxiety associated with 
reproduction;
• to allow couples at risk to embark on having a family knowing that they may avoid 
the birth of seriously affected children through selective abortion;
• ensure optimal treatment of affected infants through early diagnosis.
The same report makes it clear that at least from an ethical perspective, ensuring 
women make an informed choice to have or not have prenatal diagnosis is perhaps the 
most important objective for professionals to attain when offering prenatal diagnosis:
Prenatal diagnosis should be undertaken within the general principles of informed 
consent, including the possibility that after testing, the question of terminating the 
pregnancy may have to be faced. Women must therefore have the right to refuse 
testing, even at a fairly preliminary stage, and must understand the implications of 
their decision (Royal College of Physicians, 1989: section 8.5).
1.2 Informed decision making.
Informed decision making, or informed consent, is a well established concept within the 
applied medical decision making literature (Mazur, 1986; Royal College of Physicians, 
1989; Royal College of Obstetricians and Gynaecologists, 1993; Buchanen, 1995; 
Llewellyn-Thomas, 1995; Robinson, 1995; ASHG, 1996; Ubel and Loewenstein, 1997; 
Coulter, Entwhistle and Gilbert, 1999; Sugarman, McCroy, Powell, Krasny, Adams, Ball 
and Cassell, 1999). The following two components are usually referred to as necessary 
for informed decision making to occur (Emery, 1984; Mazur, 1986; RCP, 1989; 
Abramsky, 1994; Clark, 1994; Buchanen, 1995; Llewellyn-Thomas, 1995; Mueller and 
Young, 1995; O’Connor, 1995; ASHG, 1996; Ubel and Loewenstein, 1997). Firstly, it is 
the responsibility of the health professional to provide women with sufficient information 
to be able to make the decision. Sufficient information refers to all the facts a 
reasonable person would need to know to be able to make the decision. These facts 
should include information about the abnormalities being tested for, explanations of all 
the alternatives available and the risks and consequences associated with those 
alternatives. Secondly, informed decision making is concerned with the woman’s 
autonomy in making the decision. The information should be presented neutrally so that
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women may assimilate the information in accordance with their own values. The 
information consultation should be non-directive and the decision made without undue 
pressure from the health professional. However, it is the role of the health professional 
to facilitate the decision making process; to communicate the information in sympathy 
with the woman’s values.
Despite consensus on the above factors required for informed decision making, there 
are few agreed criteria on what constitutes an informed decision (Marteau, 1995). 
Consequently, assessing whether or not women make informed decisions about 
prenatal diagnosis is complicated by the apparent difficulty in operationalising the 
concept. The following section of the chapter explores a few of the psychological 
theories and areas of research that have aimed to explain individual’s decision making. 
One of the primary concerns of researchers within this area of psychology has been the 
issue of explaining and defining 'good’ decision making. Discussed in more detail later 
within this section are some of the ways to operationalise and assess good decision 
making.
1.2.1 Decision making theories.
1.2.1.1 Classical decision theory.
The theoretical basis for informed decisions is to be found within the social sciences. 
For over forty years, models of decision making under uncertainty have been developed 
by economists and psychologists. The most dominant model is that of (subjective) 
expected-utility (EU) (Edwards, 1954; Savage, 1954), sometimes referred to as 
classical decision theory (Beach and Lipshitz, 1993) or rational choice theory (Zey, 
1992, 1998). It is essentially a normative model of decision making, defining the 
characteristics that are necessary to make the most appropriate choice under 
uncertainty in an ‘ideal world’ (Bell, Raiffa, and Tversky, 1988; van der Pligt, 1998). 
Many texts describe the axioms and underlying principles of EU models in adequate 
detail (March, 1982; Eiser and van der Pligt, 1988; Yates, 1990; Baron, 1994; Garnham 
and Oakhill, 1994). For the purposes of this chapter, it is necessary to be aware of the 
assumptions of the models and how decision making is conceptualised. Some 
assumptions of EU theory are that the decision maker has volition over the decision 
making process, has access to complete information about the alternatives, has a 
stable ranking of preferences and will choose the ‘best’ alternative (Zey, 1992; Baron, 
1994; Crozier and Ranyard, 1997). The best alternative is calculated after the decision 
has been broken down into its components. The components include the perceived risk
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or probability of each consequence occurring and the decision maker’s utility or 
evaluation of how good or bad that consequence is perceived to be should it occur. An 
expected-utility figure is calculated by multiplying these two figures together in accord 
with a rational decision rule for each consequence of the decision (van der Pligt, 1998). 
The expected-utility figures of all the consequences pertaining to each action or 
alternative are added together. The correct choice is the alternative with the maximum 
expected-utility value. Essentially the EU model provides a framework for a decision to 
be made based on the relationship between the decision maker’s individual attitudes 
and evaluations of risk of the decision’ consequences.
1.2.1.2 Describing decision making.
EUT was developed from mathematical theorems and axioms that aimed to explain 
risky choice within decision contexts specific to game theories (Lopes, 1994; Crozier 
and Ranyard, 1997). The decision making described is that of a hypothetical decision 
maker, Economic Man (Beach and Lipshitz, 1993), who is able to assemble and 
evaluate all the available information about each alternative systematically and 
according to the laws of logic and probability. However, empirical evidence from 
researchers aiming to explain individuals’ actual decision making and problem solving 
established that EUT is not a descriptive theory of decision making (Simon, 1992). The 
research by Allais (1953), Simon (1955,1956), Eilsberg (1961) and Tversky (1969) 
illustrated that when making decisions involving risk, individuals violate both the axioms 
and assumptions of rational decision making as defined by EUT. Essentially, individuals 
do not have the mental capacity to assess the utilities and probabilities associated with 
the consequences of each alternative of a decision, to assimilate this information 
systematically and then to select the alternative with the greatest expected-utility. These 
cognitive limitations or 'bounded rationality’ (Simon, 1955) have implications for the 
information attended to, the judgements made about the information and the processing 
strategies employed to make the decision. Two of the observed techniques by which 
individuals reduce the cognitive load during risky decision making, heuristic methods 
(see Tversky and Kahneman, 1974, 1988) and satisficing strategies (Simon, 1955, 
1956), have implications for ensuring that individuals make informed decisions.
Heuristics are rules of thumb or principles (Tversky and Kahneman, 1974) that provide 
individuals with simpler judgements to assimilate when making a decision than the 
systematic evaluation of the probabilities and utilities of each attribute. Heuristics 
require less cognitive effort than the systematic evaluation of all the available
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information (Eagly and Chaiken, 1993). The individual tends to focus on aspects of the 
decision context rather than the decision content or information when using an heuristic 
method (Chaiken, 1980; Eagly and Chaiken, 1993). These heuristic rules are learnt 
from past experience or observation (Eagly and Chaiken, 1993) and can mediate an 
individual’s judgement during decision making. An example of an heuristic rule may be 
that ‘health professionals can be trusted with regard to health care issues’ (Eagly and 
Chaiken, 1993; Stroebe and Stroebe, 1995). A consequence of this rule may be the 
heavy weighting of information provided by a health professional during the decision 
making process, such as a personal aside like 'I had chorionic villus sampling’ or ‘most 
of my patients have amniocentesis’. This information may discourage a woman from 
surveying all the options available or may alter her perception of the risks involved. For 
some decisions the application of an heuristic to reach a decision is appropriate 
(Fischhoff, Slovic and Lichtenstein, 1980; Vlek, 1986; Eiser and van der Pligt, 1988; 
Baron, 1994; Ubel and Loewenstein, 1997). However, more ‘unsatisfactory’ decisions 
are likely to be derived from applying an heuristic rule than those made following 
systematic evaluations of the decision information (Tversky and Kahneman, 1974; 
Pious, 1993; Baron, 1994). Judgements influenced by the decision context rather than 
based upon the decision information are open to counter-arguments and are more likely 
to change (Eagly and Chaiken, 1993). For decisions that have serious negative 
consequences, an individual may experience greater post-decision regret or 
dissatisfaction when decisions are based on these labile judgements.
Decision making under uncertainty is one area where individuals are likely to employ a 
number of heuristics when making judgements about risks or probabilities (Tversky and 
Kahneman, 1974; Baron, 1994; Schwarzer, 1994; van der Pligt, 1994; Croyle, Sun and 
Hart, 1997). The concern is that the use of these heuristics may lead to biased 
judgements which, in turn, affect the quality of the decision made (Eiser and van der 
Pligt, 1988). There are a number of texts that adequately describe the heuristics and 
biases consistently employed by individuals when confronted with certain decision 
problems that lead to systematic errors in judgements and decision making (Tversky 
and Kahnemen, 1974; Tversky, 1978; Pious, 1993; Baron, 1994; van der Pligt, 1994; 
Croyle, Sun and Hart, 1997). Two examples are used to illustrate how aspects of the 
decision context may be associated with biases in women’s judgement of the risk 
information referred to during decision making about diagnostic testing.
The anchor and adjustment heuristic refers to the phenomenon that individuals make 
judgements about risk with reference to information from outside the decision domain
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(Tversky and Kahneman, 1974; Eiser and van der Pligt, 1988). To explain further, a 
woman’s perception of her triple test risk figure is likely to be influenced by her 
experience of fetal abnormality risks. For example, there are a number of risks a 
woman may refer to when evaluating her triple test result, such as her age-related risk 
of Down’s syndrome, the triple test screen positive cut-off point, a friend’s triple test 
result or a previous triple test result. If a woman’s age-related risk is greater than the 
triple test risk, she may perceive her triple test result to be a ‘low’ risk. However, if her 
triple test risk is greater than that of a friend’s, she may perceive the result to be ‘high’. 
Consequently, prior experience or information about risks of abnormality may be 
important in women’s judgement of their triple test risk figures and subsequent decisions 
to have or not have prenatal diagnosis.
Framing concerns the presentation of the decision information (see Baron, 1994; 
Kuhberger, 1997). Individuals make different judgements about the decision information 
depending on whether it is ‘framed’ negatively or positively (see Eiser and van der Pligt, 
1988; Pious, 1993; Kuhberger, 1997). For example, both of the following are 
explanations of the same triple test risk figure: there is a 1 in 100 chance that the baby 
has Down’s syndrome; there are 99 chances out of 100 that the baby is healthy. It is 
likely that a woman’s judgement of her risk figure would differ in response to the way 
the risk information was presented or framed.
The second finding of significance for the issue of informed decision making concerns 
the strategies employed by individuals to combine the decision information. One of the 
assumptions of EUT is that when individuals are making a decision they will be 
motivated to choose the ‘optimal’ choice, the alternative with the maximised expected- 
utility. Performing such a task is complex, requiring time and large cognitive effort 
(Janis and Mann, 1977). Considering individuals' cognitive limitations, it is unlikely that 
the decision maker has the resources available to weigh up systematically the 
advantages and disadvantages of each alternative. Simon (1955) suggested that 
individuals employ a less cognitively demanding strategy when evaluating alternatives, 
that of satisficing (see Simon, 1992; Janis and Mann, 1977; Garnham and Oakhill, 
1994). When satisificing, individuals are believed to have a criterion with which they 
compare the information about the decision alternatives. When the criterion is met, the 
alternative is selected. As this strategy compares alternatives on only one dimension 
and screens out the other attributes it is cognitively less demanding than the proposed 
combining of components in EUT (Eiser and van der Pligt, 1988; Garnham and Oakhill, 
1994). For example, if a woman’s goal is to know for certain whether or not her baby
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has Down's syndrome then a satisfactory alternative would be to choose to have a 
diagnostic test. As the 'no further testing’ alternative does not meet the ‘certainty’ 
criterion, information about this alternative is screened out of the decision making 
process. The empirical evidence suggests that individuals do employ non-optimising 
strategies when assimilating or ‘trading-off’ information to make decisions (see Baron 
,1994; Pious, 1993; Garnham and Oakhill, 1994). If women are screening out 
information about one of the alternatives in the diagnostic test decision, it is unlikely that 
they are making an informed decision to have or not have prenatal diagnosis.
In response to the descriptive evidence indicating that individuals do not make 
decisions in accord with EUT, research has progressed in three directions to explain 
decision making under uncertainty (Beach and Lipshitz, 1993; Neumann and Politser,
1994). Researchers in one area both accept the explanation for normative or ideal 
decision making provided by EUT and acknowledge that individuals’ behaviour deviates 
from the optimum choice. However, these researchers or ‘decision analysts’ aim to 
bridge the gap between the actual and optimum decision by changing the individuals’ 
behaviour following the application of a decision aid during decision making. A second 
area of research has developed following the rejection of EUT as an appropriate model 
from which to understand 'Psychological Woman’s’ decision making. The naturalistic 
decision making (NDM) researchers have developed a number of alternative models to 
understand and explain decision making by describing the processes individuals use 
when making ‘real-world’ decisions. A third area of research has focused on modifying 
the attributes and components of EUT, in light of the descriptive findings on individuals' 
decision making. Although these researchers want to retain the logic underlying the 
components of EUT they also want the theory to be more predictive of individuals’ 
behaviour. Each of these responses is discussed in more detail below.
1.2.1.3 Using decision aids to modify behaviour.
Researchers supporting EUT as the standard with which to evaluate the quality of 
decisions made under uncertainty acknowledge that individuals make biased 
judgements that lead to poor choices, i.e. decisions that deviate from alternatives with 
the maximum expected-utility (Neumann and Politser, 1994; Golub, 1997). However, as 
behaviour is modifiable, it is reasonable to suggest that individuals can be encouraged 
to make decisions in accord with EUT. Within the medical context, both decision and 
information aids have been used to provide clear information that enables the individual 
to understand the decision alternatives and problems (O’Connor, Llewellyn-Thomas and 
Drake, 1995). Decision aids differ from information aids by: emphasising the individual’s
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responsibility to choose between alternatives, by explicitly representing all the 
alternatives and their consequences, by alerting the individual to the risks or 
probabilities of the consequences, by eliciting the individual’s values associated with the 
consequences and by encouraging the individual to make a decision founded on this 
information (Homes-Rovner, 1995; O’Connor, Llewellyn-Thomas and Drake, 1995). In 
essence, the purpose of a decision aid, technique or support is to help the individual 
make a difficult or hard decision (von Winterfeldt and Edwards, 1986; Pitz, 1987; Eiser 
and van der Pligt, 1988; Homes-Rovner, 1995; O’Connor, Llewellyn-Thomas and Drake,
1995) rather than increase knowledge.
Decision analysis is the most established of the decision aids (Holmes-Rovner, 1995). It 
was developed to encourage individuals to make ‘better’ or more rational decisions (von 
Winterfeldt and Edwards, 1986; Clemen, 1990), i.e. decisions in accord with EUT (von 
Winterfeldt and Edwards, 1986; Jungermann and Schutz, 1992; Ubel and Loewenstein, 
1997). It is beyond the remit of this chapter to explain the steps involved in applying 
decision analysis to real world decisions in detail (see von Winterfeldt and Edwards, 
1986; Clemen, 1990; Baron, 1994; Golub, 1997; chapter 6). However, discussed briefly 
below are a number of aspects of the decision analytic technique that may enable 
individuals to employ more systematic processes and rely less on heuristic methods 
when making a decision, i.e. to facilitate good decision making.
Figure 1: Decision tree representation for the prenatal diagnosis decision.
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First, as few ‘real world’ decisions present themselves as well defined choices between 
a given set of alternatives (von Winterfeldt and Edwards, 1986; Baron, 1994; Golub,
1997), some effort is spent on structuring the decision problem. Usually a third party or 
‘decision analyst’ identifies a number of alternatives that may help the individual or 
'decision maker’ to make the decision (von Winterfeldt and Edwards, 1986; Pauker and 
Pauker, 1987; Golub, 1997). The decision problem is broken down into components: 
decisions or the choice between alternatives; consequences or uncertain events; 
objectives or goals of making the decision (von Winterfeldt and Edwards, 1986; Baron, 
1994; Golub, 1997). The association between these attributes is usually summarised 
visually by the construction of a decision tree. For decisions made under uncertainty, 
the likelihood or probability for each consequence occurring is recorded (Pauker and 
Pauker, 1987). An example of how the decision to have a prenatal diagnostic test may 
be structured and represented is illustrated in figure 1.
This structuring of the decision problem ought to encourage the individual to evaluate 
all the alternatives that may help solve the problem rather than to focus on just one 
alternative that initially appears to satisfy some pre-defined criteria. In addition, the 
visual representation of the decision problem is continuously present during the decision 
making process, so enabling the individual to rehearse an exhaustive set of scenarios 
for each possible action (von Winterfeldt and Edwards, 1986). It is likely that the 
cognitive effort required to evaluate the decision information is reduced by having this 
visual prompt.
Second, the decision analyst asks the individual to make judgements about the decision 
information, i.e. elicits utilities about the consequences of each alternative (Pauker and 
Pauker, 1987; Baron, 1994). The utilities are influenced in part by the individual’s 
judgement of the attractiveness or aversiveness of the consequence should it occur 
(Eiser and van der Pligt, 1988) and partly by their attitude towards the likelihood of the 
consequence occurring (von Winterfeldt and Edwards, 1986; Baron, 1994; Bromiley and 
Curley, 1994). The utility figures elicited are necessary for inclusion in the next stage of 
the decision analytic process: calculating the alternative with the greatest expected- 
utility.
The third stage is to calculate the expected-utility for each consequence node by 
multiplying the probability and utility values recorded on each arm of the decision tree. 
The expected-utility values associated with each alternative are added together. 
Selecting the alternative with the greatest expected-utility value is the correct or rational
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choice. It is likely that less cognitive effort is required to make a decision when the 
probabilities and elicited utilities of the decision problem are integrated explicitly, i.e. 
external to an individual’s information processing strategies (Pitz, 1986; Ubel and 
Loewenstein, 1997). Consequently, individuals should be able to evaluate the decision 
information more systematically. If individuals have not selected the option with the 
greatest expected-utility, they are encouraged to examine why their decision departed 
from the ideal decision. Such a process may lead to a re-evaluation of some of the 
decision attributes (Politser, 1981; Baron, 1994; Nease, 1996) and result in a decision 
more in accord with one theoretically derived from EUT.
Although there are several ways to evaluate utilities - including direct scaling, difference 
measurement, conjoint measurement and standard gambles (see Llewellyn-Thomas, 
Sutherlans, Tibshirani, Ciampi, Till and Boyd, 1982; Farquhar, 1984; von Winterfeldt 
and Edwards, 1986; Baron, 1994) - the most frequently used technique within the 
prenatal diagnosis context is that of the standard gamble (Pauker and Pauker, 1977; 
Pauker and Pauker, 1979; Pauker and Pauker, 1987; McNutt, 1989; Thornton, 1990a; 
Thornton, Lilford and Johnson, 1992; Baron, 1994). Individuals are asked to rank order 
the consequences of the decision from best to worse outcome (McNutt, 1989). Usually, 
the rank order of consequences for the prenatal diagnostic decision is: healthy child; 
spontaneous abortion; therapeutic abortion of affected fetus; therapeutic abortion of 
unaffected fetus; affected child (Pauker and Pauker, 1977; Pauker and Pauker, 1979; 
Pauker and Pauker, 1987). A continuous scale from 0 to 100 is used to provide a 
numerical value for the cost of the outcomes occurring. The gamble, reference lottery or 
hypothetical lottery is presented as follows: “If the probability of having a baby with 
Down's syndrome or without Down's syndrome is given as 50:50, would you (the 
woman) choose to carry on or terminate the pregnancy?” If the woman is able to make 
a choice between termination or continuing with the pregnancy, the gamble is varied 
until the woman is unable to answer the hypothetical question. For example, a woman 
may be unable to answer the question at a 25% chance of Down's syndrome and a 75% 
chance of the baby not having Down's syndrome; her level of indifference between the 
gamble and having prenatal diagnosis is 75%. The utility value associated with the 
prenatal diagnosis outcome elicited from this woman, then, is 0.75 on a scale from 0 to
1.0 (Pauker and Pauker, 1977; Pauker and Pauker, 1979; Pauker and Pauker, 1987; 
McNutt, 1989; Thornton, 1990b). Although a utility can be elicited for each 
consequence, Pauker and Pauker (1977) regard the cost or burden of a therapeutic 
abortion as the most important factor in women's decisions to have or not have prenatal
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diagnoses. It is this ‘therapeutic abortion utility' that is elicited during the prenatal 
diagnosis consultation.
The elicited utility value and the woman's probability of having a child with Down's 
syndrome are integrated with reference to a threshold probability (Pauker and Pauker,
1977, 1987; Thornton, 1990b). Pauker and Pauker (1977) used the equation for the 
threshold probability to create a threshold graph (see chapter 6). This graph provides 
the health professional with a visual prompt that is able to integrate the woman's utility 
of the therapeutic abortion (y axis) with her triple test risk figure (x axis). In brief, the 
point on the graph where the utility score and the probability figure meet either falls 
underneath or above the threshold line. The areas above or below the threshold line 
correspond to either the diagnostic test or to the no diagnostic test alternatives. In other 
words, a decision to have or not have prenatal diagnosis will be based on the woman's 
attitude towards prenatal diagnosis and her triple test risk figure.
Decision analysis has been applied to individuals’ decision making within a number of 
clinical settings, including the domain of prenatal diagnosis (Pauker and Pauker, 1977,
1978, 1987; McNutt, 1989; Thornton and Lilford, 1990; Heckerling, Verp and Hadro, 
1994; Morabia, Steinig-Stamm, Unger, Slosman, Schneider, Perrier and Junod, 1994; 
Verp and Heckerling, 1995). However, the findings of two recent systematic reviews on 
patient decision making (O’Connor, Llewellyn-Thomas and Drake, 1995; Bekker, 
Thornton, Airey M, Connelly, Hewison, Lilleyman, Macintosh, Maule, Michie, Pearman 
and Robinson, 1999) suggest that no studies have actually evaluated whether or not a 
consultation guided by the decision analytic technique is more likely to result in a 'better' 
or more rational decision than a decision made without assistance from a decision aid. It 
is equally feasible that, as individuals do not naturally make decisions in accord with 
EUT, encouraging them to do so may actually hinder the decision making process. 
Decision analysis, then, may be an inappropriate aid to facilitate decision making as it is 
based on EUT and aims to encourage accurate or rational decision making 
(Jungermann and Schutz, 1992; Beach and Lipshitz, 1993)5. The debate between 
proponents and critics of decision analysis needs to be addressed by the empirical 
investigation of decision quality following patient decision making, with or without the 
application of the decision analytic technique.
5 The theoretical criticisms and clinical concerns pertaining to the decision analytic technique are 
described in more detail in chapter 6.
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1.2.1.4 Naturalistic decision making (NDM) models.
As mentioned, classical decision theory was an untenable model for researchers 
interested in understanding how individuals make decisions and in describing the 
strategies and processes employed during decision making. Classical decision theory is 
concerned with only one aspect of the decision process, the decision event (Orasnu and 
Connolly, 1993). Its main focus is on ensuring that the predefined alternatives and 
consequences have been weighed up correctly, so achieving the optimum choice 
(Beach and Lipshitz, 1993). In 'real-world' settings, it is likely that information about the 
decision alternatives is unavailable, incomplete, irrelevant or too complex for rational 
decision making to occur. (Zey, 1992; 1998). Further, there are many different types of 
‘real-world’ decisions and few require such a detailed trade-off between the benefits and 
costs of the decision attributes (Beach and Lipshitz, 1993).
Researchers interested in describing individuals' decision making perceive classical 
decision theory to be inappropriate, not because individuals are irrational but because it 
fails to capture the complex and adaptive nature of human decision making (Cohen,
1993). It is argued that, as classical decision theory does not describe individuals’ 
decision making, it is an inappropriate standard with which to evaluate the quality of the 
decision made (Zey, 1992; Beach and Lipshitz, 1993; Cohen, 1993; Frisch and Clemen,
1994). A response of researchers to the limitations of classical decision theory has been 
to develop alternative models that describe the cognitive processes employed during 
decision making, i.e. naturalistic decision making (NDM) models. Although it is beyond 
the scope of this thesis to explore any one NDM theory in detail (see Klein, Orasanu, 
Calderwood and Zsambok, 1993; Crozier and Ranyard, 1997), two of the important 
contributions to understanding individuals’ decision making as a result of the NDM 
research are discussed.
First, new methodologies have been developed to access the data with which to inform 
the NDM models. The models are concerned with understanding the process of decision 
making, i.e. tracing the train of thought or reasoning that led to the final decision 
(Payne, 1980; Harte, Westenberg and van Someren, 1994; Harte and Koele, 1997). As 
cognitions cannot be measured directly, 'process tracing' techniques for observable 
phenomena have been developed. Data are extracted from either verbal protocols or 
information search methods (Payne, 1980, Carroll and Johnson, 1990; Baron, 1994; 
Harte and Koele, 1997). The verbal protocol technique requires the individual to 'think 
aloud’ while making a decision. Individuals are encouraged to verbalise whatever 
thoughts enter their heads and are discouraged from evaluating or introspecting about
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the thoughts (Payne, 1980; Carroll and Johnson, 1990; Crozier and Ranyard, 1997). 
The information search methods record the information searched or utilised by the 
individual when making the decision. There are a number of techniques to document 
the information searched by the individual: recording of eye movements; information or 
decision boards; computer programs; audio and video tape-recordings of inter-personal 
interactions (Payne, 1980; Carroll and Johnson, 1990; Crozier and Ranyard, 1997; 
Harte and Koele, 1997). Information search techniques require less input from the 
decision maker than verbal protocols. Although time-consuming, these methods are 
able to record the decision making process over time, concurrently with the decision 
being made.
Second, by describing the decision making process, researchers have a more 
comprehensive understanding of how individuals make decisions and the factors that 
impact on the decision making process and outcome. One of the most significant 
observations from the wealth of research in this area is the interaction between the 
decision context and the decision making process. The strategies6 and processes 
individuals employ when making decisions are a function of the demands of the 
decision and factors associated with the decision context, such as: how much expertise 
or decision-specific knowledge individuals have; their emotional state while making the 
decision; whether or not the decision is time-pressured; the seriousness and 
permanence of the consequences; the personal relevance of the decision 
consequences; the way the decision information is presented (see Klein, Orasanu, 
Calderwood and Zsambok, 1993; Lipshitz, 1993; Raynard, Crozier and Svenson, 1997). 
In addition, most NDM models suggest that individuals create mental images or schema 
of the decision which include information about the alternatives and consequences as 
well as their personal goals and preferences (Klein, Orasanu, Calderwood and 
Zsambok, 1993). The use of schema implies that decision making is a more dynamic 
process than selecting the best choice from given alternatives, as strategies and 
alternatives are appraised with reference to the schema and subsequently either 
rejected from or integrated into the decision image.
Although it is feasible that the strategy of maximising utility is employed to make some 
decisions (Ubel and Loewenstein, 1997), no single theory is able to understand and 
facilitate all the different types of real-world decisions (Lipshitz, 1993). NDM researchers 
argue that, by explaining how individuals actually make decisions and understanding 
why poor decisions occur, more appropriate aids and alternative standards can be
6 The cognitive strategies employed during decision making are discussed further in chapter 5.
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developed to facilitate and evaluate the quality of the decision made (Beach and 
Lipshitz, 1993). However, operationalising a NDM model for a decision aid may be 
difficult as the decision context and process are interrelated (Klein and Woods, 1993); it 
is possible that each decision could require a different decision aid. As yet, there is little 
empirical evidence to suggest that a decision aid grounded in NDM theory facilitates the 
decision making process or leads to more informed decisions than either one structured 
using decision analysis or one that is unaided (O'Connor, Llewellyn-Thomas and Drake, 
1995; Bekker, Thornton, Airey M, Connelly, Hewison, Lilleyman, Macintosh, Maule, 
Michie, Pearman and Robinson, 1999).
1.2.1.5 ‘Synthesis’ models of decision making.
There are a number of psychological models that have modified EUT to account for the 
systematic variations in decision making as documented by empirical findings. Some 
examples are: prospect theory (Kahneman and Tversky, 1979); regret theory (Bell, 
1982; Loomes and Sugden, 1982); the health belief model (HBM) (Becker, 1974); the 
theory of planned behaviour (TPB) (Ajzen, 1985). These models retain the assumption 
that an individual's behaviour is consistent with the goals, expectations and values of 
the decision maker (van der Pligt, 1998). The models are also descriptive because they 
attempt to identify some of the psychological processes associated with individual’s 
decision making, such as perceptions of risks, attitudes, intentions, self efficacy, and 
perceptions of normative behaviours (see Conner and Norman, 1996). As these factors 
are implicit, measurement requires 'elicitation' using questionnaire scale methods. 
Several of the models have been applied within the area of health to understand and 
explain health decisions or behaviour. In addition, these models have been used to 
inform interventions with the purpose of changing behaviour (see Marteau, 1989; 
Stroebe and Stroebe, 1995; Conner and Norman, 1996). Although these 'synthesis' 
models are better able to describe the decision making process, they do not aim to 
explain or operationalise informed decision making. In essence, these models are 
concerned with predicting health behaviours and not providing a standard with which to 
evaluate the quality of the decision made.
1.2.2 Defining inform ed decision making (IDM).
One goal common to each of the research areas discussed is to facilitate good' 
decision making. Unfortunately there are no established, objective criteria with which to 
evaluate the quality of a decision (Vleck, 1987; Pitz, 1987; Llewellyn-Thomas, 1995; 
Broadstock and Michie, in press). The quality of a decision may be evaluated along the 
following dimensions: behavioural measures such as whether or not an alternative was
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selected or length of decision making; cognitive measures such as knowledge, 
perceived risks, perceived benefits, accuracy of decision making and informed decision 
making; affective measures such as anxiety, satisfaction or decisional conflict 
(O’Connor, 1994; Llewellyn-Thomas, 1995). Selecting a measure to evaluate the 
decision quality depends largely on the theoretical perspective of the researcher rather 
than on an objective standard of good decision making (Llewellyn-Thomas, 1995).
The standard with which to evaluate the quality of the decision within the prenatal and 
genetic testing context is to ensure that individuals make informed choices (Royal 
College of Physicians, 1989; American Society of Human Genetics, 1996). As 
mentioned earlier, informed decision making has not been adequately operationalised 
within the applied setting (Marteau, 1995; Broadstock and Michie, in press). However, a 
standard of good or 'ideal' decision making has evolved from the research into theories 
of decision making, the components of which correspond with those criteria considered 
necessary for informed decision making to occur. The development of this standard is 
discussed in more detail below.
As mentioned, the criticisms of classical decision theory encouraged decision research 
to focus more on understanding the decision process than on the decision outcome 
(Baron, 1994). A good quality decision should be associated with a process of reasoned 
choice rather than with the selection of the rational alternative (Zey, 1992; 1998). 
Consequently, proponents of 'reasoned choice’ models (Zey, 1992; 1998) suggest that 
an appropriate standard to evaluate decision quality ought to be based on the process 
of decision making (Janis and Mann, 1977; Beach and Lipshitz, 1993; Frisch and 
Clemen, 1994). After reviewing the literature on determinants of high quality decision 
making, Janis and Mann (1977) selected seven criteria for the 'ideal' decision making 
procedure:
1. to thoroughly canvass a wide range of alternative courses of action;
2. to survey the full range of objectives to be fulfilled and of the values implicated by 
the choice;
3. to carefully weigh whatever he [sic] knows about the costs and risks of negative as 
well as the positive consequences that could flow from each alternative;
4. to intensively search for new information relevant to further evaluations of the 
alternatives;
5. to correctly assimilate and take account of any new information or expert judgement 
to which he [s/c] is exposed, even when the information or judgement does not 
support the course of action he [s/c] initially prefers;
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6. to re-examine the positive and negative consequences of all known alternatives, 
including those originally regarded as unacceptable, before making a final choice;
7. to make detailed provisions for implementing or executing the chosen course of 
action, with special attention to contingency plans that might be required if various 
known risks were to materialise.
More recently, criteria to evaluate the decision making process (Frisch and Clemen, 
1994) suggest that a good decision ought to be based on (a) the relevant consequences 
of the different options (consequentialism), (b) an accurate assessment of the world and 
consideration of all relevant consequences (thorough structuring) and (c) trade-offs of 
some kind (compensatory decision rule). This standard of good or reasoned decision 
making provides an adequate operationalisation of informed decision making. To 
explain further, evaluating whether or not an individual has made an informed decision 
requires evidence that (a) the final decision was founded on the consideration of the 
desirability and likelihood of the consequences of all alternatives, (b) the structure of the 
decision information encouraged a more accurate consideration of the relevant 
consequences and reduced the impact of biasing processes that may alter evaluations 
of likelihood and desirability and (c) the decision was made as a result of trade-offs 
between these factors. In other words, an assessment of informed decision making 
requires a description of the process employed by the decision maker when reaching 
the decision.
1.3 Prenatal diagnosis and informed decision making.
The final section of this chapter summarises the empirical findings from research into 
women’s prenatal diagnosis test decisions. The results are discussed with reference to 
the two factors considered necessary for informed decision making to occur: the 
provision of sufficient information by health professionals; the utilisation of consultation 
information by women to make a decision in accordance with their values.
1.3.1 The provis ion o f suffic ien t inform ation: em pirical evidence.
Over the last twenty years, most of the research into prenatal diagnosis information 
giving has been within the context of genetic testing, counselling and decision making 
(Pauker and Pauker, 1978; Kessler, 1981; Lippman, 1991; Verjaal, Leschot and 
Treffers, 1982; Royal College of Physicians, 1989; Donnai, 1992; Harper, 1992; Clarke, 
1994; British Medical Association, 1998). The genetic counselling information provision 
literature falls into three areas: the principles of genetic counselling and the type of 
information to be included within the ideal consultation (Emmery, 1984; Royal College
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of Physicians, 1989; Harper, 1992; Clarke, 1994; British Medical Association, 1998); 
self-reports by genetic counsellors of the information they offer (Czeizel, Metneki and 
Osztovics, 1981; Verjaal, Leschot and Treffers, 1982; Wertz, Sorenson and Heeren, 
1988; Rapp, 1989; Burke and Kolker, 1994); the impact of genetic counselling on 
women’s reproductive decision making, perceptions of risk, attitudes and knowledge 
(Evers-Kiebooms and van den Berghe, 1979; Lippman-Hand and Fraser, 1979; Lubs, 
1979; Swerts, 1987; Somer, Mustonen and Norio, 1988; Lippman, 1991; D Amico, 
Jacopini, Vivona and Frontali, 1992; Frets, Duivenvoorden, Verhage and Niermeijer, 
1992). Despite this breadth of research, few, if any, studies have described the 
information provided during the genetic counselling consultations (Kessler, 1992; 
Marteau, Plenicar and Kidd, 1993). In consequence, whether or not the information 
provided within the genetic counselling context was sufficient to enable individuals to 
make an informed decision remains an empirical question.
Although the majority of research into prenatal diagnosis information giving has taken 
place in the domain of genetic counselling, women deciding to have or not have a 
diagnostic test following a screen positive triple test result do so in the context of 
‘routine’ prenatal care. There is a paucity of research describing and evaluating the 
provision of information within this health care setting. However, it is likely that the 
provision of prenatal diagnosis information will vary between this health care setting and 
that of the genetic counselling clinic, for at least two reasons. First, non-directive 
information giving about genetic diseases and risk figures is a necessary skill acquired 
by genetic counsellors during their professional training (Emmery, 1984; Rapp, 1988; 
Wertz and Fletcher, 1988; Clarke, 1994; Marteau, Drake and Bobrow, 1994; British 
Medical Association, 1998). Obstetricians and midwives do not receive the same 
education as genetic counsellors with regard to the communication of risk, explanation 
of genetic and chromosomal diseases, evaluation of reproductive alternatives and 
ethical principles of non-directive consultations. Empirical evidence does suggest that 
knowledge of genetic disorders, attitudes towards testing, termination and prenatal 
diagnosis, confidence in discussing these new technologies and directiveness of 
information giving does differ by medical discipline (Rapp, 1988; Firth and Lindenbaum, 
1992; Green, 1994; Khalid, Price and Barrow, 1994; Marteau, Drake and Bobrow, 1994; 
Smith, Slack, Shaw and Marteau, 1994; Bernhardt, Geller, Doksum, Larson, Roter and 
Holtzman, 1998). Second, a woman receiving a screen positive triple test result for 
Down’s syndrome requires different result-related information than a woman who has 
received a positive carrier test result. To explain further, a screen positive triple test 
result usually occurs within the context of a 'normal', low risk pregnancy. The test result
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is a ‘one-off with few implications for subsequent pregnancies and relatives. In contrast, 
the result of a screen positive carrier test has life-long implications for an individual, 
each pregnancy and the carrier’s relatives. For the purposes of this thesis, the following 
discussion focuses on describing the information considered necessary to ensure 
informed prenatal diagnosis decision making upon receipt of a screen positive triple test 
result and summarises the empirical research carried out to evaluate the quality of this 
information.
There is no one definitive set of guidelines describing the information considered 
sufficient for women to make an informed decision about prenatal diagnosis following 
receipt of a screen positive triple test result. In consequence, the literature on 
information provision for both serum screening (Royal College of Obstetricians and 
Gynaecologists, 1993; Kennard, Goodburn, Golightly and Piggott, 1995; Sheridan, 
Williams, Caine, Morgan, Mason and Mueller, 1997) and prenatal diagnosis and genetic 
testing (Emmery, 1984; Harper, 1992; Royal College of Physicians, 1989; Donnai, 1992; 
Kessler, 1992; Abramsky, 1994; Clarke, 1994; Marteau, Shaw and Slack, 1995; British 
Medical Association, 1998) was referred to when compiling the list of information to be 
discussed with women before they decide, to accept or decline the offer of prenatal 
diagnosis. The common themes extracted from this literature suggest that the 
consultation content should include the following information:
• a description of the cause, prognosis and prevalence of Down’s syndrome;
• an explanation of the triple test result with reference to the meaning of a screen 
positive, screen negative, 1 in 250 cut-off point, other abnormalities tested for, 
woman’s actual risk figure for having a baby with Down’s syndrome and the 
chances of receiving a screen positive in subsequent pregnancies;
• a discussion of the options to have or not have further diagnostic testing. 
Information about the subsequent procedures associated with each option (fetal 
anomaly scan, amniocentesis and chorionic villus sampling) should include details 
about the accuracy of a test, the likelihood of a test identifying an abnormality, the 
abnormalities identified, the associated risks, a description of the test procedure, the 
meaning of a positive and negative test result, confirmation about the method of 
receiving the results and timing of the test results;
• a discussion of the options available should women receive a positive diagnostic 
test result, i.e. the choice to terminate the pregnancy or continue with the 
pregnancy;
This information should be presented neutrally or non-directively to ensure the 
autonomy of the individual when making an informed decision about prenatal diagnosis
27
(Royal College of Physicians, 1989). That is to say, the health professional should be 
required to refrain from persuading a women to pursue a particular test alternative 
(Kessler, 1992). Directive information can be expressed both explicitly and indirectly. 
An example of an explicit directive statement is. ‘I think it would be best if you were to 
have chorionic villus sampling'. There are several more subtle ways for health 
professionals to be directive, such as spending more time talking about one alternative, 
making value judgements about the woman’s choice, expressing a preference for an 
alternative and implying that one alternative is the normative or more common choice 
(Kessler, 1992).
There is a paucity of research evaluating the provision of information by health 
professionals when offering prenatal diagnosis. Few, if any, studies have described the 
information given during a prenatal diagnosis consultation following receipt of a screen 
positive triple test result. However, the content of the information given during 
consultations with women at increased risk of having a baby with Down's syndrome 
because of raised maternal age has been described (Kessler, 1981; Marteau, Plenicar 
and Kidd, 1993; Bernhardt, Geller, Doksum, Larson, Roter and Holtzman, 1998). The 
findings from these studies suggest that although the risk of Down's syndrome and 
procedure related miscarriage of amniocentesis were consistently mentioned, issues 
pertaining to the condition of Down's syndrome and termination were discussed 
infrequently (Marteau, Plenicar and Kidd, 1993; Bernhardt, Geller, Doksum, Larson, 
Roter and Holtzman, 1998). In addition, consultations included misrepresentations of 
information or misinformation and an implicit assumption that 'at risk’ women should 
undergo prenatal testing (Marteau, Plenicar and Kidd, 1993; Bernhardt, Geller, Doksum, 
Larson, Roter and Holtzman, 1998). Further empirical evidence suggests that not all 
obstetricians and midwives have complete knowledge of prenatal testing (Smith, Slack, 
Shaw and Marteau, 1994) From these findings, it seems unlikely that all women have 
received sufficient information to make informed choices about the decision to have or 
not have prenatal diagnosis and it is likely that women’s decision making autonomy 
was, in part, compromised by the directiveness of some test information.
1.3.2 W om en’s utilisation o f consu lta tion  inform ation: em pirical evidence.
As mentioned, there is limited empirical research describing women’s prenatal diagnosis 
decision making following receipt of a screen positive triple test result. In consequence, 
the findings from studies assessing the decision to have prenatal diagnosis upon receipt 
of either a screen positive triple test result or because of raised maternal age were 
integrated. These two decision contexts were sufficiently similar as the women's choice
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was between a risk of miscarrying following prenatal diagnosis and the 'increased' risk 
of having a baby with Down's syndrome as a consequence of either age or biochemical 
screening. However, differences between the two groups of women have been 
observed for some variables. Unsurprisingly, the mean age of women was lower in the 
biochemical screening group and the reproductive history more varied in the raised 
maternal age group (Evans, Pryde, Evans and Johnson, 1993; Julian-Reynier, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994). In addition, women had 
lower anxiety scores when offered prenatal diagnosis as a consequence of raised 
maternal age (Beeson and Golbus, 1979). The relationship between maternal age and 
accepting or refusing prenatal diagnosis was unclear (Evans, Pryde, Evans and 
Johnson, 1993; Beekhuis, de Wolf, Mantingh and Heringa, 1994; Julian-Reynier, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994); one study suggested that 
the tendency to refuse a diagnostic test increased with age (Beekhuis, de Wolf, 
Mantingh and Heringa, 1994) whereas another implied that younger women were more 
likely to refuse testing (Julian-Reynier, Macquart-Moulin, Moatti, Aurran, Chabal and 
Ayme, 1994). There was no empirical evidence to suggest that women's decision 
making processes differed when choosing to have or not have prenatal diagnosis as a 
consequence of Down's syndrome screening test. In consequence, the following 
discussion includes empirical evidence from studies describing women’s diagnostic 
choices as a consequence of raised maternal age and upon receipt of a screen positive 
triple test result.
The prenatal diagnosis studies have investigated factors associated with women’s 
decisions to have: a diagnostic test or not (Lippman-Hand and Cohen, 1980; Bernhard 
and Bannerman, 1982; Verjaal, Leschot and Treffers, 1982; Swerts, 1987; Pauker and 
Pauker, 1987; French, Kurczynski, Weaver and Pituch, 1992; Beekhuis, de Wolf, 
Mantingh and Heringa, 1994; Julian-Reynier, MacQuart-Moulin, Aurran, Chabal and 
Ayme, 1994; Piggot, Wilkinson and Bennet, 1994; Halliday, Lumley and Watson, 1995; 
Jorgensen, 1995; Williamson, Harris, Church, Fiddler and Rhind, 1996; Kenen, Smith, 
Watkins and Zuber-Pittore, 1997); chorionic villus sampling or amniocentesis (Lippman, 
Perry, Mandel and Cartier, 1985; McGovern, Goldberg and Desnick, 1986; Sjogren and 
Uddenberg, 1988; Evans, Bottoms, Critchfield, Greb and Laferla, 1990; Evans, Pryde, 
Evans and Johnson, 1993; Burke and Kolker, 1993; Kolker and Burke, 1993; 
Heckerling, Verp and Hadro, 1994; Halliday, Lumley and Watson, 1995); amniocentesis 
only (Farrant, 1985; Nielsen, 1991); no diagnostic test (Volodkevich and Huether, 1981). 
As the main findings from these studies have been outlined in numerous texts (Green, 
1990, 1994; Marteau and Slack, 1992; Marteau, 1995; Green and Statham, 1996;
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Hewison, 1996; Shilou, 1996), the subsequent discussion focuses on how these 
empirical findings can inform the following: a description of how women make the 
decision to have prenatal diagnosis; the adequacy of the methodologies employed to 
assess informed decision making; the conclusions that may be drawn about women’s 
informed decision making.
1.3.2.1 Describing women’s decision making processes: empirical evidence.
Although none of the published studies have described the decision making process 
concurrently with women making the decision (Marteau, 1995), the findings do provide 
an idea of the factors considered by women when making prenatal diagnosis decisions. 
As the decision making models suggest (see Marteau, 1989; Baron, 1994; Shafir, 
Simonson and Tversky, 1994; Conner and Norman, 1996), women do appear to make 
decisions by weighing up the advantages and disadvantages of the alternatives 
available. Reasons given by women for choosing to have no diagnostic test were: not 
being offered the tests; negative attitudes towards termination of pregnancy; low 
perception of risk of having a child with an abnormality; high perception of the 
procedure-related risk of miscarriage; low perceived benefit of diagnosis (Volodkevich 
and Huether, 1981; Verjaal, Leschot and Treffers, 1982; French, Kurczynski, Weaver 
and Pituch, 1992; Julian-Reynier, MacQuart-Moulin, Aurran, Chabal and Ayme, 1994). 
Reasons given by women for deciding to have a diagnostic test were: high perceived 
risk of having a child with an abnormality; positive attitudes to diagnosis and termination 
of pregnancy; relief of anxiety or uncertainty; experience of an acquaintance with an 
abnormality; reassurance of a negative result (Nielson, 1982; Verjaal, Leschot and 
Treffers, 1982; Farrant, 1985; McGovern, Goldberg and Desnick, 1986; Swerts, 1987; 
Sjogren and Uddenberg, 1988; French, Kurczynski, Weaver and Pituch, 1992; Julian- 
Reynier, MacQuart-Moulin, Aurran, Chabal and Ayme, 1994; Jorgensen, 1995). 
Reasons for choosing amniocentesis over chorionic villus sampling were: lower risk of 
test-related miscarriage; less risk of fetal damage; confidence in physicians test-related 
skills (Lippman, Perry, Mandel and Cartier, 1985; McGovern, Goldberg and Desnick, 
1986; Heckerling, Verp and Hadrow, 1994). Reasons for the choice of chorionic villus 
sampling over amniocentesis were: quicker notification of results so reducing period of 
uncertainty; earlier diagnosis resulting in first trimester terminations (Lippman, Perry, 
Mandel and Cartier, 1985; Burke and Kolker, 1993; Evans, Pryde, Evans and Johnson, 
1993; McGovern, Goldberg and Desnick, 1986; Heckerling, Verp and Hadrow, 1994).
The empirical evidence from these studies suggested that other factors external to 
women's cognitive processes were also associated with women’s prenatal diagnosis
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decisions. First, some studies observed demographic variations in women choosing 
whether to have or not have a diagnostic test (Nielsen, 1982; Beekhuis, de Wolf, 
Mantingh and Heringa, 1994; Halliday, Lumley and Watson, 1995) and those choosing 
between chorionic villus sampling or amniocentesis (Evans, Bottoms, Critchfield, Greb 
and Laferla, 1990; Kolker and Burke, 1993; Heckeriing, Verp and Hadrow, 1994; 
Halliday, Lumley and Watson, 1995). These variations in decision making by 
demographic characteristics may be better understood by explaining the psychological 
pathways that mediate the relationship (Rutter and Quine, 1994, 1996). Although most 
of these studies described the demographic variations by test decision, they did not 
adequately operationalise models of decision making to further knowledge of the 
psychological processes that may mediate the observed association. The findings 
suggest that women choosing to have no further diagnostic testing tended to have had 
more children and were older than women having the diagnostic tests; women choosing 
to have chorionic villus sampling rather than amniocentesis tended to be better 
educated, older, have a lower parity and a fewer number of miscarriages. This pattern 
of demographic differences by test decision was not observed across all studies 
(Sjogren and Uddenberg, 1988; Heckerling, Verp and Hadrow, 1995). It is unclear from 
these studies how the demographic variables and reproductive experiences of women 
were associated with women’s decision making strategies and subsequent decisions.
Second, in some studies describing women’s decisions to have prenatal diagnosis, 
women felt obliged to have a test (Farrant, 1985; Sjogren and Uddenberg, 1988; 
Santalahti, Hemminki, Latikka and Ryynanen, 1998). In other words, women who had 
prenatal diagnosis perceived the social or health professional norm to be in favour of 
testing. From the research to date it is unclear whether this finding implies that health 
professionals encourage women towards the prenatal diagnosis option or that women 
having prenatal diagnosis perceive the test information differently from those who 
choose to have no diagnostic test. It is likely that women's uptake of prenatal diagnosis 
is partly influenced by the health professional, as associations have been found 
between characteristics of obstetricians and referral patterns for amniocentesis 
(Lippman-Hand and Cohen, 1980; Bernhardt and Bannerman, 1982; Heckerling, Verp 
and Hadrow, 1994; Verp and Heckerling, 1995). However, the strength of this 
association has not been established for women’s uptake of prenatal diagnosis following 
triple test screening within the UK. In addition, women's perceived directiveness of the 
prenatal diagnosis information provided by health professionals has not been 
adequately addressed in studies to date. It remains an empirical question as to whether
31
or not women perceive information provided about prenatal diagnosis as directive and 
what factors may be associated with this perception.
An associated research question concerns the relationship between women's perceived 
directiveness of prenatal diagnosis information and the observed directiveness of the 
information provided. Few, if any, studies have compared measures of the information’s 
directiveness with women's perception of directiveness. As mentioned (section 1.1), 
guidelines suggest that health professionals provide non-directive information to 
encourage women’s autonomy to make the decision (Royal College of Physicians, 
1989; Harper, 1992; Clarke, 1994; Kessler, 1992). However, there is a line of argument 
to suggest that women may prefer the health professional to be directive (Czeizel, 
Metneki and Osztovics, 1981; Savage and Armstrong, 1990). Although few studies 
within the prenatal diagnosis context have adequately addressed this empirical 
question, the issue of preference for information and decision making has been 
investigated in other health contexts (Ende, Kazis, Ash and Moskowitz, 1989; Llewellyn- 
Thomas, McGreal, Thiel, Fine and Erlichman, 1991; Borgers, Mullen, Rijken, Eussen, 
Plagge, Visser and Blijham, 1993; Verheggen, Jonkers and Kok, 1996; Thompson, Pitts 
and Schwankovsky, 1993; Avis, 1994; Fallowfield, Hall, Maguire, Baum and A’Hern, 
1994; Silverman and Altman, 1996). In brief, the findings suggest that most patients 
want to be informed about subsequent treatment but vary in their preferences for taking 
the responsibility for the treatment choice (Ende, Kazis, Ash and Moskowitz, 1989; 
Thompson, Pitts and Schwankovsky, 1993; Fallowfield, Hall, Maguire, Baum and 
A’Hern, 1994). This preference for decision making autonomy was lower in more severe 
illness and higher in decisions requiring less medical knowledge. In other words, 
patients have preferences about making treatment decisions but not regarding the 
receipt of information. It seems reasonable to assume, therefore, that women would 
want complete information about prenatal diagnosis but may differ in their preferences 
for making the testing choice.
1.3.2.2 Assessing informed decision making: empirical evidence.
This section describes the most frequently employed measures reported in these 
studies of women’s prenatal diagnosis decision making. A number of methodological 
issues are discussed that suggest that informed decision making has not been 
adequately assessed within the published empirical research to date.
• All studies employed questionnaire or interview techniques to assess women's 
cognitions and characteristics either before or after the prenatal diagnosis decision. 
Although some studies evaluated these cognitions more than once (Verjaal, Leschot
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and Treffers, 1982; Swerts, 1987; Sjogren and Uddenberg, 1988), no studies 
described women's utilisation of information during the prenatal diagnosis 
consultation. As no studies have described the decision making process it is unlikely 
that informed decision making has been evaluated.
• The majority of designs evaluated women’s cognitions retrospectively, i.e. after the 
prenatal diagnosis decision had been made (Volodkevich and Huether, 1981; 
Nielsen, 1982; Farrant, 1985; Burke and Kolker, 1993; Julian-Reynier, MacQuart- 
Moulin, Moatti, Aurran, Chabal and Ayme, 1994; Jorgensen, 1995). Studies 
assessing memory for medical information (see Ley, 1988) suggest that it is unlikely 
that women were able to remember all the factors important to the decision in 
retrospect (Carroll and Johnson, 1990). Further, it is uncertain whether the reasons 
provided and recorded to support a decision made a week, a month, or a year 
earlier were the same as the reasons alluded to during the decision making period 
(Nisbett and Wilson, 1977; Yates, 1990). There is a body of evidence documenting 
the association between the performance of an action and subsequent changes to 
attitudes, such that the individual's attitudes become congruent with the behaviour 
(Eagly and Chaiken, 1993). This process of reason re-alignment is founded on the 
concept of cognitive dissonance (Festinger, 1957) and suggests that post-hoc 
evaluations of the decision are unlikely to be comprehensive representations of the 
decision making process and, therefore, of informed decision making.
• Only a small proportion of the studies evaluated the psychological processes 
associated with the decision to have or not have prenatal diagnosis (Verjaal, 
Leschot and Treffors, 1982; Swerts, 1986; French, Kurczynski, Weaver and Pituch, 
1992; Beekhuis, de Wolf, Mantingh and Heringa, 1994; Julian-Reynier, MacQuart- 
Moulin, Moatti, Aurran, Chabal and Ayme, 1994; Jorgensen, 1995). As mentioned, 
most studies investigated factors associated with only one prenatal diagnosis 
alternative, either the decision to have a diagnostic test or the choice of having no 
further testing. A prerequisite of informed decision making is the evaluation of the 
consequences associated with both testing alternatives. As a significant proportion 
of the studies did not assess the decision to have or not have prenatal diagnosis, it 
is unlikely that researchers described all the attributes associated with the informed 
decision making processes.
• The measures referred to within studies were not designed to assess informed 
decision making. Most studies reported the behaviour or test decision women made, 
i.e. the decision outcome. Some studies employed measures to assess the decision 
making process, such as perceptions of risk (Volodkevich and Huether, 1981; 
McGovern et al, 1986; Swerts, 1986; Sjogren and Uddenberg, 1988; French,
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Kurczynski, Weaver and Pituch, 1992; Burke and Kolker, 1993; Kolker and Burke, 
1993; Heckerling, Verp and Hadrow, 1994; Julian-Reynier, MacQuart-Moulin, 
Moatti, Aurran, Chabal and Ayme, 1994), perceived benefits, attitudes, utilities and 
reasons (Volodkevich and Huether, 1981; Swerts, 1986; French, Kurczynski, 
Weaver and Pituch, 1992; Burke and Kolker, 1993; Heckerling, Verp and Hadrow, 
1994). Others reported women’s knowledge of the testing procedure, perceived 
autonomy in decision making and need for further information (Volodkevich and 
Huether, 1981; Nielson, 1982; Verjaal, Leschot and Treffors, 1982; Farrant, 1985; 
Swerts, 1986; French, Kurczynski, Weaver and Pituch, 1992). No studies within the 
prenatal diagnosis context have yet reported a process tracing technique or 
measure that assesses informed decision making (Marteau, 1995). In consequence, 
the exact relationship between the current measures of the decision making process 
and that outcome with assessments of informed decision making remains unclear.
1.3.2.3 Women’s informed decision making: empirical evidence.
From the previous discussion of research to date, it is clear that no studies have 
assessed women’s informed decision making in the context of prenatal diagnosis. That 
is to say, there is no published empirical evidence that women utilised the consultation 
information and integrated this with their values about prenatal diagnosis before making 
a decision. However, some studies aimed to describe the quality of women’s prenatal 
diagnosis decision making by assessing the accuracy of the decision, women’s 
knowledge of testing and the degree of autonomy in decision making. The evidence 
suggests that more women made prenatal diagnosis decisions in accord with EUT or 
‘accurately’ than did not (Pauker and Pauker, 1986; Heckerling, Verp and Hadrow, 
1994), that women’s knowledge of prenatal diagnostic tests was found to be varied and 
often incomplete (Volodkevich and Huether, 1981; Farrant, 1985; Swerts, 1986; French, 
Kurczynski, Weaver and Pituch, 1992) and that the final decision to have or not have 
testing was influenced or made by the health professional (Verjaal, Leschot and 
Treffers, 1982; Julian-Reynier, MacQuart-Moulin, Moatti, Aurran, Chabal and Ayme,
1994). Whether or not these findings imply that women’s prenatal diagnosis decisions 
were informed or not is unclear. Certainly, women’s final decisions appear to be based 
on evaluations of test specific information but their knowledge of testing was incomplete 
and the decision was partly influenced by the health professional’s opinion. It was 
unlikely, therefore, that all women made fully informed decisions to have or not have 
prenatal diagnosis.
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1.4 Chapter summary.
One objective for health professionals offering prenatal diagnosis is to ensure that 
women make an informed decision about testing (Royal College of Physicians, 1989). 
This chapter has discussed the issues pertaining to informed decision making in the 
context of women choosing to have or not have prenatal diagnosis upon receipt of a 
screen positive triple test result. Both psychological theory and medical guidelines on 
informed decision making were referred to in order to provide a working definition of 
informed decision making. Briefly, an informed decision is one where the final decision 
was based on an accurate evaluation of the advantages and disadvantages of the 
consequences of all the alternatives and that the decision was associated with a trade­
off between these factors (section 1.2). Two conditions are considered necessary to 
enable women to make an informed decision: the provision of sufficient information by 
health professionals for women to assimilate; the provision of non-directive information 
to encourage women’s autonomy in making the decision. The theoretical review 
summarising the empirical evidence of women’s prenatal diagnostic decision making 
indicated that few, if any, studies had defined and operationalised informed decision 
making, had described the information provided by health professionals, had assessed 
the information utilised by women when making the decision to have or not have testing 
or had evaluated factors associated with the facilitation of informed decision making. It 
remains an empirical question, therefore, as to whether or not women make an 
informed decision about prenatal diagnosis.
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2. Facilitating informed patient decision making: an 
integrative review.
The purpose of the preceding theoretical review (see chapter 1) was to provide an 
overview of the main issues involved in describing, assessing and facilitating informed 
decision making within the context of prenatal diagnosis. A theoretical review is most 
frequently used to assimilate empirical evidence with theoretical assertions to inform 
subsequent research questions and provide the rationale for further investigation 
(Cooper, 1989). Theoretical reviews do not aim to be inclusive summaries of all the 
available findings; the empirical evidence is utilised selectively to support, counter and 
develop theories about the phenomenon under investigation. As a consequence, 
theoretical reviews focus only on prior research that is of direct relevance to the new 
study’s research agenda (Cooper, 1989).
This chapter contains a description of the methods, results and conclusions derived 
from an integrative review (Cooper, 1989) of studies carried out to assess the facilitation 
of informed patient decision making (Bekker, Thornton, Airey, Connelly, Hewison, 
Lilleyman, Macintosh, Maule, Michie, Pearman and Robinson, 1999). The purpose of an 
integrative, research or systematic review is to efficiently summarise a large amount of 
empirical evidence from many separate studies that are believed to address a similar 
research question (Cooper, 1989). An integrative review aims to include the findings 
from all empirically based studies fulfilling a given set of criteria to provide a 
comprehensive knowledge base of the quantity and quality of research addressing a 
particular research question (Cooper, 1989; Mulrow, 1995). The information contained 
within each study in an integrative review is approached and integrated more 
systematically than findings are utilised in a theoretical review. In essence, each study 
within an integrative review is the equivalent of the participant in primary, empirical 
research. To explain further, the information documented in an article1 provides the 
data by case for a review; the cognitions of the participant are the data by case for a 
primary empirical study. Both cognitions and article information are extracted from the 
data source following the application of a questionnaire or review coding sheet. The 
questionnaire or review coding sheet is informed by the operationalisation of a research 
agenda. As each participant answers all the items within a questionnaire, so all items 
within the coding sheet are completed by the researcher utilising the information
1 An article may contain more than one empirical study. However, for congruity in this text it is 
assumed that an article describes only one empirical study.
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contained within each article. The extracted data from both sources can be synthesised 
following the application of either qualitative or quantitative statistical methods (Cooper, 
1989; Clarke and Stewart, 1995; Eysenck, 1995).
This chapter describes in more detail the rationale for, and findings from, one of the 
systematic reviews referred to in the preceding chapter, Informed decision making: an 
annotated bibliography and systematic review (Bekker, Thornton, Airey, Connelly, 
Hewison, Lilleyman, Macintosh, Maule, Michie, Pearman and Robinson, 1999). This 
review provided evidence to support the following assertions: no published studies have 
empirically evaluated interventions aimed at facilitating informed decision making within 
the prenatal diagnosis context (section 1.3.2); despite the rhetoric of informed consent 
and decision making, there is a dearth of research assessing techniques to facilitate 
informed decision making by patients within most health care areas (section 1.2.1.3). 
The aim of the informed patient decision making (IPDM) review, carried out by the 
author of this thesis and colleagues, was to provide a comprehensive bibliography of 
empirical research of interventions that might have an effect on informed health care 
decision making by patients. The IPDM review was commissioned and, after peer 
review, published by the UK Health Technology Assessment (HTA) National Health 
Service Research and Development (NHS R&D) programme. The executive summary 
of the review’s report appears in Appendix I.
The paucity of studies explicitly evaluating interventions aimed at the facilitation of 
informed patient decision making resulted in the IPDM review being qualitative or 
‘illustrative’ rather than quantitative (Cooper, 1989). The information systematically 
extracted from each article provided a summary of the types of interventions, 
measures, theories, decisions, study designs and health areas researched rather than 
concise conclusions based on the results of meta-analyses. Primarily, this review is a 
resource, a bibliography of articles to refer to when embarking on empirical research 
aimed at the explanation and/or facilitation of informed patient decision making. It is 
unlikely that any one research question or agenda would demand reference to all the 
categories of all the articles classified in the final IPDM review. For example, the 
categories in the IPDM review pertinent to this thesis are those that classify article 
information according to the use of decision aids within the intervention and prenatal 
testing as the context of health care. The main focus of this chapter is to synthesise the 
findings from those IPDM review articles of pertinence to this thesis. The findings will be 
integrated and reported in a manner consistent with the presentation of results in the 
published IPDM report (Bekker et al, 1999).
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The structure of the remainder of this chapter begins with a description of the theoretical 
issues that informed the IPDM review's research questions and coding sheet (section 
2.1). Section 2.2 describes the methodology of the IPDM review: the criteria for 
inclusion of articles; the development of search strategies to identify articles that may 
be associated with the facilitation of informed patient decision making; the information 
categories developed to extract data systematically from articles. Section 2.3 outlines 
the IPDM review procedure for extracting information from those articles that fulfilled 
the IPDM review’s criteria. In addition, section 2.3 describes the procedure for the 
integration of findings from those IPDM review articles that were of pertinence to this 
thesis, i.e. interventions designed to facilitate informed decision making and/or 
interventions carried out in the context of prenatal testing. This chapter’s results section 
(section 2.4) focuses on describing and synthesising the findings of those articles 
selected from the IPDM review that were of pertinence to this thesis. The final section 
(section 2.5) discusses the findings from the further analysis of those articles selected 
from the IPDM review that were of pertinence to the thesis. Some general observations 
are made concerning the effectiveness of published empirical research to facilitate 
informed decision making.
2.1 IPDM systematic review: background.
The purpose of this IPDM review was to provide an integrated summary of information 
from intervention studies that may plausibly influence informed patient decision making 
(Bekker et al, 1999), so highlighting those areas that have been well- or under­
researched (Mulrow, 1995). Following numerous meetings, reference to the decision 
making literature (see chapter one) and utilisation of the IPDM review members’ 
expertise2, several categories of information were identified as useful in understanding 
and facilitating informed patient decision making: factors associated with a patient’s 
ability to make informed decisions; ways of measuring or assessing informed decision 
making; the theoretical framework or model of the primary research; the study quality; a 
summary of the empirical findings. These pre-defined categories were used to guide the 
identification of appropriate articles, inform the structure of the review coding sheet and 
classify information extracted from published empirical research. The operationalisation 
of these categories should enable the systematic extraction and integration of
2 The IPDM steering group included a multi-disciplinary team of senior researchers with expertise 
in decision making and health services research. I was employed on the review to integrate these 
different perspectives and operationalise the ideas formulated in meetings by defining the 
inclusion criteria of articles, developing the coding frame, extracting article information, inputting 
the data, analysing results and co-writing the final report (see acknowledgements).
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information from published empirical research. The pre-defined categories were not 
designed to identify an exhaustive list of factors associated with informed decision 
making. However, the data provided by this process should be sufficient for a review of 
interventions associated with the facilitation of informed patient decision making. A 
more detailed explanation of the type of information contained within these categories is 
described below.
2.1.1 Factors associated with informed decision making: IPDM review.
Prior evidence suggested that a number of factors might be associated with a patient's 
ability to make an informed decision, those pertaining to the decision context, the 
decision maker, and other influences (see Yates, 1990; Baron, 1994; Ranyard, Crozier 
and Svenson, 1997; chapter 1). Systematically extracting information about these 
factors from each study might be useful in subsequent explainations of the 
effectiveness of interventions to facilitate informed patient decision making.
The following features of the health decision context might be associated with the 
likelihood of patients making more or less informed decisions:
• type of health decision. For example, it is likely that the following decisions differ 
in the degree of motivation and responsibility required to carry out the action: 
smoking or drinking alcohol; attending a health-care appointment; adhering to 
medication; having a diagnostic test; participating in choice of treatment and so on;
• seriousness of the outcome. For example, choosing whether or not to take a 
headache pill has less serious consequences than deciding to donate an organ;
• familiarity with the decision. For example, deciding to exercise or not is more 
commonly experienced by most individuals than choosing to have or not have a 
genetic test;
• level of certainty. For example, the consequences of declining insulin always 
makes diabetics ill whereas declining prenatal screening only carries a risk of 
having a Down’s syndrome child;
• health domain. For example, differences in the decision context, such as the type 
of medical speciality - medicine, surgery or primary care;
• recipient. For example, an individual making a decision that affects the individual’s 
health may require different decision making strategies compared with an individual 
making a decision for a third party such as a child.
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Factors pertaining to the individual that might be associated with the likelihood of 
making an informed decision are: preferences for information; preferences for 
involvement in the decision making process; beliefs about and attitudes towards health 
professionals, health and illness (see chapter 1; Bekker et al, 1999). In other words, 
whether or not a person utilises the information considered necessary to be able to 
make an informed decision depends in part on their motivation to engage in the 
decision making process and their beliefs about health, illness and the doctor-patient 
role.
Other influences that might be associated with the likelihood of a decision being 
informed are those that impact on strategies employed to process information and those 
that limit the availability of options from which to make the decision. Such factors as the 
presentation and quantity of information, an individual's mood state and time pressure 
might influence whether information was processed systematically or whether an 
heuristic was employed (see Ranyard, Crozier and Svenson, 1997; chapter one). On the 
other hand, legislation, provision of services and payment for services are factors that 
might limit the alternatives available for inclusion in some patient's decision making 
(Bekker et al, 1999).
2.1.2 Measures o f inform ed decision making: IPDM review.
Prior reviews suggested that the most frequently employed measures used to assess 
informed decision making were: behaviour; knowledge; utilities and attitudes; affect; 
satisfaction or regret (Llewellyn-Thomas, 1995; Marteau, 1995; Bekker et al, 1999; see 
chapter 1). In general, most of these measures evaluate the outcome of the decision 
made, whereas informed decision making requires some evaluation of the process of 
reaching the decision (see chapter 1). It is unclear how many studies have employed a 
process tracing technique to evaluate the information utilised during decision making. It 
therefore remains an empirical question as to how many studies have actually assessed 
informed decision making. Without adequate operationalisation or measurement, it is 
unlikely that studies have comprehensively investigated the facilitation of informed 
decision making. The limitations specific to each measure in providing an assessment 
of informed decision making are described in more detail below:
• recording a health behaviour indicates that a decision was made but no more than 
this;
• knowledge assesses the individual’s ability to recall information provided by the 
health professional, not the information utilised when making a decision The
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relationship, if any, between measures of knowledge and informed decision making 
has yet to be established;
• utilities assess an individual’s values or attitudes towards the choices available. 
These measures evaluate an attribute that may be used during the decision making 
process. As an informed decision is made following the integration of an individual’s 
attitudes with the knowledge of the consequences of the available alternatives (see 
chapter 1), it is likely that measures of utility assess some aspect of the decision 
making process. However, a measure of utility cannot evaluate whether or not that 
attitude or value was utilised in the decision making process or allude to other 
information referred to when making the decision;
• affect such as anxiety, satisfaction, regret and decisional conflict are measures of 
affect taken before and after decisions have been made. As discussed, there may 
be associations between increased affect and the likelihood of employing 
systematic information processing strategies. However, these are measures of 
outcome which may have some clinical significance but do not assess either the 
utilisation of information or integration of attitudes during the decision making 
process.
2.1.3 Models o f decision m aking: IPDM review.
A number of decision making models have been developed from both theory and 
empirical evidence to explain an individual’s behaviour (see chapter 1). Facilitating 
informed patient decision making depends, in part, on explaining how patients currently 
make decisions and how they can be assisted to make better decisions (Bekker et al, 
1999). These models have described several psychological processes associated with 
an individual’s health care decision making and factors that may hinder or facilitate 
informed decision making. It is argued that interventions aimed at changing or 
facilitating decision making are more likely to obtain their objectives if they have been 
informed by such theories of behaviour (Marteau, 1995). In addition, it is likely that 
studies operationalising a decision making model within the applied clinical setting 
provide a more comprehensive explanation of the intervention and associated (non-) 
significant effects with which to inform subsequent research and/or modify existing 
models. As yet, the extent to which decision making theories have been operationalised 
or used to inform studies within the context of patient health behaviour is unclear.
2.1.4 Application o f the IPDM review report.
As stated, the aim of the IPDM review was to provide a systematic integration of 
information from interventions that may plausibly inform patient health care decision
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making (Bekker et al, 1999). The authors of the IPDM review anticipated that the review 
would be utilised in one of two ways. First, researchers might refer to the review’s 
synthesis of findings to inform or address research questions raised with regard to 
informed decision making. The discussion of the IPDM review findings were structured 
with reference to five 'naive’ questions. These questions were considered by the IPDM 
review's authors to be representative of the type of issues with which informed decision 
making researchers may be concerned:
• Can decision making be facilitated?
• Do people who have more information make better decisions?
• Does the way in which information is presented change the effectiveness of the 
decision?
• Does the context affect decision-making?
• Does the effectiveness of information on decision making vary by medical setting? 
Second, that researchers might select articles from the bibliography for secondary or 
additional analysis to inform a more specific research agenda.
This chapter provides an example of how a selection of articles from the IPDM review 
has been analysed in more detail to inform a research agenda concerned with the 
facilitation of informed decision making in the context of prenatal testing. In particular, 
this secondary analysis focuses on the facilitation of informed decision making following 
the application of a decision aid to a health care decision. In consequence, articles were 
selected from the IPDM review’s bibliography either because they included information 
about decision making in the context of prenatal testing or they evaluated the 
effectiveness of a decision aid to facilitate patient decision making (see section 2.4).
2.2 IPDM systematic review: methodology.
2.2.1 Study inclusion criteria
The study criteria were developed over four months, during which over 300 abstracts 
downloaded from the pilot Medline and Psychlit search strategies were circulated to all 
project group members. At monthly meetings, each IPDM review member fed back the 
inclusion or exclusion status of each abstract. When members disagreed, a discussion 
took place until a set of working rules was developed. At the end of this development 
phase, agreement between members on the inclusion and exclusion criteria was good. 
Nevertheless, in this area there are no pre-defined or obvious boundaries to be used for 
selection criteria and some of the 'cut off’ categories may appear arbitrary. For 
inclusion, each study published within an article had to fulfil the following criteria:
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• Study participants must be patients. A patient was defined as any individual making 
a health decision. Studies using university student participants were excluded. 
Studies assessing health professional decision making about another individual's 
care were excluded.
• A study must report a behavioural measure of the health decision made. This 
measure of reported or observed behaviour assesses decision making, a more 
inclusive category than informed decision making. The health behaviour outcome 
may include actual, intended or hypothetical decisions. This broad health behaviour 
outcome measure incorporates many decisions, including: smoking or not; 
adherence to medication; attendance for screening; choices between treatments 
like chemotherapy or surgery. Studies were excluded if the health behaviour 
measure only assessed the effectiveness of a pharmacological treatment such as 
one comparing the effects of placebo gum with nicotine gum on smoking cessation. 
In addition, studies that reported outcomes such as bio-physiological levels, 
knowledge, satisfaction, preferences, utilities or affect were excluded. Although it is 
likely that some of these measures are associated with decision making and are 
frequently used to infer informed decision making (see chapter 1, section 2.1), they 
are not direct measures of decision behaviour.
• A study assessing an experimental intervention. The definition of an experimental 
study was interpreted broadly to include any design that evaluated an 'experimental' 
group with a comparison group. Studies with one of the following six designs were 
included: randomised controlled trial (RCT) with a low risk of bias (RCTa, the 
method of randomisation was delivered by a third party, a computer or on opening a 
previously numbered, sealed, opaque envelope); RCT with an unknown risk of bias 
(RCTb, the method of randomisation was not clearly described); RCT with a high 
risk of bias (RCTc, approaching patients on alternate days or following the toss of a 
coin); non-randomised concurrent; historical studies or 'before and after 
intervention' with different samples; 'before and after intervention' studies with the 
same sample. Studies assessing predictors of a behaviour such as factors 
associated with breast screening attendance or preferences for treatment were 
excluded. The definition of an intervention was broad, to incorporate the many 
factors that may alter decision making: offering additional information; framing 
figures in different ways; patient use of a decision aid; comparison of information 
mediums; changes in the delivery of the health care service such as the provision 
of mobile units for mammography screening; legislation such as compulsory 
wearing of seat-belts and so on.
• The study was published in English.
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2.2.2 Developm ent o f the search strategy.
Studies considered for inclusion within the IPDM review were first identified from 
abstracts generated from one of two sources: electronic databases and hand-searches 
of complete sets of journals. Articles were retrieved if the IPDM review criteria were met 
or the abstract contained insufficient information to assess the criteria.
Over six months a search strategy was developed for the electronic databases Medline, 
Psychlit and BIDS (social science). A pilot strategy had been developed for inclusion 
within the initial protocol from a set of keywords chosen by the project group. Additional 
keywords were included within the strategy, derived from 17 articles considered 
relevant to the field of informed patient decision making, 100 articles considered for 
inclusion within the review following application of the pilot strategy to Medline and 
hand-searching of the journal Medical Decision Making. The keywords of the final 
strategy were modified and expanded within each of the electronic databases. The final 
strategy included terms from three categories: decision making; health care users; 
comparative study designs (Bekker et al, 1999). The sensitivity of the search strategy 
was evaluated by comparing the number of articles identified by hand-searching a 
second journal, Patient Education and Counselling. The pilot strategy identified 7% of 
articles considered for inclusion while the final strategy identified 62%. This sensitivity 
figure was considered satisfactory, as electronic searches identify between 17%-82% of 
relevant articles (Cooper, 1995). However, these efforts to increase sensitivity resulted 
in significantly reducing the specificity of the final strategy as 17,860 abstracts were 
generated for the years 1991-1996 alone. Consequently, the application of the strategy 
was limited to articles published between these years to ensure completion of the IPDM 
review given the resources available.
Three journals were selected for hand-searching because of their relevance to the 
health care users decision making area: Medical Decision Making, Patient Education 
and Counselling, and Preventive Medicine. In the hand-search, every abstract within 
every volume was read and considered for inclusion. All volumes were hand-searched 
for the years 1986 to 1996 inclusive.
2.2.3 Developm ent o f the coding form.
To ensure that consistent information was extracted from each study of each article, a 
data extraction sheet or coding form was developed over a six month period (see 
Appendix II). The categories within the coding form were informed with reference to the
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decision making and integration of research literature, and to the expertise of members 
of the project group. Each draft coding frame was piloted on articles derived from the 
search strategies and modifications agreed within the group monthly meetings. 
Following piloting, several categories were simplified or omitted because it proved 
impossible to achieve consistency between articles as the information published was 
neither described nor presented in a format compatible with the review’s research 
questions.
2.3 IPDM systematic review: procedure.
2.3.1 A rtic le  identification.
All abstracts generated from the search strategies were assessed for inclusion by the 
first author. Articles were retrieved if the IPDM review criteria were met or the abstract 
contained insufficient information to assess the IPDM review criteria. The original 
research questions investigated by the authors of the primary articles were not 
evaluated, i.e. articles were included in this review independent of the primary authors' 
research aims. In other words, articles included in the IPDM review may not have been 
designed to evaluate interventions aimed at the facilitation of informed patient decision 
making. Batches of ten articles were sent in rotation to each member of the project 
group. The inclusion criteria were again assessed by that member of the project group 
and, if included, s/he completed a coding form for each study of each article. 
Completed forms were returned to the first author and checked. Classification 
disagreements were resolved by discussion. All IPDM review details and extracted 
information were entered into the project electronic database.
2.3.2 Data synthesis.
The results of the IPDM review were presented in four ways:
• descriptive summaries and listings of articles by study number, grouped by health 
domain, decision and theoretical context;
• identification of ‘good’ studies. Good studies reported an RCT design with a low risk 
of bias (RCTa), referred to a theory to inform the intervention and assessed at least 
one decision making measure. As an insufficient number of studies (n=5) fulfilled 
these criteria, no meaningful quantitative meta-analysis were applied;
• non-parametric analyses were used in an attempt to answer the five questions 
raised at the end of section 2.1;
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• a trajectory of knowledge tracing the number of studies using different types of 
methodology, decision making theory and recording an informed decision outcome 
were analysed by publication year.
Most results were generated directly from variables that classified information extracted 
by the IPDM review coding form. However, two additional variables were created by 
combining data from these information category variables: theory operationalisation and 
reported effects. These variables were created to facilitate the integration of the IPDM 
review findings with the IPDM review research questions (section 2.1). The variables 
are described in more detail below:
• the theory operationalisation variable combined information with reference as to 
whether or not the authors mentioned a theory to inform their study or described 
measures to assess the decision making process. Four classifications were created: 
theory and decision making process measure; theory only; decision making process 
measure only; neither theory nor decision making process measure.
• the summary of reported effects variable was a crude record of whether or not the 
authors reported a significant effect between the intervention and health behaviour 
outcome measure.
The extracted information included within this chapter was derived from fewer articles 
than those for the IPDM review. The application of statistical analysis to these findings 
was not appropriate because of the small sample size. As a consequence, the content 
and structure of this chapter's results section differs from that of the IPDM review and 
includes:
• descriptive summaries of the following extracted information by article: authors, 
titles and journal; health care area and type of decision; study design and 
intervention description; theory reference and description of measures; summary of 
findings.
• frequency summaries of the information extracted from articles grouped by: study 
design; health care context; type of decision; content of intervention; reference to a 
theory; other measures assessed; theory operationalisation; theory 
operationalisation by reported effect size. As this chapter is concerned with the 
facilitation of informed decision making, an additional reported effect variable was 
created to assess whether or not the primary research reported an association 
between the intervention and measures of the decision making process;
• a qualitative synthesis of findings based on a more detailed description of the 
extracted information from those selected articles that operationalised a theory.
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2.4 Integrative review: results.
The criteria for inclusion in the final report was met by 547 articles, published between 
1991-19963. The main findings from the IPDM systematic review are described briefly in 
its executive summary (Appendix I). The results reported in this chapter are specifically 
concerned with the findings of articles that either included a decision aid in the 
intervention or investigated decision making in the context of prenatal diagnosis.
2.4.1 Inclusion o f articles: decision aids and prenatal testing.
As mentioned, articles of pertinence to this thesis are those that assess the facilitation 
of informed patient decision making and /or evaluate interventions carried out in the 
prenatal testing health context. No studies within the IPDM review were designed 
specifically by the primary-source authors to facilitate informed decision making in the 
prenatal testing context. However, a number of interventions were designed by the 
primary-source authors to evaluate changes either in the patient's utilisation of 
consultation information or in prenatal testing decisions.
Obstetrics, gynaecology and midwifery (n=31) and genetics (n=7) were the two IPDM 
review classification categories of the health context that may have included decisions 
about prenatal diagnosis (Bekker et al, 1999). The IPDM review tables summarising the 
information extracted from articles were referred to for further details about the health 
decision being made. The types of health decisions described in the obstetrics, 
gynaecology and midwifery category were associated with: breast feeding (n=9); 
substance use and/ or risk factor reduction (n=9); prenatal care (n=4); other post-partum 
care (n=3); menopause (n=2); issues about service provision changes (n=4). The types 
of health decisions described in the genetics category were associated with: uptake of 
carrier testing (n=4); awareness and coping with genetic diseases (n=2); genetic 
counselling and reproduction (n=1). Articles were selected if the health care context was 
associated with women’s prenatal testing behaviour. Five articles described decisions 
carried out in the context of either prenatal care (n=4) or genetic counselling and 
reproduction (n=1) (table 1; Appendix III). These articles were selected for inclusion in 
this chapter’s more in-depth analysis of the IPDM review bibliography.
Patient prompt (n=55) was the IPDM review classification category of interventions that 
aimed to change the patient’s decision making processes or utilisation of consultation
3 Articles extracted from the electronic database searches were published between 1991 and 
1996. Articles identified after handsearching journals dated from 1986
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information. The tables summarising the information extracted from all 55 patient 
prompt articles in the IPDM review report were referred to for a more detailed 
description of the interventions. On further investigation, the patient prompt 
interventions were classified as: prompts to facilitate decision making (n=5); prompts to 
encourage active or shared participation in the doctor-patient consultation (n=5); 
reminder or memory prompts to increase adherence with medical regimens (n=45). 
Articles were selected if the intervention either facilitated patient decision making or 
increased active participation in the consultation. Of these studies, less than a third 
evaluated interventions aimed at encouraging patient participation in the consultation. In 
total, thirteen articles were selected for further analysis as their interventions included 
either a decision aid or specific information on being pro-active during a consultation 
(table 1, Appendix III). As none of these thirteen articles were carried out in the context 
of prenatal testing, eighteen articles were included in this chapter’s further analysis of 
the IPDM review bibliography.
2.4.2 Summ ary o f in form ation: extracted inform ation by study.
A description of the information extracted systematically from each article is 
summarised in Appendix III: table 2 includes information about the health context and 
the type of decision made; table 3, the study design, description of the intervention, 
number of experimental groups and sample size; table 4, the theory referred to and 
measures assessed; table 5 summarises the articles’ main findings, i.e. the association, 
if any, between the intervention and the decision behaviour. In essence, this information 
provides the raw data by case for use in the following analyses.
2.4.3 Summ ary o f in form ation: frequencies.
Frequency analyses provide a simple integration of findings i.e. what proportion of 
studies assessed which variables. Frequencies of following classification categories are 
described: the health care context; the type of intervention; the study design; the type of 
decision; the theory used to inform study; the measures employed; the reported effects 
of the intervention on the decision behaviour.
Health care context (table 2.1): five articles were selected for inclusion in this chapter 
on the basis of their health care context (either from obstetrics, gynaecology and 
midwifery or genetics). Of those studies selected for inclusion on the basis of their 
intervention, primary health care was the most frequent health care context, followed by 
oncology and then mental health.
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Table 2:1 frequency of studies by health care context.
n (%)
obstetrics, midwifery & gynaecology and genetics 5 (28)
primary care 5 (28)
oncology 3 (17)
mental health 2 (10)
other (arthritis, geriatrics, diabetes) 3 (17)
Content of intervention (table 2.2); most studies included in this results section were 
selected on the basis of their intervention (patient prompt). Despite this selection 
criteria, only a fifth of studies (4/18) evaluated the effectiveness of a decision aid in the 
facilitation of patient decision making. The majority of interventions included more than 
one manipulation, such as a change in the delivery of information and the use of a 
memory prompt. The most frequently employed intervention was to alter the amount of 
information the patient received.
Table 2:2 frequency of studies by content of intervention.
n (%)
change in number of visits 3 (17)
additional information (face-to-face, telephone, written, video) 16 (89)
group delivery information 1 (6)
decision aid 4 (22)
patient participation / information prompt 7 (39)
memory prompt 1 (6)
Study design (table 2.3); one of the IPDM review criteria was to include only articles 
with an experimental study design (see section 2.2). The majority of articles 
subsequently selected for this chapter's analysis employed a randomised control trial 
design (16/18). However, only four adequately described the randomisation procedure 
and/ or used a procedure with a low risk of bias.
Type of decision (table 2.4): question asking during the consultation and utilisation of 
services were the most frequently assessed decision behaviours. Few studies 
systematically investigated patient choices between treatment options.
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Table 2:3 frequency of studies by design.
RCTa RCTb RCTc Concurrent Historical Before/after
low bias unknown bias high bias same sample
n (%) n (%) n (%) n (%) n (%) n (%)
4 (22) 3 (16) 9 (50) 1 (6) 0 (0) 1 (6)
Table 2:4 frequency of studies by decision investigated.
n %
utilisation services (attendance appointments, call-out services) 6 (33)
question asking (information seeking) 5 (28)
adherence regimens (medication, diet, recommendations) 3 (17)
decisions about treatment 2 (10)
making living wills 1 (6)
reproductive decisions (to have more children or not) 1 (6)
Theory driven research (table 2.5): half of the articles did not refer to any theory when 
describing the study aims or methods. Only one study was informed by a theory of 
decision making.
Table 2:5 frequency of studies by type of theory.
n %
No theory 9 (50)
Doctor-patient communication 8 (44)
EUT 1 (6)
Type of measures evaluated (table 2.6); all studies assessed a number of other 
measures besides the decision behaviour (see table 2.4). The most frequently reported 
measures concerned the demographic details of the patients. Less than half the studies 
employed measures to assess psychological strategies that might be associated with 
the process of decision making (decision making).
Theory operationalisation (table 2.7). information from tables 2.5 and 2.6 were 
combined to create a variable assessing the operationalisation of theoretical driven 
research (see section 2.3.2). Less than half of the selected articles had used a theory to
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inform the study and assessed either some aspect of the information utilised during the 
consultation or a decision making process measure.
Table 2:6 frequency of studies assessing other measures.
n (%)
demographics age, sex, level education, employment 17 (94)
personal history medical and family history 13 (72)
decision making attitudes, self-efficacy, reasons, perception of 
risk, decision autonomy, decision confidence,
8 (44)
knowledge knowledge, recall of information 5 (28)
satisfaction perceived usefulness, satisfaction 11 (61)
affect anxiety, depression, worry 5 (28)
individual differences need for cognition, optimism, locus of control 2 (11)
other social support, coping, clinician measures 4 (22)
Table 2:7 frequency of studies by operationalisation of theory.
n (%)
Theory + decision making process measure/ question asking outcome 8 (44)
Theory only 2 (11)
Decision making process measure/ question asking outcome only 3 (17)
No theory or decision making process measure/ question asking outcome 5 (28)
Reported effect (table 2.8); two additional variables were created from the summary of 
the studies’ findings to assess whether or not the intervention was associated with 
differences in the decision behaviour or decision making process measures (see section 
2.3.2). Eleven studies (61%) reported a change in the decision behaviour by 
intervention group; seven studies (39%) reported a change in the measures of 
information utilisation or decision process by intervention group. Most of the studies 
(7/11) reporting an association between the intervention and decision behaviour did not 
operationalise a theory and/or assess the decision making process. All studies (7/7) 
reporting an association between the intervention effect and decision making process 
measures had operationalised a theory.
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T a b le  2 :8  fre q u e n c y  o f  s tu d ie s  re p o r t in g  an a s s o c ia t io n  b e tw e e n  th e  
in te rv e n t io n  g ro u p s  a n d  th e  d e c is io n  b e h a v io u r  o r  d e c is io n  p ro c e s s  m e a s u re s .
Behaviour
E ffe c t
Process
E ffe c t
n (%) n (% )
T o ta l n u m b e r  o f  s tu d ie s . 11 (61) 7 (39)
Operationalised theory and measures (n=8)
Not operationalised theory and measures (n=10)
4 (17) 
7 (44)
7 (39) 
0 (0)
2.4.4 Summary of information: synthesis of findings.
The main purpose of this final results section is to integrate the findings of those 
intervention studies that may plausibly influence informed patient decision making. As 
stated, most of the articles included in this chapter were selected on the basis of their 
intervention (table 2.2). However, as the focus of this thesis is on understanding 
informed patient decision making within the context of prenatal diagnosis, five 
additional studies associated with women’s prenatal testing behaviour were also 
selected for inclusion in this chapter’s analysis (table 2.1). None of these five articles 
evaluated interventions aimed at changing women’s involvement in the decision making 
consultation. In consequence, the subsequent synthesis of findings first briefly 
summarises the results of the five articles selected on the basis of their health care 
context and then focuses on those studies that may address issues pertaining to 
informed patient decision making.
2.4.4.1 Interventions in the prenatal testing context: synthesis o f findings.
The two health care categories of the IPDM review most likely to involve a decision 
about prenatal testing were (a) obstetrics, gynaecology and midwifery and (b) genetics. 
Following reference to the IPDM review report, five articles were selected for inclusion 
in this chapter’s analysis of articles (Binstock and Wolde-Tsadik, 1995; Rowley, 
Hensley, Brinsmead and Wlodarczyk, 1995; Shiloh, Reznik, Bat-Miriam-Katznelson and 
Goldman, 1995; Sikorski, Wilson, Clement, Das and Smeaton, 1996; Thornton, 
Hewison, Lilford and Vail, 1995). No studies in this health care context assessed an 
intervention aimed at increasing patient involvement in a decision making consultation 
or referred to a decision making theory to inform the research. The interventions 
assessed can be broadly divided into those that evaluated either the delivery of care 
(Binstock and Wolde-Tsadik, 1995; Rowley et al, 1995; Sikorski et al. 1996) or
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information provided (Shiloh et al, 1995; Thornton et al, 1995). Although no studies 
operationalised or evaluated informed decision making, two studies did assess 
measures associated with the decision making process (Shiloh et al, 1995; Sikorski et 
al, 1996). Most of the studies (4/5) reported an association between the intervention and 
decision behaviour. However, as these studies did not evaluate an intervention aimed at 
facilitating the patient’s participation in the decision making consultation, it is beyond the 
scope of this thesis to explore these findings in more detail.
2.4.4.2 Interventions facilitating informed decision making: synthesis o f findings.
As previously discussed (see sections 1.2; 2.1), informed patient decision making 
requires some assessment of the decision making process. In addition, it is likely that a 
better understanding of the decision process and outcome may be achieved if empirical 
research is informed with reference to a theory. In consequence, only the eight studies 
that operationalised a theory (table 2.7) are referred to in this synthesis of findings 
(Brennan et al, 1995; Butow et al, 1994; McCann and Weinman, 1996; Rost et al, 1991; 
Sander et al, 1996; Shepperd et al, 1995; Whelan et al, 1995; Tabak, 1988). A 
quantitative integration of results would be appropriate were the data within these 
studies homogenous, i.e. if the interventions, patients, decision, decision contexts, 
research questions and results were similar or comparable (Cooper, 1989; Eysenck, 
1995). However, the studies were too few and disparate to carry out meaningful 
quantitative analyses. In consequence, the information extracted from each study is 
discussed in more detail with reference to: the design, theory, and measures employed; 
the decision behaviour and context; the type of intervention; the article's findings.
Design, theory, and measures: most of the studies (Brennan et al, 1995, Butow et al, 
1994; McCann and Weinman, 1996; Rost et al, 1991; Sander et al, 1996; Whelan et al, 
1995; and, Tabak, 1988) employed a randomised control design to evaluate the 
intervention. Only one study was designed to encourage ‘better’ decision making 
(Brennan et al, 1995); the remainder were designed to facilitate shared doctor-patient 
decision making and consultations. In addition, Brennan et al (1995) was the only study 
to refer to a specific theory of decision making; no studies operationalised informed 
decision making. Most studies (Butow et al, 1994; McCann and Weinman, 1996; Rost et 
al, 1991; Sander et al, 1996; Tabak, 1988) assessed question asking or information 
seeking during the consultation. Three additional variables were employed to evaluate 
the quality of decision making: confidence with the decision made (Brennan et al, 1995; 
Shepperd et al, 1995); perceived participation or autonomy in the decision making
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(Butow at al, 1994; Whelan et al, 1995; Sander et al, 1996); individual preferences for 
information (Rost et al, 1991; Butow et al, 1994).
Decision behaviour and context: although it was argued in some articles that 
increased patient participation was associated with changes in lifestyle and medical 
regimen adherence, the primary decision behaviour for most studies (6/8) was the 
facilitation of information seeking or question asking (Butow et al, 1994; McCann and 
Weinman, 1996; Rost et al, 1991; Sander et al, 1996; Tabak, 1988). Only Whelan et al 
(1995) and Shepperd et al (1995) assessed differences in the choice of treatment by 
intervention group. Although Brennan et al (1995) assessed decision making on behalf 
of a third party, most studies focused on the decision made by the patient for the 
patient. Half of the studies (McCann and Weinman, 1996; Sander et al, 1996; Shepperd 
et al, 1995; Tabak, 1988) were carried out in the primary health care context. The 
remaining studies investigated decision making in the context of cancer (Butow et al, 
1994; Whelan et al, 1995), diabetes (Rost et al, 1991) and Alzheimer's (Brennan et al, 
1995). No studies operationalising a theory were carried out in the context of prenatal or 
genetic testing.
Type o f intervention: all the interventions included changes in the provision of 
information, five using leaflets, one using information cards attached to a decision 
board, one using a computer link and one using a video-tape recording. Four studies 
included information prompts to specifically encourage patients to ask questions about 
their health issue during the consultation (Butow et al, 1994; McCann and Weinman, 
1996; Sander et al, 1996; Tabak, 1988). The four studies classified as employing 
decision aids provided additional information about the consequences of the 
alternatives available structured, either by a decision tree or by a visual representation 
of the choices available (Brennan et al, 1995; Rost et al, 1991; Shepperd et al, 1995; 
Whelan et al, 1995). Although the focus of the decision aid interventions was the 
facilitation of patient decision making, only the computer link decision aid (Brennan et 
al, 1995) was concerned with helping the patient reach a decision. The computer link 
decision aid provided a technique to associate factual information about the 
consequences of alternatives with a patient’s individual evaluations of these outcomes 
to obtain a 'best' or ‘correct’ decision as defined by expected utility theory.
Integration o f findings: the results associating the interventions and facilitation of 
decision behaviour were mixed: two of the information prompt studies (McCann and 
Weinman, 1996; Sander et al, 1996) and two of the decision aid studies (Rost et al,
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1991; Shepperd et al, 1995) reported an increased effect on patient participation within 
the consultation. Butow et al (1994) found that although the total number of questions 
asked was not associated with the information prompt intervention, the type of 
information sought did differ by group. Of those studies that assessed perceived 
autonomy and confidence in decision making, all of the decision aid studies reported a 
positive association (Brennan et al, 1995; Shepperd et al, 1995; Whelan et al, 1995) but 
the one information prompt study found no such relationship (Butow et al, 1994). 
Brennan et al (1995) found no association between the skill or ‘correctness’ of the 
decision made with the decision aid intervention. It seems unlikely that patient 
preference for information was associated with differences in the intervention groups 
(Rost et al, 1991; Butow et al, 1994).
2.5 Discussion.
The aim of the IPDM review was to provide a comprehensive bibliography of empirical 
research of interventions that might have an effect on informed health care decision 
making by patients. Between the years 1991-1996, 17, 860 abstracts were generated by 
the IPDM review’s electronic search strategy. Following evaluation of each abstract, 547 
articles were identified by members of the IPDM review working group as fulfilling the 
review's criteria. This chapter has been concerned with focusing on those articles that 
might facilitate informed patient decision making following the application of a decision 
aid to a health care decision. In total, 18 articles classified in the IPDM review's 
bibliography were pertinent to this chapter. The results reported in this chapter were 
based on a detailed analysis of the information extracted from these 18 selected 
articles.
As mentioned, the main advantage of carrying out an integrative, systematic or 
research review is to efficiently integrate findings from a large number of studies. 
Articles are selected for inclusion in the review according to the research agenda of the 
review. The review's research agenda also informs the coding sheet applied to each 
article used when systematically extracting study information. The integration of this 
information provides a comprehensive knowledge base for researchers to address the 
questions posed by the review (Cooper, 1989; Mulrow, 1995). The conclusions based on 
the findings of this type of review may be seen to be less biased than those derived 
from theoretical reviews. Integrative reviews include all articles that fulfil their inclusion 
criteria, whereas theoretical reviews select articles to support or counter their argument. 
In addition, it is likely that the article inclusion technique of integrative reviews 
encourages a wider range of articles to be considered for the final review than that of a
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theoretical review, as integrative review articles are judged on their information content 
rather than on the intended aims of the primary-source authors. In other words, articles 
were included in the IPDM review because the information contained within an article 
fulfilled the review’s criteria and not because the article’s authors intended to evaluate 
the facilitation of informed decision making.
The main disadvantage of integrative reviews is the systematic exclusion of articles that 
do not fulfil the review’s criteria. There are several areas of empirically-based studies 
that may have informed some of the research questions raised in the IPDM review, 
including: studies of patient’s preferences for health care; comparative studies 
assessing predictors of behaviour; studies evaluating changes in an alternative outcome 
measure such as knowledge; experimental or student-based studies operationalising 
decision making theory (Bekker et al, 1999). It is likely that reviews in all of these areas 
would increase researchers’ understanding of informed decision making and the 
strategies employed by individuals to make decisions. However, specific issues 
concerning the facilitation of informed patient decision making are most likely to be 
answered by a review carried out in the area of research identified by the IPDM review.
The remainder of the discussion focuses on general conclusions drawn from this 
integrative review’s results pertaining to the facilitation of informed patient decision 
making in the context of prenatal diagnosis. The discussion is structured to address the 
following questions adapted from those described in the IPDM review report (see 
section 2.1.4):
• Can informed decision making be facilitated?
• Do decision aids facilitate informed decision making?
• What other factors are associated with informed decision making?
2.5.1 Can informed patient decision making be facilitated?
Although the interventions of studies included within the IPDM review may be 
associated with issues of informed decision making, none were explicitly designed to 
evaluate the facilitation of informed patient decision making. The purpose of those 13 
articles selected for further analysis in this chapter on the basis of their intervention 
content was to either facilitate active patient participation in the consultation or to 
encourage better decision making. The aims of the five studies selected for further 
analysis in this chapter on the basis of their health care area were more varied and 
included assessing changes in attendance, reproduction and other pregnancy 
outcomes. None of the 18 studies defined informed decision making or attempted to
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measure the process of informed decision making. Nine articles referred to a theory 
when designing the study but only one was a theory of decision making. In essence, 
there is little evidence that informed decision making was operationalised. It remains an 
empirical question as to whether or not informed patient decision making has or can be 
facilitated. However, findings from the 13 studies aiming to facilitate patient 
participation in the consultation can be used to inform some general observations 
concerning the association between the experimental interventions and changes in both 
decision behaviour and decision process measures.
The findings suggested a mixed association between the patient prompt interventions 
and changes in the decision process and outcome measures. About half of the studies 
(7/13) reported an association between the intervention and decision behaviour, 4/8 of 
those that operationalised a theory and 3/5 of those that did not. Of those studies 
aiming to facilitate active patient participation in the consultation, 3/5 reported an 
associated increase. Less than half of these studies (6/13) included other measures to 
evaluate the process of decision making. Most of these interventions (4/6) were 
associated with an increase in the quality of the decision making process. These results 
suggest that interventions aimed at encouraging active patient participation in the 
consultation were likely to be associated with reliable and positive changes in the quality 
of the decision making process rather than with increasing or decreasing the decision 
behaviour.
2.5.2 Do decision aids facilitate informed patient decision making?
There is insufficient empirical evidence to address this question. As stated, none of the 
547 IPDM review articles systematically selected from 17,680 abstracts had 
operationalised informed patient decision making and designed an intervention to 
facilitate informed patient decision making. Of the eight articles that had described a 
patient prompt to facilitate active patient participation in the consultation and used a 
theory to inform the study, only four were classified as decision aids. All of the articles 
classified as decision aids did make explicit the issue of choice, the presentation of 
options, information about the risks and benefits of the options and the individual 
tailoring of information to the patients needs. Only one of these decision aids (Brennan 
et al, 1995) was used to explicitly gauge the patient’s values associated with the 
proposed outcomes and assist the patient in reaching a decision. As all of these 
components are considered necessary for a patient prompt to be classified as a 
decision rather than information aid (see chapter 1; O’Connor et al, 1994), it is likely 
that the IPDM review’s classification of interventions as decision aids was generous. In
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other words, few studies have adequately operationalised a decision aid in an 
intervention-based study. Furthermore, no studies included in the IPDM review had 
adequately assessed the relationship, if any, between the employment of a decision aid 
and changes in patient’s decision making processes.
Some general observations about the efficacy of decision aid interventions can be 
made with reference to the findings from the eight studies that operationalised a theory 
and assessed patient prompt interventions. In brief, four interventions were essentially 
information aids or prompts to encourage active consultation participation and four were 
decision aids to facilitate treatment decisions. Only half of these studies reported an 
association between the patient prompt and decision outcome measure, two studies 
included information prompts and two studies incorporated decision aid interventions. 
The results suggest that the information prompts and decision aids were equally likely to 
be associated with changes in the decision behaviour outcome measures and that 
factors other than the patient prompt interventions were associated with changes in the 
decision behaviour. Only four studies assessed some aspect of the decision making 
process, such as decision autonomy and confidence with the decision made. All three 
decision aids reported a positive association with these measures; the information 
prompt did not. These findings suggest that decision aid interventions are likely to 
facilitate some aspect of the decision making process but there is little empirical 
evidence to support such an association with information prompt interventions. Only 
one study (Brennan et al, 1995) assessed the ‘theoretical correctness' of the decision 
made; no differences in measures of decision correctness as a consequence of using a 
decision aid were found. Until other studies have adequately operationalised and 
evaluated decision aids, this finding suggests that theory driven decision aids are not 
associated with the facilitation of theoretically correct decisions.
2.5.3 What factors are associated with informed patient decision making?
During the development of criteria for article inclusion and coding form content by IPDM 
review members, a number of pre-defined categories were suggested as factors that 
might be associated with a patient’s ability to make an informed decision (see section 
2.1; Bekker et al, 1999): aspects of the decision context, such as the type of health 
decision or riskiness of the decision; individual differences, such as preferences for 
information or attitudes towards health care; other factors, such as legislation which 
may limit the number of options available to a patient. Information pertaining to these 
factors was systematically extracted from each study and summarised in the IPDM 
review. As previously mentioned, no studies within the IPDM review adequately
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operationalised informed patient decision making. In addition, few studies included 
measures of the decision making process. In other words, there is insufficient empirical 
evidence to adequately address this question. However, it is likely that this particular 
research question may be better addressed by a review with a different set of inclusion 
criteria. For example, a subsequent review might include studies designed to assess 
factors associated with the decision behaviour, i.e. a study measuring predominantly 
cognitive mechanisms.
2.6 Chapter summary.
The IPDM review provided a comprehensive bibliography of empirical research carried 
out between 1991-1996 that might be associated with the facilitation of informed health 
care decision making by patients. Of the 547 articles included in the IPDM review, 18 
articles were considered of relevance to this thesis and analysed in more detail. There 
were no studies that directly evaluated the facilitation of informed decision making in 
the context of prenatal diagnosis. Further, no studies operationalised or measured 
informed decision making in any health care domain. Nine studies referred to a theory 
to inform their research questions and interventions but only one was a theory of 
decision making. Four studies evaluated decision aid interventions but none of them 
were carried out in the context of prenatal diagnosis. Only four studies included other 
measures of the decision quality such as decision autonomy and confidence. Despite 
the dearth of theoretically operationalised studies assessing informed patient decision 
making, the findings were integrated and suggest that patient prompt interventions were 
more likely to be associated with changes in measures of the process of decision 
making than the decision behaviour outcome; decision aid interventions were more 
consistently associated with changes in decision autonomy and confidence than 
information prompt interventions; the application of decision aids to health decisions 
was not associated with changes in the correctness of the decision made.
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3. Research questions and thesis overview.
The application of psychological theory to understanding risky decision making in a 
'real-world' health-care setting provides the main theoretical context for this thesis. The 
real world decision is one confronted by a significant minority of pregnant women, the 
choice to have or not have prenatal diagnosis following a screen positive triple test 
result for Down’s syndrome. The decision is termed risky because both alternatives 
offered to women have a probability of a negative consequence occurring (see section 
1.1.4). Prenatal diagnosis carries between a 0.5%-2% risk of miscarrying the pregnancy, 
while continuing the pregnancy upon receipt of a screen positive triple test result carries 
a risk of between 0.4%-20% of the baby having Down’s syndrome. As prenatal and 
genetic testing are associated with iatrogenic consequences (see section 1.1.5), one of 
the primary objectives of offering testing in this real world context is to ensure that 
women make informed decisions to have or not have tests (Royal College of 
Physicians, 1989). The empirical evidence summarised in both the theoretical and 
integrative reviews (chapters one and two) suggested that few studies have adequately 
addressed the issues pertaining to informed decision making in women choosing to 
have or not have prenatal diagnosis. The preceding overviews have been used to 
inform the research questions for this thesis. Section 3.1. summarises the main 
research questions addressed in this thesis. Section 3.2 outlines the four subsequent 
empirical chapters and contains descriptions of the research aims, objectives and study 
design for each.
3.1 Research questions.
As stated, this thesis is concerned with the application of psychological theory to 
women’s decision making about prenatal diagnosis. The theoretical review (chapter 1) 
integrated findings from empirically based studies of women’s prenatal diagnosis 
decisions (section 1.3) with models of decision making (section 1.2.1). A definition of 
informed decision making was operationalised (section 1.2.2) with reference to 
reasoned-based theories of decision making and criteria identified as significant by 
prenatal and genetic testing committees. The facilitation of individuals’ decision making 
was also discussed as decision aids, particularly the decision analytic technique, have 
been used in the prenatal diagnosis context (section 1.2.1.3). The findings summarised 
in the theoretical review (chapter 1) suggested that few, if any, studies had 
operationalised informed decision making within the prenatal diagnosis context. From 
the integration of empirical research in chapter 2, it was evident that informed decision
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making has not been adequately defined or assessed in any health care context. 
Further illustrated by the integrative review (chapter 2) was the dearth of studies 
evaluating decision aids as a means of facilitating decision making. In addition, there is 
a paucity of research to indicate whether or not women have been provided with 
sufficient information to enable the process of informed decision making (section 1.3.1). 
Most of the applied studies have been carried out to understand the factors associated 
with women’s prenatal diagnosis decisions (section 1.3.2). However, a number of 
methodological concerns were discussed (section 1.3.2) which may limit the 
explanations provided of women's (informed) decision making about prenatal diagnosis.
The following research questions have been broadly separated into those that address 
the objective of encouraging women’s informed decision making about prenatal 
diagnosis and those that may inform psychological explanations of decision making 
under risk.
Ensuring informed decision making in the context of prenatal diagnosis:
• Do women receive sufficient information to be able to make an informed decision 
about prenatal diagnosis?
• Are women making informed decisions about prenatal diagnosis?
• Can informed decision making be facilitated?
Understanding decision making under risk:
• What information processing strategies are employed by women when deciding to 
have or not have prenatal diagnosis?
• What psychological factors are associated with the decision to have or not have 
prenatal diagnosis?
• Does the application of the decision analytic technique to the prenatal diagnosis 
decision modify decision behaviour and lead to more accurate or better decisions?
3.2 Overview of empirical studies included in the thesis.
The following four chapters describe the empirically based studies designed to provide 
evidence to address the proposed research questions. Brief summaries of each chapter 
are provided below.
Chapter 4: this chapter describes the prenatal diagnosis information provided to 
women upon receipt of a screen positive triple test result. The study employed a non- 
experimental, cross-sectional, structured observational design. A checklist was
61
designed to categorise the information provided by the health professional during the 
consultation. Over a three month period, all the information giving consultations 
provided by health professionals at the Leeds General Infirmary (LGI) for women who 
had received a screen positive triple test result were audio tape-recorded. The purpose 
of this study was to assess whether or not women had received sufficient information to 
enable them to make an informed, autonomous choice about the decision to have or not 
have prenatal diagnosis.
Chapter 5: this chapter describes the processes employed by women when making 
the decision to have or not have prenatal diagnosis. The study employed an 
observational, cross-sectional design. The 22 transcripts from chapter 4 and an 
additional 22 transcripts from a further three months of audio tape-recording the 
information giving consultations were used in this chapter. The first aim of this study 
was to describe the information utilised by women when making the decision to have or 
not have prenatal diagnosis. A coding frame was developed using content analysis to 
classify women’s utterances during the information-giving consultation. The findings 
from this process tracing technique provided evidence of the way women processed or 
at least utilised information when making this risky decision. To ascertain whether or not 
there was an association between the utilisation of consultation information and test 
decision, the pattern of information utilisation was presented by prenatal diagnosis test 
decision. The second aim of this study was to operationalise the concept of informed 
decision making (see chapter one) and develop a measure with which to assess the 
informed decision making process.
Chapter 6: this chapter evaluated the application of the decision analytic technique 
to the prenatal diagnosis consultation. The purpose of the consultation was to compare 
the efficacy of a consultation structured by decision analysis with that of a routine 
information-giving consultation to facilitate informed decision making. The study 
employed a randomised control trial (RCT) design to evaluate the efficacy of the 
decision analytic technique. Both process tracing techniques and questionnaire-based 
measures were used to evaluate differences in the decision making process and 
outcome by intervention group. In total, complete data sets for 106 women randomised 
to either the decision analysis or routine consultation were analysed. The study findings 
were used to inform research questions about the facilitation of informed decision 
making and the ability of decision analysis to modify the decision quality and outcome.
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Chapter 7: this chapter describes the psychological factors associated with 
women’s decision to have or not have prenatal diagnosis. The data obtained from the 
RCT in chapter 6 were used in this chapter to provide a more comprehensive 
understanding of women’s prenatal diagnostic test behaviour. The findings from the 
following process tracing and questionnaire measures were used to assess factors 
associated with the decision to have or not have prenatal diagnosis: informed decision 
making; cognitive mechanisms such as utilities and perceived social norms; knowledge; 
demographic characteristics.
Chapter eight discusses the findings summarised in these four empirical chapters with 
reference to the research questions of this thesis. The chapter focuses on describing the 
extent to which the research questions were addressed by these empirical studies, the 
strengths and limitations of the methodologies employed and outlines areas for further 
decision making research in the context of prenatal diagnosis decision making.
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4. Prenatal diagnosis: describing the provision of 
information.
This chapter is concerned with the provision of information by health professionals for 
women choosing to have or not have prenatal diagnosis upon receipt of a screen 
positive triple test result. To enable informed decision making about prenatal diagnosis, 
it is the responsibility of health professionals to provide sufficient information about the 
test decision and to communicate this information in a neutral or ‘non-directive’ manner 
(section 1.2). These conditions should provide women with the opportunity to integrate 
the test information with their beliefs and values, so encouraging informed and 
autonomous decision making. As mentioned in chapter one, there is a paucity of 
research evaluating the provision of information by health professionals for women 
choosing to have or not have prenatal diagnosis upon receipt of a screen positive triple 
test result (section 1.3). A few studies described the content of the prenatal diagnosis 
consultation between health professionals and women with an increased risk of Down's 
syndrome as a consequence of raised maternal age (Kessler, 1981; Marteau et al, 
1993; Bernhardt et al, 1998). The findings suggest that women did not receive sufficient 
information about the test alternatives and that health professionals did not impart all 
information in a neutral manner (section 1.3).
The purpose of the study reported in this chapter is to describe the information provided 
by the health professional for women making the decision to have or not have prenatal 
diagnosis upon receipt of a screen positive triple test result. The main aim is to assess 
whether or not the information-giving consultation enables women to make an informed 
and autonomous decision about prenatal diagnostic testing.
4.1 Methodology.
4.1.1 Sample.
The triple test is routinely offered to all pregnant women aged 29 years or over at 
estimated date of delivery at the Leeds General Infirmary (LGI). For the year preceding 
the study, 63% (1044/1661) of pregnant women offered the triple test at the LGI were 
tested. Thirteen percent (133/1044) of screened pregnant women received a positive 
triple test result. Prenatal diagnosis was offered to the 133 women who screened 
positive and 90% (120/133) chose to have a diagnostic test. All women who received a 
screen positive triple test result from the Leeds General Infirmary (LGI) from April to
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June 1995 were invited to take part in this study. Over this three month period, none of 
the 22 women who received a screen positive triple test result refused to take part in the 
study.
4.1.2 Design.
A non-experimental, cross-sectional, structured observational study design (Robson, 
1993) was employed to describe the information provided by health professionals for 
women deciding to have or not have prenatal diagnosis following receipt of a screen 
positive triple test result. An audio tape-recorder was used to record the content of the 
prenatal diagnosis information-giving consultations. The consultation audio tape- 
recordings were transcribed fully by a third party (KM). The transcribed health 
professional’s utterances provided the data source for this study. Any statement 
proffered by the health professional during the consultation was classified, including: 
triple test result information; details concerning the decision to have or not have 
prenatal diagnosis options; responses to women's questions. This observational 
technique enabled the actual information given during the consultation to be coded for 
analysis rather than relying on the health professional’s or woman’s recall of the 
consultation information (Robson, 1993). It is argued that an observer or audio tape- 
recorder may subtly alter the woman-health professional interaction (Robson, 1993). 
Alternatively, such a direct technique may increase the validity and reliability of the 
findings by reducing the likelihood of memory, reporting and social desirability biases 
(Robson, 1993; Smith, 1995; Bowling, 1997). In an effort to reduce any 'observer' 
effects, the author (HB) was introduced as a member of the ante-natal care team, 
initially as a trainee and later as the main information-giver for this prenatal diagnosis 
consultation. On balance, a structured observational design was considered the most 
appropriate to achieve the aims of this study.
4.1.3 Materials.
4.1.3.1 Triple test result sheet.
During each consultation, the health professional structured the consultation with 
reference to the woman’s triple test result sheet (Appendix IV). The following details 
were recorded on the triple test result sheet: the woman's name, address and LGI 
maternity reference number; two gestation dates informed by the first day of her last 
period and the LGI’s dating scan; maternal serum levels for the hormones unconjugated 
oestriol (uE3), human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP); 
maternal age; maternal weight at time of screening; estimated date of delivery; risk
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figure for Down’s syndrome based on the triple test calculation; risk figure for Down's 
syndrome based on maternal age; risk figure for Edward’s syndrome; risk figure for 
spina bifida.
4.1.3.2 Information giving checklist: categories and inter-rater reliability.
A structured observational study design requires the development of a checklist or 
coding scheme to classify the information observed in the real world' setting (Robson,
1993). The categories developed for this type of checklist were informed more by the 
guidelines outlining criteria to enable informed decision making in the context of 
prenatal diagnosis (Royal College of Physicians, 1989; Royal College of Obstetricians 
and Gynaecologists, 1993; section 1.3) than by the development of themes from the 
health professional’s utterances (Robson, 1993). In other words, most of the categories 
included within the checklist were previously identified within the literature as necessary 
to ensure informed decision making (Royal College of Physicians, 1989; Royal College 
of Obstetricians and Gynaecologists, 1993; Kennard, Goodburn, Golightly and Piggott, 
1995; Marteau, Shaw and Slack, 1995; section 1.2). In brief, the consultation 
information should contain sufficient information to enable an informed decision to be 
made and this information should be presented neutrally to encourage women’s 
autonomy in decision making (section 1.3). However, as the checklist was used to 
classify all the health professional’s utterances, three further categories were 
incorporated within the checklist. These additional categories classified information 
provided by the health professional that were specific to this health care context but not 
directly associated with women’s informed prenatal diagnosis decision making.
Coding the information giving consultation requires the comparison of information 
contained within the checklist to be compared with that documented in the transcript. 
The transcript either contains the information outlined in the checklist or not. In total, 
seventeen categories were identified to classify the content and delivery of the 
information contained within the transcripts (Appendix V). Fourteen categories classified 
information pertaining to the provision of sufficient information and the neutral 
communication of information, while three categories classified additional information 
specific to this consultation context. The content of these categories are discussed in 
more detail below.
Sufficient information.
As mentioned, one of the conditions considered necessary to enable women to make an 
informed decision about the decision to have or not have prenatal diagnosis following
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receipt of a screen positive triple test result for Down's syndrome is the provision of 
sufficient information (Royal College of Physicians, 1989; Royal College of 
Obstetricians and Gynaecologists, 1993; Kennard, Goodburn, Golightly and Piggott, 
1995; Marteau, Shaw and Slack, 1995; section 1.2). This information should include a 
discussion of the consequences of all the decision alternatives and the benefits and 
risks associated with each alternative. The information included within the following 
categories has been identified within the literature as sufficient to enable informed 
decision making (section 1.3).
• A description of the abnormality being tested for, in this instance Down's syndrome. 
The description should include the following information: the population incidence (1 
in 650 live births); the life expectancy (between 55 and 60 years); the prognosis (a 
range of severity which may lead to premature ageing and signs of Alzheimer’s 
disease); the impairment (many who have Down's syndrome lead independent lives, 
are usually very loving and caring, have a slower mental and physical development, 
have 'typical' facial features and require possible medical interventions for physical 
abnormalities); cause and recurrence (spontaneous chromosomal abnormality 
located on chromosome 21 with a recurrence in subsequent pregnancies of 
approximately 1%) (Leeds Antenatal Screening Service, 1993; Royal College 
Obstetricians and Gynaecologists, 1993; Kennard et al, 1995; Marteau, Shaw and 
Slack, 1995; Barnes and Bryan, 1996; section 1.1). Any information provided by the 
health professional concerning Down's syndrome was classified in category hp7 of 
the checklist (Appendix V).
• An explanation of the maternal serum screening test result. Women should be aware 
of the following information explaining the triple test maternal serum screening 
result: the meaning of a screen positive and negative result; an explanation of the 
cut-off risk figure between screen positive and negative result; the likelihood of 
detecting a fetus with Down's syndrome; the abnormalities identified by the triple 
test; an explanation of the details used to calculate the risk figure included in the 
triple test equation (Leeds Antenatal Screening Service, 1993; Royal College of 
Obstetricians and Gynaecologists, 1993; Kennard et al, 1995; Marteau, Shaw and 
Slack, 1995, section 1.1). Triple test screening information was classified in category 
hp1 of the checklist (Appendix V). In addition, information given regarding two other 
first trimester screening tests, maternal age and nuchal pad risk figures for Down's 
syndrome, was classified in category hp1 of the checklist (Leeds Antenatal 
Screening Service, 1993; section 1.1). Any actual risk figures mentioned by the 
health professional during the consultation were coded separately in category hp9 of 
the checklist (Appendix V).
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• An explanation of the ‘no test’ alternative. Women are only able to make an informed 
decision about prenatal diagnostic testing if they are aware that there is a choice 
between having or not having prenatal diagnosis (Marteau, Shaw and Slack, 1995). 
In consequence, health professionals ought to make this choice explicit during the 
information-giving consultation. Category hp2 of the checklist classifies any 
utterance from the health professional that explicitly refers to the consequences 
associated with not having a diagnostic test (Appendix V). The information classified 
in this no test alternative category may include reference to: not having an invasive 
test; the 19 week fetal anomaly scan; delaying the prenatal diagnosis decision until 
after the results of the 19 week fetal anomaly scan. This 19 week fetal anomaly scan 
is seen as a likely course of action or alternative following a screen positive triple 
test result for spina bifida (Royal College of Physicians, 1989; Royal College of 
Obstetricians and Gynaecologists, 1993; Marteau, Shaw and Slack, 1995). In 
addition, this scan may be used as another screening test for Down's syndrome, 
identifying physical abnormalities or ‘markers' associated with an increased risk of 
Down's syndrome (Leeds Antenatal Screening Service, 1993; Marteau, Shaw and 
Slack, 1995; Barnes and Bryan, 1996; section 1.1).
• A description of the diagnostic test alternative. Women need to have information 
about the risks and benefits associated with each diagnostic test if they are to make 
an informed choice about prenatal diagnosis. For each diagnostic test offered, health 
professionals should include the following information: the condition(s) testing for; 
the test procedure; the timing of the test; the meaning of a diagnostic test result; the 
risk of procedure related miscarriage; the options available should the test result be 
positive (Marteau, Shaw and Slack, 1995). At the LGI, both amniocentesis and 
chorionic villus sampling were offered to women upon receipt of a screen positive 
triple test result. Details specific to these two diagnostic tests have been described in 
section 1.1. Category hp3 of the checklist classified utterances pertaining to the 
provision of amniocentesis information, category hp4 chorionic villus sampling 
information (Appendix V). Information given about the miscarriage consequence of 
testing was classified in category hp5 of the checklist (Appendix V). Specific 
information provided about termination as an option following receipt of a positive 
diagnostic test result was coded in category hp6 of the checklist (Appendix V).
• The provision of misinformation about prenatal diagnosis. Prior empirical research 
has documented the provision of inaccurate information about prenatal diagnosis 
(Marteau, Plenicar and Kidd, 1993; Bernhardt, Geller, Doksum, Larson, Roter and 
Holtzman, 1998). As the provision of inaccurate information may be associated with 
women’s ability to make an informed decision about prenatal diagnosis, category
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Alps of the checklist coded any reference to misinformation by the health 
professional (Appendix V).
Neutrally communicated information.
The second component enabling the making of informed decisions is to ensure 
women’s autonomy in the decision making process. In other words, allowing women the 
opportunity to assimilate the ‘sufficient information’ with their own attitudes or values 
(section 1.2). Communicating directive information is regarded as exerting undue 
pressure on the individual; whereas communicating neutral or non-directive information 
is believed to encourage the individual's ability to make the decision autonomously 
(Kessler, 1993, section 1.3). In other words, directive information alludes to or explicitly 
states a desirable course of action, so reducing the opportunity for an informed decision 
to be made, while non-directive information requires the individual’s assessment of the 
information, so encouraging the process of informed decision making. The directiveness 
of information can be communicated subtly or overtly (Kessler, 1993; Marteau, Plenicar 
and Kidd, 1993; Bernhardt, Geller, Doksum, Larson, Roter and Holtzman, 1998). An 
example of an overt, non-directive communication is the health professional explicitly 
stating that, ‘the decision is yours [the woman’s]’; an overt, directive communication 
may be 'chorionic villus sampling is not the right choice for you’. Some examples of 
subtle, non-directive communications are: focusing equally on the reasons for and 
against each option; encouraging women to take time to evaluate the information; 
rephrasing risk figures. Examples of subtle, directive communications are: the health 
professional’s value judgements about the ’sufficient' information; omitting to discuss 
the advantages or disadvantages of one alternative; alluding to a 'norm' for decisions 
about prenatal screening, diagnosis and termination (Donnai, 1992; Kessler, 1993; 
Marteau, Plenicar and Kidd, 1993; Bernhardt, Geller, Doksum, Larson, Roter and 
Holtzman, 1998). Within the checklist, categories hp10 - hp13 (Appendix V) classify the 
way in which information was communicated during the consultation. An additional 
category, hp14 (Appendix V), was included in the checklist to classify the direct 
questions posed by the health professional. These direct questions provided women 
with the only opportunity to express their attitudes or opinions about the consequences 
of the prenatal diagnosis decision during the consultation. The elicitation of these 
attitudes may encourage women to integrate their opinions about prenatal diagnosis 
with the consultation information and facilitate the informed decision making process.
Additional categories.
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Although the aforementioned fourteen categories of the checklist were developed with 
reference to the literature on informed decision making, three additional categories were 
also included to accommodate information provided by the health professional specific 
to the setting of this study. In brief, category hp15 of the checklist (Appendix V) 
classifies information provided by the health professional that pertains to the prenatal 
diagnosis decision, but the relationship of these factors to issues of informed decision 
making is unclear. For example, the health professional may compare the advantages 
and disadvantages of the two diagnostic tests offered rather than provide the details of 
each test sequentially. Category hp16 of the checklist (Appendix V) classifies 
information provided by the health professional during the consultation that was not 
directly associated with the prenatal diagnosis decision, such as the results of routine 
antenatal tests. Finally, category hp17 (Appendix V) classifies information pertaining to 
the elicitation of utilities following application of the decision analytic technique to the 
prenatal diagnosis consultation (section 1.2, chapter 6). The decision analytic technique 
was not applied routinely by the health professionals at LGI. However, the author was 
permitted to practise the elicitation of utilities with consenting women after they had 
made their decision to have or not have prenatal diagnosis. The piloting of this 
elicitation technique will be discussed in more detail in chapter 6.
Inter-rater reliability.
As stated, most of the checklist' categories were developed with reference to the 
literature on informed decision making. This literature broadly defined the content and 
style of information considered necessary to enable women to make an informed 
prenatal diagnosis decision. The checklist modified these criteria for application to the 
prenatal diagnosis decision upon receipt of a screen positive triple test result. In 
consequence, additional categories were included to accommodate health 
professional's utterances specific to this health context. As such, the checklist was a 
non-standardised instrument with which to classify qualitative data To assess the 
reliability of the checklist to accurately classify health professional’s information giving, 
a test for inter-rater reliability was carried out (Robson, 1993). Ten per cent of the 22 
transcripts (n=3) were selected for use in the inter-rater reliability test. The three 
selected transcripts represented each of the following prenatal diagnosis test decision 
outcomes: no further diagnostic testing; amniocentesis; chorionic villus sampling The 
transcripts were coded separately by the author (HB) and a third party (SA). In total, 137 
statements were coded by both the author and SA. Cohen's Kappa coefficient was 
calculated to assess the degree of concordance between the two raters' applications of 
the checklist to the three transcripts. The value of the Kappa coefficient was 0.73. As
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this figure falls between 0.60 and 0.75, it suggests a good degree of agreement 
between the two raters (Robson, 1993). This finding provides some evidence that the 
checklist may be a robust classification system for the categorisation of health 
professional’s information-giving within the context of prenatal diagnosis.
4.1.4 Procedure.
The routine practice of the ante-natal staff at the LGI for informing women of their triple 
test results and subsequent prenatal diagnostic test decisions was maintained 
throughout the study period. Women with a screen negative triple test result were not 
routinely informed of their risk figure, although a few individual consultants sent letters 
to women under their care informing them of their triple test status. All women with a 
screen positive triple test result were contacted by telephone or letter if a telephone 
number was not available. Contacting women about a screen positive triple test result 
and informing them of their reproductive options during a consultation was the 
responsibility of one midwife within the ante-natal team. Minimal information was 
provided to women over the telephone: the purpose of the phone call; the triple test 
figure, both as an odds number and percentage; the appointment time for a further 
information consultation; addressing the immediate concerns raised by women. On 
attending the antenatal clinic for the prenatal diagnosis information giving consultation, 
women were informed of the study. Participation in the study involved having the author 
sitting in the room and audio tape-recording the consultation. No women refused to take 
part in the study.
4.1.5 Analysis.
The results are summarised using descriptive statistics. Frequencies are recorded for 
the number of consultations that referred to a particular category of information. 
Although some categories of information were mentioned more than once during a 
consultation, this results section focuses only on whether or not the necessary 
information to enable informed decision making was provided. Text considered to be 
representative of the 22 transcripts is used to illustrate the information categories of the 
checklist when describing the study's findings. The main purpose of the study was to 
describe the information provided by the health professional during the consultation. As 
a consequence, no formal statistical analysis was applied to the data. However, to 
illustrate the pattern of information given by test decision1, the category frequencies
1 The test decision refers to those who chose either to have or not have prenatal diagnosis. It is 
outside the remit of the thesis to assess differences between those who chose chorionic villus 
sampling rather than amniocentesis.
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were reported for both the complete sample and separately by whether or not women 
decided to have a subsequent prenatal diagnostic test.
4.2 Results.
Of the 22 women participating in the study, five chose not to have a diagnostic test and 
seventeen chose a diagnostic test (ten amniocentesis and seven chorionic villus 
sampling). The categorised information provided by the health professional during the 
prenatal diagnosis consultations is summarised in table 4:1 and table 4:2. The findings 
from this study are discussed in more detail below.
4.2.1 Provision of sufficient information.
4.2.1.1 Description o f the condition.
Information about Down's syndrome, the abnormality being tested for, was mentioned in 
27% (6/22) of consultations (hp7, table 4:1). The following are examples of the 
information given about Down's syndrome:
description: “Well, it's 20 or 30 years down the line when you've got what is essentially a 
baby still.”
description: “ But yes, there are varying degrees of Down's syndrome so you're not 
going to Know until the baby gets here."
cause: “It's a one off. Nobody knows exactly why Down's syndrome occurs. But what it is, is 
an extra number 21 chromosome. When the sperm and the egg meet instead of dropping 
the chromosome for some reason whenever number 21 occurs, it's kept hold of three not two 
and that's what causes the features of Down's syndrome. 'Cos it's the sperm and the egg, it's 
decided at conception. So don't think it's anything you've done, could or should have done."
Table 4:1 frequency summary of ‘sufficient information’ provided by the health 
professional during the prenatal diagnosis consultation.
Information category Total No test Test
(n = 22) (n=5) ("= 17)
n % n % n %
hp1 Triple Test 22 100%
hp1.1 meaning / describing tt 22 100% 5 100% 17 100%
hp1.2 Edward's syndrome 16 73% 0 0% 16 94%
hp1.3 Spina Bifida 16 73% 0 0% 16 94%
hp1.4 age screening 15 88% 0 0% 15 88%
hp1.5 nuchal pad screening 3 18% 0 0% 3 18%
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Table 4:1 continued...
Information category Total 
(n = 22)
No test 
<"■*>
Test
<n=17)
hp2 No test option 22 100%
hp2.1 explicit “do not have to have test” 21 96% 4 80% 17 100%
hp2.2 19 week scan / screening DS 10 45% 5 100% 5 29%
hp3 Amniocentesis 22 100%
hp3.1 procedure 22 100% 5 100% 17 100%
hp3.2 timing results 22 100% 5 100% 17 100%
hp3.3 abnormalities testing for 17 77% 2 40% 15 88%
hp3.4 certainty diagnostic tests 18 82% 4 80% 14 82%
hp4 Chorionic villus sampling 22 100%
hp4:1 procedure 22 100% 5 100% 17 100%
hp4:2 timing results 19 86% 4 80% 15 88%
hp4.3 Mosaicism 19 86% 3 60% 16 94%
hp5 Miscarriage 15 68%
hp5.1 reasons for miscarriage 15 68% 2 40% 13 76%
hp5.2 other miscarriage 1 4% 0 0% 1 6%
hp6 Termination 10 45%
hp6.1 procedure termination 9 41% 2 40% 7 41%
hp6.2 other termination 5 23% 2 40% 3 18%
hp7 Down’s syndrome 6 27%
hp7.1 description / severity DS 5 23% 2 40% 3 18%
hp7.2 cause / recurrence DS 1 4% 0 0% 1 6%
hp7.3 more information DS/ other service 0 0% 0 0% 0 0%
hp8 Misinformation 16 73
hp8.1 tt cut off point - calculation 7 32% 1 20% 6 35%
hp8.2 mosaicism risk figure - 3/300000 7 32% 1 20% 6 35%
hp8.3 tt unreliable 2 9% 0 0% 2 12%
hp8.4 other screening tests more reliable 4 18% 3 60% 1 6%
hp8.5 other 2 9% 1 20% 1 20%
hp9 Risk figures
hp9.1 tt risk Down's syndrome 22 100% 5 100% 17 100%
hp9.2 age risk Down’s syndrome 14 64% 2 40% 12 71%
hp9.3 amniocentesis miscarriage 22 100% 5 100% 17 100%
hp9.4 chorionic villus sampling 21 96% 4 80% 17 100%
hp9.5 1: 250 cut off triple test 7 32% 2 40% 2 12%
hp9.6 1:100 background risk miscarriage 3 14% 1 20% 2 12%
hp9.7 other 3 14% 1 20% 2 12%
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Table 4:2 frequency summary of the ‘directiveness dimension’ communicated by 
the health professional during the prenatal diagnosis consultation.
Information category Total
(n=22)
No
(n=<
test
5 ]_
Test
(n=17)
n % n % n %
hp10 Comparison risks
hp10.1 comparison tt and age risk 6 27% 1 20% 5 29%
hp10.2 comparison tt and amniocentesis 14 64% 3 60% 11 65%
hp10.3 comparison tt and CVS 11 50% 3 60% 8 47%
hp10.4 other comparisons 4 18% 0 0% 2 12%
hp11 Perception risk
hp11.1 minimise Down’s syndrome risk 15 68% 5 100% 10 59%
hp11.2 augment Down’s syndrome risk 8 36% 2 40% 6 35%
hp11.3 minimise miscarriage risk 2 9% 0 0% 2 12%
hp11.4 augment miscarriage risk 1 5% 0 0% 1 6%
hp12 Facilitate IPDM 22 100%
hp12.1 diagnostic patient’s choice 17 77% 2 40% 15 88%
hp12.2 termination patient’s choice 2 9% 1 40% 1 6%
hp12.3 think about it / reduce time pressure 12 54% 3 60% 9 53%
hp12.4 some have test, others not 10 45% 1 20% 9 53%
hp12.5 invert miscarriage risk / % 21 96% 5 100% 16 94%
hp12.6 invert Down’s syndrome risk / % 21 96% 4 80% 17 100%
hp13 Impair IPDM 17 77%
hp13.1 health professional suggests option 6 27% 1 20% 5 29%
hp13.2 clinician’s own test decision 8 36% 1 20% 7 41%
hp13.3 increase time pressure / don’t wait 3 14% 0 0% 3 18%
hp13.4 why have test if not terminate 14 64% 3 60% 11 65%
hp13.5 woman ‘x ’ had test, baby fine 6 27% 1 20% 5 29%
hp13.6 most have test - not balanced 2 9% 0 0% 2 12%
hp13.7 had triple test so have diagnostic 1 4% 0 0% 1 6%
hp14 Direct questions
hp14.1 ask about termination 13 59% 1 20% 12 71%
hp14.2 ask about having baby abnormality 0 0% 0 0% 0 0%
hp14.3 how Down’s syndrome affect family 2 9% 0 0% 2 12%
hp14.4 how miscarriage affect family 1 4% 0 0% 1 6%
hp14.5 do you need to know for certain 7 32% 3 60% 4 24%
hp14.6 can you live with not knowing 2 9% 1 20% 1 20%
hp14.7 other 0 0% 0 0% 0 0%
hp15 Miscellaneous
hp15.1 compared CVS and amniocentesis 12 54% 2 40% 10 59%
hp15.2 discuss scan/ tt date discrepancy 2 9% 1 20% 1 6%
hp15.3 worst - no test / DS baby 6 27% 2 60% 4 24%
hp15.4 worst - test / miscarry healthy baby 8 36% 2 60% 6 35%
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4.2.1.2 Explanation o f a screen positive triple test result.
All women received an explanation of their screen positive triple test result (hp1, table 
4:1). Most women (16/22) were informed that the triple test also screened for Edward’s 
syndrome and spina bifida (hp1, table 4:1). The cut-off risk figure between a screen 
positive and negative was mentioned in just seven consultations (hp9, table 4:1). 
Typical explanations provided for the triple test result are illustrated below:
screen positive calculation: “I'll go through your report with you as it's come back to me... 
The reason your weight goes into the calculation is you're gonna have less circulating 
hormone if you're six stone wet through than if you're 20 stone wet through. So it's to work 
out the hormones per body weight. That's why that's gone in. The triple test is so called 
because it's worked out on three hormones: alhpa-fetoprotein coming from the baby; 
unconjugated oestriol that is coming from the placenta; and human chorion-gonadtrophin 
that is coming from you.”
screen positive meaning: “What they do in it's simplest terms, it's a diagram, is if we plot a 
graph which is what they do in the labs, we know that there is a normal curve for a normal 
baby. And all the values are gonna cluster within that curve somewhere. And what they're 
going to do is read off how many weeks pregnant you are and what your risk is and that's 
how they work it out. In retrospect if we were to test all the babies that we know have Down’s 
syndrome they would show a completely different curve and the two overlap but you see the 
curve pushed this way for the babies that have got Down’s syndrome. If it's screened you at 
risk, it's not saying that baby has got Down’s syndrome, we're a long, long way off that, but 
they've seen it in this bit of the curve. So they've seen it in this half of the curve if you like. 
So that's in its simplest terms how it's worked out.”
4.2.1.3 Explanation o f the choice to have or not have prenatal diagnosis.
The health professional stated that the choice to have or not have a prenatal diagnostic 
test was the woman’s in 77% (17/22) of consultations (hp12, table 4:2). In almost all of 
the consultations (21/22) women were explicitly told they did not have to have a 
diagnostic test (hp2, table 4:1). Typical examples from the health professional’s 
transcript are:
choice: “I'm not here to say ‘do this, this and this’ ‘cos those days are long gone. I give 
you all the information and support you in the decision you make but it’s up to you what 
you want to do."
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no further testing: “So what I’ll do is I’ll go through the options with you as to what you 
can do about it... now the first thing you could do is nothing. You could say ‘Fine I know 
that I’ve got a 1 in 140 risk of having a baby with Down’s and I’ve a 139 out of 140 risk 
of the baby being normal, so I’m not going to do anything'.”
fetal anomaly scan: “Taking you back to scanning when you said could you see things on 
scan. It would be wonderful if we could diagnose conclusively from scan. We know that 
babies have got 17 markers for Down’s syndrome that you can pick out on the scan. And 
they're things like: they tend to have heart defects but you get a normal baby with a heart 
defect; they tend to get a fatty pad at the back of the neck; they tend to g e t... they hold their 
thumb well away from the fingers; they hold their big toe well away from the other toes. One 
of them in isolation means absolutely nothing but if you saw two or three of those things 
alarm bells would start to ring and we would say at that stage, ‘Perhaps it might be worth 
having testing done’. Now we wouldn't bring your scan forward because it's not big enough to 
see. While at this stage you scan see its heart and you can see it flicking, you can't see if all 
the chambers and the vessels leading from it which is what you're going to need to do to look 
for a defect. But we also know that 50% of babies with Down’s syndrome don't show anything 
on the scan at all. So 50% of babies will be missed on scan. So you could say that we pick 
up the worst ones on the scan. If we don't see any, it's thought to reduce your odds of you 
having a baby with Down’s, but nobody knows to what.”
4.2.1.4 Describing the available diagnostic test procedures.
All women received information about the two diagnostic tests, amniocentesis and 
chorionic villus sampling (hp3 and hp4, table 4:1). The extract below shows the 
information about the test procedure and timing of results that was consistently given. In 
addition the procedure-related miscarriage risk figures were mentioned in most 
consultations (hp9, table 4:1). About two thirds (15/22) of the women received an 
explanation about the reasons for a miscarriage (hp5, table 4:1). Just under half (10/22) 
were given information on termination (hp6, table 4:1). However, the health professional 
also asked women a direct question about termination of pregnancy (hp14, table 4:2). 
When references to both the direct question about termination of pregnancy and 
providing termination information were combined, the issue of termination was raised in 
86% (19/22) of consultations (hp6, table 4:1; hp14, table 4:2).
description tests: “The second would be to have an amniocentesis, which involves putting a 
needle through the wall of your tummy and taking off 15 mils of fluid from around the baby. 
Within that fluid are cells from the baby, both living and dead. By taking off 15 mils we're not
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going to harm the baby but within that fluid we can hopefully get some cells to grow. So we 
would put that fluid in a flask in an incubator and shut the door for three weeks. We're 
simulating conditions inside you and getting those cells to multiply and divide. Hopefully at 
the end of three weeks there will be enough cells grown to look at all the cells and to analyse 
them. Now we can tell you with 99 point whatever percent certainty that baby is normal or 
baby has got Down's syndrome. Nothing in medicine is 100% certain, but as near as we can 
get to it. The risk of you losing a baby from having that done is 1 in 200 or half a percent. So 
you’re weighing up 1 in 130 with 1 in 200. So you could have it done and you could miscarry 
and we could tell you it was normal. The other option that you’ve got is something called a 
CVS or a CVB and it means exactly the same thing, chorionic villus sampling or biopsy. 
Instead of going into the fluid around the baby we can go into the placenta. Within the 
placenta are rapidly dividing cells that you can set up and analyse straight away. We could 
look at those within 24 hours and we could get you a provisional result 24 hours later but 
they'd be 98% accurate. The reason it's only 98% accurate is because we can miss 
something called mosaic downs and those cells don't rapidly multiply and divide. So, to 
capture that, we put the other half of the culture to long term culture the same as the amnio, 
and we leave it for three weeks the same. The backup result that you get at 3 weeks is the 
same as the amnio, 99 point whatever. But the advantage is that you get a faster result in 24 
hours. The disadvantage is it's got a higher risk of miscarriage, it's 1% or 1 in 100.”
miscarriage: “It is - the biggest time is up to ten days after having it done. Once you get 
beyond ten days it's unlikely that you're going to miscarry. I mean it could happen but it's 
unlikely that it's going to happen and if it does you've got to question whether it's the amnio 
that's caused it or whether you were gonna miscarry any way. There are two reason that you 
might, are more likely to miscarry. One is thought to be just the trauma of having the test 
done and that you'd disturbed things within the uterus really, which is unlikely. The biggest 
thing is infection and that's not because we've not cleaned everything and not cleaned your 
tummy but if you're putting a needle through somebody's skin you've got about seven layers 
to get down into the baby, so if there's bacteria sat between the layers then the needle is 
gonna push it through and it's gonna be bacteria that you're never gonna see so it's no good 
saying, 'I think I've got a chest infection or I think I've got a urine infection’ because it's 
bacteria that are unharmful in the right place but harmful in the wrong place. So, if you're 
pushing a needle through various layers if bacteria gets in your uterus that should be there, 
bacteria in your uterus are gonna cause an infection and an infection is gonna cause you to 
miscarry. And we know it would take 10 days for the infection to set up. Now, after having 
either done you don't need to take to your bed or rest completely 'cos if it's gonna happen it's
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gonna happen, whatever. And if infection has gone through, you're not going to stop it getting 
through by resting and carrying on as normal.”
termination: “We'll bring you in as soon as possible but I've got to say to you, it's labour. 
There is no other way to terminate beyond 12/13 weeks. So, I mean, I'll tell you that now. I 
need to put the cards on the table, really, if the worst should come to the worst. And the 
reason is the baby is too big to do it any other way. We can't do like a D&C, suction 
termination, because we'd have to stretch the neck of your womb far too much, so it's putting 
you at risk and it’s potentially putting any future babies at risk. I mean, you might say, 'I don't 
want any more after this’ but we never know what's around the comer for us. So it would 
stretch the neck of your womb too far. The only other way would be to operate, which is 
virtually a caesarean section; so we're putting you at risk for a non-viable baby. So the only 
other way, I mean it's not a full blown labour like it would be if you were at term, but 
nevertheless that's the only way to do it, if the worst should come to the worst.”
4.2.1.5 Misinformation about prenatal diagnosis.
Misinformation about some aspect of the prenatal diagnosis decision was given in 73% 
(16/22) of the consultations (hp8, table 4:1). The inaccuracies most consistently referred to 
by the health professional were explaining the reason for the triple test screen positive cut-off 
point and the likelihood of mosaicism occurring.
explanation cut-off risk: “Every risk comes back individual and it depends on your hormones 
and the baby's hormones. Anything less than 250 we consider high risk. The reason, where 
we drum up the magic 250, is the risk of miscarriage at amnio which is half a per cent or 1 in 
200 and we put the 50 on for people that might have a discrepancy between dates and 
scans, and then you're capturing those three or four days. So that's where we've drummed 
up this magic 250.”
mosaicism: “In all the reported literature, 3 mosaic Down’s have been missed in 300,000. So 
it's remote but nevertheless it's there and I've got to tell you about it.”
In addition, the health professional consistently (22/22) referred to the lowest procedure- 
related miscarriage rates associated with the prenatal diagnostic tests. These figures are half 
the risk of the rates suggested in the appropriate guidelines (Royal College of Obstetricians 
and Gynaecologists, 1993; Marteau, Shaw and Slack, 1995).
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4.2.2 Neutrally communicated information.
To enable informed decision making, it has been suggested that the health professional 
communicate the decision information in a neutral or non-directive style (see section 1.3). 
The following results suggest that the health professional communicated information in a 
manner that might encourage woman’s autonomy in decision making. As mentioned, in 77% 
(17/22) of consultations the health professional explicitly stated that the prenatal diagnosis 
decision was the woman’s choice (hp12.1, table 4:2). In addition, the health professional 
rephrased the risk figures as percentages or inverse risks in most consultations (21/22) (see 
exerpts in 4:2.1.3 and 4:2.1.5). This rephrasing of risk is likely to reduce biasing in the 
appraisal of risk information. Finally, in just over half the consultations (13/22), the health 
professional directly asked women to think about the consequences of a positive diagnostic 
test result, i.e. encouraging discussion of the consequences of testing (hp14, table 4:2). 
These techniques might facilitate a more informed decision making process. However, the 
results also suggest that some statements were communicated in a more directive, less 
neutral style. In each consultation, the health professional expressed at least one personal 
judgement, belief or attitude that may be seen as directive (hp10, hp11 and hp13 in table 
4:2). The directive statements included: direct advice about the options available; reference 
to personal experience of undergoing chorionic villus sampling; judgements about the risk 
figures; inferences as to a ‘correct’ decision or normative behaviour. These directive 
statements may impair women’s decision making autonomy.
direct advice: “To be honest, with it being Bank Holiday, if you have the CVS today 
you're not going to get it while Wednesday. So you've almost waited a week. So with 
the CVS you've taken a high risk and it's not doing what you wanted to do [early result].”
personal experience: “I had chorionic villus sampling... Mine was 1 in 20 when I had mine 
done. And he's fine, normal, healthy."
risk judgements: “So, I mean, we’re talking about a fairly low risk if you turn the figures 
round... the odds are in your favour at 230 to 1."
risk judgements: “You can get a risk of 1 in 10,000 and somebody has got to be the one.”
correct choice: “Now, I mean, I always said if my risk is less than a hundred then I would 
probably go for the CVS because I've got more risk of a Down’s than losing it at CVS and I 
get a faster result. But if it was over a hundred then I would sit tight and have the amnio 
because I'd have the one with the least risk.”
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correct choice: “What I would say to you is, if there is no way you would have a termination, 
there is little point in putting a pregnancy at risk if you're not going to do anything about it, 
ultimately, at the end of the day.”
correct choice: “I would say to you, 'why have you had the triple test done if you’re not going 
to do anything about it?”'
4.2.3 Additional classification categories.
This chapter is concerned with the provision of sufficient information by the health 
professional to ensure women's informed and autonomous decision making. Of the 
additional information categories incorporated in the checklist, only the utterances 
classified by category hp15 (Appendix V) were associated specifically with the prenatal 
diagnosis decision information (see section 4:1.3.2). This section focuses on describing 
the type of information classified by category hp15. The health professional referred to 
one of the following additional, decision-related statements in most consultations (14/22): 
comparing the risks and benefits of the two diagnostic tests; discussing discrepancies in the 
gestation dates based on either the first day of the last period or the dating scan; rephrasing 
the negative consequences of both testing alternatives.
comparison diagnostic tests: “So, with your amnio, you get over 10 days and you think, 
Thank goodness for that, I'm over it’ and then you think, ‘Oh my God, the results are looming 
in another ten days time’. With the CVS you get the results in 24 hours, probably find out it's 
normal and then think, ‘Oh my God I could miscarry up to ten days and I know it's normal’.”
gestation date: “Now that's based on your scan. So that's presuming that you were 15 weeks 
and 6 days. You think that's [scan date] more accurate? Right. If you said to me that I know 
I'm 17 weeks then it would be a completely different risk. It would probably give you a slightly 
higher risk ... because you're further on in pregnancy. But if you think 15 and 6 is more 
accurate then we'll stick to the 15 and 6. So that's what that’s saying, it's based on scan.”
rephrasing negative consequences: “The worst things that can happen to you is you can do 
nothing about this and you can be the one at 40 weeks that gets a baby with Down’s 
syndrome. And it's how would that affect you two and how would it affect your marriage. Is it 
your first baby? How it would affect you two, and you three as a family. At the other end of 
the scale, you could do everything possible and you could have all the tests going and you 
could miscarry and you could lose this baby and we could ring you up and tell you it was
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normal. And it's how would that affect you two, you know, if you'd gone through all the 
testing then they tell you that the baby is perfectly normal.”
4.2.4 Information giving differences by test decision
The frequency pattern of information classified by categories was presented both as a 
complete sample and by test decision (tables 4:1 and 4:2). No formal statistical analyses 
were earned out on these data for two reasons: the main purpose of the study was to 
describe the information provided, not to assess differences or associations; the results of an 
analysis would be meaningless because of the small sample size and large number of 
coding categories. However, broad observations made from the frequency tables suggest 
that women deciding to have or not have a diagnostic test generally received similar 
consultation information. Specifically, women choosing to have no further testing were: 
provided with more information about the fetal anomaly scan (hp2, table 4:1); more likely to 
be informed that the triple test was less reliable than other screening tests (hp8, table 4:1); 
more likely to have the risk of Down's syndrome minimised (hp11, table 4:2); less likely to be 
explicitly informed that the decision was their choice; more likely to be asked if they needed 
to know for certain whether or not the baby had Down's syndrome (hp14, table 4:2). Whereas 
women choosing to have a diagnostic test were: provided with more detail about diagnostic 
testing and miscarriage (hp3-hp5, table 4:1); more likely to be asked whether or not they 
would terminate for Down's syndrome (hp14, table 4:2).
4.3 Discussion.
The purpose of this study was to describe the information provided by the health 
professional when women were making the decision to have or not have prenatal 
diagnosis following receipt of a screen positive triple test result. In particular, the aim of 
the study was to assess whether or not sufficient information was being communicated 
in a neutral manner to enable informed decision making. From the few empirical studies 
that have described the prenatal diagnosis information-giving consultation (Kessler, 
1981; Marteau et al, 1993; Bernhardt et al, 1998), findings suggest that there was 
incomplete information about the testing alternatives to enable informed decision 
making by women. The study reported in this chapter was one of the first to 
systematically document the provision of prenatal diagnosis information by the health 
professional following a screen positive triple test result. There are at least three 
consistencies between the findings of this study and those of prior empirical research.
First, there was little variation in the consultation content between women; and the 
information content of the consultations was similar to that of prior research (Marteau et
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al, 1993; Bernhardt et al, 1998). Most women received the following information: an 
explanation of the triple test result and risk figure; details about amniocentesis and 
chorionic villus sampling, including information about the procedure, timing of the 
results, procedure-related miscarriage rate and identification of chromosomal disorders 
other than Down's syndrome; explicit reference to the woman taking responsibility for 
the final decision; explicit reference to the possibility of termination following a positive 
diagnostic test result. Further, the type of information routinely omitted was similar to 
that of previous research (Marteau et al, 1993; Bernhardt et al, 1998): a description of 
Down's syndrome that included details of its prognosis, occurrence and recurrence rate; 
descriptions of the type of abnormalities not tested for, such as genetic disorders; 
explicit statements about the option to have a termination or not following a positive 
diagnostic test result. In addition, Marteau et al (1993) noted some misinformation given 
during the prenatal diagnosis consultations. This study also described some 
misinformation routinely mentioned during the consultation, the explanation provided for 
the screen positive cut-off point and the likelihood of mosaic Down's syndrome being 
identified; procedure-related risks of miscarriage.
Second, the communication of some information in all the consultations was directive 
(Marteau et al, 1993; Bernhardt et al, 1998). it was clear from the consultation 
transcripts that the health professional had a belief about a correct course of action and 
this was implicitly communicated during the consultation. To explain further, the health 
professional asserted in the majority of consultations that having a prenatal diagnostic 
test and terminating a pregnancy were associated decisions, i.e. that if a woman had a 
diagnostic test she should be considering termination of pregnancy for Down's 
syndrome. Although less frequently stated, the health professional also made a 
connection between having the triple test and choosing to have a diagnostic test, i.e. 
that if a woman has a screening test she should have a diagnostic test. There were a 
number of more subtle communications that may be seen as directive and suggestive 
of a 'correct' course of action (Kessler, 1992; Marteau et al, 1993; Bernhardt et al,
1998): more information was provided about the diagnostic test options and 
consequences than the no further testing alternative; the test alternative was framed as 
an active choice whereas the no test alternative was framed as 'doing nothing’; the 
procedure-related risks of miscarriage were half those documented in guidelines and 
were consistently compared with the triple test risk, so implying that the tests were a 
less risky option than no testing; concrete examples were provided of women having a 
screen positive test result, choosing a diagnostic test and the baby being ‘healthy’, but
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no such comprehensive scenarios were given about women choosing to have no further 
invasive testing.
Third, despite the directiveness of some of the communications, the health professional 
attempted to promote autonomy in women’s decision making by explicitly stating that 
the decision to have prenatal diagnostic testing was their choice (Bernhardt et al, 1998). 
Further, two additional communications within the consultation suggest that the health 
professional was providing conditions amenable with informed decision making: 54% of 
women were encouraged to take their time making a decision; risks were rephrased as 
both percentages and inverse risks in the majority of consultations. To explain further, 
reducing time pressure to make a decision is associated with the employment of more 
systematic decision making strategies (Donnai, 1992; Maule and Edland, 1997). In 
addition, the rephrasing of the risk figures is likely to reduce the effect of ‘framing’ and 
subsequent employment of heuristic processing strategies (section 1.2). Both of these 
factors are akin to a more informed process of decision making (section 1.2).
The structured observational study design was employed to assess the content and 
style of the information communicated by the health professional during the prenatal 
diagnosis decision making consultation. The checklist was developed to classify only 
the health professional’s utterances during the prenatal diagnosis consultation. As a 
consequence, the findings reported in this chapter have limited application to 
understanding the relationship, if any, between the provision of information and 
women’s prenatal diagnosis decision outcomes. For example, the frequency summaries 
suggested that women received broadly similar information by test decision. However, 
frequency patterns from a few sub-categories appeared to differ by test decision. From 
this analysis of the data it is difficult to ascertain whether the health professional 
modified the information given in response to comments from the women stating a 
preferred course of action or whether the women’s prenatal diagnosis decision was 
made following changes to the information provided by the health professional. There is 
little empirical research systematically evaluating the relationship between the style and 
content of information with subsequent decision making outcomes in the context of 
prenatal diagnosis for Down's syndrome (Marteau et al, 1993; Figueires and Marteau,
1999). It is likely that some directively communicated information is detrimental to the 
informed decision making process, whereas another communication provides 
appropriate reassurance (Kessler, 1992). An example might be the health professional’s 
description of the triple test risk for Down's syndrome (section 4:2.2): stating a value 
judgement for a 1 in 230 risk as ‘low’ may influence the woman’s evaluation of the risk
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and, therefore, the subsequent decision about testing; stating that most women will have 
a normal baby or “the odds are in your favour at 230 to 1” is a more accurate evaluation of 
the risk and may be appropriately reassuring. As this thesis is concerned with informed rather 
than shared doctor-patient decision making (Coulter, Entwhistle and Gilbert, 1999), it is 
beyond its scope to explore the woman-health professional interaction further.
4.4 Chapter Summary.
The main aim of the study was to assess whether or not the information-giving 
consultation would enable women to make an informed and autonomous decision about 
prenatal diagnostic testing. The findings reported in this chapter suggest, then, that 
women had sufficient information to have a diagnostic test but not to make a decision to 
have or not have a diagnostic test for Down's syndrome. In addition, some of the 
information communicated implied a correct course of action, that of having a 
diagnostic test. However, the health professional did explicitly specify the women’s role 
in and responsibility for making this prenatal diagnosis decision. Although these findings 
indicate a comprehensive provision of test information for women, it is unlikely that the 
conditions have been met to enable women to make a fully informed decision about 
prenatal diagnosis following receipt of a screen positive triple test result. For the 
consultation to contain ‘sufficient’ information, a description of Down's syndrome and a 
more detailed discussion of the decision to terminate or not should be included. 
Reducing the directiveness of the information communicated requires a number of 
changes: rephrasing the no invasive testing option as an active choice; the provision of 
accurate information or reduction of misinformation; explicit emphasis on any course of 
action being acceptable, such as whether to have no invasive testing or testing for 
information only.
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5. Prenatal diagnosis: describing the process of 
women’s decision making.
This chapter focuses on describing the decision making process of women choosing to 
have or not have prenatal diagnosis upon receipt of a screen positive triple test result. 
In particular, this chapter is concerned with describing whether or not women’s prenatal 
diagnosis decision making was informed. One of the main objectives for those offering 
prenatal diagnosis is to ensure that women make an informed decision about testing 
(Royal College of Physicians, 1989). As there are few agreed criteria on what 
constitutes an informed decision within the medical literature (Marteau, 1995), there is 
little empirical research operationalising and assessing patients’ informed decision 
making (see chapter two). However, proponents of reasoned-choice theories of decision 
making (Janis and Mann, 1977; Zey, 1992, 1998; Baron, 1994; Frisch and Clemen,
1994) have developed a standard with which to evaluate the quality of individuals’ 
decision making. This standard of good decision making provides an adequate 
operationalisation of informed decision making (see section 1.2). In brief, assessing the 
quality of a decision requires an appraisal of the decision making process, i.e. a 
description of the strategies employed to reach a decision. A good decision ought to be 
based on an evaluation of the consequences of the different options, an accurate 
assessment of the consequences and a trade-off between the consequences of the 
decision alternatives (Frisch and Clemen, 1994; section 1.2).
Few, if any, empirical studies evaluating the quality of women’s prenatal diagnosis 
decision making have employed a methodology to assess the decision making process 
(see section 1.3.2). The majority of studies used a prospective or retrospective study 
design. In other words, women completed questionnaires or were interviewed before or 
after they had made their decision to have or not have prenatal diagnosis. No published 
studies assessed the decision making process concurrently with women making the 
prenatal diagnosis decision. In addition, the dominant decision making theory or 
paradigm underpinning the development of these questionnaires and semi-structured 
interviews is that of expected-utility theory (EUT). That is to say, there is an assumption 
amongst researchers that women's prenatal diagnosis decisions are logically associated 
with evaluations of the likelihood of the consequences occurring and the value attached 
to their occurrence. In consequence, most empirical studies within the prenatal 
diagnosis context have assessed women's attitudes, perceptions of risk and measures 
of decision outcome, such as knowledge, affect and satisfaction. The findings from
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these studies suggest that women do make decisions about prenatal diagnosis by 
weighing up the advantages and disadvantages of the two testing alternatives (see 
section 1.3.2). In addition, factors such as attitudes towards termination of pregnancy, 
perception of the risk of abnormality and perceptions of the miscarriage risks are 
associated with the decision to have or not have testing. However, there is little 
empirical evidence assessing whether or not women made informed decisions, as no 
published studies to date have operationalised informed decision making.
The naturalistic decision making (NDM) approach to understanding individuals’ decision 
making has been to describe the strategies employed by individuals when making real- 
world decisions (Lipshitz, 1993). In part, the development of NDM research was a 
response to findings of earlier studies which ascertained that individuals have a 
‘bounded rationality' (Simon, 1955). To explain further, it is unlikely that individuals 
have the cognitive capacity to assimilate evaluations of the probabilities and values 
associated with the consequences of all decision alternatives as proposed by EUT 
(Allais, 1953; Ellsberg, 1961; Tversky, 1969; see section 1.2). Indeed, evidence 
suggests that individuals employ information processing strategies such as heuristics 
and satisficing to limit the amount of information assimilated when making a decision 
(see section 1.2.1.2). If individuals selectively attend to aspects of the decision 
information, it is unlikely they are making fully informed decisions. As no published 
studies to date have described the process of women’s prenatal diagnosis decision 
making, it is unclear what strategies women employ when assimilating the test 
information and whether or not these strategies facilitate or impair informed decision 
making.
The purpose of the study reported in this chapter is to describe the process of women’s 
decision making about prenatal diagnosis following receipt of a screen positive triple 
test result. As cognitions cannot be directly measured, a process tracing technique was 
employed to assess the information utilised by women during the prenatal diagnosis 
information giving consultation. Two common techniques employed to trace the 
decision making process are verbal protocols and information tracing techniques 
(Payne, 1980; Harte, Westenberg and van Someren, 1994; Harte and Koele, 1997). As 
discussed in chapter 1, the most direct process tracing technique is that of the verbal or 
‘think-aloud’ protocols. The researcher encourages the individual to verbalise the 
thoughts raised while making the decision. Verbal protocols do not require the individual 
to reflect on the decision making process but to talk through normally silent cognitions.
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Although it is unlikely that the generation of verbal protocols alters the decision made, 
there is evidence that verbal protocols slow down the decision making process (Payne, 
1980). In additional, there is evidence that introspecting about the decision making 
process may be associated with greater post-decision regret or dissatisfaction (Wilson, 
Lisle, Schooler, Hodges, Klaaren and Lafleur, 1993; Wilson, Hodges and Lafleur, 1995). 
As women find the prenatal diagnosis decision distressing (section 1.1.4), such an 
active tracing technique was not considered appropriate for this health context and 
decision.
The information search methods are less interactive and require the researcher to 
document the information utilised or referred to by individuals when making their 
decision. The use of an audio or video tape-recorder would record the information 
referred to by women concurrently with their decision making. The information giving 
consultation women receive prior to making their prenatal diagnosis decision provides a 
good opportunity to employ an information search technique. In each consultation, the 
information provided by the health professional is consistent (see chapter four) and the 
purpose of the consultation well defined. That is to say, the conditions of the decision 
context are comparable for each woman making the decision to have or not have 
prenatal diagnosis upon receipt of a screen positive triple test result.
The aims of this study are (a) to describe the information referred to by women when 
making the prenatal diagnosis decision, (b) to assess differences in the pattern of 
information referred to by women choosing to have or not have prenatal diagnosis and 
(c) to evaluate whether or not the decisions made by women were informed.
5.1 Methodology.
5.1.1 Sample.
Forty-six women who received a screen positive triple test result from the Leeds 
General Infirmary (LGI) were invited to take part in this study. Forty-four women agreed 
to participate (section 4.1.1 provides a more detailed explanation of the triple test 
screening protocol for the LGI).
5.1.2 Design.
A non-experimental, cross-sectional observational study design was used to describe 
the process of women’s decision making during this information giving consultation. An 
audio tape-recorder was used to record the content of the prenatal diagnosis
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information-giving consultations (see section 4.1.2). The consultation audio tape- 
recordings were transcribed fully by a third party (KM). The transcribed women's 
utterances provided the data source for this study.
The demands of this study’s research questions were important in selecting an 
appropriate sample size for subsequent analysis. Studies aiming to generate data- 
driven theories about women’s decision making are inclined to focus on between five 
and twelve transcripts (Payne, 1980: Smith, 1995). The transcripts may require detailed 
analysis on a number of different levels such as: noting the occurrence of certain words 
or phrases; carrying out a phenomenological interpretation of utterances to suggest 
associations between phrases with underlying meanings of pertinence to the individual; 
coding of paralinguistic features such as interruptions, intonation, pauses and repetition; 
applying a theoretical analysis to make associations between the different patterns 
coded from within the data (Robson, 1993; Charmaz, 1995; Smith, 1995). However, the 
purpose of this study was to describe the process of women’s decision making 
concurrently with the decision to have or not have prenatal diagnosis.
A quantitative content analysis (Millward, 1995) was applied to the consultation 
transcripts to identify themes or categories classifying women’s utilisation of information 
when making the prenatal diagnosis decision. This type of analysis provides a 
numerical summary of the presence or absence of theoretically driven categories within 
the real-world setting rather than the generation of a new theory. In this decision 
context, theories of decision making and empirical evidence from prenatal diagnosis 
studies were used to inform the identification of themes and subsequent categories. 
Each consultation transcript was assessed for the presence or absence of these themes. 
In other words, the transcript data was systematically coded and interpreted with 
reference to an appropriate literature (Millward, 1995; Bowling, 1997). Although no 
optimum sample sizes were provided for this type of analysis, data from 20 individuals 
is referred to as small and from more than 60 as unlikely to contribute more to the 
interpretation of the data (Millward, 1995). In essence, the sample size for this study 
was based on a compromise between adequately answering the research questions 
within the permitted study time and consideration of the aforementioned range of 
participants.
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5.1.3 Procedure.
The procedure employed for this study is the same as that described in chapter four. In 
brief, all women with a screen positive triple test result were informed of their result by 
telephone or letter if a telephone number was not available. On attending the antenatal 
clinic for the prenatal diagnosis information giving consultation, women were informed 
of the study. The consultations of women agreeing to participate were audio tape- 
recorded. The utterances of 22 women included in this study were transcribed from the 
same consultations described in chapter four.
As mentioned, this sample size was an insufficient number to carry out a quantitative 
content analysis. To increase the number of participants in this analysis, transcripts 
from another study audio tape-recording this information giving consultation were added 
to the analysis. To explain further, the author (HB) carried out a randomised control trial 
to assess the effectiveness of decision analysis in facilitating women's decision making 
about prenatal diagnosis. Although this study is described in greater detail elsewhere 
(see chapter six), it is necessary to mention its control and experimental groups. The 
information giving consultation for women randomised to the control group was the 
same as that described in chapter four, i.e. routine care offered by the LGI. The 
information giving consultation for women randomised to the experimental group 
received information structured by the decision analytic technique (section 1.2.1.3). As 
mentioned, the author (HB) was introduced to women as a member of the ante-natal 
team throughout the data collection period of this thesis. Initially, the author observed 
the content and structure of the information giving consultation in order to be 
acquainted with the routine delivery of information in this health context. Once the ante­
natal team was confident of the author’s ability, the author became the primary 
information-giver for women receiving a screen positive triple test result. The author 
aimed to follow the same pattern of information giving and to provide the same type of 
information during the control arm of the trial as was offered routinely by the ante-natal 
staff at LGI. In essence, the consultation described in chapter four and the control group 
of the randomised control trial were comparable consultations. To increase the sample 
size for this chapter's analysis, the consultation transcripts of the first 22 women 
allocated to the randomised control trial’s control group were also included for 
assessment. During this six-month data collection period of the randomised control trial, 
two women invited to take part declined participation.
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5.1.4 Coding frame development.
Transcripts of consultations generate a large amount of qualitative data. The purpose of 
a coding frame is to develop themes to summarise this plethora of information in a 
meaningful manner. By applying the same coding frame to each transcript, information 
can be extracted and classified systematically. The most important aspect of content 
analysis, then, is the generation of themes (Robson, 1993; Bowling, 1997). The themes 
or categories group items together, thus enabling the data to be managed more 
efficiently. The theme content may be defined according to an aspect of theory or 
following assessment of similarities between items within the transcript data (Millward, 
1995). Themes are designed to be both exhaustive and mutually exclusive (Robson, 
1993; Smith, 1995). That is to say, all items within a transcript can be assigned to one 
theme only. In practice, the items derived from conversational transcripts are often 
inter-related and not independent utterances. Therefore, in some situations, the 
researcher is either required to make judgements about an item to ensure exclusivity or 
to occasionally multiply categorise an item (Robson, 1993). The generation of themes is 
laborious and time-consuming as it requires continual reference to the transcript, items 
extracted, working themes and theoretical basis of categories (Robson, 1993; Smith,
1995).
The themes for this study were developed in five stages. First, the unit of analysis was 
defined, i.e. the aspect of the text to be classified. Second, the items identified from 
preliminary analysis of the text were clustered by similarity of meaning. Third, 
preliminary themes and theme titles were generated from these item clusters and 
piloted on a half the transcripts. Fourth, the themes and theme titles were revised to 
incorporate changes from the first piloting and applied to remaining transcripts. Finally, 
the themes and theme titles were modified again to form the final coding frame. The 
final coding frame was applied to all forty-four transcripts. These five stages are 
discussed in more detail below.
5.1.4.1 Unit o f analysis: coding frame development.
So far, the woman has been referred to as the decision maker because (a) the woman 
experiences the consequences of any prenatal diagnosis decision and (b) it is the 
woman’s consent that is required before any procedures can be carried out. However, it 
is unlikely that the decisions made about tests, terminations or continuations of a 
pregnancy are made solely by the woman. Indeed, most women (40/44) attended this 
information giving consultation with a companion to whom the purpose of the
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consultation had been disclosed. During the consultation, it was frequently observed 
that the companion and woman decision-maker talked with each other about the 
decision and finished off the other’s sentences. In addition, the companions raised 
questions and concerns of their own as well as referring to issues expressed previously 
by the woman decision-maker. The woman decision-maker was exposed to both the 
reasoning, questions and additional information following a question of the companion 
during the consultation. The purpose of the study was to describe the information 
referred to during the consultation and not the nature of the interactions between the 
health professional, woman and companion. As the woman decision-maker and 
companion were both focused on issues associated with making the decision to have or 
not have a test, utterances made by either party were coded as information utilised 
during the consultation. For consistency, these collective utterances were referred to as 
those of the woman decision-maker.
The unit of analysis, coding unit (Millward, 1995) or recording unit (Robson, 1993) is the 
verbal utterance that is used to form the content of the categories in the coding frame. 
This unit of analysis may be anything from counting the occurrence of words to the 
number of stories on a page within a newspaper. Again, the researcher defines the unit 
of analysis in accord with the aims of the research questions. Complete phrases were 
used as the unit of analysis within this study. As the transcripts were of conversational 
interactions, a phrase could be part of a sentence or include more than one sentence. 
The phrase ought to provide a unit of analysis that unambiguously referred to a piece of 
information used by a woman while making the prenatal diagnosis decision. All 
complete phrases or ‘items’ from each transcript were recorded on a separate document 
referred to as the ‘item-list’ (see Appendix VI). This document was updated following 
analysis of each transcript. Once all the items had been generated, an item-list was 
completed for each transcript so documenting the number of times an item was referred 
to by a woman. Some examples of the types of items included on the item-list are: 
“Down's syndrome is not in our family”; “I had the triple test to find out so I should have 
a diagnostic test”; “my husband would not cope with a Down’s syndrome child”; “Does 
the test hurt?’’.
5.1.4.2 Item clustering: coding form development.
Broad titles were created to aid the first author in locating items coded when updating 
the item-list (see Appendix VI). Items were clustered under the following titles: questions 
asked; comments about the triple test; use of risk figures; perception of risk; causes of 
Down's syndrome; reasons for not having a diagnostic test; reasons for having a
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diagnostic test; reasons for choosing one diagnostic test over another; planning to have 
a test or not; perceptions of having a child with an abnormality; comments about 
termination; perceptions of norms; experience of Down's syndrome; experience of 
prenatal and genetic testing; comments about pregnancy and health; expressed affect 
and dissonance with decision making; previous advice or comments by health 
professionals.
5.1.4.3 Preliminary themes and titles: coding frame development.
The preliminary themes were informed with reference to both decision making theory 
and empirical evidence from studies of women's prenatal diagnosis decision making 
previously summarised in chapter one. The preliminary themes focused on issues of 
women’s informed decision making within the context of prenatal diagnosis and are 
described in more detail below.
Classical decision making theory: The expected-utility explanation of decision 
making has influenced much of the prior research assessing women’s prenatal 
diagnosis decision making. In consequence, attributes of EUT, such as evaluations of 
attitudes and risks associated with the decision consequences of alternatives, provided 
themes for subsequent categorisation of items.
Decision making strategies: The NDM models and evidence from studies describing 
the decision making process suggest that a number of strategies are used by individuals 
when making decisions. The coding frame included themes to classify examples of 
either an heuristic or systematic evaluation of the decision information. In addition, the 
evidence from real-world decision making research suggests that people use reasons 
rather than attitudes to rationalise their decisions (Shafir, Simonson and Tversky, 1993). 
In consequence, reasons for and against attributes of the prenatal diagnosis decision 
were included as themes.
Inform ed decision making: The seven stages of vigilant information processing (Janis 
and Mann, 1977) provided additional themes for classification of women’s utterances. In 
brief, these seven stages include: canvassing a wide range of alternatives; identifying 
values associated with the consequence of the choice; weighing the costs and benefits 
of each consequence; search for new information; correctly assimilating new 
information; re-examining the costs and benefits of the consequences; making provision 
for the implementation or execution of the chosen alternative.
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Autonomy in decision making: Empirical evidence that suggests women may receive 
directive information from others that compromises their ability to make an informed 
decision. A theme was included to classify utterances of women which indicated that the 
woman had received advice from a third party about a particular course of action.
Decisional conflict: Empirical evidence suggests that women find making the decision 
to have or not have prenatal diagnosis difficult. The decision making literature refers to 
this difficulty in choosing between two risky alternatives, both with negative 
consequences, as decisional conflict. One theme classified items as pertaining to 
explicit utterances about the experience of making a decision.
Affect: Aside from decisional conflict, there is empirical evidence to suggest that 
women are distressed upon receiving a screen positive triple test result. In addition, 
some women expressed reassurance upon receipt of tests during pregnancy. One 
theme classified utterances that expressed some dimension of affect.
The items from the first set of 22 transcripts were grouped with reference to these 
themes. During this process, it was clear that the Janis and Mann stages of systematic 
decision making and the expression of attitudes towards the consequences of the 
decision were inappropriate themes to categorise women’s utterances. First, women’s 
information seeking about alternatives could be classified as both information seeking 
and/or planning to implement a chosen course of action. Second, women seldom made 
explicit reference to the utility or attitude of a consequence; consequences were more 
likely to be referred to within either a positive, neutral or negative frame. For example, 
women were more likely to say “I don’t want to miscarry” rather than “miscarrying is 
bad” or “I couldn’t cope with a Down's syndrome child” rather than “I perceive the 
severity of Down’s syndrome to be great”. These themes were revised during the next 
stage of the coding frame development.
5.1.4.4 Revised themes and theme titles: coding frame development.
The revised themes simplified the categories describing informed decision making. 
Items about the ‘no test’ and 'test' alternatives were grouped into one of four categories: 
information seeking about the alternative; consequences of the alternative; systematic 
reasons for selecting or rejecting the alternative; heuristic reasons for selecting or 
rejecting the alternatives. A systematic reason was one that referred to the 
consequences of the alternative, such as “I want a diagnostic test because I would 
terminate for Down's syndrome”; a heuristic reason was one that did not refer to the
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consequence, such as “I had the triple test, so I should have the diagnostic test”. The 
two themes that grouped items by actual and perception of risk were maintained. In 
addition, a number of themes were developed to account for the information referred to 
during the consultation outside the parameters of informed decision making: further 
information about the triple test; affect about the triple test; affect about decision 
making; reflections on the decision making process; questions about Down's syndrome; 
reference to their personal prenatal testing experience; reference to others’ prenatal 
testing experience; reference to other sources of information. These themes provided a 
more comprehensive classification system for coding all women’s utterances.
Each phrase on the item-list was allocated to a theme. The appropriateness of the item 
included within a theme was discussed with a colleague familiar with the applied 
literature on prenatal testing (JH). The revised coding frame was applied to the second 
set of 22 transcripts. In addition, a colleague familiar with the area of genetic 
counselling (AM) along with the first author applied the coding frame to three transcripts 
selected at random from the first set of twenty two transcripts. The discussions from 
these activities and the difficulties in allocating items to themes initiated further changes 
within the coding frame:
• The informed decision making themes were simplified to reflect the three stage 
standard proposed by Frisch and Clemen (1994): an evaluation of the 
consequences of the different options; an accurate assessment of the 
consequences; a trade-off between the consequences of the decision alternatives.
• The distinction between ‘heuristic’ and ‘systematic’ reasons for selecting an 
alternative was unreliable and, in consequence, removed from the coding frame. 
The simplified categories classified reasons for an alternative as either reasons for 
or against a course of action (Shafir, Simonson and Tversky, 1993). An additional 
category was required to classify the seeking of information rather than the 
generation of reasons for or against an alternative.
• Previously, the consequences associated with an alternative were attributed to 
either the ‘test’ or 'no test' alternative and classified accordingly. However, the 
consequences may be associated with both decision alternatives. For example, a 
woman may have a Down's syndrome baby whether or not she chooses to have a 
diagnostic test. Three themes were subsequently included to classify items 
pertaining to the consequences of the prenatal diagnosis decision independent of 
the two decision alternatives. The consequence themes contained three sub­
categories to classify utterances as either information seeking, positively framed or 
negatively framed references.
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5.1.4.5 Final themes and titles: coding frame development
The revised coding frame was applied to all transcripts (see Appendix VII). Twenty 
themes were developed to include issues of informed decision making and other factors 
referred to when making the prenatal diagnosis decision. Five transcripts were selected 
at random to assess the inter-rater reliability of coding between the first author and a 
colleague (AM). In total, ninety statements were coded by both the author and AM. 
Cohen’s Kappa coefficient was calculated to assess the degree of concordance between 
the two raters’ application of the checklist to the five transcripts. The value of the Kappa 
coefficient was 0.83. As this figure falls above 0.75, it suggests an excellent degree of 
agreement between the two raters (Robson, 1993). The themes and sub-categories that 
classify women’s utterances during the information giving consultation about prenatal 
diagnostic testing are described in more detail below. Quotes from the transcripts of 
women's utterances are used to illustrate further the theme's content.
1. No test option: The theme included items referring to alternatives other than the 
diagnostic tests offered, such as having no invasive testing, and to queries about the 
non-invasive alternatives such as the nineteen-week fetal anomaly scan. The theme 
had three sub-groupings: information seeking or planning for this alternative; reasons in 
favour of this alternative; reasons against this alternative. The following are examples 
of the information seeking items coded within this theme: “ If we went on, can they test 
the baby when it is born?’’; “Would it be possible to wait and see from the scan?"; “What 
sort of markers do they look for in the scan for Down's syndrome?”; “But there might be 
markers if it’s an ordinary person?”. The following are examples of reasons generated 
for an alternative; “So we have the reassurance of the scan anyway”; “I would like to 
have the scan and know how much information you can get from the scan"; “The 
advantage is that there is no risk to the child”. The following are examples of reasons 
generated against an alternative: “The scan might not tell us for definite”; “I definitely 
couldn't go on for six months without knowing”; “There’s also that risk that if you don’t, 
for the full term baby [being Down’s syndrome]”.
2. Test option: The theme included items about diagnostic tests in general. The same 
three sub-groupings as the 'no test’ option were retained. The following are examples of 
the information seeking items coded within this theme: “So if you decided to have the 
test, how soon can it be done?”; “Are the tests a hundred per cent reliable?”; “I read the 
more experienced the person the less risk there is so obviously we wouldn’t want 
anyone inexperienced doing the test” ; “Do they scan while they are doing it?”. The 
following examples as reasons generated for this alternative: “I think for our own peace
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of mind we have got to know”; “But I would like the choice, I think I would like to know, I 
think I would like to make an informed choice"; “I think it's better to know. It’s better to 
prepare ourselves”; “I know that there is that risk you can miscarry but I think it 
outweighs the problem having, at nine months, a baby that is going to be [Down’s 
syndrome]”. The following are examples of reasons generated against this alternative: 
“I’m pretty sure in my mind I don’t want amniocentesis or chorionic villus sampling, I 
suppose my reasoning is that it is likely to be a normal baby and there is quite a high 
risk of miscarriage”; “the thought of having needles stuck in my stomach is completely 
horrible”; “there is a bit of me that doesn’t want to know”; “ I think I would prefer not to 
have an invasive test”.
3. Choice between tests: This theme included items that made neutral comments 
about choosing between tests, for example: “It gives us time to think about it and 
discuss which test we would want to have then”; “So both tests is what, a three week 
period waiting for them [the results]”; “Why would you want to do a chorionic villus 
sampling rather then an amniocentesis?".
4. Chorionic villus sampling: Items referring explicitly to chorionic villus sampling 
were classified within this theme. The sub-groupings were the same as the previously 
defined. So, examples of information seeking utterance about this testing option are: 
“I’m just going through it in my head . . .  the next day you would be able to say yes it 
definitely has got it but you wouldn’t be able to say no it definitely hasn’t until three 
weeks afterwards?”; “Is the risk of miscarriage with chorionic villus sampling less or 
greater if you’re further, you know, for your pregnancy”; “Are the chances of miscarriage 
the same as with the other [amniocentesis] test?”. The following are examples of 
reasons for the test alternative: “I can see the attraction of the chorionic villus sampling 
with it being so quick”; “The only advantage of that is you get a quicker result?”. The 
following are examples of reasons against the alternative: “You are taking an additional 
one per cent risk just for that [quicker result] and there is no need for that at this stage 
anyway”; “You would have to wait three weeks anyway for the chorionic villus sampling 
to be absolutely positive”; “But the miscarriage risk is a lot higher for that isn't it” .
5. Amniocentesis: Items referring explicitly to amniocentesis were classified within this 
theme maintaining the same sub-groupings as previously used. Examples of the 
information seeking utterances are: “Do you have a per centage on how many people 
have the amniocentesis?”; “You know the amniocentesis, how long do you wait for that 
one [the results]?”; “[Does] the risk of amniocentesis vary between clinics?’’. The
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following are examples of reasons generated for the alternative: “You've still got to go 
through the same outcome [termination] whether it was tomorrow or three weeks, so I 
would rather cut down the risk”; “It’s worth it, just for the peace of mind, it’s worth waiting 
those three weeks"; “I suppose my initial reaction would be to sit with the 
amniocentesis”; “ the reasons that we had the amniocentesis last time are even stronger 
this time”. The following are examples of reasons generated against the test alternative: 
were “Three weeks is a long time to wait”; “The problem we have got is that with the 
amniocentesis there is an elevated risk of miscarriage”; “I hate the three or four weeks 
waiting”.
6. Down's syndrome (consequence): Items referring explicitly to the consequence of 
having a baby with Down's syndrome were classified within this theme. The three sub­
classifications were maintained but were referred to as information seeking, positive or 
neutral reference and negative reference rather than information seeking, reasons for 
and reasons against. The following are examples of information seeking items about the 
consequence: “Does it make any difference that we are half cousins, I mean there is no 
history of disabilities on either side of the family?’’; “The thing is that if we are told at 
some point that this is likely to be a Down's syndrome baby then obviously I would want 
to know a lot more about life expectancy and the quality of life”; “Have you any idea 
what actually causes this extra [chromosome]?”; “Can they tell straight away when it’s 
born?”. The following are examples of neutral or positive comments about Down's 
syndrome: “A kid with Down's syndrome is fair enough . . . it’s still a child”; “ I have heard 
them on the radio, they can read”; “We know what a Down’s syndrome baby is . . .  It’s a 
very wide ranging disability” ; The following are examples of negative references or 
images of the consequence; “I’d be hysterical if I had a baby like that, I just couldn’t 
cope with one”; “We wouldn’t be happy with the responsibility of a Down’s and we’d 
always be worried”; ”1 know this sounds awful but it [baby with Down’s syndrome] is 
imperfect and that is how we would see it”.
7. Miscarriage (consequence): All items referring to miscarriage were included within 
this theme with the sub-classifications of information seeking, positive or neutral 
comments and negative comments. The following are examples of information seeking 
itmes about the consequence: “What creates the risk of miscarriage?’’; “How long would 
it be if I were to miscarry, within days?”; “Can I ask an ironic question? If I were to 
miscarry as a result of having the amniocentesis, do they tell you whether the baby was 
OK or not?”; The following are examples of the neutral or positive comments about the 
consequence: “ I’d rather take the chance [miscarry as a result of test] than worry for the
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next few months"; “ If we have a miscarriage, we have a miscarriage and that's it. We’ll 
try again”. The following are examples of negatively classified items: “It’s the risk of 
miscarriage that bothers me”; “ I’m not scared of amniocentesis, I’m scared of 
miscarrying as a result”.
8. Termination (consequence): All items referring to termination were included within 
this theme, with the same sub-groupings as the other consequence themes. Examples 
of information seeking items are: “If it’s got Down's, now am I right in saying that in 
three weeks time if it’s got Down’s and we have to terminate we have to go through 
labour, now is that the case?’’; “Let us assume that it is Down's syndrome, how soon 
after that would I be booked in for termination”; “What's the last date you can 
terminate?”. Positive or neutral items about termination were: “Well, we said we would 
have a termination”; “Because as I say, I don’t think we would have gone through with 
the tests if we weren't going to do something about it”; “I'd consider termination I think”. 
Examples of negative references to termination were: “I wouldn’t terminate, I don’t think 
I could”; “So that’s [labour termination] going to be pretty horrendous"; “ I don’t think we 
would want an abortion for the sake of Down’s syndrome".
9. Risk figure reference: Simple categories of reference to risk were developed for this 
study in an attempt to describe general patterns of information used by women when 
making the decision to have a diagnostic test. This theme's sub-groupings were 
reference to a single risk figure for Down's syndrome, a single risk figure for miscarriage 
and a comparison of risks. Examples of the single risk reference to Down's syndrome 
are: “Did you say the borderline was 1 in 250?”; “So basically we’ve got less than a 1% 
chance having a Down’s syndrome child?”; “I just wanted to know exactly how sort of 
you knew it was 1 in 250?”. Examples of the single risk figure for miscarriage were: “So 
that 1 in 100 is a national figure?”; “The current risks, do amniocentesis run into 1 in 100 
or 1 in 200?”. Examples of the comparison between risks are: “It's the balance of the 
risk of not knowing against the risk of [miscarriage], it’s not brilliant”; “I think the risk of 
Downs of 1 in 10 is slightly higher than that of the procedures we are talking about”.
10. Perception o f risk reference: Four sub-groupings were used to classify perception 
of risk items: minimising Down’s syndrome risk; augmenting Down’s syndrome risk; 
minimising risk miscarriage; augmenting risk miscarriage. Examples of minimising risks 
are: “I wouldn’t bet on that”; “It’s still pretty good odds though”; “ It’s only 1%”; ”So it’s a 
very small chance". Examples of augmenting risks are: “But you never know if you’re
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going to be that 1%”; “I know but it’s still a lot”; “There is quite a high risk of 
miscarriage”.
11. Decision making process (decisional conflict): Women’s utterances pertaining to 
the decision making process were classified by this theme. The sub-categories reflected 
decision making about the following: the triple test decision; making a diagnostic test 
decision before the information giving consultation; expressed delay in making the 
diagnostic test decision. Examples of each of these categories are: “We wanted the 
triple test for our own personal knowledge”; “We had made it [decision to have 
diagnostic test] before we had the triple test”; “I think we might need to think about it for 
a bit”.
12. Expressed affect: This theme incorporates three sub-groupings pertaining to items 
of affect mentioned by women during the consultation: negative comments about 
receipt of the triple test result; phrases reflecting difficulty or ‘decisional conflict’ in 
making the diagnostic test and termination decisions; references to reassurance or 
positive phrases about testing. Examples of items within each category are: (receipt 
triple test), “It’s a bit of a shock really” , “ It’s hard just to take it in isn’t it?” and "I mean, 
it’s just another knock is this”; (decisional conflict), “It’s a hard decision”, “ I mean all the 
way through you’re thinking we’ll face that when we come to it”, “I don’t want to do it but 
that is the decision, it sounds ambiguous doesn't it?” and “morally it’s the hardest 
decision because technology puts that decision upon you doesn’t it?”; (reassurance 
about tests), “It [triple test screen negative] might be reassuring for some women”.
13. Triple test: This is a broad theme incorporating all the items expressed by women 
about the triple test. No sub-classifications of this theme have been created as the 
decision to have or not have a diagnostic test should, theoretically, be independent of 
the previous decision to have the triple test. Some examples of the items within this 
category are: “What do they actually test for, it’s Down's and what else?”; “I never got 
screened with the first baby and if I had of been would that have been high as well?”; 
“Would they have told us if it was over 250?”; “I’m just clutching at straws here but can 
the bleeding I had, can that have an abnormal reading on the blood results?’’.
14. Confidence with screening results: This theme includes items mentioned by 
women when discussing the reliability of screening tests and their results. Some 
examples are: “But the hospital she had the triple test done in is not doing it anymore 
because they say there were such incoherent inaccuracies in the triple test”; “So that
99
[triple test risk result] is more factual than that [age related risk result]?”; “Yes it’s 
strange that just a week could make such a difference . . .  you know it’s just curious”.
15. Comparison with norms: The items within this theme were mentioned by women 
trying to establish a consensus with the normative prenatal diagnosis response. For 
example: “On the whole what, if people are at this stage, what do they do?”; “Which is 
the best one to have then? What would you recommend?”; “Out of those people could 
you actually give a percentage who have actually had the test that have said ‘yes, it’s a 
Down’s’ or ‘not it’s not’?”; “Am I common or not [triple test result risk figure]?”.
16. Personal experiences: Within this theme the four sub-groupings were items 
referring to the woman’s experience: physical changes with pregnancy; complications 
with pregnancy; previous pregnancies and prenatal testing; familiarity with abnormalities 
or genetics. Examples for each category are: “It’s different once you start feeling 
something” and “The worse thing was I saw it last week on the scan”; “ It is difficult 
because we have lost three pregnancies” and ” l’ve been to the doctor’s this morning 
because I had a bleed yesterday and a slight bleed this morning”; “We had a child about 
18 months ago and we had the triple test done with her” and “We hit a Bank Holiday last 
time . . . nearly four weeks before we got the results”; “I’ve had quite a few scans and 
the sort of genetic risk was 50-50".
17. Others experience: Items were coded under two sub-groups within this theme, 
prenatal testing and abnormalities or genetics. Examples of each sub-category are: “A 
friend recently who was pregnant with twins and she had amniocentesis and she lost 
them both and they were normal girls" and “My sister had a baby . . . and she had a 
high result as well” ; “ I mean ‘cause my friend had a Down’s” and “My cousin is Down’s 
syndrome, I know how hard it is”.
18. Preparation pregnancy and birth: Examples of items are: “The other thing I would 
be scared of is an epidural”; “It’s a shock finding out I’m pregnant, it’s going to be hard 
with a healthy baby to look after and work . . . ”; “ I just don’t think there’s any point in 
telling the parents because, you know, if the worst comes to the worst . . .  I think we’ll 
hang, wait three weeks”.
19. Health professionals’ advice: The items within this theme were classified under 
the following sub-groupings: neutral-positive comments about consultations; negative- 
dissatisfied comments about consultations; contradictory information to current
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consultation. Neutral-positive items included the following examples: “I was very lucky 
when I was first pregnant and went to see my GP, he was very good and talked me 
through"; “It’s really helped to talk it through”; ‘“Cause the doctor said they can’t do a lot 
of tests 'til you’re so far on [in pregnancy]”. Negatives or dissatisfied items included: 
“ I’ve just heard a lot of midwives say they wouldn’t have it [the triple test]”; “I just don’t 
think there was enough feedback about the test, I mean how vital it [dating scan] would 
have been”. Examples of items pertaining to contradictory information are: “That’s 
interesting 'cause I was given different information when I asked before about the triple 
test. I said ‘does it screen for anything else other than Down’s syndrome’ [and she said] 
‘no’”.
20. Other sources o f information: Women mentioned referring to other sources of 
information about pregnancy and prenatal tests, such as the media and hospital 
literature. The phrases that follow are examples of these items, “ I’ve read it all before I 
came" and “ I mean I’ve looked it up a lot and there was that programme recently”.
5.1.5 Analysis.
The preliminary aim of this analysis was to establish what information was referred to by 
women when making the decision to have or not have a diagnostic test. In other words, 
the subsequent findings will illustrate a pattern of information searched by women 
concurrently with their decision making. In consequence, the subsequent analyses are 
based on data that represent whether or not a woman referred to an item or theme. That 
is to say, a woman could score only ’0’ or ‘1’ for each theme or sub-categorisation, i.e. a 
woman either mentioned an item within the theme during the consultation or not. In this 
instance, the data do not report how many times a woman referred to the themes. The 
analyses and results are presented in three sections:
• Descriptive statistics are used to summarise the frequency with which themes were 
referred to by women when making the decision to have or not have testing (table 
5:1).
• Descriptive and univariate analyses are used to illustrate differences in the pattern 
of information utilised by women choosing to have either a diagnostic test or no 
further invasive testing (table 5:2).
• Four informed decision making variables were created from the data contained 
within the following themes: no test alternative; test alternative; amniocentesis; 
chorionic villus sampling; choice between diagnostic tests; Down's syndrome 
(consequence); miscarriage (consequence); termination (consequence). To explain 
further, an informed decision is based on an evaluation of the information about the
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consequences of each alternative and a trade-off between the advantages and 
disadvantages of the consequences. These theme titles of the coding frame classify 
the information required to assess whether or not women made informed prenatal 
diagnosis decisions. In other words, summarising the information referred to under 
these themes provides an operationalisation of informed decision making. Four 
variables were calculated from these themes: a total informed decision making 
score (IDM-T); a score summarising the information seeking utterances of women 
about the test alternatives (IDM-I); a score summarising the generation of reasons 
for selecting an alternative (IDM-F); a score summarising the generation of reasons 
against the selection of an alternative (IDM-A). The IDM-T score was a global 
measure assessing whether or not women made reference to any items pertaining 
to the no test alternative, the test alternative, Down's syndrome, miscarriage and 
termination. For the purposes of the IDM-T score, items referring to all utterances 
about the test alternatives were aggregated (aggregated themes were the test 
alternative, amniocentesis, chorionic villus sampling and comparison between 
tests), If, for example, a woman mentioned any item classified under the ‘no test' 
theme she scored ‘1’, if she did not say anything about the 'no test’ alternative she 
scored ‘O’. The IDM-T score was calculated by addition of the five recoded 
alternative and consequence themes (range 0-5). The remaining three informed 
decision making variables provided summaries more representative of the decision 
making process: information seeking; reasons for an alternative; reasons against an 
alternative. Scores for these variables were generated as follows: if women referred 
to an item classified as information seeking for the above themes, the score was ‘1’ 
for each theme; if the woman did not refer to an information seeking item, the score 
was ‘O'. These recoded information seeking sub-category scores were added 
together to form the IDM-I score (range 0-8). The same process was carried out 
twice more for women referring to items classified either as reasons for or reasons 
against alternatives under each of the aforementioned themes. However, omitted 
from the IDM-F and IDM-A calculations was the theme that classified utterances 
comparing the two diagnostic tests. As these comparisons simultaneously provided 
both a reason for selecting one test and for rejecting another, they were 
incorporated in the information seeking informed decision making variable only. In 
consequence, the range of the IDM-F and IDM-A scores was 0-7. Univariate and 
multivariate analyses were carried out to (a) describe women's informed decision 
making (table 5:3 and table 5:4) and (b) assess differences in informed decision 
making between those choosing to have a test with those choosing to have no 
further invasive testing (table 5:5).
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5.2 Results.
5.2.1 Describing the pattern of information utilised by women: results.
The average consultation length was 22.7 minutes (s.d. 7.0; range 8.6 - 40.7). Eight 
women chose to have no further diagnostic testing; thirty-six women had a diagnostic 
test (twenty-nine had amniocentesis, seven chorionic villus sampling). Table 5:1 
illustrates the pattern of information utilised by women when making the decision to 
have or not have prenatal diagnosis. The frequency of reference to theme titles 
suggests that over two-thirds of women utilised the following information during decision 
making: screening and the calculation of the triple test result; the test alternative; 
termination consequences; risk figures; perception of risk; reflection on the making of 
prenatal testing decisions; personal reproductive experiences. Fewer women referred to 
themes incorporating items about: the ‘normative’ prenatal testing behaviours, i.e. what 
other people do in this situation; the no test alternatives; Down’s syndrome; miscarriage; 
expression of affect; the validity of screening test results; others’ reproductive 
experience; preparation for the birth of a child; the advice of other health professionals; 
additional sources of prenatal diagnosis information.
Table 5:1 number of women referring to one or more phrases within a theme
Theme titles women
(n=44)
%
1. IMo Test Option (non invasive/ scan) 26 59%
1.1 information seeking or planning about non-invasive option 17 39 %
1.2 reasons for not having a diagnostic test 7 16 %
1.3 reasons against not having a diagnostic test 18 41 %
2. Test Option 44 100 %
2.1 information seeking or planning about tests in general 39 89 %
2.2 reasons for having a test 38 86 %
2.3 reasons against having a test 12 27%
3. Choice between tests - neutral comment 13 30 %
4. Chorionic villus sampling choice 31 71 %
4.1 information seeking about chorionic villus sampling 22 50 %
4.2 reasons for chorionic villus sampling 13 30 %
4.3 reasons against chorionic villus sampling 27 61 %
5. Amniocentesis choice 40 91 %
5.1 information seeking about amniocentesis 35 80 %
5.2 reasons for having amniocentesis 17 39 %
5.3 reasons against amniocentesis 21 48 %
6. Down’s syndrome consequence 23 52 %
6.1 information seeking/planning 12 27 %
6.2 neutral-positive reference 6 14 %
6.3 negative reference 13 30%
Table 5:1 continued.
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Theme titles women
(n=44)
%
7. Miscarriage consequence 25 57 %
7.1 information seeking/planning 22 50%
7.2 neutral - positive reference 4 9 %
7.3 negative reference 2 4 %
8. Termination consequence 31 71 %
8.1 information seeking/ planning 20 45 %
8.2 neutral - positive comment 17 39 %
8.3 negative reference 13 30 %
9. Risk figure reference 31 71 %
9.1 single risk Down’s syndrome 19 43%
9.2 single risk miscarriage 16 36 %
9.3 comparison risks 17 39%
10. Perception of risk reference 33 75 %
10.1 minimised Down’s syndrome risk 12 27 %
10.2 augmented Down's syndrome risk 19 43 %
10.3 minimised miscarriage risk 11 25 %
10.4 augmented miscarriage risk 4 9 %
11. Decision Making 31 71 %
11.1 triple test 12 27 %
11.2 pre-consultation discussion of decision outcome 17 39 %
11.3 delay in making decision 14 32 %
12. Expressed Affect 25 57 %
12.1 triple test (shock) 19 43 %
12.2 diagnostic / termination (hard decision / stage at a time) 12 27 %
12.3 reassurance testing 1 2 %
13. Triple test - further explanation 32 73 %
14. Confidence with screening results 17 39%
15. Comparison norms (others / you do) 27 61 %
16. Personal experiences 29 66%
16.1 physical aspects of pregnancy (e.g. scan, baby moving) 8 18 %
16.2 complications with pregnancy (e.g. miscarriage, infertility) 15 34 %
16.3 prior pregnancies and testing 11 25%
16.4 familiarity abnormalities or genetics 3 7%
17. Others’ experience 17 39 %
17.1 prenatal testing and pregnancies 15 34 %
17.2 familiarity abnormalities or genetics 4 9 %
18. Preparation for pregnancy (birth, telling others) 12 27 %
19. Health professionals’ advice 18 41 %
19.1 neutral or positive comments about advice given 14 32 %
19.2 dissatisfaction or directive advice given 4 9%
19.3 inaccurate or conflicting information 5 11 %
20. Other sources of information (e.g. media, books) 18 41 %
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5.2.2 Differences in information utilised by decision outcome: results.
The purpose of this analysis was to look for differences in the pattern of information 
referred to by those choosing to have or not have a diagnostic test. A Chi-square 
analysis is the most appropriate test of significance for differences in frequency data 
(Howell, 1985; Coolican, 1990). However, there are two limitations with applying Chi- 
square statistics to this data. First, only eight women chose not to have a test, meaning 
that any analysis will result in at least one cell having fewer than the recommended five 
cases. The Chi-square statistic may not be a reliable or meaningful statistic in such 
situations (Howell, 1985). Second, the content analysis was detailed and generated a 
large number of themes with sub-categorisations. Although these classifications were 
independent categories, occasionally items within phrases were related to each other. 
Carrying out multiple analyses on related data may lead to the reporting of statistical 
significance when no such association exists (Tabachnick and Fidell, 1989).
There are a number of methods that, when applied, may increase the reliability of 
statistics generated. The first method combines categories or levels of variables to 
reduce the number of cells within the model to increase the number of cases per cell 
(Coolican, 1990). As all the variables presented are dichotomous, categories cannot be 
further combined. The second method employs a multivariate statistic such as a logit 
analysis (Tabachnick and Fidell, 1989) to reduce the degree of error generated by 
performing multiple uni-variate analyses. A logit analysis is still sensitive to the 
minimum five cases per cell but, provided there are an equal number of cases within 
each category of the dependent variable, such an analysis may be acceptable. 
Unfortunately, the split of cases 'no test / test' was 18% to 82%, suggesting that such 
an analysis was not appropriate. Thirdly, if cell frequencies are less than five cases, 
then it is acceptable to employ a Fischer’s exact test of significance (Coolican, 1990). 
Finally, to reduce the margin of error generated from performing multiple analyses, 
variables can be deleted or collapsed on theoretical grounds to reduce the number of 
analyses carried out (Tabachnick and Fidell, 1989). The data and analyses of this 
section of results incorporated these final two points.
It is unlikely that any analysis performed on the data from this study could be regarded 
as particularly robust. However, in an attempt to illustrate differences in the pattern of 
responses by those who chose to have or not to have a test, statistical analyses have 
been applied to the data. The data was modified to reduce the number of statistical 
tests. Themes were aggregated in accord with the demands of the research aims, to 
assess patterns of informed decision making (see Appendix VII). The simplification of
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the coding form is described in brief. First, only sub-categories of themes associated 
with informed decision making were used in subsequent analyses: no test alternative; 
test alternative; Down’s syndrome consequence; miscarriage consequence; termination 
consequence; risk reference; perception of risk; comments about the decision making 
process. In addition, the test alternative was aggregated to one theme and three sub­
categories to include all references to the invasive testing alternatives. All other sub­
categories of themes were aggregated so that if a woman mentioned any one of the 
items within the sub-classification, this was recorded as ‘1’, whereas if the woman had 
not referred to any of these items this was recorded as ‘O’. As only one woman 
commented that testing may be reassuring, this item was removed from further 
analyses.
Table 5:2 differences in utilisation of information by test decision.
Theme Title no test 
n = 8 %
test
n=36 %
Chi* / Sig.
1. No Test Option 7 88 % 19 53 %
1.1 information seeking non-invasive 7 88 % 10 28 % 9.8 <0.01
1.2 reasons for non-invasive 7 88% 0 0 % 37.5 <0.01
1.3 reasons against non-invasive 5 63 % 13 36 % NS
(2.) Test O ption (com bined 2+3+4+5) 8 100 % 36 100 %
information seeking about test 8 100 % 35 97 % NS
reasons for test 6 75 % 35 97 % NS
reasons against test 7 88% 30 83% NS
6. Down’s syndrom e consequence 6 75% 17 47%
6.1 information seeking about Down's 5 63 % 7 19% 6.12 0.02
6.2 neutral-positive reference Down’s 3 38 % 3 8% NS
6.3 negative reference Down’s 1 13 % 12 33 % NS
7. M iscarriage consequence 4 50 % 21 58 %
7.1 information seeking miscarriage 2 25 % 20 56 % NS
7.2 neutral/ positive reference miscarriage 2 25 % 2 6 % NS
7.3 negative reference miscarriage 0 0 % 2 6 % NS
8. Term ination consequence 6 75% 25 69 %
8.1 information seeking termination 4 50 % 16 44% NS
8.2 neutral/ positive comment termination 3 38 % 14 39 % NS
8.3 negative reference termination 3 38 % 10 28 % NS
9. Risk figure  reference 5 63 % 26 72%
9.1 single risk Down’s syndrome 3 38 % 16 44 % NS
9.2 single risk miscarriage 0 0% 16 44% 5.59 0.02
9.3 comparison risks 5 63 % 12 33 % NS
10. Perception o f risk reference 8 100 % 25 69%
10.1 minimised Down’s syndrome risk 7 88 % 5 14% 17.8 <0.01
10.2 augmented Down’s syndrome risk 1 13% 18 39% NS
10.3 minimised miscarriage risk 1 13 % 10 28 % NS
10.4 augmented miscarriage risk 3 38 % 1 3 % 4.0 0.05
Table 5:2 continued.
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Theme Title no test 
n = 8 %
test
n=36 %
C h r/S ig .
(11.2) pre-consultation discussion decision 3 38% 14 39 % NS
(11.3) delay in making decision 5 63% 9 25% 4.24 0.05
(12.) Negative affect 6 75% 19 52% NS
13. Trip le test - fu rthe r explanation 6 75% 26 72% NS
14. Confidence w ith screening results 6 75% 11 31 % 5.45 0.03
15. Com parison norms 4 50% 23 64% NS
16. Personal experiences 6 75% 23 64% NS
17. O thers experience 4 50 % 13 36% NS
18. Preparation pregnancy 3 38 % 9 25% NS
19. Health p ro fessiona ls ’ advice 4 50 % 14 39 % NS
20. O ther sources in form ation 4 50% 14 39 % NS
Chi-square statistics were applied to all the informed decision making and aggregated 
themes (table 5:2). Fischer’s exact significance tests were reported for differences 
between themes if the probability was ^ 0.05. Any significance value should be 
interpreted with caution as the sample is small and multiple analyses have been carried 
out. Despite these limitations, there do appear to be differences in patterns of 
information utilised by those choosing to have or not have a diagnostic test. Those 
women who chose not to have an invasive test were more likely to enquire about the no 
test alternatives (p < 0.01) and the consequences of having a baby with Down’s 
syndrome (p = 0.02) than those who chose to have a diagnostic test. However, both 
sets of women were as likely to enquire about the test alternatives, miscarriage and 
termination consequences. Women choosing the no test alternative were less likely to 
refer to the risk of miscarriage figure alone (p = 0.02), more likely to interpret this risk as 
large (p = 0.05) and more likely to minimise the risk of Down’s syndrome (p < 0.001). 
Additionally, women choosing not to have a further invasive test were more likely to 
question the validity of the triple test screening result and method (p = 0.03). Finally, 
women choosing not to have an invasive test were more likely to comment on needing 
more time to make the decision (p = 0.05). However, there was no significant difference 
in consultation length between the no test and the test decision (respectively: mean = 
25.6 minutes (s.d. = 8.1), mean = 21.3 minutes (s.d. = 6.6); t = 1.6; d.f. = 42; p = 0.12).
5.2.3 Describing informed decision making: results.
The purpose of this analysis was to describe whether or not women were utilising 
sufficient and appropriate information during the consultation to ensure informed 
decision making. Four informed decision making variables were created from eight
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themes included within the coding frame (see section 5.1.5): total informed decision 
making (IDM-T) (Table 5:3); information seeking (IDM-I); generation of reasons for 
alternatives (IDM-F); generation of reasons against selecting an alternative (IDM-A) 
(table 5:4).
Table 5:3 frequency of women referring to the informed decision making 
themes.
1 theme 2 themes 3 themes 4 themes 5 themes
n (%) n (%) n (%) n (%) n (%)
Total 8 (18%) 12 (27%) 16 (36%) 6 (14%) 2 (5%)
No test 0 (0%) 2 (25%) 3 (38%) 2 (25%) 1 (12%)
Test 8 (22%) 10 (28%) 13 (36%) 4 (11%) 1 (3%)
Only five per cent of women (2/44) utilised information about both test alternatives and 
all three consequences of testing when making their decision to have or not have 
prenatal diagnosis (table 5:3). Most women referred to information classified by two or 
three of the informed decision making themes (table 5:3). Women tended to seek for 
more information than they used when reasoning about decision consequences and 
alternatives (table 5:4).
Table 5:4 description of the informed decision making scores.
Informed decision making (IDM) measures range min-max x (s.d.)
IDM-I: seek information about alternatives
(from 1.1, 2.1, 3.0, 4.1, 5.1, 6.1, 7.1 & 8.1)
0 -8 1 - 5 2.6 (1.1)
IDM-F: reasons for selecting alternatives
(from 1.2, 2.2, 4.2, 5.2, 6.2, 7.2 & 8.2)
0 - 7 1 -4 1.7 (0.8)
IDM-A: reasons against selecting alternatives
(from 1.3, 2.3, 4.3, 5.3, 6.3, 7.3 & 8.3)
0 -7 0 -4 1.9 (1.1)
A multiple analysis of variance (MANOVA) was carried out to assess differences in 
informed decision making by women choosing to have or not have prenatal diagnostic 
testing. The three dependent variables included in the analysis were the ‘process 
measures’ of informed decision making, IDM-I, IDM-F and IDM-A. The global measure 
of informed decision making (IDM-T) was not included in this analysis as it summarised 
the same information referred to by women as that classified separately in the three 
'process’ measures. As the sample size of the test and no test group was unevenly split,
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a Bartlett-box M test of significance was included within the analyses to assess the 
homogeneity of variance of the group distributions.
Table 5:5 differences in informed decision making by test decision.
No test 
(n=8)
mean (s.d)
Test
(n=36)
mean (s.d)
MANOVA
(1,42)
F Sig.
IDM-I: information seeking 3.3 (1.0) 2.4 (1.1) 3.9 0.06
IDM-F: reasons for 2.6 (0.7) 1.9 (1.2) 20.6 <0.001
IDM-A: reasons against 2.0 (0.8) 1.5 (0.6) 0.10 NS
The tests for homogeneity of variance within the MANOVA were not significantly 
different suggesting that subsequent findings were robust. No differences by test 
decision were observed for the reasons generated against the decision alternatives 
(table 5:5). However, women choosing not to have any further testing were likely to 
generate reasons for more of the alternatives and consequences than those deciding to 
have a diagnostic test (p<0.001, table 5:5). In addition, there was a trend towards 
significance suggesting that women who decided to have no further testing were likely 
to ask for information about more of the alternatives and consequences than women 
who chose to have a diagnostic test (p=0.06, table 5:5).
5.3 Discussion
The purpose of this study was to describe the process of women making the decision to 
have or not have prenatal diagnosis upon receipt of a screen positive triple test result. 
Most, if not all, of the previously published empirical research in this health context had 
used questionnaires or semi-structured interviews to assess factors associated with 
women’s decision making. This study employed a non-experimental, cross-sectional 
observational design to describe women’s decision making processes when deciding to 
have or not have prenatal diagnosis. The use of an information search strategy should 
enable the following: an evaluation of the factors involved in women’s decision making 
concurrently with the making of the decision; an opportunity to operationalise the criteria 
of informed decision making. In consequence, the results should provide a more 
accurate representation of the decision making processes employed by women than 
previously described and an evaluation of whether or not women’s decision making was 
informed. The following discussion focuses on the extent to which this study design has 
adequately addressed these research aims. This section is divided into four parts: a 
discussion of the reliability and validity of the findings; a description of the processes
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employed by women to reach the prenatal diagnosis decision; an assessment of 
women’s informed decision making; implications of these findings for changes in the 
provision of prenatal diagnosis information giving.
5.3.1 Information search strategy: re liab ility  and valid ity.
The advantage of an observational study design is that it enables the direct observation 
of an individual's behaviour to be made without relying on the interpretation of that 
behaviour from the individual (Robson, 1993). However, this type of design has an 
associated number of problems. First, it is suggested that an individual’s behaviour may 
subtly alter or change as a consequence of being observed (Robson, 1993; Bowling, 
1997). Second, as the researcher is required to interpret the individual’s behaviour, it is 
possible that the subsequent interpretation will reflect the researcher’s perception of the 
behaviour alone and the findings are not replicable or reproducible by a third party. 
Third, cognitions can only be inferred from the verbal behaviour of an individual (see 
introduction). Any difficulties in interpreting another’s actions are likely to be augmented 
in a study aiming to assess the psychological process involved in making decisions. In 
consequence, issues pertaining to the reliability and validity of measures assessing 
observational data are paramount. In other words, are researchers able to replicate the 
coding frame developed for this study and does the coding frame assess factors 
associated with the process of women’s decision making?
In practice, it is not possible to assess the effects, if any, of observation on individuals’ 
behaviour (Robson, 1993). However, an effort was made to reduce the profile of the 
study and minimise the impact of an observational technique on women’s consultation 
behaviour. First, the author (HB) was introduced as a member of the ante-natal team 
with an interest in the prenatal diagnosis consultation rather than a ‘psychologist’ or 
‘researcher’ observing the woman’s behaviour. Second, the information giving 
consultation was an established part of the routine care provided by the LGI for women 
receiving a screen positive triple test result and not an interview conducted specifically 
for the study. Finally, the consultation was audio tape-recorded and transcribed at a 
later date. The effects of this observational technique on participants' behaviour are 
believed to be minimal (Bowling, 1997). Although women were aware that the 
consultation was being audio tape-recorded, few comments were made about its use 
before, during or after the consultation. In consequence, it is fair to assume that the 
observational design of this study had a minimal impact on women’s behaviour and 
decision making about prenatal diagnosis.
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The method carried out to develop the coding frame was rigorous. The coding frame 
was developed in stages, requiring continual reference to the consultation transcripts, 
the literature on decision making and prior empirical research of women’s prenatal 
decision making. During its development, the themes and rationale used to classify 
women’s utterances were discussed with two colleagues (JH and AM) familiar with the 
issues of prenatal diagnosis. The coding frame was piloted twice and, where 
appropriate, revised. In addition, a Cohen’s Kappa coefficient was carried out to assess 
the inter-rater reliability of the final coding frame. The resulting coefficient (0.83) 
indicated an excellent rate of agreement between the two raters (HB and AM). In 
consequence, there is evidence to suggest that the coding frame developed to classify 
women’s utterances during the information giving consultation was a highly reliable 
instrument.
As discussed, the process tracing technique employed in this study described the 
information utilised by women during the information giving consultation. It is argued 
that process tracing techniques do provide a more comprehensive understanding of 
individuals’ decision making than questionnaires informed by EUT (Carroll and Johnson, 
1990). However, there are at least two concerns with using an information search 
technique to assess psychological processes. First, it has been suggested that 
individuals may be unable to verbalise the cognitions that underpin a final decision 
(Harte, Westenberg and van Someren, 1994). Second, although individuals acquire 
information when making decisions, this information is not processed or utilised to 
inform the decision (Payne, 1980). Although it is difficult to address these concerns, the 
context of the real-world decision described in this chapter may minimise their impact 
on subsequent findings. It is worth noting that these concerns have arisen from research 
investigating individuals’ acquisition of information (Payne, 1980; Carroll and Johnson, 
1990; Baron, 1994; Harte, Westenberg and van Someren, 1994; Harte and Koele, 
1997). In this chapter’s decision context, the health professional provided women with 
most of the information considered necessary to make the prenatal diagnosis decision 
(see chapter four), i.e. woman did not have to actively search for information. In 
addition, the audio tape-recording of the consultation recorded all women’s utterances, 
not just those pertaining to information seeking. In other words, questions asked to 
obtain information, statements referring to peripheral decision information and the 
verbalisation of reasons were all recorded. It is feasible to suggest that within this 
context, women verbalised information they were assimilating when making a decision. 
It is possible that women may have utilised information when making the decision 
without verbally referring to it. In consequence, the data summarised by the coding
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frame may under-represent the cognitions employed by women when making their 
prenatal diagnosis decisions. Despite this under-representation, a number of findings 
from this study replicate results from prior empirical research that have used alternative 
methodologies to assess factors associated with women’s prenatal diagnosis decision 
making. The following discussion briefly summarises the similarities between the 
findings from this study and prior empirical evidence.
Reasons: The questionnaire and interview based studies summarised in section 1.3.2.1 
identified a number of reasons provided by women supporting their prenatal diagnosis 
decision, such as: needing to know for certain whether or not the baby has Down's 
syndrome; not believing in termination of pregnancy; the timing of the diagnostic test 
results (Nielsen 1981; Volodkevich and Huether, 1981; Verjaal, Leschot and Treffers, 
1982; Farrant, 1985; Lippman, Perry, Mandel and Cartier, 1985; McGovern, Goldberg 
and Desnick, 1986; French, Kurczynski, Weaver and Pituch, 1992; Julian-Reynier, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994). The information utilised by 
women during this study included these reasons for selecting a decision alternative 
(themes 1-8; table 5:1). In addition, women generated a number of other reasons for 
rejecting or selecting an alternative, such as: not being able to cope with a Down's 
syndrome baby; waiting for the results of the fetal anomaly scan; a child with Down's 
syndrome being 'fair enough’.
Perception risk: Prior research also identified women’s perception of risk as important 
in women’s prenatal diagnosis decision making, both the risk of miscarriage and the 
likelihood of having a baby with Down's syndrome (see section 1.3.2.1). The information 
search technique coded 71% of women referring to an actual risk figure and 75% 
evaluating the risks figures (themes 9 and 10; table 5:1).
Timing o f decision: Raised in a few of the interview based studies were issues 
reflecting women’s perception of the decision making process: making a decision about 
testing prior to the offer of prenatal diagnosis (Sjogren and Uddenberg, 1988); feeling 
obliged to have the test (Farrant, 1985; Sjogren and Uddenberg, 1988). Although these 
statements were raised by women during the information giving consultation of this 
study, fewer women referred to them (theme 11; table 5:1). This difference may support 
the assertion that retrospective study designs are subject to biases in the recall of 
information. That is to say, women interviewed after having a test perceived themselves 
to be more certain of their choice in retrospect than woman observed concurrently with 
their decision making.
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Comparison norms: The observational study design illustrated that 61%  of women 
asked for information about the normative behaviour, i.e. what other people tend to 
choose in this situation (theme 15; table 5:1). This search for normative behaviour may 
reflect findings from choice of treatment studies within cancer suggesting that patients 
want to be informed about the medical options but find the responsibility for making the 
final treatment choice difficult (Fallowfield, 1997). Ascertaining what others do in the 
sam e situation may serve to diffuse the responsibility for any negative consequences of 
their final choice.
Affect: As discussed in section 1.1.4, women are anxious upon receipt of a screen 
positive triple test result and concerned about the prenatal diagnosis decision (Beeson 
and Golbus, 1979; Nielsen, 1982; Verjaal, Leschot and Treffers, 1982; Berne-Fromell, 
Uddenberg and Kjessler, 1983; Fava, Trombini, Michelacci, Linder, Pathak and 
Bovicelli, 1983; Burton, Dillard and Clark, 1985; Farrant, 1985; Pauker and Pauker, 
1987; Sjogren and Uddenberg, 1988; Marteau, Kidd, Cook, Michie, Johnston, Slack and 
Shaw, 1992; Evans, Pryde, Evans and Johnson, 1993; Burn, Fairgrieve, Franks, W hite  
and Magnay, 1996). Indeed, Burn et al (1996) reported that, in retrospect, 78%  of 
women receiving a screen positive triple test result were worried or devastated by their 
test result. Forty-three per cent of women in this study expressed worry at their triple 
test result (theme 12; table 5:1). In addition, 27%  m ade a comment about the difficulty 
of making the prenatal diagnosis decision.
Triple test: Although all women chose to have the triple test and were provided with 
information about screening, 73%  requested further information about the triple test and 
calculation of screening results (theme 13; table 5:1). This finding m ay support 
evidence from empirical work on serum screening suggesting that women do not have  
sufficient information to enable them to choose whether or not to have a screening test 
(Marteau, Johnston, Plenicar, Shaw, Slack, 1988; Smith, Shaw and Marteau, 1994; 
Michie, Smith, McClennan and Marteau, 1997).
5.3.2 Describing women’s decision making.
If, as inferred in section 5.3.1, the coding frame is a reliable and valid instrument with 
which to classify wom en’s utterances, the following suggestions can be made about the 
processes employed by women when making the decision to have or not have prenatal 
diagnosis.
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First, although the majority of women in this study referred to most of the information 
provided by the health professional when making their decision (themes 1-10; table 
5:1), few utilised information pertaining to all the consequences of both alternatives. 
That is to say, most women mentioned the testing option, details about amniocentesis 
and chorionic villus sampling, termination and risk figures for either Down's syndrome or 
miscarriage. This finding suggests that most women employed a systematic strategy to 
process the decision information. As the prenatal diagnosis decision is a risky decision, 
has two well-defined alternatives and has serious consequence for the individual, it is 
likely that an individual would employ such a cognitively demanding strategy to process 
the information (Chaiken, 1980; Eagly and Chaiken, 1993; Ubel and Loewnstein, 1997).
Second, most women also referred to information outside that provided by the health 
professional when making the decision. In particular, most women referred to 
information about the triple test and their own experiences of testing, pregnancy and 
abnormality (themes 13 and 16; table 5:1). From the perspective of a classical decision 
approach to decision making, the consequences of a previous decision ought not to be 
associated with a current decision. This finding suggests that women also employ some 
heuristic strategies to process the decision information. For exam ple, they m ay refer to 
a previous experience or scenario when assimilating information. Such a scenario may 
act as a ‘cognitive short-cut’ for reaching a decision. It is likely that both processes need 
to be employed to enable an individual to reach a decision (Vlek, 1987; Eagly and 
Chaiken, 1993).
Third, most women referred to both a risk figure and an evaluation of the risk when 
making the prenatal diagnosis decision (themes 9 and 10; table 5:1). The empirical 
evidence from the majority of interview or questionnaire based studies finds that the 
perception of risk and not the actual risk predict behaviour (section 1.3.2.1). One 
explanation for the discrepancies in findings is that women utilise the risk information 
during the information giving consultation, evaluate the risk when assimilating it with 
existing beliefs and recall only their perception of risk when asked in retrospect.
Fourth, although most women are likely to have employed a systematic strategy to 
process the information attended to, the pattern of results suggests that most women do 
not apply an optimising strategy when appraising the decision information (themes 1-10; 
table 5:1). To explain further, the pattern of information utilised suggests that half of the 
women screened out the no test alternative, focusing mainly on the test alternatives. 
Further, the sub-categories of these themes suggest that trade-offs between the
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advantages and disadvantages of consequences were minimal. As suggested by prior 
research, describing individuals’ decision making processes, it is likely that women used 
a satisficing strategy to limit the amount of information required for assimilation (see 
section 1.2)
Fifth, although the sample size was small and the use of multiple analyses limited the 
interpretation of findings, some differences were observed in the decision making 
processes by test decision (table 5:2). Eight significant differences were reported by 
decision outcome, suggesting a coherent difference in the pattern of information utilised 
by women choosing to have or not have a diagnostic test. W om en choosing not to have  
a diagnostic test were: more likely to search for information about the non-invasive test 
option and Down’s syndrome; less likely to refer to the actual risks of miscarriage but 
more likely to describe this particular risk as high; more likely to refer to the risk of 
Down’s syndrome as low and further reduce the threat of Down’s syndrome by 
expressing dissatisfaction with screening tests and results; more likely to mention the 
need for more tim e to think about the information before making a decision. These  
findings suggest that most women choosing to have no further testing were more likely 
to survey the consequences of both prenatal testing alternatives. One explanation for 
these differences in information utilisation by prenatal testing decision is that women  
choosing to have no further testing have to actively ‘opt out’ of the testing process 
whereas women choosing to have a test merely agree with the offer of a test (Marteau, 
Johnston, Kidd, Michie and Cook, 1992).
This quantitative content analysis described the information utilised by women during 
the information giving consultation. It was beyond the remit of this chapter’s aims to 
explore the interaction between the health professional’s provision of information and its 
subsequent utilisation by women. As mentioned in chapter four, a more in-depth 
analysis of the transcripts would be required in order to assess whether it was the health 
professional’s information that encouraged women to utilise that information in their 
decision making or whether the women's questions prompted the health professional to 
impart an appropriate response (table 4:1 and table 5:1). In addition, the data extracted  
from the transcripts might be used to explore more detailed relationships between the 
decision making themes, for example: relationship between affect and type of 
information processing strategy employed (themes 12.1 and themes 1-10; table 5:1); 
association between information utilised and whether or not the decision was m ade  
before the consultation (theme 11.2 and themes 1-10, table 5:1); the association 
between Down's syndrome and reduced confidence in the triple test screening test
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result (Croyle, Sun and Hart, 1997) (themes 14 and 10.1; table 5:1). However, as 
stated, the main purpose of this chapter was to describe the processes employed by 
women when making the prenatal diagnosis decision upon receipt of a screen positive 
triple test result.
5.3.3 Assessing informed decision making.
The final aim of the study was to ascertain whether or not women were making informed 
decisions to have or not have a diagnostic test. This study is one of the first within the 
prenatal diagnosis context to operationalise criteria associated with the making of an 
informed decision (Frisch and Clem en, 1994; section 1.2); a good decision ought to be 
based on an evaluation of the consequences of the different options, an accurate 
assessment of the consequences and a trade-off between the consequences of the 
decision alternative. The final coding fram e included them es to classify information 
pertaining to the two decision alternatives and three consequences of the prenatal 
diagnosis decision. In addition, the them es’ sub-categories were informed by the 
reason-based choice (Shafir, Simonson and Tversky, 1994) explanation for how 
individuals ‘trade-o ff information when making a decision. Four informed decision 
making scores were created from the data contained within these themes: a global 
measure (IDM -T); one assessing the information searched for an alternative or 
consequence (IDM -I); one assessing the reasons provided to support an alternative or 
consequence (IDM -F); one assessing the reasons provided to reject an alternative or 
consequence (IDM-A).
The findings reported that only five per cent of women (2/44) referred to information 
from all five them es included in the ID M -T  measure (table 5:3). Most women utilised 
information pertaining to two or three of the themes when reaching their prenatal 
diagnosis decision (table 5:3). In addition, women were more likely to search for 
information than provide reasons for or against the alternatives or consequences (table 
5:4). One explanation for these findings may be that women do not verbalise the 
process of information assimilation when making the decision. However, the pattern of 
information referred to by women as described in table 5:1 and the findings from 
previous empirical research in this health context suggest an alternative explanation, 
that most women were not making fully informed decisions about the decision to have 
or not have prenatal diagnosis. This explanation is further supported by this chapter’s 
findings evaluating the difference in informed decision making by whether or not women 
had had diagnostic tests. W om en choosing to have no further testing generated more 
reasons and tended to search for more information about test alternatives and
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consequences than women having diagnostic tests (table 5:5). In other words, 'no test’ 
wom en were utilising and assimilating more information to reach a decision than ‘test’ 
wom en.
5.3.4 Implications for the provision of prenatal diagnosis information.
These findings describing the information utilised by women when making their prenatal 
diagnosis decisions have specific implications for the provision of information about 
prenatal diagnosis and screening tests within this health context. Few women were 
utilising information during the consultations to indicate that they were making fully 
informed decisions. In particular, most women were not referring to information about 
the no test alternative, the consequence of miscarriage and the condition of Down’s 
syndrome. It was clear that women arrived at this consultation with different 
experiences of, information about and opinions towards prenatal testing: some had 
discussed the diagnostic test decision although most had not; others had ‘stories’ about 
their own and acquaintance’s prenatal testing experiences; some referred to advice  
proffered by other health professionals; some women had searched for additional 
information via the media and information leaflets. However, it is the responsibility of 
the health professional to provide information about all the consequences of both 
alternatives and to address women's a priori beliefs, thus enabling women to m ake an 
informed decision to have or not have a diagnostic test (Royal College of Physicians, 
1989; American Society of Human Genetics, 1996). As this prenatal diagnosis 
information giving consultation is the last opportunity for the health professional to 
establish whether women have received and evaluated all the appropriate information, 
these consultations ought to provide a more detailed discussion of the ‘no test’ 
alternative, the consequence of miscarriage and the consequence of having a Down’s 
syndrome child.
In addition, the findings from this study and previous empirical research evaluating 
knowledge of women undergoing serum screening tests, suggest that a significant 
proportion of women did not have sufficient information to be making informed choices 
to have or not have screening tests (Marteau, Johnston, Plenicar, Shaw and Slack, 
1988; Smith, Shaw, Marteau, 1994; Michie, Smith, McClennan and Marteau, 1997). All 
of the women in this study knew they had undertaken the triple test and that the test was 
‘looking for’ Down's syndrome. However, over seventy per cent of these women asked 
for further information about screening and the triple test result. The types of questions 
raised involved information about: clarification on the meaning of a screening test 
result; how the triple test risk figure was derived; the association between fertility
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treatment, familial and personal pre-dispositions to hormone generation on receipt of a 
screen positive result; the likelihood of recurrence of a screen positive result in 
subsequent pregnancies; the justification of the screen positive cut-off point; the validity 
of the triple test result compared with age and nuchal-pad screening figures. The nature 
of these questions and the developm ent of more screening technologies suggests that 
the content of prenatal testing information needs to be modified. Those receiving 
screening test results appear to require a more sophisticated explanation of the risk 
figure generation than is currently provided. Additionally, a more comprehensive 
explanation of the screening tests available during pregnancy, with the advantages and 
disadvantages of each test, may help women to make more informed choices about 
which screening test is best for them. This information may reduce the confusion of 
comprehending which risk figure for Down’s syndrome should be used during the 
decision to have a diagnostic test or not.
As yet, there is little evidence to suggest that altering the information giving consultation 
would be associated with changes in women's informed decision making. For example, 
Pauker and Pauker (1977; 1978; 1987) have used decision analysis as a technique to 
facilitate w om en’s prenatal diagnosis decision making (see chapter one). During a 
consultation, women are encouraged to systematically utilise and evaluate information 
pertaining to both the test and no test alternatives and assimilate this information with 
their a priori attitudes. To date, there is no published evidence suggesting that this 
technique is associated with the making of a more informed or better decision (Bekker 
et al, 1999). It is possible that if health professionals provide women with a more 
structured discussion of both decision alternatives, women may utilise information 
pertaining to both these alternatives when making their prenatal diagnosis decision. 
However, it is as likely that changing the structure of an information giving consultation 
will not lead to a more balanced appraisal of the decision information. Further, there is 
some evidence to suggest that poorer decision outcomes, such as post-decision 
satisfaction, are associated with a more systematic evaluation of the decision 
information (Wilson, Lisle, Schooler, Hodges, Klaaren and Lafleur, 1993). Empirical 
research is required to evaluate the consequences of altering the prenatal diagnosis 
information on measures of wom en’s decision making processes and outcomes.
5.3.5 Chapter summary.
In brief, few, if any, published empirical studies have assessed the processes employed 
by women concurrently with their decision to have or not have prenatal diagnosis. In 
addition, little empirical research has operationalised informed decision making in the
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context of prenatal diagnosis. This study employed an observational design to classify 
the information utilised by women when making the prenatal diagnosis decision. The  
coding frame developed to classify wom en’s utterances satisfactorily summarised the 
information referred to by women when making the decision to have or not have a 
diagnostic test. Most women did not utilise all the necessary information within a 
consultation to ensure fully informed decisions. Although 70%  of women referred to the 
test alternative, termination, actual risk figures and evaluations of risk, over 40%  of 
women did not refer to the no test alternatives, miscarriage or condition of Down’s 
syndrome. W om en used both systematic and heuristic information processing strategies 
to assimilate information about testing. Consistent differences in the pattern of 
information referred to were observed by decision outcome, women choosing to have a 
test appeared to employ a satisficing strategy to screen out the ‘no test’ information. 
The findings suggest that those choosing not to have a test were making a more 
informed decision than those deciding to have prenatal diagnosis. It was suggested that 
information about all the consequences of both diagnostic test alternatives should be 
presented equally during the consultation and that the a priori beliefs of women 
discussed to ensure that women m ake an informed choice whether or not to have a test.
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6. Facilitating informed decision making in the 
prenatal diagnosis context: a randomised control trial.
This chapter describes the findings from a randomised control trial carried out to 
evaluate the effectiveness of decision analysis in the facilitation of wom en’s informed 
decision making within the prenatal diagnosis context. The theoretical review, described 
in chapter one, found there to be little empirical research that had operationalised 
informed decision making in the context of prenatal diagnosis. In addition, few  empirical 
studies have developed interventions designed to facilitate patient decision making in 
the health care domain (see chapter two). The findings from over 500 intervention 
studies were summarised in an integrative review described in chapter two (Bekker et 
al, 1999). In total, just 18 studies evaluated interventions aimed at encouraging patient 
participation in the consultation. None of these studies had assessed whether or not 
their interventions were associated with changes in patient’s informed decision making. 
In other words, there is a paucity of research assessing the facilitation of individuals’ 
informed decision making in the health care domain.
There is empirical evidence from studies describing wom en’s experiences of and 
reasons for undergoing prenatal diagnosis which suggests that women are not making 
informed decisions about testing (see chapter one). Within the literature, at least two 
explanations have been proposed as to why women are not making informed decisions 
about prenatal diagnosis (Marteau, 1995). First, health professionals are not providing 
women with sufficient information to enable informed decision making. Second, the 
health professionals have provided women with sufficient information but women have 
not utilised all the necessary information to ensure that the decision was informed. The  
empirical findings described in chapter four provide some support for the assertion that 
health professionals are not providing sufficient conditions to enable women to m ake an 
informed decision about prenatal diagnosis. However, there is also evidence to suggest 
that individuals employ cognitive strategies to reduce the information to be assimilated 
when making risky or difficult decisions (see chapter one). The findings discussed in 
chapter five provide support for this explanation of decision making, i.e. that women do 
not utilise all the available information when making the prenatal diagnosis decision. In 
essence, facilitating informed decision making requires a technique that both improves 
the quality of the information provided by the health professional and encourages a 
more systematic evaluation of this information by women.
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A technique that enhances the decision making process is known as a decision aid 
(Pitz, 1987). Most decision aids have developed from decision analysis (Holmes- 
Rovner, 1995). As mentioned in chapter one, decision analysis is a formal technique 
based on expected-utility theory (EUT) that both restructures the decision information 
and encourages women to explicitly explore the risks and consequences of each 
alternative. In addition, the decision analytic technique enables individuals to assimilate 
their utility values of the decision consequences with their perceptions of the likelihood 
of these consequences occurring. This process culminates in the identification of the 
optimum, accurate or correct choice for the individual (Thornton and Lilford, 1990; 
Lilford and Thornton, 1994; Pauker and Pauker, 1987; Pitz, 1987; O ’Connor, 1995; 
Holmes-Rovner, 1995; Nease, 1996; Ubel and Loewenstein, 1997; see chapter one).
In brief, the purpose of applying decision analysis to real-world decision making is to 
encourage individuals to make ‘better’ decisions. The limitations of human information 
processing abilities suggest that intuitive decision making leads to poorer decisions 
(Politser, 1981; Ubel and Loewenstein, 1997). Decision analysis is supposed to lead to 
better decision making for a number of reasons: it provides the structure with which to 
identify the decision-specific information (Dowie, 1995); the provision of a decision tree 
reduces the cognitive load for the decision m aker as the information is constantly 
visually available in the form of a visual prompt (Arkes, 1981; Pitz, 1987); the technique 
allows the elicitation of utilities and the opportunity to integrate these values during 
decision making, a process not incorporated by more intuitive approaches to decision 
making (Politser, 1981; Baron, 1994; Ubel and Loewenstein, 1997); it is argued that 
these conditions encourage more informed, systematic or rational decisions as all the 
information can be attended to without bias and the technique encourages trade-offs 
between attributes (Arkes, 1981; Travis, Phillipi, Tonn, 1989; Ubel and Loewenstein, 
1997); the technique is able to represent the conflicting information that makes many 
risky decisions hard or difficult (Pitz, 1987; Ubel and Loewenstein, 1997); finally, by 
explicitly discussing all the information associated with the decision, the individual is 
less likely to m ake a choice based upon an expert’s opinion (Ubel and Loewenstein, 
1997).
A number of concerns have been raised regarding the application of decision analysis 
to the clinical or ‘real-world’ setting. The first set of concerns to be discussed focus on 
the more ‘theoretically-based’ issues. First, the real-world setting is such that it is 
unusual for individuals to be faced with a well-defined, single decision. Most real-world 
decisions are dynamic and involve a number of related decisions over a period of time
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(Politser, 1981). In consequence, it may be unrealistic to define one discrete decision 
event appropriate for decision analysis in the real-world setting. Second, many 
decisions are made with incomplete or inaccurate information. Applying a decision 
analytic technique to incomplete information may lead to an erroneous decision being 
made. Third, some attributes within the decision structure are difficult to quantify (Vlek, 
1987; Ubel and Loewenstein, 1997) which may result in an over-representation of the 
attributes that are easier to quantify. Fourth, decision analysis is concerned with 
emphasising the systematic processing of information. As most decisions require the 
application of both systematic and intuitive processes (Vlek; 1987), it is unclear how 
effective decision analysis would be in facilitating the whole decision process. Equally 
the efficacy of the decision analytic technique relies on the notions that all individuals 
would prefer to make decisions systematically and that all decisions are best made 
systematically. It is likely that the preference for style of information processing differs 
between individuals, with some favouring a more predominantly heuristic approach to 
decision making while others a more systematic style (Cacioppo, Petty and Kao, 1984; 
Scheier and Carver, 1985; Burnett, 1991; Scheier, Carver and Bridges, 1994; W ebster 
and Kruglanski, 1994; Sorrentino, Holmes, Hanna and Sharp, 1995). Finally, there is 
evidence that different decisions are associated with different types of processing. In 
other words, the uniform application of decision analysis and the encouragement of 
systematic processing may not always result in decision facilitation or better outcomes 
(Lipshitz, 1993; Ubel and Loewenstein, 1997).
The application of decision analysis to the health-care context raises a number of 
‘clinically-based’ concerns in addition to the theoretical issues previously discussed. 
Som e argue that, as all decisions are approached uniformly, the technique is insensitive 
to the clinical situation and that this consultation style may de-humanise the patient 
(Schwartz, 1979). Others suggest that the technique devalues the expert’s clinical 
judgem ent by regulating all consultations as well as needlessly increasing consultation 
tim e (Schwartz, 1979). Decision analysis may also be perceived as directive since the 
expert calculates the optimum decision for the individual and the expression of this 
decision may be seen to compromise the individual’s autonomy in decision making 
(Falek, 1984; Kessler, 1992). Equally, the application of decision analysis m ay be 
stressful for some individuals as they may not understand the justification for being 
asked such explicit and difficult questions during the consultation (Pauker and Pauker, 
1987; Ubel and Loewenstein, 1997). In addition, such a consultation may raise issues 
that the expert is unable or unwilling to address (Schwartz, 1979). The decision analytic 
technique is not regarded as being able to fully incorporate the emotions encountered
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within many clinical situations, such as anxiety, regret and uncertainty (Ubel and 
Loewenstein, 1997). Finally, there is some evidence to suggest that encouraging 
individuals to think systematically about their reasons for a decision may be associated 
with an increase in post-decisional regret or dissatisfaction (Wilson, Lisle and Schooler,
1993), i.e. decision analysis may be associated with worse rather than better decision 
outcomes.
Although decision analysis has been applied to patient decision making for a number of 
decades (Pauker and Pauker, 1979, 1987; Thornton, 1990; Morabia, Steinig-Stamm, 
Unger, Slosman, Schneider, Perrier and Junod, 1994), there is little published evidence 
to suggest whether or not decision analysis leads to better patient decision making than 
decisions made during routine clinical care (Pitz, 1987; O ’Connor, Llewellyn-Thomas 
and Drake, 1995; Bekker et al, 1999). Few, if any studies, have employed a randomised 
control trial (RCT) design to evaluate the effectiveness of decision analysis to facilitate 
patient decision making. Most studies have described either the application of the 
decision analytic technique within the health care setting (Pauker and Pauker, 1977; 
1979; 1987) or assessed the degree to which an individual's decision deviates from that 
predicted by EUT (Heckerling, Verp and Hadro, 1994; Verp and Heckerling, 1995). Few  
if any studies have addressed the issue of whether decisions based on decision analysis 
based decisions are ‘better’ than unaided decisions.
This dearth within the literature may in part be attributable to the difficulty of evaluating  
the quality of the decision and of defining what is meant by a good decision (Pitz 1987; 
Frisch and Jones, 1993). From a theoretical or decision analytic perspective, a ‘good’ 
decision is the choice with the maximum expected utility. Several studies have applied 
decision analysis within the prenatal diagnostic testing context to exam ine whether or 
not women were making optimal decisions (Pauker and Pauker, 1987; Thornton and 
Lilford, 1990; Heckerling, Verp and Hadro, 1994; Verp and Heckerling, 1995). The  
studies suggest that not all women make decisions consistent with the theoretically 
accurate choice. However, an accurate decision is not necessarily the best or good 
decision (Frisch and Jones, 1993). Other studies within the clinical setting assess the 
quality of the decision by the decision outcome, such as the prognosis of the disease 
(Whitbeck and Brooks, 1983; Morabia, Steinig-Stamm, Unger, Slosman, Schneider, 
Perrier and Junod, 1994). The main limitation of this evaluation for most individual- 
based or value-laden decisions is that there is no objective assessment of an 
individual’s judgement, i.e. no external reference with which to ascribe a ‘correct’ or 
‘incorrect’ choice (Frisch and Jones, 1993; O ’Connor, 1995). As there is no objective
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standard with which to assess the quality of a decision, the choice of measure to 
evaluate good decision making is usually determined by the researchers' aims and 
theoretical perspective (Llewellyn-Thomas, 1995). In the context of prenatal diagnosis 
testing, one of the main objectives of prenatal diagnosis is to encourage women to 
m ake informed decisions.
The numerous measures employed by researchers to assess the quality of decisions fall 
into three broad categories: behavioural, cognitive and affective (Llewellyn-Thomas, 
1995). Behavioural assessments include, recording the number of people choosing 
each of the alternatives and recommending the decision to others (Pitz, 1987). 
Cognitive measures may include evaluations of both the process and outcome, such as: 
utilisation of information during decision making (see chapter five); reasons for and 
against alternatives (W helan, Levine, Gafni, Lukka, Mohide, Patel and Streiner, 1995); 
recording of perceptions of risk (Pitz, 1987) and utilities or attitudes (Pauker and 
Pauker, 1987; d ’Ydewalle and Evers-Kiebooms, 1987; Heckerling, Verp and Hadro, 
1994: Heckerling and Verp, 1995); ranking of the order of utilities (McNutt, 1989; 
Thornton and Lilford, 1990; Nease, 1996); knowledge or understanding of the 
information (Pitz, 1987; Holmes-Rovner, 1995; O ’Connor, Llewellyn-Thomas and Drake, 
1995). Affective measures may include: decisional satisfaction (Holm es-Rovner, Kroll, 
Schmitt, Rovner, Breer, Rothert, Padonu and Talarczyk, 1996); confusion or conflict in 
making the decision (O ’Connor, 1995); confidence with the final decision (Pitz, 1987); 
anxiety (O ’Connor, 1995); worry; regret with the decision. Arguably, a fourth area of 
evaluation is that of the experience of the clinical situation such as satisfaction with the 
care provided. As discussed in chapters one and five, few studies have assessed the 
process of informed decision making.
The purpose of the current study is to evaluate the effectiveness of the decision analytic 
technique to facilitate wom en’s decision making in the context of prenatal diagnosis. 
The aim is to compare the quality of decisions made during the routine information 
giving consultations with those made during a consultation structured by the decision 
analytic technique. Behavioural, affective, cognitive and clinical measures were 
assessed to evaluate any differences in the quality of the decision process and 
outcome.
6.1 Methodology.
O ver a six month period, the study was integrated into the routine care provided by the 
antenatal department at Leeds General Infirmary (LGI) following: the application for
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ethical approval from the Leeds and St Jam es’ ethical and scientific committee; training 
and advice from those obstetricians and midwives actively involved in the provision of 
information about prenatal diagnosis (see chapters four and five); piloting of the 
information giving techniques (see chapters four and five); piloting of study materials 
(see section 5.1). During the data collection period of this thesis, the author (HB) was 
responsible for the follow-up care of all women receiving a screen positive triple test 
result. These duties included contacting women about their triple test result (chapter 
four) and providing women with the prenatal diagnosis information during the 
consultation described in chapter four. For consistency, the author (HB) is subsequently 
referred to as the study health professional.
6.1.1 Design.
The most appropriate method for evaluating the effectiveness of any intervention is to 
employ a true experimental design or randomised control trial (Bowling, 1997). Ideally, 
both the health professional and the woman should be ‘blind’ to the allocated 
experimental condition in order to reduce experim enter and sampling biases. However, 
as this intervention requires the health professional to deliver information in one of two 
styles, it was necessary for the health professional to be aware of the experimental 
condition. Equally, the nature of human experimental research requires participants to 
be informed about the study. The women were aware that the information they received 
was delivered in one of two ways but they were not informed of the experimental group 
they had been randomised to. As this particular decision was a ‘one-off for most of the 
women, it was unlikely that they were aware of the differences between a routine and an 
experimental consultation.
This study was conducted within a real-world situation and concerned a particularly 
distressing test result and decision. It was not appropriate, therefore, to include a ‘no 
treatment' group within the design. In consequence, a two-condition randomised control 
trial was employed. As mentioned, over a three-month piloting period, the study health 
professional (HB) was integrated into the LGI antenatal team . Further, the study health 
professional had been trained to provide women with information that was considered 
routine practice by the LGI antenatal team. In addition, the study health professional 
was also trained to elicit w om en’s utilities firstly, by observing an obstetrician proficient 
in the application of the decision analytic technique apply the lottery question to three 
women making the decision to have or not have prenatal diagnosis (Thornton, 1990a; 
1990b; Thornton, Lilford and Johnson, 1992) and, secondly, by practising the elicitation 
method on five women who had already made their prenatal diagnosis decision during
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the information giving consultation (see chapters four and five). The two conditions or 
study groups are described briefly below.
Routine information giving consultation: the consultation between the health 
professional and the woman was conducted in accord with the routine practice of the 
antenatal staff at the LGI (see chapter four). The consultation was structured with 
reference to the triple test result sheet. The following information was mentioned in 
each consultation: the triple test result and risk; the choice between diagnostic testing 
and no diagnostic testing; the risks and procedures of the fetal anomaly scan, 
amniocentesis and chorionic villus sampling; a direct question enquiring about 
termination for Down's syndrome.
Decision analysis consultation: in essence, the consultation content was the sam e as 
that provided in the routine consultation. However, the consultation was structured with 
reference to: the triple test result sheet; the decision tree visual aid; the lottery decision 
visual aid; the threshold graph visual aid (Appendix VIII). Although, the elicitation of 
utilities in the context of prenatal diagnosis was mentioned in section 1.2.1.3 , the 
structure of the decision analysis consultation is described in more detail. First, women 
in the decision analysis group were provided with the same triple test result information 
and visual prompt as women in the routine group, i.e. the triple test result sheet. 
Second, the decision tree representing the alternatives and consequences of the 
prenatal diagnosis decision was shown to women when the study health professional 
provided information about the choice to have or not have prenatal diagnosis. Third, 
women were informed that they were going to be asked a hypothetical question about 
terminating for Down's syndrome. The study health professional stated that the purpose 
of this exercise was to gauge the value women attached to the offer of prenatal 
diagnosis. W om en were shown the lottery decision visual aid and asked the following 
hypothetical question, “If the probability of having a baby with Down's syndrome or 
without Down's syndrome is given as 50:50, would you (the woman) choose to carry on 
or terminate the pregnancy?”. As mentioned in section 1.2.1.3, the gamble is varied 
until the woman is unable to answer the hypothetical question. This figure for the ‘level 
of indifference’ between terminating and continuing with the pregnancy is the utility 
figure (range 0 - 100). Fourth, women were shown the threshold graph visual aid. The 
point of intersection between their utility value and triple test risk was identified. This 
point usually fell above or below the threshold line, so indicating whether or not the 
woman should be thinking about having a prenatal diagnostic test. Finally, the resulting 
decision analysis decision was discussed with women. It was emphasised that the final
126
decision to have or not have prenatal diagnosis was entirely the wom an’s, regardless of 
the decision analysis decision.
The information for each condition was delivered by the same health professional. The  
sam e health professional was responsible for all consultations within which the women 
discussed the receipt of a screen positive triple test result and subsequent testing 
decisions. The disadvantage of using the sam e health professional for each condition 
was that there was a potential increase in experimenter bias. However, had two health 
professionals had been used, one for each condition, there would have been potential 
for differences in information-giving to occur as a function of individual style. As the 
experimental condition requires the manipulation of information, it was considered more 
important to control for the information given during the consultation than introduce 
techniques that may or may not have reduced the likelihood of experim enter bias.
6.1.2 Measures.
The following section is concerned with discussing all the measures that were used to 
evaluate the effectiveness of decision analysis in facilitating wom en’s decision making 
to have or not have prenatal diagnosis.
6.1.2.1 Consent form.
Ethically, all research involving humans requires the individual to provide informed 
consent of participation (Bowling, 1997). Written information ought to be provided to the 
participant about the study purpose, the demands of participation, the associated risks, 
the voluntary nature of participation, the confidentiality of participation as well as 
indiciating that it is appropriate to withdraw from the study at any point during the 
research (Coolican, 1990; Bowling, 1997). Written informed consent should be obtained 
from the individual after receipt of this study information.
A  consent form was developed for this study which included the following information: a 
measure of anxiety (Short-form Spielberger STAI: Marteau and Bekker, 1992); four 
likert-scale items assessing perception of risk for having a healthy child, a child with 
Down’s syndrome, miscarrying a fetus with Down’s syndrome and miscarrying a healthy 
fetus; three open-ended questions for the women to note any other concerns they had 
about their health, pregnancies and babies (Appendix IX). The following factors 
prompted the inclusion of these measures on the consent form. First, there is some 
evidence that those who decline to participate differ from those who do not and 
documentation of these differences is necessary for accurate interpretation and
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generalisability of results (Marteau, Johnston, Kidd, Michie and Cook, 1992). Second, 
there is evidence that anxiety and perception of risk are two factors associated with the 
decision making process (Janis and Mann, 1977; Marteau, Johnston, Kidd, Michie and 
Cook, 1992; Van der Pligt, 1988; Van der Pligt and de Vries, 1998). Third, an indication 
of the pre-consultation levels of these factors was considered useful by the LGI 
antenatal staff.
6.1.2.2 Consultation.
Within this clinical setting, the most efficient and least obtrusive method of observing 
the decision making process was to audio tape-record the consultation (see chapter 
five). The resulting transcripts provided a rich source of data. There are numerous 
techniques that can be employed to analyse transcript data, the choice of which 
depends on the study aims and research questions (see chapters four and five). The  
main purpose of this study was to evaluate the effect of decision analysis on women's 
informed decision making. However, one of the functions of employing a decision aid is 
to decrease the confusion or conflict associated with making a difficult decision 
(O ’Connor, 1995). In consequence, two techniques were applied to the consultation 
transcripts to assess both the reasoning and affective content of w om en’s utterances: a 
theme-based coding frame assessing informed decision making and a text analysis 
programme assessing the emotional and cognitive content.
Theme-based coding frame: Chapter five described the development of the them e- 
based coding frame to assess informed decision making. The application of the coding 
fram e to each consultation transcript systematically classified all the information the 
women referred to during the consultation when making the decision to have a 
diagnostic test or not. By assessing references to these themes, it was possible to 
ascertain whether the women were utilising sufficient information to make an informed 
decision to have or not have a diagnostic test.
The Linguistic Inquiry and Word Count (SLIWC): This text analysis package was 
developed specifically to look at the emotional and cognitive processes within written 
texts, such as essays, but has since been applied to transcripts of speech (Pennebaker 
and Francis, 1997). The package has a powerful dictionary that classifies words in four 
ways: a linguistic analysis such as counting words and identifying pronouns or articles; 
psychological constructs, such as affect and cognition; concepts of ‘relativity’, such as 
time, space and motion; issues of a personal nature, such as work, home and leisure. 
The external validity of the package has been reported to be good in a number of
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populations and countries (Pennebaker and Francis, 1997). As this programme was not 
developed specifically for this study, not all of the categories coded by SLIW C were 
appropriate for this analysis. The categories that were consistent with the research aims 
included the number of words in the transcript, the percentage of positive emotion-laden  
words, the percentage of negative emotion-laden words, the percentage of cognitive 
associated words and the percentage of words referring to social or communication 
issues (Appendix X).
6.1.2.3 Post-decision Questionnaire - time 1 (T1).
As discussed, the choice of measure to assess the quality of value-laden decisions 
depends upon the research aims of the study (Llewellyn-Thomas, 1995; O ’Connor, 
1995). The purpose of this study was to evaluate the effectiveness of decision analysis 
to facilitate wom en’s decision making within the prenatal diagnosis consultation. As this 
is one of the first studies to address this issue, there are few validated or reliable 
measures to assess the decision quality within this decisional context. However, 
empirical research on decision making and the application of psychological theory to 
understanding health behaviours have generated a number of measures that could be 
modified to address this study’s aims. Behavioural, affective, cognitive and clinical 
measures of decision quality were developed with reference to the literature on: the 
application of decision analysis to w om en’s prenatal diagnostic decision making (Pauker 
and Pauker, 1978; Pauker and Pauker, 1987; Thornton, 1990; Heckerling, Verp and 
Hadro, 1994; Verp and Heckerling, 1995); explaining wom en’s prenatal screening and 
diagnostic behaviour (Marteau, Johnston, Plenicar, Shaw and Slack, 1988; Marteau, 
Cook, Kidd, Michie, Johnston, Slack and Shaw, 1992; Bekker, Modell, Denniss, Silver, 
Mathew, Bobrow and Marteau, 1993; Evans, Pryde, Evans and Johnson, 1993; Smith  
and Marteau, 1995; Michie, Smith, McClennan and Marteau, 1997); models of decision 
making and behaviour (Eagly and Chaiken, 1993; Shafir, Simonson and Tversky, 1994; 
Conner and Sparks, 1996).
As the final questionnaire (Appendix XI) was developed with reference to a number of 
diverse areas and sources, the items included within it were selected following three 
stages of piloting: the development of a semi-structured interview; the developm ent of a 
draft questionnaire for peer review: the piloting of the draft questionnaire on a sample of 
women similar to the population of the main study. The semi-structured interview was 
completed by five women in the delivery ward. All women included in the pilot of the 
semi-structured interview were under 30 years of age. Triple test screening is only 
offered to women at the LGI who will be 30 years of age at estimated date of delivery.
129
Consequently, no women in this pilot had been offered prenatal screening, which m eant 
that the resulting interview focused mainly on women's attitudes and beliefs towards 
prenatal screening, testing, abnormalities and termination rather than on decision 
making during pregnancy. In response to this pilot, a questionnaire was drafted to focus 
m ore on items evaluating the quality of wom en’s prenatal diagnosis decision making 
and less on questions pertaining to their attitudes and beliefs towards triple test 
screening, abnormalities and termination. As the structure or tem plate of many of these 
item s was informed by previous research, the resulting measures have likert scales with 
different lengths, with either five-, six- or seven- point scales. This version of the 
questionnaire was circulated for comments to colleagues with a range of expertise: AP  
and JM in theoretical and applied decision making research; RP and CA in the 
application of social cognition models to food health behaviours; JG T and JH in prenatal 
care and application of psychological theory to health services research. In addition, the 
questionnaire was completed by fourteen women waiting to undergo diagnostic testing 
in the LGI antenatal clinic. That is to say, the pilot sample were sufficiently similar to the 
target sample of the main study.
The women completed the questionnaire (T1) after they had m ade their decision to 
have or not have further diagnostic testing but before they had had the diagnostic test 
or the nineteen week fetal anomaly scan. Most of the women m ade this decision after 
the information giving consultations described in chapters four and five. The final items 
included within the study questionnaire are discussed in detail below, with reference to 
the appropriate literature and comments from the piloting exercises. The items are 
grouped by type of measure: behavioural; affect; cognitive processes; clinical quality; 
socio-demographic characteristics and individual differences.
6 .1 .2 .3 .1  B e h a v io u ra l m e a s u re s .
The actions of undergoing diagnostic testing or of continuing the pregnancy without 
diagnosis provided the main behavioural measures. In addition, the questionnaire 
included three ‘intention to behave’ items: intention to have a test (7 point likert scale); 
intention to recommend diagnostic testing (5 point likert scale); intention to recommend 
the triple test (5 point likert scale) (Appendix XI: Q17, Q31, Q 39). In the first instance, 
the intention to behave item was informed by the literature on reasoned and rational 
choice models of behaviour which propose that intention and actual behaviour are 
causally related (Conner and Sparks, 1996). Intended behaviour has frequently been 
used in studies as the main measure of behaviour when it has not been possible to 
assess actual behaviour. These items were informed by the literature aiming to evaluate
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the quality of decision making (Pitz, 1987). Assessing whether or not a course of action 
would be recommended by the individual is an indirect measure of satisfaction (Pitz, 
1987). There are at least two problems with attempting to assess satisfaction directly in 
this context. First, evaluations were made by the women after a decision was reached. 
It is likely that some cognitive readjustments could have taken place such as those 
described by dissonance theory and thus biasing the response (Festinger, 1957; Olson 
and Zanna, 1993; see chapter one). Second, the women were being asked to comment 
on their satisfaction with their health care half-way through their prenatal care. It is likely 
that women would be encouraged to provide a socially desirable answer (Bowling,
1997), one that did not jeopardise subsequent care.
6 .1 .2 .3 .2  A ffe c t m ea su re s .
The emotional response of the women to the prenatal diagnosis decision making 
process was assessed by a number of measures of affect. It has been well documented  
that prenatal screening and diagnosis are associated with short-term variations in 
anxiety and worry about the procedure and subsequent results (Farrant, 1980; Nielson, 
1981; Verjaal, Leschot and Treffers, 1982; Burton, Dillard and Clark, 1985; McGovern, 
Goldberg and Desnick, 1986; Evans, Pryde, Evans and Johnson, 1993; Green, 1990,
1994). In addition, other studies report the distress of making a difficult decision about 
such value-laden choices (Pauker and Pauker, 1977; Farrant, 1980; Sjorgen and 
Uddenberg, 1988). Measures of affect were included within the questionnaire to 
evaluate whether or not decision analysis was associated with a decrease in distress.
There are a number of established, validated and reliable measures of mood states 
including: the Zung Self-Rating Depression Scale (SDS: Zung, 1965); the Leeds 
Hospital Anxiety and Depression Scale (HADS: Zigmond and Snaith, 1983); the Beck 
Depression Inventory (BDI: Beck, W ard, Mendelson, Mock and Erbaugh, 1961); 
G eneral Health Questionnaire (GHQ: Goldberg, 1987); the Spielberger State-Trait 
Anxiety Inventory (STAI: Spielberger, 1976). The majority of these measures were 
developed to assess the mood states of clinical populations to evaluate the prognosis of 
patients. As the study sample were not patients, the most appropriate measure was one 
validated within a well population. Also, the discrete nature of the test context suggests 
that anxiety rather than depression was the more appropriate emotional response to 
assess. The STAI has been validated within a number of populations (Spielberger, 
Gorsuch, Lushene, Vagg and Jacobs, 1976; Knight, W aal-M anning and Spears, 1983) 
and applied within the prenatal testing context for over ten years (Beeson and Golbus, 
1979; Marteau, Kidd, Cook, Michie, Johnston, Slack and Shaw, 1992; Marteau, Cook,
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Kidd, Michie, Johnston, Slack and Shaw, 1992; Michie, Marteau and Kidd, 1992; Evans, 
Pride, Evans and Johnson, 1993; Thornton, Hewison, Lilford and Vail, 1997). In 
addition, the original twenty items of the STAI (state scale) have been shortened to a 
six-item version and validated within a pregnant population (Marteau and Bekker, 
1992). In consequence, the questionnaire included the short-form STAI as a general 
m easure of state anxiety.
It has been suggested that general measures of affect may not be sensitive enough to 
the emotional responses of specific events such as pregnancy and prenatal testing 
(Green, 1990; Marteau, Kidd, Michie, Cook, Johnston and Shaw, 1993). Consequently, 
som e researchers have developed context specific measures of affect (Green, 1990;). 
Item s from the Worries Questionnaire (Thornton, Hewison, Lilford and Vail, 1997) were 
modified for inclusion in the pilot questionnaire. The content of the original measure  
included items about testing and attachment with a multiple choice response layout. 
Measures of attachment were not considered appropriate for inclusion within the 
questionnaire. The main reason for this omission was the ever-increasing length of the 
questionnaire. In essence, the purpose of the study was to evaluate the effectiveness of 
decision analysis on the decision making process. Measures of the impact, coping and 
adjustment following the decision were beyond the primary concern of this study. The  
items included were: worry that the scan, medication, emotion, amniocentesis and 
chorionic villus sampling may harm the baby; worry that the baby would be physically ill, 
mentally ill or have a serious health complaint. An alternative seven-point likert scale 
response layout for the selected items was piloted (Appendix XI: Q 43 and Q 44). This 
likert scale format was shared with several other items within the questionnaire and no 
adverse comments were made about their completion. The main advantage of 
converting from a multiple choice to likert scale format was the generation of continuous 
rather than categorical data for subsequent analyses.
There are fewer measures of affect associated with the process of decision making. At 
the tim e of questionnaire development, two measures were being referred to within the 
decision making literature: the Flinders Decision-Making Questionnaire, now published 
as the Melbourne Decision-Making Questionnaire (M DM Q : Mann, Burnett, Radford and 
Ford, 1997); the Decisional Conflict Scale (DCS: O'Connor, 1995). The theoretical 
foundations of both the M D M Q  and DC S derive from conflict theory (Janis and Mann, 
1977). However, the M DM Q  is concerned with individual coping styles and the DC S  
with the affective state associated with the decision making process. Although the 
M D M Q  has been applied to health care decisions, it was developed within the context of
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career and business decision making amongst student populations. The DC S was 
developed within the context of health care treatment choices by patients. As the DCS  
m et the research aims more fully than the M DM Q, the measure was included within the 
questionnaire. Since development of the questionnaire, a Satisfaction with Decision 
Scale (SDC: Holmes-Rovner, Kroll, Schmitt, Faan, Padonu and Talarczyk, 1996) has 
been published. Subsequent studies may wish to consider the inclusion of this measure 
to assess the decision quality.
6 .1 .2 .3 .3  C o g n it iv e  m e a s u re s .
M easures aimed at inferring the cognitive processes employed by women when making 
the decision to have or not to have a diagnostic test were particularly important to the 
evaluation of decision analysis as a technique to facilitate decision making. The  
purpose of decision analysis is to change the way an individual understands the 
decision (Pitz, 1987) by aiming to encourage a more systematic, analytic or rational 
processing of information. As discussed, there are a number of cognitive changes that 
m ay be expected following the application of the decision analytic technique: increased 
reasoning; greater understanding of the decision attributes; a more realistic 
interpretation of the risks; a greater awareness of the utilities and attitudes. The  
measures of cognitive process considered for inclusion in the T1 questionnaire are 
discussed in more detail below. The T1 questionnaire is reproduced in Appendix XI.
Assessing reasoning of the information used to make a decision is an item common to 
the different literatures. Several studies have included a simple, open-ended item to 
ascertain what the reasons were for the final choice (Verjaal, Leschot and Treffers, 
1982; Roelofsen, Kamerbeck, Tymstra, Beekhuis and Mantingh, 1993; Julian-Reyner, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994). An open-ended question 
was included within the questionnaire to document the respondent’s main reason for 
having the triple test. However, it is likely that individuals hold both reasons for and 
against the choice they accept or reject (Shafir et al, 1994). That is to say that they 
have an am bivalent attitude towards the behaviour (Eagly and Chaiken, 1993; Olson 
and Zanna, 1993; Conner and Sparks, 1996). Certainly the decision making and social 
cognition literature suggest that decisions are made following a trade-off between the 
reasons for and against alternatives (Eagly and Chaiken, 1993; Frisch and Clem en, 
1994; Shafir et al, 1994; Conner and Sparks, 1996). Consequently, an open-ended item  
was developed from a study assessing attitudes to breast cancer screening (Bekker, 
Morrison and Marteau, 1999) to assess the individual’s perception of reasons for and 
against prenatal testing. An open-ended question design was selected to ensure that the
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reasons generated were salient to the respondent rather than to an evaluation of the 
researcher’s agenda. The reasons for having tests in pregnancy were referred to as 
‘advantages’ and reasons against as ‘disadvantages’. On the sam e line as each space 
for the advantages and disadvantages responses was a five-point likert scale (either 
sm all to great advantage or small to great disadvantage) informed by a study assessing 
am bivalent attitudes to food (Povey, 1997). These evaluations of the respondent’s 
reasons may go some way towards describing the trade-off between reasons.
Most of the empirical research within decision analysis and social cognition applications 
is concerned with assessing utilities or attitudes and perceptions of risk or probability, 
that is to say, with cognitive processes that are less easily expressed than reasons. 
C hapter one highlighted the breadth of issues researched under the umbrella term  
‘prenatal testing’, such as attitudes and perception of risks towards screening, prenatal 
diagnosis, abnormality, termination and new technologies. As demonstrated by piloting 
of the semi-structured interview, the attempt to assess all the different prenatal testing 
decisions within one research project proved to be an unrealistic aim. The purpose of 
the study was to evaluate the effectiveness of decision analysis to facilitate prenatal 
diagnosis decision making. Consequently, the final questionnaire contained only 
attitude and perception of risk items associated with the four outcomes of the prenatal 
testing decision: the birth of a healthy baby; a miscarriage (spontaneous abortion); a 
termination (elective abortion); the birth of a child with an abnormality (Pauker and 
Pauker, 1978).
The subjective norm is a concept within the social cognition literature which represents 
an individual’s evaluation of a third person’s opinion about the individual performing the 
action (see Conner and Sparks, 1996; Trafimow, 1998). That is to say, it provides an 
evaluation of the perceived normative action. Some argue that the perceived social 
norm is a concept distinct from measures of attitudes; others argue that attitudes and 
subjective norms are measures of the same underlying construct (see Trafimow, 1998). 
For the purposes of this study, the subjective norm was operationalised as an 
independent predictor of behaviour, distinct from other evaluations of the behaviour. A  
single item (on a seven-point likert scale) was included within the questionnaire to 
assess the w om en’s perceived social norm towards prenatal diagnosis.
As mentioned in chapter one, there are many methods of eliciting utilities or 
measuring attitudes. During the consultation, those within the decision analysis group 
provided a utility following the lottery or standard gamble technique (Pauker and
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Pauker, 1978; Thornton and Lilford, 1990; Baron, 1994). However, such a technique  
could not be used within the questionnaire without potentially confounding the decision 
making process of the routine consultation group. A direct scaling technique would be 
less confrontational (Pauker and Pauker, 1978; Baron, 1994). One direct scaling 
method requires the respondent to place on a line, labelled from zero to one hundred, 
the desirability of all the possible consequences of the alternatives (Pauker and Pauker, 
1977, 1978, 1987). The 'best' consequence is placed at one hundred, the ‘worst’ at zero 
and the other consequences somewhere between the two points. The best consequence 
usually refers to the birth of a healthy child, the worst consequence the birth of a child 
with Down’s syndrome. This measure provides both a utility figure and the relative 
relationship of the consequences to each other. During piloting, this question had to be 
modified. First, the demands of this question are unusual for standard self-completion 
questionnaires. The written explanation was longer than other items and required 
additional verbal prompting to encourage the placing of consequences at ‘0 ’ and ‘100 ’. 
Second, respondents frequently mentioned the difficulty in ranking the consequences as 
som e were perceived to be equally good or as bad as others. The final utility measure  
simplified the demands of the task for respondents by placing a line labelled zero to one 
hundred alongside each consequence of the prenatal diagnosis decision. The  
respondent placed a mark along each line to represent how bad or good that 
consequence was perceived to be. It was the responsibility of the researcher to note 
both the utility and ranked position of the consequence in relation to the others. This 
revised item allowed the respondent to answer the question in a more ‘naturalistic’ 
m anner without enforcing an EU T structure on the subsequent response.
In addition to the above measure of utility, a number of more routine belief items were  
included within the questionnaire. In an attempt to assess respondents’ beliefs about the 
cause of Down's syndrome, an open-ended question was provided for respondents to 
suggest what may increase or decrease the likelihood of having a child with Down’s 
syndrome. A question was developed to assess respondents’ beliefs about a child with 
Down’s syndrome. From preliminary observations within consultations (chapter five), 
comments concerning Down’s syndrome focused on either coping with a child with 
Down’s syndrome or the quality of life a child with Down’s syndrome might experience. 
The questionnaire contained two seven-point likert scales to assess the quality of life 
and amount of care of three abnormalities: a predominantly mental abnormality, Down’s 
syndrome; a physical abnormality, Spina Bifida; a less severe physical abnormality, 
cleft palate. The aim of the last four items was to assess respondents' general beliefs 
about the purpose of testing during pregnancy. Following the semi-structured interviews,
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four statements from the w om en’s responses were selected: that tests are necessary for 
the w om an’s well-being; that tests improve the chance of having a healthy baby; that 
tests are necessary for the well being of the fetus; that tests decrease the chances of 
miscarrying. Five-point likert scales were used to assess the degree of agreem ent with 
each statement. Although these items were informed by the literature and piloted, they 
have not been validated or their reliability established. The items were included within 
the questionnaire as a preliminary stage in the assessment of their feasibility as more 
established or standardised measures.
Perception of risk is the other cognitive process of importance when assessing 
decision making. Numerous studies have reported a relationship between individuals’ 
perception of risk and subsequent health behaviour (see Van der Pligt, 1998; chapter 
one). However, it is well documented that an individual’s judgem ent of risk information 
is sensitive to the context of presentation (Vlek, 1987; Croyle, Sun and Hart, 1996; Van 
der Pligt, 1998). The subsequent utilisation of biased information m ay lead to poorer 
decision outcomes. As decision analysis visually represents all the risks associated with 
the decision, it is argued that an individual’s subsequent perceptions should be more 
accurate than a method which may or may not focus equally on all the information 
(Yates and Stone, 1994). As perception of risk is a multi-attributed concept, there is no 
optimum measure to assess evaluations of risk (Vleck, 1987; van der Pligt, 1998). This 
questionnaire included three assessments for perception of risk: an evaluation of the 
personal risk for Down’s syndrome as low, medium or high; estimates for the likelihood 
of occurrence of seven possible prenatal diagnosis consequences; five items to assess 
the comparative likelihood of the respondents developing health or pregnancy problems 
compared with other similarly aged women. For each item contained within the last two 
questions, respondents circled numbers on verbally labelled likert scales. This type of 
scale has been found to be a good predictor of behavioural intentions (Van der Pligt,
1998).
An assessment of knowledge of the test procedures is one of the most frequently used 
m easures within the applied literature (French, Kurczynski, W eaver and Pituch, 1992; 
Julian-Reynier, Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994; Jorgensen,
1995). Knowledge is an indirect measure of informed decision making or of 
understanding of information, as such measures assess whether or not respondents 
rem em ber information they may or may not have been provided with. These measures 
are unable to assess what information was used by the women when making their 
prenatal diagnosis decision. The format for most measures of knowledge is to include a
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num ber of multiple choice items based on factual information considered necessary to 
enable informed decision making (French, Kurczynski, W eaver and Pituch, 1992; 
Bekker, Modell, Denniss, Silver, Mathew, Bobrow and Marteau, 1993; Marteau, Kidd, 
Michie, Cook, Johnston and Shaw, 1993; Michie, Smith, McClennan and Marteau, 
1997). The study questionnaire included ten multiple choice knowledge items, which 
included questions about factual information associated with diagnostic testing, 
miscarriage and Down’s syndrome.
6 .1 .2 .3 .4  C lin ic a l q u a lity  m e a s u re s .
The following measures were included in order to address some of the concerns 
expressed when decision analysis is applied to a real-world clinical situation: that it is 
tim e consuming; that it confuses the lay population; that it compromises the individual's 
autonomy when making decisions. As this was one of the first studies to evaluate  
decision analysis within the prenatal testing context, there were few exam ples of 
measures employed to provide evidence supporting or counteracting these concerns. In 
addition, it is unclear whether all these clinical concerns are adverse or undesirable. For 
example, an increased length of time to make a decision may be associated with a 
more systematic evaluation of the information whereas a short consultation length may 
suggest that an heuristic was applied when making the decision (Eagly and Chaiken, 
1993; Michie, Smith, McClennan and Marteau, 1997). Equally, within a paradigm of 
shared doctor-patient decision making, directiveness is perceived negatively. However, 
there is some evidence that patients want to be informed but do not necessarily want to 
m ake decisions about their treatm ent (Fallowfield, 1997). Finally, it is likely that some 
patients m ay not be aware that information or advice provided by health professionals 
about a desired course of action might be considered directive or inappropriate.
The questionnaire included a seven-point likert scale to estimate the perceived length of 
tim e taken to make the decision and a categorical variable to assess whether the 
decision was made before or after the consultation. The consultation length had been 
noted during transcription of the audio-tapes of consultations. As perceived autonomy in 
decision making is seldom assessed (Sjorgen and Uddenberg, 1988), an item was 
developed and piloted specifically for this study. A five-point likert scale assessed 
whether or not a number of health professionals and significant others were forthcoming 
about their choice of an appropriate course of action. Usefulness of information was 
evaluated with a single seven-point likert scale. In an attempt to avoid the interviewer 
and social desirability bias raised earlier in this section, the wording to elicit reponses 
about the quality of the consultation was carefully selected. For example, the terms
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‘d irective’ and ‘satisfied’ imply a certain or socially desirable response. Consequently, 
the more positive and less ambiguous term ‘encouraged’ was used in the autonomy in 
decision making question. Equally, the term ‘satisfied’ requires the patient to comment 
directly on the care they have received. As most of the women will continue to be seen 
by the sam e health care team, this type of question may have resulted in a response 
bias. The term ‘useful’ replaced the ‘satisfied’ term as it required the women to focus on 
an aspect of the care provided and not on an evaluation of the service.
G.1.2 .3 .5  P ro file  c h a ra c te ris tic s  o f w o m e n .
In addition to measures evaluating the effectiveness of the intervention on w om en’s 
decision making, the questionnaire included a set of variables to describe the following 
profile characteristics of participants: socio-demographic variations; reproductive 
history; individual differences in information processing. A number of studies have 
reported associations between these types of measures and subsequent prenatal 
diagnosis decisions (see chapter one). Consequently, descriptions of these differences  
may assist in the interpretation and generalisability of findings. In an attempt to restrict 
the length of the questionnaire, items most closely associated with the research aims 
were selected from the range of available measures.
Socio-demographic characteristics included four items: marital status; level of 
education; religious activity; ethnic origin. A four-category, single item assessed 
whether a woman was married, living as married, single or another category. A measure  
for level of education was included rather than socio-economic status (SES). As the 
intervention was concerned with information presentation and processing, an item  
describing respondents’ educational training seemed a more useful measure than SES. 
In addition, accurately evaluating the SES of fem ale ‘reproductive’ respondents is more 
difficult as their employment status is likely to be influenced by having had children. The  
item assessing religious activity had been developed for use in a multi-cultural, primary- 
care based population (Bekker, 1994). The first part of the item allowed respondents to 
indicate which religion, if any, they followed. The second part of the item rated how 
often they attended religious gatherings. The item aimed to differentiate those 
respondents with an active set of religious beliefs from those with an affiliation to a 
particular faith. The measure of ethnic origin was informed by those categories of the 
Officie of Population, Censuses and Surveys in the UK (1993).
Reproductive history included three items assessing prior experience of prenatal 
testing and Down’s syndrome. These single items were developed for the study and
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piloted following a review of the appropriate literature. There is evidence that prior 
behaviour is a predictor of future behaviour (Van der Pligt, 1994). It is likely, therefore, 
that choice of diagnostic test m ay be associated with past reproductive decisions, such 
as previous prenatal tests, experiences of abnormality and terminations. Information 
about the previous number of pregnancies, miscarriages and terminations was derived 
from the w om en’s notes.
There are numerous measures assessing individual differences, personality traits or 
dispositional constructs that have been developed within psychological research. 
Previous research suggested an association between preferences for a style of 
judgem ent and decision making (Schwarzer, 1994; Van der Pligt, 1994; W ebster and 
Kruglanski, 1994; Sorrentino, Holmes, Hanna and Sharp, 1995). Considered for 
inclusion within this questionnaire, then, were standardised measures assessing 
differences in style of judgement only, in particular the Need for Cognition (NC: 
Cacioppo, Petty and Kao, 1984) and the Need for Cognitive Closure (NFC: W ebster and 
Kruglanski, 1994); Life Orientation Test (LOT: Scheier and Carver, 1985). The NC 
assesses “an individual’s tendency to engage in and enjoy effortful cognitive 
endeavours” (pg. 306; Cacioppo, Petty and Kao, 1984); the NFC a “desire for 
predictability, preference for order and structure, discomfort with ambiguity, 
decisiveness, and close-mindedness” (page. 1049, W ebster and Kruglanski, 1994); the 
LO T “dispositional optimism, a habitual style of anticipating favourable outcomes” 
(page. 41, Johnston, Wright and W einm an, 1994). The NFC was not included within the 
final questionnaire because it was reported to be highly correlated with the NC (W ebster 
and Kruglanski, 1994) and also included 42 items within the measure. An eight-item  
short-form measure of the NC scale modified from the eighteen-item short-form  
measure (Cacioppo, Petty and Kao, 1984) was included within the questionnaire. The  
developm ent of the eight-item measure is reported in Appendix XII. The short-form LOT  
(Johnston, Wright and W einm an, 1994) was also included within the final questionnaire.
6.1.2.4 Follow-up questionnaire - time 2 (T2).
The literature suggests that the effectiveness of decision analysis to facilitate decision 
making should have post-decisional advantages. Essentially, the more accurate 
judgem ents of risk information and explicit evaluations at the tim e of decision making 
should result in more robust attitudes (Eagly and Chaiken, 1994) and greater 
satisfaction, or less regret, with the final choice (Pitz, 1987; O ’Connor, 1994). The 
questionnaire T1 was modified and used as a follow-up questionnaire (Appendix XIII). 
The following items were omitted from the T2 questionnaire because they should have
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rem ained constant over the one-month time period: socio-demographic characteristics; 
reproductive history; individual differences. As the purpose of T2 was to evaluate the 
long-term impact of decision analysis on decision quality, only items pertaining to the 
prenatal diagnosis decision and information consultation were evaluated at T2. All the 
cognitive, affective and clinical measures of decision quality were included within the 
final questionnaire.
6.1.3 Procedure.
The LG I’s routine clinical practice for contacting women, informing them of their triple 
test result and providing the prenatal diagnosis information giving consultation was 
maintained throughout the fifteen-month study period (March 1996 - June 1997). 
Chapter four described this routine clinical practice in more detail. All the women  
attending the clinic for the prenatal diagnosis information giving consultation were 
informed of the study both verbally and with written information before the start of the 
consultation. All women completed a consent form stating whether or not they agreed to 
participate in the research. The women declining to participate in the study received the 
routine care consultation from the study health professional. No further contact was 
m ade with those women declining to participate in the study once they had reached a 
decision about prenatal diagnosis.
The women agreeing to participate in the study were allocated to one of the study 
consultations following the opening of a previously sealed, numbered, opaque 
envelope. Within the envelope was an instruction stating whether the consultation was 
to be conducted according to routine care or structured using decision analysis. The  
differences in the structure of the two consultations have been described in section 
6.1.1 . This simple random sampling technique ensured that each woman had an equal 
chance of allocation to one of the two experimental conditions. The audio tape-recorder 
was switched on as soon as the woman agreed to participate in the study. At the end of 
the consultation, most women m ade a decision to have or not have a diagnostic test. 
The women were given the questionnaire (T1) to complete at this point. To reduce the 
influence of the author on the wom en’s responses, they completed the questionnaire 
(T1) alone. Ideally, all the women would have completed the questionnaire in the clinic 
after the consultation and before undergoing any procedures. However, this was a real 
decision being made within a clinical setting. Occasionally, the women either required 
more tim e to reach a decision or wanted to discuss the decision made with a partner not 
present during the consultation. There were also instances of some women undergoing 
the diagnostic test procedure before completion of the questionnaire because of the
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availability of the other health care professionals. These women were provided with 
stamped addressed envelopes and encouraged to return the questionnaires (T1) as 
soon as was convenient.
Those women who had participated in the study were sent a follow-up questionnaire 
(T2) and stamped addressed envelope four to five weeks after the screen positive triple 
test consultation. Originally the follow-up questionnaire (T2) was to be sent at a time  
when all the consequences of the prenatal diagnosis alternatives would have occurred: 
after the birth of a baby with or without Down’s syndrome; after termination; after 
miscarrying. However, following discussions with the antenatal team  it was considered 
inappropriate and insensitive to send questionnaires to those women who had had an 
undesired consequence. In addition, the questionnaire (T2) would have had to have 
been sent six months after the women made the decision not to have or to have a 
diagnostic test to ensure that all the consequences had occurred, i.e. after the birth of 
the baby. It is likely that the evaluation of the information intervention at this stage 
would be particularly sensitive to the memory and cognitive readjustment biases of 
human processing raised earlier in this thesis (see chapter one). Most of the following 
consequences of the prenatal diagnosis decision apart from the birth of a child with or 
without Down’s syndrome would have occurred four to five weeks after the screen 
positive triple test consultation: diagnostic test result; nineteen-week fetal anomaly  
scan; test-related miscarriage; termination. In consequence, those women who had not 
miscarried or received a positive diagnostic test result within this tim e period were sent 
a follow-up questionnaire (T2). If the women had not returned the follow-up 
questionnaires (T2) within two weeks, reminder questionnaires (T2) and stamped 
addressed envelopes were sent in an attempt to decrease attrition rates.
In theory, all the women who received screen positive triple test results throughout the 
study period were eligible for inclusion in the study. However, there were a number of 
situations which meant that some women were subsequently excluded from the study 
both pre- and post-randomisation. These situations meant that it was either difficult to 
control the amount and quality of information the women were exposed to or that the 
decision process and outcome could not be evaluated. The reasons for exclusion fell 
into two categories: those women that did not fulfil the study criteria; factors associated 
with wom en’s decision making. The criteria issues were: those women with a 
complication that influenced the interpretation of the triple test result, such as diabetes 
and twins; those women informed about their test result by another m em ber of the 
antenatal team  on occasions when the author was not available; those women receiving
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a screen positive triple test result for either spina bifida or Edward’s syndrome; those 
wom en who participated in the study but during the course of the consultation found an 
error on their triple test result sheet and, following re-calculation, received a screen 
negative result; those women who could not read and write English. The factors 
associated with the wom en’s decision making were: those women paying for prenatal 
care; those women who made a decision about prenatal diagnosis over the telephone; 
those women who participated in the study but did not return their post-decision 
questionnaire (T1). It was likely that the women paying for treatment, those deciding not 
to have a test or have a test over the telephone and those not returning their post­
decision questionnaire (T1) differed in their decision making from those agreeing to take 
part in the study who had completed the post-decision questionnaire (T1). However, it 
was beyond the scope of this study to adequately explore this assertion.
Power calculations were used to estimate a sufficient sample size. As previously 
alluded to, there were few standardised measures at the tim e of questionnaire 
developm ent to assess the quality of the decision. Only anxiety (STAI: Spielberger et al, 
1976; Marteau and Bekker, 1992) and decisional conflict (DC: O ’Connor, 1994) had 
been validated. O f these, the most widely applied measure within the prenatal testing 
and other contexts is anxiety (STAI). Consequently there are a number of exam ples of 
expected anxiety levels in various situations (Spielberger et al, 1976; Beeson and 
Golbus, 1979; Marteau and Bekker, 1992; Marteau, Kidd, Cook, Michie, Johnston, Slack  
and Shaw, 1992). In a non-pregnant sample of women aged between 19-39, the mean 
anxiety score was recorded as 36.2 and the standard deviation 11.0 (Spielberger et al, 
1976). Within a pregnant population a similar value is recorded, m ean 37.1 and 
standard deviation 11.0 (Marteau and Bekker, 1992). In women undergoing 
amniocentesis, higher mean anxiety scores are reported, between about 42 and 52 
points, with no standard deviation scores reported (Beeson and Golbus, 1979; Marteau, 
Kidd, Cook, Michie, Johnston, Slack and Shaw, 1992). As decision analysis has not yet 
been evaluated, how much anxiety can be estimated to decrease from routine practice 
is unclear. For the purposes of the power calculation, a six-point difference in mean 
anxiety scores between groups was estimated to be a reasonable clinical decrease. The 
standard deviation reported within the shortened and full form STAI publications of 
eleven points was also used. The power was set at 80%  and the degree of significance 
at 5% (0.05). An estimated sample size, then, would be approximately 52 women in 
each arm of the trial.
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6.1.4 Analysis.
6.1.4.1 Missing values.
Frequencies were run for all the variables contained within the data files. The study 
numbers of the women were noted for any erroneous figures or missing data entry 
points. Questionnaires and transcripts were used to correct any mis-typed figures. 
Missing data can be dealt with in a number of ways: deletion of the whole case; using 
the m ean to estimate a missing value; repeating the analysis with and without missing 
data; analysing all cases by missing data (Tabachnick and Fidell, 1989; Robson, 1997). 
The method used for this data was to replace the missing values with a mean value. As 
the subsequent analysis was carried out to evaluate differences between the routine and 
decision analysis groups, the estimated mean value of the appropriate group was used. 
If the missing value was pertained to a single item measure, the inserted m ean was 
calculated from all the values of the remaining sample. If there was a missing value for 
an item within a standardised measure and more than 50% of the measure had been 
completed by the participant, then the mean value was calculated ‘pro-rata’ from the 
completed items. If less than 50%  of the items of the measure had been completed by 
the participant, then the mean replacement was calculated from the remaining group 
data. However, if the same value was missing from more than 10%  of the sam ple (n = 
11), the measure was omitted from further analysis.
6 .1.4.2 Outliers and normality of distribution
Outliers are cases with values on a variable or variables that can unduly influence 
statistics (Tabachnick and Fidell, 1989). Dichotomous variables with uneven splits 
between the two categories are regarded as outlier variables; 90%  to 10% splits should 
not be used in subsequent analysis (Tabachnick and Fidell, 1989). How outliers are 
identified depends on the analysis to be carried out. The purpose of this analysis was to 
assess differences in measures by grouped data, routine consultations compared with 
decision analysis information giving. Consequently, the SP SS explore command was 
run by group to identify any outliers. The values of all outliers were checked with the 
raw data and altered where appropriate.
The S P S S  explore command was used on the complete data set of both questionnaires 
to identify variables with distributions that varied significantly from the normal 
distribution. A z-value of 3.67 (p < 0.001) was used to determine which variables 
required transformation and/or elimination from further analysis (Tabachnick and Fidell, 
1989).
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6.1.4.3 Calculating Standardised Measures.
The post-decision questionnaire included items from four standardised measures: 
anxiety; decisional conflict; need for cognition; life orientation test (Appendix X I). The  
manipulation of the raw data to form these scores is discussed below.
Anxiety (Q 9 - 14) - the positively framed items 'calm', ‘relaxed’ and ‘content’ were 
recoded in reverse order. All values from the six items were combined and the total pro­
rated to be compatible with the complete form, i.e. multiplied by twenty and divided by 
six (Marteau and Bekker, 1993). The higher the score, the greater the expressed 
anxiety (range 20 - 80).
Decisional conflict (Q 19 - 29) - the negatively framed items were recoded in reverse 
order. Three scores were calculated following addition of the items according to 
O ’Connor, 1996: uncertainty with decision; informed decision making; efficacy in 
decision making. The higher the scores, the greater the expressed decisional conflict 
(ranges from 3 -1 5 ,  4 - 20 and 4 - 20 respectively)
The need for cognition scale (eight item) was calculated in accord with Cacioppo, 
Petty, Kao (1984) (see Appendix XII). The values of items reflecting little desire to think 
in depth were recoded in reverse order. All values were combined and the total pro­
rated to be compatible with the complete 34-item form. The lower the score, the greater 
the need for cognition (range 34 - 170).
The life orientation test (short-form) score was calculated in accord with Scheier and 
Carver (1985). The value of the negatively framed item was recoded in reverse order. 
The two items of the measure were combined and the final score pro-rated to be 
compatible with the complete 8-item scale. The lower the score, the greater the 
optimism outlook of the participant (range 8 - 40).
6.1.4.4 Calculating Study Specific Measures.
Measures from consultation transcripts: three informed decision making variables 
were calculated from the results of the application of the them e-based coding fram e to 
the consultation transcripts: information seeking informed decision making score (ID M - 
I); reasons for pursuing an option or alternative informed decision making score (ID M - 
F); reasons against pursuing an option or alternative informed decision making score 
(IDM -A) (see chapter five).
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Measures from post-decision questionnaire (T1): Fourteen measures were 
calibrated from items within the questionnaire: number of advantages and 
disadvantages of testing in pregnancy; strength of advantages and disadvantages; 
expected utility scores associated with the five consequences of testing; rank ordering 
of the values of the consequences of testing; directiveness of the diagnostic test 
information; knowledge about testing. The calibrated measures enabled some of the 
open-ended responses to be used within more formal and robust analyses.
N u m b e r o f advantages and disadvantages o f  testing in pregnancy. Although the 
question permitted up to six responses for both advantages and disadvantages, the 
wom en reported no more than three advantages or disadvantages. Six new  
dichotomous variables for the advantages and disadvantages were calculated, 
representing whether or not an advantage or disadvantage had been referred to. From  
these new variables two scores were calculated: an addition of the dichotomous 
advantages variables to obtain the num ber o f advantages total and an addition of the 
dichotomous disadvantages variables to obtain the num ber o f d isadvantages total 
(ranges 0 - 3 ) .
Strength o f p erce ived  advantages and disadvantages o f testing in pregnancy. Two  
continuous scores were calculated by combining all the evaluations of the listed 
advantages or disadvantages and dividing this total score by the frequency of 
advantages or disadvantages recorded (range 0 - 5).
E xpected  utility score for the five consequences o f testing. Five variables were 
calculated from two questions to form the expected-utility of a consequence. The utility 
or value of the consequence was multiplied with the perceived likelihood of the 
consequence occurring. For exam ple, the responses to “having a healthy baby is good - 
bad” and “the likelihood that I will have a healthy baby is 0 - 6 ” were multiplied together. 
Before multiplication of the values, the utility score was divided by ten resulting in an 
expected-utility score for each consequence of between 0 - 60. The higher the score, 
the greater the expected-utility of the consequence. Following exploration of the 
distribution of scores, a dichotomous variable was created for the expected-utility value 
associated with terminating a child with Down's syndrome. As the data suggested a bi- 
modal distribution, a median split was used as the cut-off for the for the dichotomous 
variable.
145
R an k  ordering o f utility scores. A dichotomous score was calculated to represent 
whether or not the women were able to rank in order the utilities of the prenatal testing 
consequences. Those women not completing this question or who gave the sam e value 
to two or more of the consequences scored zero, those marking a different utility for 
each consequence scored one (categorical variable 0/1).
Directiveness o f information given about diagnostic tests. The information contained 
within this question was simplified to form three variables: perceived directiveness of 
researcher information; directiveness of other health professional information; 
directiveness of friends and family information. First, the values for each item were 
recoded to form four categories from the original six: not discussed (0); neutral 
information (1); encouragement towards an option (2); discouragement from an option 
(3). Second, responses to the general practitioner, obstetrician and midwife items were 
collapsed to form one health professional variable (categorical 0 - 3); partner, friends 
and others were collapsed to form one friends and family variable (categorical 0 - 3).
A total know ledge score was calculated from the multiple choice questions about 
diagnostic tests, miscarriage and Down's syndrome. Answers to question fifty-three 
were not included within the final score because the forced responses were not 
sufficiently different to generate a meaningful response. A correct response to all parts 
of a question scored ‘one’, an incorrect response ‘zero’. Most questions were worth a 
m aximum score of two, one correct response for amniocentesis and one correct 
response for chorionic villus sampling. Ideally there would have been only one correct 
response for each multiple choice item. However, as medicine is an imprecise science, 
there are occasions when more than one response may be correct. For exam ple, within 
the prenatal testing context women are exposed to a range of risk figures for 
miscarriage and Down’s syndrome. In addition, verbal expressions of probability are 
frequently used with some having subjectively similar evaluations. In consequence, a 
response was scored as correct for either of the following responses: it is unlikely the 
baby has Down's syndrome or the baby might have Down’s syndrome; the risk of 
amniocentesis is 1 in 100, 1 in 150 or 1 in 200; the risk of chorionic villus sampling is 1 
in 50 or 1 in 100; the average population risk of a baby being born with Down’s 
syndrome is either 1 in 600 or 1 in 1000. A higher score was associated with a greater 
number of correct responses (range 0 - 20).
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6.1.4.5 Excluding variables from further analysis.
As reported in the previous sections, the post-decision questionnaire (T1) was designed 
with reference to theories of decision making and prior empirical research within the 
context of prenatal testing. The T1 questionnaire was also piloted in an appropriately 
representative sample. However, despite the careful selection of items included within 
the T1 questionnaire, a number of measures were not included in this chapter’s 
analyses. The two main reasons for excluding measures are discussed in more detail 
below.
First, a number of the non-standardised measures that appeared acceptable during the 
pilot study raised some concern during the main study. The data exploration showed the 
distribution of scores to be not normally distributed. A closer examination of the 
questions and replies suggested that either the wording of the question was ambiguous 
or the validity of the response was uncertain, resulting in the data being meaningless. 
Fortunately, a number of observational or standardised measures included in the 
evaluation assessed similar constructs to those of the study-specific measures to be 
excluded. The excluded variables were: the study-specific measure of intention to have  
a test; the perceived length of time to make the diagnostic test decision; the qualitative  
variables assessing helpfulness of information; the ‘worry’ questions; the prenatal 
testing belief items. The measures with similar constructs were respectively the actual 
behaviour to have or not to have testing, the actual length of the consultation, the likert 
scale assessing usefulness of information, the anxiety measures and the m easure of 
decisional conflict.
Second, a number of questions were included in T1 that may be considered to be 
associated with the decision to have a diagnostic test or not but were not direct 
evaluations of the decision making process or outcome. It was thought that such items 
would encourage the women to focus on the context of the prenatal diagnosis decision 
rather than pregnancy perse. These items were not essential to the analyses evaluating  
an association between decision analysis and the facilitation of prenatal diagnosis 
decision making. The items excluded were: all questions exploring the triple test 
decision and experience; questions about coping with and the perceived quality of life of 
children with a cleft palate and Spina Bifida.
6.1.4.6 Structuring the Analyses.
The variables selected for analyses either provided information to evaluate the quality 
of the decision or helped to interpret the generalisability of subsequent findings. The
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analyses included descriptive, univariate and multivariate tests. Two tailed tests of 
significance were used because there was no a priori evidence to indicate that the 
application of decision analysis would lead to 'better' decisions, 'worse' decisions or no 
difference in outcomes from routine consultations. A brief overview of the analyses are 
described below. More specific details about the tests employed are described in more 
detail undereach of the subsequent results sections.
1. O ver the fifteen-month study period, 178 women received a screen positive triple 
test result. Reasons for exclusion from the study have been described above. The  
following variables extracted from the w om en’s notes were used to assess the 
representativeness of the final sample compared with women not included in the 
study: age, gestation, number of children, family history of abnormality, num ber of 
miscarriages, number of terminations and test decisions. In addition, an analysis 
was carried out to assess differences in pre-consultation anxiety by those that 
completed a consent form (n = 132): those agreeing to take part (n = 106); those 
agreeing to take part but later excluded post randomisation (n = 11); those declining 
participation (n = 15).
2. In total, 106 women were included within the final study sample: 56 women were 
randomised to the routine consultation; 50 women to the decision analysis 
consultation. The following variables were used to assess the comparability of the 
women within each of the study groups: age, gestation, number of children, family  
history of abnormality, number of miscarriages, number of terminations, previous 
diagnostic test experience, marital status, level of education, religious activity, 
ethnicity, pre-consultation measures of anxiety, optimism (LOT), need for cognition 
and return rate of post-decision questionnaire (T1).
3. Analyses were carried out to assess any differences in the process of decision 
making measures by study group (n = 106). The data used within this section were  
extracted from the consultation transcripts. The results of the them e-based coding 
frame assessing informed decision making and the computer based text analysis 
SLIW C  (Pennebaker et al, 1997) were presented.
4. Analyses were carried out to assess any differences in the post-decision 
questionnaire (T1) measures by study group (n = 106). The variables included 
within these analyses were grouped by the type of measure: behaviour; affect; 
cognitive processes; consultation quality. The variables were: the test decision; post 
consultation anxiety and decisional conflict; expected-utilities of the consequences 
of prenatal diagnosis, rank ordering of the values of the testing consequences, 
perception of personal risk of Down's syndrome, perceived advantages and
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disadvantages of prenatal screening, perceived social norm and knowledge; 
perceived directiveness of information, perceived usefulness of information and 
consultation length.
5. S ix women miscarried within four weeks after the study consultation or received a 
true positive diagnostic test result. These six women were not sent a follow-up 
questionnaire (T2). O f the remaining 100 study sample, 68 women returned a 
follow-up questionnaire (T2). All these women had received either a true negative 
diagnostic test result and/or the results of a ‘normal’ 19 week fetal anomaly scan. 
The variables used to assess the representativeness of the women completing the 
T 2  questionnaire with those not completing it were grouped by: socio-demographic 
characteristics, reproductive history and individual differences; behavioural 
measures; measures of affect; measures of cognitive processes; measures of 
consultation quality. All the variables mentioned in the previous three paragraphs 
were assessed by completion of T2 (n = 100).
6. The variables included to evaluate the long term effect of decision analysis on the 
quality of decision making were classified by the type of measure (n = 68): affect; 
cognitive processes; clinical quality. The variables assessed at T2 by study group 
were: anxiety and conflict in decision making; knowledge, expected utility of the 
consequences of prenatal diagnosis, ranking of utilities of the consequences of 
prenatal diagnosis, perception of personal risk for Down’s syndrome, perceived  
advantages and disadvantages of testing in pregnancy, and perceived social norm; 
usefulness of information and directiveness of information.
7. The final analysis carried out looked at the pattern of responses for m easures 
assessed more than once (n = 68). Repeated measures analyses were carried out 
to evaluate the group, time and group by tim e associations for the following interval 
measures: anxiety and decisional conflict; advantages and disadvantages of 
prenatal testing and knowledge; usefulness of information.
6.2 Results.
6.2.1 Assessing the representativeness of the study sample.
During the fifteen-month study period at the LGI teaching hospital, 178 women received  
a screen positive triple test result. O f these 178 women, 28 (16% ) were not invited to 
participate because they did not fulfil the study criteria for one of the following reasons: 
they were private patient; they were unable to write in English; the information giving 
consultation was led by a health professional other than the author; the triple test result 
screened positive for either Edward’s syndrome or Spina Bifida. A further 18 (10% )
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wom en were not invited to participate in the study because they made a decision to 
have or not have testing during the phone call informing them of their test result. These 
w om en declined the invitation to attend the clinic for further information and either 
m ade an arrangement to have a prenatal diagnostic test immediately or stated that they 
did not desire a diagnostic test. O f those women attending the clinic for further 
information all were informed of the study. Fifteen women (8% ) declined to participate 
in the study, 117 (66% ) agreed to participate and were randomised accordingly. 
However, during the consultation seven women (4% ) identified discrepancies in the 
triple test result sheet and following re-calibration of their result subsequently screened 
negative. A further four (2% ) women were excluded because they failed to complete 
and return the questionnaire at the end of the information consultation (Appendix XIV: 
table 1). The following analyses exam ine the representativiness of the study sample. 
Systematic differences for the following variables, age, reproductive and test decision, 
are assessed for differences between those who declined or accepted the invitation to 
participate.
6 .2 .1.1 Age, reproductive characteristics and test decision by participation.
The data extracted from the women's notes describing their age, reproductive history 
and test decision appear in Appendix X IV . The findings describing this population and 
assessing differences by participation are summarised below. Complete data pertaining 
to these characteristics were not available for five per cent (9/178) of the women. These  
nine women were private patients and their notes were not immediately accessible. The  
following summary refers to those women for whom there was complete information.
Sixty-four per cent of women had one or more children, 20%  had had a previous 
miscarriage, 21%  a family history of abnormality and six per cent had had a termination. 
The mean age of women receiving a screen positive triple test result was 35.3 years, 
mean gestation 14.7 weeks (Appendix XIV: table 3). Eighty per cent (135/169) of 
women with a screen positive result chose to have a diagnostic test. Twnety per cent 
(34/169) chose no further testing (Appendix XIV: table 4).
To assess the representativeness of the study sample, tests for statistical significance 
between the above variables were carried out using Chi square analyses for the 
categorical variables and a single multi-variate analysis of variance (M ANO VA) for the 
interval measures. A single M ANO VA was used to reduce the likelihood of type I errors 
occurring. The five levels of invitation were: exclusion because the study criteria were 
not fulfilled; exclusion because women made a decision over the telephone; exclusion
150
after invitation because the test result was actually negative or the post-decision 
questionnaire (T1) was not returned; declining participation; participation (Appendix XIV: 
table 1). One variable was found to differ significantly by level of invitation: the decision 
to have a diagnostic test or not (Appendix XIV: table 5 - Chi2 = 9.4, d.f. = 4, p = 0.05). 
The data suggested that the women declining to participate were more likely to have a 
diagnostic test than those completing the study whereas the women making a decision 
over the telephone were less likely to have a diagnostic test (Appendix XIV: table 4). It 
was beyond the remit of this study to satisfactorily explain or explore the differences in 
attendance for diagnostic testing by level of invitation.
6.2.1.2 Pre-consultation anxiety by study participation.
The women invited to participate in the study (n = 132) were asked to complete a 
consent form which contained a pre-consultation measure of anxiety (Appendix XIV: 
table 6). A single analysis of variance (ANO VA) was carried out to ascertain whether 
there were differences in anxiety between the women agreeing to participate with those 
declining participation and those who were subsequently excluded from the analysis. 
There was no significant difference in anxiety observed following this analysis 
(participated, mean = 62.1 (s.d. = 13.6); excluded because re-calculated negative  
result, mean = 53.3 (s.d. = 14.3); excluded because not returned T1, mean = 60 .7  (s.d. 
= 23.4); declined participation, mean = 69 .9  (s.d. = 10.2), (f = 2.12, d.f. = 3, p = 0.10).
6.2.2 Comparability of women in each study group.
One hundred and thirty-two women were invited to take part in the study. O f these, 
fifteen women declined to participate. The remaining 117 women were allocated to 
either the routine or decision analysis group following the opening of sealed, numbered, 
opaque envelopes. Six women (five in the decision analysis group, one in the routine 
group) were excluded post randomisation because their triple test result was re­
calculated during the consultation and found to be screen negative. These six women 
were subsequently classified as not fulfilling the study criteria and excluded from further 
analysis. Five women were excluded post randomisation (four from the decision 
analysis group, one from the routine group) because they did not complete the post­
decision questionnaire (T1). Those women not returning the T1 questionnaire were 
subsequently treated as declining to take part in the study. Taking these adjustments 
into consideration, the study response rate was 84%  (106/126: six women were 
excluded from these figures because their triple test result changed from positive to 
negative during the information giving consultation).
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The majority of the women were Caucasian (103/106) (Appendix XIV: table 7). Most 
were married or living as married (103/106) (Appendix XIV: table 7). Few were actively 
religious with only 8% (9/106) frequently attending a place of worship (Appendix XIV: 
table 7). A quarter of the women had degree-level qualifications (27/106); just under a 
third (33/106) had A ’ level equivalent qualifications; the remainder had G C SE  
equivalent qualifications or less (46/106) (Appendix XIV: table 7). O f those who had 
been pregnant before (81/106), 75%  (61/81) reported having had a scan in the previous 
pregnancy, 38%  (31/81) the triple test and only 5%  (4/81) a diagnostic test (Appendix 
XIV: table 8). Seventy-four per cent (78/106) of women attended the information giving 
consultation with a companion (Appendix XIV: table 9).
O f those 106 women agreeing to participate and for whom full data were available, 56 
received the routine consultation information, 50 the decision analysis consultation 
information. The independent samples design ought to have ensured a comparable set 
of women in each study group. The following variables were used to assess the 
similarity of the profiles of the women in each study group: socio-demographic 
characteristics; reproductive history; prenatal testing experience; measures of individual 
differences; pre-consultation anxiety. The prenatal testing experience variables and the 
two measures of individual differences, optimism (LOT) and the need for cognition 
(NFC ), were obtained at the end of the consultation following completion of the post­
decision questionnaire (T1). Chi square analyses were used to assess differences in the 
categorical variables by group allocation (Appendix XIV: tables 7 - 9); a single M ANO VA  
was used for the interval measures (Appendix XIV: table 10). There were no differences 
by study group for age, pre-consultation anxiety, marital status, level of education, 
religious activity, number of children, number of miscarriages, family history of 
abnormality, previous prenatal testing experience, presence of a companion and need 
for cognition. Two significant differences by study group were observed for gestation 
(Appendix XIV: table 10; f = 6.0, d.f. = 1, 104, p = 0.02) and optimism (Appendix XIV; 
table 10; f = 5.2, d.f. = 1, 104, p = 0.03). Those in the routine group had a greater 
gestation figure and a lower level of optimism than those in the decision analysis group.
Any significant difference in the profiles of the women within the two study groups has 
implications for the interpretation of subsequent analyses evaluating the impact of the 
intervention on w om en’s decision making. For example, should subsequent analyses 
reveal an association between the quality of decision making variables with the study 
group, then it could be argued that optimism or gestation were the underlying factors of 
the relationship rather than the attributes of the information manipulation intervention. In
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consequence, in the two following sections describing the analyses evaluating the 
impact of the intervention on wom en’s decision making, preliminary correlations were 
carried out between gestation and optimism with the study’s process and outcomes 
variables. W here significant associations were observed, subsequent multi-variate 
analyses statistically controlled for the effect of either gestation or optimism by including 
them within the analyses as co-variates.
6.2.3 Analysis of the information giving consultation by study group.
This section summarises the information utilised by the women when making the 
prenatal diagnosis decision. The verbal utterances of the women were transcribed from  
audio tape-recordings of the information giving consultation. Both the them e-based  
coding frame describing wom en’s decision making and the SLIW C text analysis 
programme were applied to the data. This section describes the findings from the 
subsequent analyses. First, summaries of the themes classifying the information 
utilised, the categories coding the emotional and cognitive content and the measures of 
informed decision making for the complete sample are described (n = 106). Second, 
findings from the analyses assessing differences in informed decision making by study 
group are described. Finally, the results from the analyses evaluating differences by 
study group in the cognitive and emotional content of the verbal utterances are 
reported.
6.2.3.1 Describing the decision making process, the emotional and cognitive 
content, and the informed decision making of the information giving 
consultations.
As previously discussed (see chapters one, four and five), the analysis of the 
information utilised by women during the consultation provides one of the most direct 
ways to access the process of decision making. The theme-based coding fram e  
developed for this study categorised the information utilised by women during the 
consultation under twenty themes (see chapter five). The them e-based coding fram e  
was applied to all the transcripts of the consultations within this randomised control 
study. Table 6:1 summarises the number of women referring to each of the them es of 
the coding frame, as a total sample and by study group. The frequencies presented in 
this table illustrate the pattern of information utilised by the women during the 
consultation. The purpose of this chapter’s analyses was to evaluate differences in 
informed decision making by study group. In consequence, no formal analysis was 
carried out to evaluate differences in cognitive strategies employed by women to 
assimilate the decision information. However, there follows a brief description of the
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findings summarising the frequency with which the women utilised the consultation 
information when making the decision to have or not have prenatal diagnosis.
T a b le  6:1 fre q u e n c y  s u m m a ry  fo r  th e  th e m e -b a s e d  a n a ly s is  o f tra n s c rip ts .
T h e m e T o ta l 
n = 106
R o u tin e  
n =  56
D e c is io n  A n a ly s is  
n =  50
% n % n %
1. N o  T e s t O p tio n  (n o n -in v a s iv e /s c a n ) 69% 38 68% 35 70%
1.1 information seeking/planning 53% 26 46% 30 60%
1.2 reasons for 29% 17 30% 14 28%
1 .3 reasons against 43% 23 41% 23 46%
2. T e s t O p tio n  c o m b in e d 100% 56 100% 50  100%
2.1 information seeking/planning 99% 55 98% 50 100%
2.2  reasons for 94% 52 93% 48 96%
2.3  reasons against 88% 50 89% 43 86%
6. D o w n ’s s y n d ro m e  c o n s e q u e n c e 69% 37 66% 73 69%
6.1 information seeking/planning 36% 24 43% 14 28%
6.2  neutral-positive reference 31% 17 30% 16 32%
6 .3  negative reference 43% 18 32% 28 56%
7 . M is c a rr ia g e  c o n s e q u e n c e 61% 33 59% 32 64%
7.1 information seeking/planning 52% 29 52% 26 52%
7 .2  neutral-positive reference 17% 6 11% 12 24%
7 .3  negative reference 18% 6 11% 13 26%
8. T e rm in a tio n  c o n s e q u e n c e 81% 42 75% 44 88%
8.1 information seeking/planning 43% 23 41% 23 46%
8.2 neutral-positive comment 57% 22 39% 38 76%
8.3 negative reference 21% 9 16% 13 26%
9. R isk  f ig u re  re fe re n c e 77% 43 77% 39 78%
9.1 single risk Down’s syndrome 65% 35 63% 34 68%
9.2 single risk miscarriage 37% 19 34% 20 40%
9.3 comparison risks 44% 24 43% 23 46%
10. P e rc e p tio n  o f risk  re fe re n c e 75% 39 70% 41 82%
10.1 minimised Down's syndrome risk 38% 20 36% 20 40%
10.2 maximised Down's syndrome risk 42% 23 41% 22 44%
10.3 minimised miscarriage risk 19% 9 16% 11 22%
10.4 maximised miscarriage risk 11% 6 11% 6 12%
11. E x p re s s e d  A ffe c t
11.1 triple test: shock, worry 44% 22 39% 25 50%
11.2 diagnostic test: hard, conflict 43% 23 41% 23 46%
11.3 termination: hard, conflict 33% 13 23% 22 44%
11.4 testing reassurance 6% 2 4% 4 8%
11.5 anticipated regret 19% 11 20% 9 18%
154
Table 6:1 continued. . .
T h e m e T o ta l 
n = 106
R o u tin e  
n = 56
D e c is io n  A n a ly s is  
n =  50
% n % n %
12. D e c is io n  M ak in g
12.1 triple test 26% 13 23% 15 30%
12.2  test decision m ade before consultation 38% 2 2  39% 18 36%
12.3  each prenatal testing stage a different 
decision/termination decision not made
29% 16 29% 15 30%
12.4  delay in making decision 32% 18 32% 16 32%
12.5  confidence with decision 23% 10 18% 14 28%
12.6  discussed decision with other 42% 22  39% 23  46%
13. T r ip le  T e s t: fu r th e r  e x p la n a tio n 83% 44 79% 44 88%
14. C o n fid e n c e  w ith  S c re e n in g  R e s u lts 37% 23 41% 39 37%
15. C o m p a r is o n  N o rm s 36% 21 38% 17 34%
16. P e rs o n a l E x p e rie n c e s 67% 37 67% 34 68%
16.1 physical aspects pregnancy 34% 18 32% 18 36%
16.2  complications in pregnancy 24% 13 23% 13 26%
16.3  prior testing and pregnancies 39% 19 34% 2 2  44%
16.4  abnormalities or genetics 18% 10 18% 9 18%
17. O th e rs  E x p e rie n c e 45% 25 45% 23 46%
17.1 prenatal testing 36% 20  36% 18 36%
1 7.2  abnormalities or genetics 20% 9 16% 12 24%
18. P re p a ra tio n  P re g n a n c y 15% 10 18% 6 12%
19. H e a lth  P ro fe s s io n a ls ’ A d v ice
19.1 neutral or positive comments 34% 20 36% 16 32%
19 .2  dissatisfaction or directive 27% 13 23% 16 32%
19.3  inaccurate or conflicting consultation 8% 8 14% 1 2%
20 . O th e r  s o u rc e s  in fo rm a tio n 35% 21 37% 16 32%
The pattern of information utilised by the women during this randomised control trial 
showed some similarities to the pattern of responses in chapter five. All the women 
referred to information about the ‘test option’ during the consultation (theme 2, table 6:1) 
but not all the women (69% ) referred to items classified under the ‘no test’ option 
(theme 1, table 6:1). In addition, fewer of the women utilised information about Down's 
syndrome (69% ) and miscarriage (61% ) than termination of pregnancy (81% ) (themes 
6, 7 and 8, table 6:1). About a third of the women commented on various aspects of the 
prenatal testing decision making process (themes 12.1 - 12.6, table 6:1). Most of the 
women (83% ) wanted further information about the triple test result (theme 13, table
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6:1). Forty-four percent (theme 11.1, table 6:1) mentioned the screen positive test result 
was a shock and about the same number referred to difficulty in making the diagnostic 
test decision (theme 11.2, table 6:1). About a third expressed some concern over the 
reliability of the triple test result (theme 14, table 6:1) and about the same proportion 
tried to compare their own situation with that of a 'norm' (theme 16, table 6:1). Sixty- 
seven percent of women reflected on their own prenatal experiences (theme 16, table  
6:1) and 45%  on others prenatal experiences (theme 17, table 6:1). About a third 
referred to other health professionals’ advice (themes 19.1 - 19.3, table 6:1) and other 
sources of information (theme 20, table 6:1) during the consultation.
In summary, this pattern of utilised information suggests that most of the women  
referred to information about the alternatives and consequences necessary to m ake an 
informed decision during the consultation. In addition, a significant number of the 
wom en referred to information associated with more heuristic type processes, such as 
reference to prenatal testing experiences, others’ advice and comparison with social 
norms. It was also evident that at least half of the women found the prenatal testing 
experience emotionally difficult. In essence, the pattern of findings described in table  
6:1 are similar to those reported in table 5:1.
6.2.3.2 Differences in informed decision making by study group.
Three informed decision making scores were calculated from the application of the 
them e-based coding frame to the consultation transcripts: information seeking or 
planning for a consequence score (IM D-I: range 0 - 5); reasons for or favourable  
comments about a consequence score (IM D-F: range 0 - 5); reasons against or 
unfavourable comments about a consequence score (IMD-A: range 0 - 5). As these 
three variables provided an efficient summary of the informed decision making 
references by the women during the consultation, they were used in the analysis to 
ascertain whether or not decision analysis facilitated informed decision making. A 
preliminary correlation was carried out between the informed decision making variables  
with the two profile characteristics of the women found to differ significantly by study 
group allocation, gestation and optimism (see section 6 .2 .1). Only one of the profile 
characteristics, gestation, was found to be significantly associated with one of the 
informed decision making variables, IDM -F (table 6:2). In consequence, gestation was 
included in subsequent analysis as a co-variate to adjust for the effect between 
gestation and the informed decision making variables.
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T a b le  6 :2  c o rre la tio n  m atrix  fo r  g e s ta tio n  an d  o p tim is m  w ith  ID M  m e a s u re s .
ID M -I ID M -F ID M -A
Pearson R S ig . Pearson R S ig . Pearson R S ig .
g e s ta tio n 0.005 0.96 -0.19 0.05 -0.06 0.51
o p tim is m -0.04 -0 .68 -0.13 0.20 0.06 0 .56
A  multiple analysis of co-variance (M ANCO VA) was carried out to assess the 
relationship between the informed decision making variables and the information 
intervention. A  single equation was used in an attempt to decrease the likelihood of type 
I errors occurring. The Bartlett-box M criteria for homogeneity of variance for the 
dependent variables was not significant, suggesting no threat to the interpretation of the 
main effect results (Box’s M = 5.8, C h i2 = 5.6, p = 0.47). Main effects were observed for 
ID M -F  and IDM -A but not for IDM-I (table 6:3). In essence, the women in the decision 
analysis group referred to more reasons for and against alternatives during the 
consultation than the women in the routine consultation. No difference in information 
seeking about alternatives was observed by the women in the two study groups. These  
findings suggest that reasoning rather than information seeking was greater in the 
decision analysis consultation.
T a b le  6 :3  in fo rm e d  d e c is io n  m a k in g  v aria b le s  b y  s tu d y  g ro u p .
T o ta l
n = 106
R o u tin e
n = 56
D e c is io n
A n a ly s is
n = 50
M A N C O V A
d.f. (1,103)
X (s.d) X (s.d) X (s.d) f S ig .
informed decision making - 
in fo rm a tio n  s e e k in g  (ID M -I) 2.8 (1.1) 2.8 (1.1) 2.9 (1.1) 0.08 0.78
informed decision making - 
re a s o n s  fo r  o p tio n  (ID M -F ) 2.3 (1.0) 2.1 (1.0) 2.6 (1.0) 5.24 0 .02
informed decision making - 
re a s o n s  a g a in s t o p tio n  (ID M -A ) 2.1 (1.1) 1.9 (0.9) 2.4 (1.2) 5.33 0 .02
6.2.3.3 Differences in emotional and cognitive content by study group.
The five SL IW C  ways of classifying the content of consultations used in this analysis 
were: the number of words within the consultation; the percentage of positive emotion­
laden words; the percentage of negative emotion-laden words; the percentage of 
cognitive mechanisms or ’thinking’ words; the percentage of social processes or 
’communication with others’ words. As the purpose of the analysis was to ascertain
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differences in the content of the consultation by study groups, preliminary correlations 
were carried out between the SLIW C  variables and the two profile characteristics found 
to differ significantly by group allocation, gestation and optimism. In addition to these 
two profile characteristics, it was considered appropriate to include the consultation 
length in a preliminary correlation. The previous text analysis (theme-based informed 
decision making) counted the number of women referring to a theme, whereas the 
SLIW C  analysis counts the number of utterances made by a woman during the 
consultation. It was feasible to suggest that the length of consultation would be 
associated with the number of utterances recorded.
T a b le  6 :4  c o rre la tio n s  b e tw e e n  g e s ta tio n , L O T  a n d  c o n s u lta tio n  le n g th  w ith  th e  
S L IW C  v a r ia b le s .
w o rd  c o u n t p o s itiv e
e m o tio n
n e g a tiv e
e m o tio n
c o g n itiv e
m e c h a n is m
s o c ia l
p ro c e s s e s
R S ig . R S ig . R S ig . R S ig . R S ig .
g e s ta tio n 0.12 0 .20 -0 .05 0.60 0.04 0.70 -0 .15 0 .13 -0 .08 0.41
o p tim is m 0.17 0.08 0.10 0.31 0.06 0 .54 -0.01 0 .9 4 0.19 0 .05
c o n s u lta tio n
le n g th
0.81 <0.001 -0 .09 0.93 0.15 0.13 0.12 0.21 0.32 0.001
Eleven per cent of the words mentioned during the consultation were associated with 
cognitive mechanisms or ‘thinking’, 9 .5%  with social processes such as communicating  
with others and about 3% with affect-laden words. Only one of the profile characteristic, 
optimism (LOT), was associated with one of the SLIW C variables, social processes 
(table 6:4). The length of consultation was significantly correlated with both the number 
of words mentioned during the consultation and the percentage of words about social 
processes (table 6:4). In consequence, optimism and consultation length were included 
in subsequent analysis as co-variates to adjust for the effect between optimism and 
consultation length with the SL IW C  variables.
A M ANC O VA was used to evaluate the relationship between group allocation and the 
five SL IW C  variables with length of consultation and the LOT score as co-variates. The  
Bartlett-box M criteria for homogeneity of variance for the dependent variables was not 
significant (Box's M = 23.3, Chi2 = 22.1, p = 0.10). After controlling for the effects of 
consultation length and differences in optimism, two main effects were observed for 
differences in the percentage of positive emotion-laden words used and the percentage  
of cognitive mechanisms or thinking words used by study group (table 6:5). The women
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in the decision analysis group were less likely to use language associated with positive 
emotions such as ‘good’ or ‘happy’ and more likely to use words associated with 
cognitive processes such as ‘think’ and ‘cause’. There was also a trend towards 
significance, suggesting that the women in the decision analysis group were more likely 
to use negative emotion-laden words such as ‘sad’ or ‘tense (p = 0.09, table 6:5). There  
was no difference in the number of words uttered or references to social processes by 
study group.
T a b le  6 :5  S L IW C  te x t a n a ly s is  v a r ia b le s  by  s tu d y  g ro u p .
T o ta l 
n = 106
R o u tin e  
n = 56
D e c is io n  A n a ly s is  
n = 50
M A N C O V A  
d .f. (1 ,10 2 )
X (s.d.) X (s.d.) X (s.d.) f S ig .
w o rd  c o u n t 1117 .8 (917.6) 966 .2 (785.8) 1287 .5 (1027.4) 0.12 0 .73
p o s itiv e
e m o tio n 1.9 (0.7) 2.0 (0.8) 1.8 (0.6) 4 .7 0 .03
n e g a tiv e
e m o tio n 0.9 (0.5) 0.8 (0.4) 1.0 (0.5) 2.8 0 .09
c o g n itiv e
m e c h a n is m 11.3 (1.7) 10.8 (1.8) 11.8 (1.5) 6 .5 0.01
so c ia l
p ro c e s s e s 9.5 (2.2) 9.5 (2.1) 9.5 (2.2) 1.0 0 .33
6.2.4 Analysis of post-decision questionnaire (T1) by study group.
The first part of this results section provides a summary of the women's responses to 
the post-decision questionnaire (T1) as a complete sample. The results of the analysis 
assessing differences in post-decision questionnaire measures by study group are 
described in the second part of this section. The measures included within the T1 
questionnaire fall into one of four categories: behaviour; affect; cognitive processes; 
clinical quality. The findings in each of the two sections are grouped and reported by 
category of measure. For exam ple, all the cognitive process variables with their 
different levels of measurement and different types of analyses will be described 
together.
6.2.4.1 Descriptions of behaviour, affect, cognition and clinical quality measures.
The following descriptions are verbal summaries of all the wom en’s responses to items 
asked within the questionnaire (T1). The raw data supporting these summaries are 
reported in the tables presented in the next section, i.e. the discussion of differences in 
measures by study group.
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Behaviour: Deciding whether to have a diagnostic test or not was the behavioural 
measure for this study. 84%  (89/106) of women decided to have a diagnostic test; 16%  
chose to have no diagnostic test. O f those women choosing to have a diagnostic test, 
12 opted to have chorionic villus sampling and 77 amniocentesis.
Affect: Anxiety and decisional conflict were the measures of affect for this study. The  
sam ple mean for anxiety was high at 60.1 (s.d. = 14.8) points on the STAI scale (range 
20 - 80). The mean values for the three decisional conflict sub-category scores were: 
uncertainty with the decision made, 8.4 (s.d. = 2.8); perception made an informed 
decision, 6 .8 (s.d. = 1.7); perceived efficacy in decision making, 7.5 (s.d. = 2.2).
Cognitive process: Measures of the cognitive processes in this study number were: 
the perceived advantages and disadvantages of testing; the strength of advantages and 
disadvantages of testing; the perception of the triple test risk; the perceived social norm 
for testing behaviour; the expected-utility values associated with the consequences of 
prenatal testing; the ability to rank order the consequences of testing; knowledge of the 
tests.
Number of perceived advantages and disadvantages of prenatal testing: 12%  of the 
women listed no advantages; 27%  listed one advantage; 46%  listed two advantages; 
15%  three advantages to prenatal testing. 18% of women listed no disadvantages; 30%  
one advantage; 35%  two advantages; 17% three advantages to prenatal testing. The  
advantages and disadvantages listed by the women are described in table 6:6. The  
frequency scores do not total 100 as the women were able to identify more than one 
advantage or disadvantage.
T a b le  6 :6  th e  n u m b e r  o f w o m e n  id e n tify in g  a d v a n ta g e s  a n d  d is a d v a n ta g e s  o f  
p re n a ta l te s tin g .
N u m b e r  o f w o m e n  s ta tin g  an  a d v a n ta g e N u m b e r o f w o m e n  s ta tin g  a  d is a d v a n ta g e
n % n %
check baby's health, OK 51 48% worry, stress, waiting for results 49 46%
informed decision making 39 37% miscarriage 48 45%
find abnormality 29 27% making difficult decisions 29 27%
certainty 17 16% testing unreliable 15 14%
discuss Down's syndrome 10 9%
other (sex, scan, mother’s health) 18 17% other (pain, late gestation) 11 10%
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Strength o f advantages and d isadvantages o f prenata l testing: 87 of the women 
provided both at least one advantage and disadvantage of testing and evaluated the 
strength of that advantage or disadvantage on a five-point likert scale. The mean 
strength of advantages was 4.5 (s.d. = 0.9) and of disadvantages was 3.8 (s.d. = 1.2). 
The perceived advantages of prenatal testing were significantly stronger than the 
perceived disadvantages of testing (paired t-test: t=4.6, d.f. = 86, p < 0.0001). As not all 
women in the sample completed this question, this measure was not included in 
subsequent multi-variate analyses assessing differences in cognitive processes by 
study group.
Perception o f triple test risk: 50%  of women rated their triple test risk as high; 43%  rated 
the risk as medium and 12% rated their risk as a low risk.
P erceived  social norm  for testing behaviour. The responses to this single item assessing 
wom en’s perception of other’s attitude to prenatal testing were skewed to the 'should 
have testing’ end of the scale. The mean score was 1.5 (s.d. = 1.6) on a scale from 0 -
6 .
Expected-utility values associated with the consequences o f p ren ata l testing: The mean 
values for the expected-utility values (EU V) of the five consequences of testing listed in 
order were: h a v in g  a h e a lth y  b a b y , m ean 39.5 (s.d = 10.9);
te rm in a tin g  a b a b y  w ith  D o w n ’s s yn d ro m e , mean 28.7  (s.d.= 21.7); 
m is c a rry in g  a b a b y  w ith  D o w n ’s s y n d ro m e , mean 13.0 (s.d. = 11.1); 
h a v in g  a bab y  w ith  D o w n ’s s y n d ro m e , mean = 3.5 (s.d. = 6.6); 
m is c a rry in g  a h e a lth y  b ab y , mean 1.2 (s.d. = 2.1).
Ability to rank order the consequences o f testing: Although the means of the whole 
sam ple’s EUVs suggest a pattern to the women's evaluation of the consequences of 
testing, most of the women (55% ) were unable to rank order the consequences of 
prenatal testing so that each consequence was perceived as better or worse than the 
other four consequences.
Know ledge o f the tests: 10% of women scored less than half of the correct responses; 
54%  scored between half and three-quarters of the correct responses and 36%  scored 
more than three-quarters of the correct responses on the multiple-choice knowledge 
questions.
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Clinical quality: Consultation length, usefulness of information and perceived 
directiveness of study (HB) and other health professionals' information were the 
measures of clinical quality. The mean length of consultations was 29.0 (s.d. = 12.2) 
minutes; the information was perceived to be useful, the mean being 5.2 (s.d. = 1.1) on 
a scale from 0-6. 8%  of the information provided by both the study and other health 
professionals was perceived to be ‘encouraging1.
6.2.4.2 Assessing differences in behavioural, affect, cognitive processes and 
clinical quality by study group.
This section of the results describes the analyses that evaluated the impact of the 
decision analysis consultation on the quality of wom en’s decision making. Preliminary 
correlations were carried out between the two profile characteristics found to differ 
significantly by study group allocation, gestation and optimism, with all the interval 
measures of decision quality. Optimism was significantly associated with two of the 
decision quality measures, EU V of having a healthy baby and knowledge (table 6:7). In 
consequence, optimism was included in subsequent analysis as a co-variate to adjust 
for the effect of optimism with the measures of decision quality.
T a b le  6 :7  c o rre la tio n s  b e tw e e n  g e s ta tio n  a n d  o p tim is m  w ith  d e c is io n  q u a lity  
m e a s u re s .
G e s ta tio n
n = 106
O p tim is m  (L O T )
n = 106
R S ig . R S ig .
a n x ie ty  a fte r  c o n s u lta tio n 0.12 0 .22 0.23 0 .02
c o n flic t  - u n c e rta in ty -0.002 0.98 0.08 0 .44
c o n flic t  - in fo rm e d 0.09 0.37 0.13 0 .17
c o n flic t  - e ffic a c y 0.14 0 .14 0.10 0 .33
E U T 1 - h e a lth y  b a b y -0 .16 0 .09 -0 .26 0 .007
E U T 2  - m isc . D o w n ’s b ab y 0.06 0 .55 0.09 0 .3 4
E U T 3  - te rm . D o w n ’s b ab y -0 .03 0 .80 -0 .12 0.21
E U T 4  - h ave  D o w n ’s b ab y -0.11 0.26 0.08 0.40
E U T 5  - m isc . n o rm a l b a b y -0 .004 0 .97 -0 .04 0 .65
a d v a n ta g e s  o f  te s tin g 0.08 0.40 -0 .16 0.11
d is a d v a n ta g e s  o f te s tin g -0 .005 0.96 -0 .18 0.06
k n o w le d g e -0 .09 0.37 -0 .20 0 .04
le n g th  c o n s u lta tio n 0.04 0.67 0.11 0 .24
u s e fu ln e s s  in fo rm a tio n 0.03 0.73 -0 .03 0 .80
The following analyses were employed to evaluate the information intervention: all the 
interval measures were entered into a single M ANCOVA to reduce the likelihood of type 
I errors; Mann-W hitney tests of significance were used for interval measures not
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normally distributed; Chi square analyses were employed for categorical variables. The  
variables included within the M ANCO VA were: post-decision anxiety; decisional conflict; 
number of advantages and disadvantages of prenatal testing; knowledge; consultation 
length; usefulness of information; the co-variate optimism. Robustness of findings is not 
guaranteed if the Bartlett-box M test for homogeneity of variance is significant at p < 
0.001 (Tabachnick and Fidell, 1989). For this analysis, the Bartlett-box M was not 
sufficiently significant to affect the interpretation of findings (M = 72.1, Chi2 = 65.5, d.f. 
= 45, p = 0.02). The distributions of six interval variables were not normally distributed, 
all the EUVs for the consequences of prenatal testing and the perceived social norm 
item. Differences by study group for all but one of the EU V variables, termination for 
Down’s syndrome, and the perceived social norm were assessed following the 
application of a Mann-W hitney analysis. The differences by study group for the E U V  for 
termination for Down’s syndrome, the perception of triple test risk, the ability to rank 
order the consequences of prenatal testing and the perceived encouragement of the 
study and other health professionals' advice were assessed using Chi square analyses. 
The findings are grouped by type of measure: behaviour; affect; cognitive processes; 
clinical quality.
Behaviour: There was no significant difference in the testing decision or behaviour by 
study group. Fourteen per cent of women in the decision analysis group and eighteen  
per cent of women in the routine group chose to have no further testing (table 6:8).
T a b le  6 :8  to  h ave  o r n o t to  have  te s tin g  by s tu d y  g ro u p .
T o ta l (n = 106) R o u tin e  (n  = 56) D ec is io n  A n a ly s is  (n = 50) C h i 2 S ig .
n % n % n % d.f. (1)
no  te s t 17 16% 10 18% 7 14%
te s t 89 84% 46 82% 43 86% 0.29 0 .59
Affect there was no significant main effect observed by group allocation with either 
anxiety or the three decisional conflict sub-categories (table 6:9).
T a b le  6 :9  d iffe re n c e s  in m e a s u re s  o f a ffe c t by s tu d y  g ro u p .
T o ta l
n = 106
R o u tin e
n = 56
D e c is io n  A n a ly s is
n = 50
M A N C O V A
(1, 103)
X (s.d.) X (s.d.) x (s.d.) f S ig .
T1 a n x ie ty 60.1 (14.8) 61.2 (13.4) 58 .9 (16.3) 0.09 0 .77
c o n flic t -  u n c e rta in ty 8 .4 (2.8) 8.4 (3.0) 8.4 (2.6) 0.01 0.91
c o n flic t -  in fo rm e d 6.8 (1.7) 6.8 (1.7) 6.9 (1.7) 0.51 0 .48
c o n flic t -  e ffic a c y 7.5 (2.2) 7.5 (2.3) 7.6 (2.2) 0.29 0 .60
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Cognitive processes: The mean number of perceived advantages of prenatal testing 
differed by group allocation (table 6:10). The women in the routine consultation group 
listed more advantages of prenatal testing than those in the decision analysis group. 
There was no difference in the number of disadvantages listed. The mean number of 
correct responses to the multiple-choice questions for knowledge of prenatal testing did 
not differ by study group allocation (table 6:10).
T a b le  6 :10  d iffe re n c e s  in a d v a n ta g e s , d is a d v a n ta g e s  a n d  k n o w le d g e  o f p ren a ta l 
te s tin g  by  s tu d y  g ro u p .
T o ta l
(n = 106)
R o u tin e
(n = 56)
D e c is io n  A n a ly s is
(n = 50)
M A N C O V A
(d.f. = 1, 103)
x (s.d.) x (s.d.) x (s.d.) f S ig .
a d v a n ta g e s  te s tin g 1.6 (0.9) 1.8 (0.9) 1.4 (0.8) 8.88 0 .0 0 4
d is a d v a n ta g e s  te s tin g 1.5 (1.0) 1.6 (1.0) 1.5 (1.0) 0.87 0.35
k n o w le d g e 14.5  (3.0) 14.3  (3.2) 14.8 (2.9) 0.19 0 .66
There was no difference in the women's perception of their triple test risk by study group 
allocation (table 6:11).
T a b le  6:11 p e rc e p tio n  o f tr ip le  te s t risk  by  s tu d y  g ro u p .
T o ta l (n = 106) R o u tin e  (n = 56) D e c is io n  A n a ly s is  (n = 50) C h i*  (d.f. = 2)
n % n % n % Chi2 S ig .
lo w 13 12% 7 13% 6 12%
m e d iu m 43 43% 18 32% 25 50%
h ig h 50 50% 31 55% 19 38% 3.77 0 .1 5
T a b le  6 :12  d iffe re n c e  in E U V  o f te rm in a tin g  fo r  D o w n ’s s y n d ro m e  by  s tu d y  g ro u p .
T o ta l 
(n  = 106)
R o u tin e  
(n  = 56)
D e c is io n  A n a ly s is  
(n  = 50)
Chi"  
d .f. = 1
n % n % n % R Sig.
E U T  v a lu e  <30 58 55% 38 68% 20 40%
E U T  v a lu e  >29 48 48% 18 32% 30 60% 8.3 0.004
O f the EU V for the consequences of prenatal diagnosis, the figure associated with 
terminating for a child with Down’s syndrome differed by study group allocation (tables
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6:12 and 6:13). The women in the decision analysis consultation provided a higher 
expected-utility value for terminating a child with Down's syndrome. There was no 
difference in perceived social norm by study group allocation (table 6:13).
T a b le  6 :13  d iffe re n c e  in E U V s  fo r  th e  te s tin g  c o n s e q u e n c e s  an d  p e rc e iv ed  s o c ia l 
n o rm  by s tu d y  g ro u p .
T o ta l 
n =  106
R o u tin e  
n = 56
D e c is io n  A n a lys is  
n = 50
M a n n -W h itn e y
X (s.d.) X (s.d.) X (s.d.) U z S ig .
E U T 1 -n o rm a l baby 39.5 (10.9) 38.1 (10.2) 41.0 (11.5) 1253.0 -0.9 0 .35
E U T 2  - m isc . DS 13.0 (11.1) 12.5 (10.7) 13.5 (11.6) 1330.0 -0.4 0 .66
E U T 3  - te rm . DS 28.7 (21.7) 24.1 (21.2) 33.8 (21.4) NA NA N A *
E U T 4  - b a b y  DS 3.5 (6.6) 3.7 (6.1) 3.3 (7.2) 1374.0 -0 .2 0 .8 7
E U T 5  - m isc . b ab y 1.2 (2.1) 1.1 (2.1) 1.3 (2.2) 1324.0 -0 .5 0 .6 3
S h o u ld  h ave  te s t 1 .5 (1.6) 1.6 (1.4) 1.4 (1.6) 1306.0 -0 .6 0 .5 4
"NA = no analysis because bi-modal distribution
There was no difference in the ability to rank order the consequences of prenatal testing 
by study group allocation (table 6:14).
T a b le  6 :1 4  d iffe re n c e s  in th e  a b ility  to  rank o rd e r  th e  E U V s  a s s o c ia te d  w ith  th e  
c o n s e q u e n c e s  o f p ren a ta l te s tin g  by s tu d y  g ro u p .
T o ta l
n = 106
R o u tin e
n = 50
D e c is io n  A n a ly s is
n = 56
C h i z
d.f. (1)
n % n % n %
ran ked 48 45% 23 41% 25 50% 0.85 0 .36
n o t ran ked 58 55% 33 59% 25 50%
T a b le  6 :15  d iffe re n c e s  in c o n s u lta tio n  le n g th  an d  p e rc e iv e d  u s e fu ln e s s  o f  
in fo rm a tio n  by s tu d y  g ro u p .
T o ta l
(n = 106)
R o u tin e
(n = 56)
D e c is io n  
A n a ly s is  (n = 50)
M A N C O V A
(d.f. = 1, 103)
x (s.d.) x (s.d.) x (s.d.) f S ig .
c o n s u lta tio n  le n g th 29 .0  (12.2) 26.2  (11.2) 32 .2  (12.6) 8.67 0 .0 0 4
u s e fu ln e s s  in fo rm a tio n 5 .2  (1.1) 5 .4  (1.0) 4 .9  (1.2) 4 .4 0 .0 4
Clinical quality: Differences in consultation length and perceived usefulness of 
information were observed by study group allocation (table 6:15). The decision analysis 
consultation was significantly longer than the routine consultation. In addition, although 
both study groups rated the consultation information to be useful, the women in the
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decision analysis group perceived the usefulness of the information to be lower than of 
those in the routine information group.
There was no difference in the perceived encouragement of information provided by 
either the study or other health professionals by study group allocation (tables 6:16 and 
6:17). Most of the women in both groups perceived the provided information to be 
neutral or non-directive.
T a b le  6 :16  p e rc e iv ed  e n c o u ra g e m e n t o f h ea lth  p ro fe s s io n a l in fo rm a tio n  b y  s tu d y  
g ro u p .
T o ta l
(n = 106)
R o u tin e
(n = 56)
D e c is io n  A n a ly s is
(n = 50)
C h i2
(d.f. = 2)
n % n % n % S ig .
n o t d is c u s s e d 10 9% 5 9% 5 10%
n e u tra l 88 83% 48 86% 40 80%
d ire c tiv e 8 8% 3 5% 5 10% 0.89 0 .6 4
T a b le  6 :17  p e rc e iv ed  e n c o u ra g e m e n t o f o th e r  h ea lth  p ro fe s s io n a l in fo rm a tio n  by  
s tu d y  g ro u p .
T o ta l
(n = 106)
R o u tin e
(n = 56)
D e c is io n  A n a ly s is  
in = 50)
C h i 2
(d.f. =
n % n % n % S ig .
n o t d is c u s s e d 54 51% 28 50% 26 52%
n e u tra l 43 41% 24 43% 19 38%
e n c o u ra g e d 9 8% 4 7% 5 10% 0.43 0.81
6.2.5 Analysis of follow-up questionnaire (T2) by study group.
Six of the women were not sent follow-up questionnaires because they had received  
either a positive diagnostic test result or had miscarried the pregnancy in the intervening 
weeks (table 6:18).
T a b le  6 :18  k n o w n  n u m b e r o f m is c a rr ia g e s  a n d  D o w n ’s s y n d ro m e  d ia g n o s e s  by  
s tu d y  g ro u p .
T o ta l
(n = 106)
R o u tin e
(n = 56)
D e c is io n  A n a ly s is
(n = 50)
n % n % n %
n e g a tiv e  te s t re s u lt o r no  te s t 100 95% 52 93% 48 96%
p o s itiv e  te s t res u lt 4 3% 3 5% 1 2%
m is c a rr ia g e  o f  p re g n a n c y 2 2% 1 2% 1 2%
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O f these six women, four received a true positive diagnostic test result. Three women  
with a diagnosis of Down’s syndrome terminated the pregnancy, whilst one carried on 
with the pregnancy to term. The notes of the women with the diagnosis of Down’s 
syndrome did not record a family history of abnormality, although one woman had 
previously miscarried and was being treated for infertility. The two women not sent a T2  
questionnaire because the pregnancy had miscarried, had both had the amniocentesis 
test. One woman who miscarried did not record any predisposition to miscarriage or a 
family history of abnormality or Down’s syndrome but did refer to a cousin with Down’s 
syndrome during the consultation. The second woman who miscarried indicated one 
previous miscarriage, one child with a disability and, during the consultation, mentioned 
that she had a kidney disease which suggested that the pregnancy would not reach 
term.
In total, a hundred women did not receive a positive diagnostic test result, did not 
miscarry and had attended the clinic for their nineteen week fetal anomaly scan. These  
women were sent a follow-up questionnaire (T2) at about twenty weeks gestation. 
Follow-up questionnaires (T2) were returned by 68%  (68/100) of the women.
Three sets of analyses are described below. The first explored any systematic 
differences in the responses to the post-decision questionnaire (T1) measures by those 
completing (T1&T2) or not completing (T1 only) the follow-up questionnaire (T2). The  
second set evaluated any long-term differences in the quality of decision m easures by 
group allocation. The final analyses assessed the changes in the quality of decision 
measures over time.
6.2.5.1 Differences in women’s consultation and post-decision questionnaire (T1) 
responses by completion of the follow-up questionnaire (T2).
The following section summarises the results of the analyses carried out to compare the 
profile characteristics, consultation information and T1 responses of the women who 
either did or did not complete the follow-up questionnaire (T2). The aim of these 
analyses was to establish the representativeness of the women that completed the 
follow-up questionnaire compared with those that only completed T1. The data and 
results of the analyses are reported in Appendix XV; the following text provides a verbal 
description of the findings. The same types of analyses were used for these 
comparisons as previously described for differences by group allocation: the five 
SL IW C  items were entered into a M ANC O VA with consultation length as the co-variate,
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the Bartlett-box M test for homogeneity of variance was borderline suggesting that the 
results should be interpreted with caution (M = 41.0, Chi2 = 38.3, d.f. = 15, p = 0.001); 
the remaining interval variables with normal distributions were entered into a M ANO VA  
to reduce the likelihood of type I errors occurring, the Bartlett-box M test for 
homogeneity of variance was satisfactory (M = 211.7, Chi2 = 168.8, d.f. = 136, p = 
0.03); the interval variables with skewed distributions resistant to data transformations 
were entered into Mann-W hitney analyses; the categorical variables were subjected to 
Chi square analysis. The results are discussed in the following order: group allocation; 
socio-demographic characteristics, reproductive history and individual differences; 
behaviour; affect; cognitive processes; clinical quality.
Group allocation: The return rate of T2 questionnaires was 75%  of the women in the 
routine consultation and 60%  of those in the decision analysis consultation. Although 
fewer women in the decision analysis group returned their T2  questionnaires than the 
‘routine’ women, these percentages were not significantly different (table 1: Appendix 
XV).
Socio-demographic characteristics, reproductive history and individual 
differences: There were no differences for the age, gestation, num ber of children, 
number of miscarriages, religious activity and need for cognition between those who did 
or did not return the T2 questionnaire (tables 2 and 3: Appendix XV). Significant 
differences were observed by completion of T2 for: family history of abnormality (p = 
0.04; table 2: Appendix XV); level of education attained (p = 0.008; table 2: Appendix  
XV); optimism (p = 0.04; table 3: Appendix XV). The women were more likely to return 
the T2  questionnaire if they did not have a family history of an abnormality, had attained 
a higher than G C SE level of education and had an optimistic trait.
Behaviour: There was no difference in the return rate of T2 by the w om en’s decision to 
have a diagnostic test or not (table 4: Appendix XV).
Affect: There were no differences in the pre-consultation measure of anxiety, 
expressed affect during the consultation (SLIW C ), post-decision measure of anxiety and 
measures of decisional conflict between those who did and did not return the follow-up 
questionnaire (tables 5 and 6: Appendix XV).
Cognitive processes: No differences by T2 return rate were observed for any of the 
cognitive measures: informed decision making and remaining SLIW C  variables
168
extracted from the consultation transcripts (tables 5 and 6: Appendix XV); perceived 
advantages and disadvantages of testing (table 6: Appendix XV); knowledge (table 6: 
Appendix XV); EUVs of prenatal testing consequences (table 7 and 8: Appendix XV); 
ability to rank order the prenatal testing consequences (table 9: Appendix XV); 
perception of their triple test risk (table 10: Appendix XV).
Clinical quality: No differences by T2 return rate were observed for usefulness of 
information (table 6: Appendix XV) and perceived encouragement of other health 
professionals’ advice (table 11: Appendix XV). However, those that returned the T2  
questionnaire had had shorter consultations (p = 0.05; table 6: Appendix XV) and 
perceived the information provided by the study health professional to be more neutral 
(p = 0.03; table 12: Appendix XV) than those that did not return the T2  questionnaire.
The differences observed for the profile characteristics and T1 measures between  
women who did and did not complete the T2 questionnaire may affect the interpretation 
of subsequent analyses assessing the association between study group allocation with 
T2 measures of decision and clinical quality. Preliminary correlations were carried out 
between the T2 measures with the five variables found to differ significantly by T2  
return rate: level of education; family history of abnormality; optimism; perceived  
directiveness of the study health professional; length of consultation (tables 13 and 14: 
Appendix XV). In addition, preliminary correlations were carried out between the 
remaining profile characteristic found to differ by group allocation, gestation, with the T2  
measures. As associations were observed between optimism, level of education and 
length of consultation with some of the T2 measures, these three variables were 
incorporated in subsequent analyses as co-variates to adjust for their effect on T2  
measures.
6.2.5.2 Differences in follow-up questionnaire (T2) by study group.
This section describes the findings of analyses carried out to evaluate differences in the 
wom en’s responses four to five weeks after the information giving consultation. All 68 
women completing a follow-up questionnaire (T2) had received ‘good’ news either upon 
receipt of a negative diagnostic result and/or following a ‘normal’ nineteen w eek fetal 
anomaly scan. The measures of affect, cognitive processes and clinical quality repeated  
in the T2 questionnaire were: measures of anxiety and decisional conflict; perceived  
advantages and disadvantages of testing, expected utility values for the consequences 
of testing, ability to rank order the values associated with the consequences of testing, 
perception of the triple test risk and knowledge; usefulness and perceived directiveness
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of information. Differences by study group were assessed using the following analyses: 
all the interval measures with normal distributions were entered into a M ANC O VA to 
reduce the likelihood of type I errors with optimism, consultation length and level of 
education as the co-variates (Bartlett-box M = 41.7, Chi2 = 36.2, d.f. = 36, p = 0.46); 
interval m easures with skewed distributions resistant to data transformations were 
analysed using a Mann-W hitney test for independent groups; Chi square tests of 
significance were applied to the categorical variables. The findings described below are 
grouped by type of measure.
T a b le  6 :19  d iffe re n c e s  in a n x ie ty  a n d  d e c is io n a l c o n flic t  by  s tu d y  g ro u p  (T 2 ).
T o ta l
n = 68
R o u tin e
n = 39
D e c is io n  A n a ly s is
n = 29
M A N C O V A
d.f. = 1,63
X (s.d.) X (s.d.) X (s.d.) f S ig .
a n x ie ty 34.9 (13.3) 34.7 (14.5) 3 5 .3 (11.8) 1.2 0 .28
c o n flic t  - u n c e rta in ty 7.5 (3.2) 8.1 (3.5) 6.6 (2.7) 6.8 0.01
c o n flic t  -  in fo rm e d 7.0 (2.1) 7.5 (2.2) 6.4 (1.8) 2.8 0 .10
c o n flic t  -  e ffic a c y 7.8 (2.7) 8.6 (2.9) 6.8 (2.1) 6.2 0 .02
Affect: There was no difference in anxiety by study group allocation at follow-up (T2). 
However, differences in two of the three sub-categories of decisional conflict were 
observed (table 6:19). W om en in the decision analysis group were more certain of their 
decision and had greater decisional efficacy at follow-up than those in the routine group.
Cognitive processes: No differences by study group allocation were observed for the 
following measures of cognitive processes: perceived advantages and disadvantages of 
prenatal testing; knowledge about testing; perception of triple test risk; EUVs associated 
with having a healthy baby, miscarrying a healthy baby, having a baby with Down's 
syndrome and miscarrying a baby with Down’s syndrome; the ability to rank order the 
consequences of prenatal testing (tables 20-23).
T a b le  6 :2 0  k n o w le d g e , p e rc e iv ed  a d v a n ta g e s  an d  d is a d v a n ta g e s  o f te s tin g  by  
s tu d y  g ro u p  (T 2 ).
T o ta l
n = 68
R o u tin e
n = 39
D e c is io n  A n a ly s is
n = 29
M A N C O V A
d.f. = 1,63
X (S.d.) X (s.d.) X (s.d.) f S ig .
a d v a n ta g e s  te s tin g 1.9 (1.0) 2.1 (1.0) 1.7 (0.9) 2.8 0 .10
d is a d v a n ta g e s  te s tin g 1.6 (1.0) 1.7 (1.1) 1.4 (0.9) 1.9 0 .17
k n o w le d g e 13.7 (2.8) 13.5 (2.8) 13.8 (2.7) 0.1 0.73
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T a b le  6:21 p e rc e p tio n  o f tr ip le  te s t risk  by s tu d y  g ro u p  (T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a ly s is
(n = 29)
C h i*
(d.f. = 2)
n % n % n % C h iz S ig .
lo w  risk 5 7% 3 8% 2 7%
m e d iu m  risk 27 40% 14 36% 13 45%
h ig h  risk 36 53% 22 56% 14 48% 0.56 0.76
T a b le  6 :22  th e  a b ility  to  ran k  o rd e r  th e  c o n s e q u e n c e s  o f  te s tin g  by  s tu d y  g ro u p  
(T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a ly s is
(n = 29) r-* 
”n
 
II
n % n % n % C h i* S ig .
ra n k e d 38 56% 21 54% 17 59%
n o t ran ked 30 44% 18 46% 12 41% 0.15 0 .70
T a b le  6 :23  p ren a ta l c o n s e q u e n c e s  a n d  p e rc e p tio n  o f s o c ia l n o rm  b y  s tu d y  g ro u p  
(T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a l.
(n = 29)
M a n n -W h itn e y
X (s.d.) x (s.d.) X (s.d.) U z S ig .
EU T1- have healthy baby 44.9 (11.6) 45.2 (10.9) 4 4 .4 (12.6) 557 -0.1 0.9
EU T2- misc. Downs baby 4 .9 (8.2) 5.7 (8.9) 3.8 (7.1) 497 -0.9 0 .4
EU T3- term. Downs baby 19.9 (20.3) 12.7 (15.5) 29.6 (22.1) NA NA NA *
EU T4- have Downs baby 1.8 (3.8) 1.7 (3.6) 1.8 (4.1) 524 -0.6 0 .6
EU T5- misc. healthy baby 0.8 (1 4 ) 0.9 (1.6) 0.7 (1.1) 565 0.0 1.0
Perception norm (should) 1.6 (1.1) 2.0 (1.6) 1.1 (1.3) 384 -2.3 0 .02
* NA = no analysis carried out, bi-modal distribution
T a b le  6 :2 4  E U V  fo r  te rm in a tin g  fo r  D o w n ’s s y n d ro m e  by  s tu d y  g ro u p  (T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a ly s is
(n = 29)
C h i2 
,!<  = 1)
n % n % n % C h i S ig .
E U T  v a lu e  <14 35 52% 26 67% 9 31%
E U T  v a lu e  >13 33 49% 13 33% 20 69% 8.5 0 .003
Two significant differences by group allocation were observed: the perception of social 
norms about prenatal testing (p = 0.02; table 6:23); the EUV associated with terminating  
a child with Down’s syndrome (p = 0.003; table 6:24). The women in the decision 
analysis group were more likely to perceive other’s attitude to be in favour of prenatal
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testing and to have a greater expected-utility value associated with terminating for 
Down’s syndrome than the women in the routine group. The mean figures by study 
group for perceived social norm at T1 were: routine group 1.6 (s.d. = 1.4); decision 
analysis group 1.4 (1.6). It is feasible to suggest that, in retrospect, women in the 
decision analysis group were more certain and women in the routine group less certain 
about their perception of the social norm regarding prenatal diagnosis. A similar pattern 
was observed for the EU V measure: women in the decision analysis group had a higher 
E U V  score regarding termination than women in the routine group. However, the 
m edian split for this variable was a lower figure at T2 (13) than at T1 (29). One  
explanation for this finding is that women evaluated the likelihood of these 
consequences occurring lower upon receipt of the ‘good news’ than at T1.
Clinical quality: No significant differences were observed for m easures of decision 
quality by study group allocation (tables 6:25, 6:26 and 6:27). The finding that there was 
no difference in perceived directiveness of the study health professional’s information 
should be interpreted with caution as the women in the sample returning the T2  
questionnaire differed from those that did not on this variable. That is to say, this 
sam ple of 68 women perceived the information to be more neutral than those not 
returning T2. It is feasible that significant differences may have been observed if all the 
wom en had returned the T2 questionnaire.
T a b le  6 :25  p e rc e iv e d  u s e fu ln e s s  o f in fo rm a tio n  by  s tu d y  g ro u p  (T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a ly s is
(n = 29)
M A N C O V A
(1 ,63)
x (s.d.) x (s.d.) x (s.d.) f S ig .
u s e fu l in fo rm a tio n 4.5 (1.4) 4.5 (1.4) 4 .4 (1.4) 0.09 0 .7 6
T a b le  6 :26  p e rc e iv e d  e n c o u ra g e m e n t o f s tu d y  h e a lth  p ro fe s s io n a l b y  s tu d y  g ro u p  
(T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a ly s is
(n = 29)
C h i2
d.f. = 2)
n % n % n % C hi' S ig .
n o t d is c u s s e d 2 3% 1 3% 1 3%
n e u tra l 61 90% 36 92% 25 87%
e n c o u ra g e d 5 7% 2 5% 3 10% 0.73 0 .6 9
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T a b le  6 :27  p e rc e iv e d  e n c o u ra g e m e n t o f o th e r  h ea lth  p ro fe s s io n a ls  a d v ic e  by  
s tu d y  g ro u p  (T 2 ).
T o ta l
(n = 68)
R o u tin e
(n = 39)
D e c is io n  A n a ly s is  
<n = 29)
C h i*
(d.f. = 1)
n % n % n % Chi' S ig .
n o t d is c u s s e d 29 43% 16 41% 13 45%
n e u tra l 39 57% 23 59% 16 55% 0.10 0.75
6.2.5.3 T1 and T2 questionnaires by study group: repeated measures analyses.
The previous sets of analyses have all used a between-subjects design to compare 
differences in measures as a consequence of the women's allocation to two different 
experim ental groups. This final set of analyses used a repeated measures design to 
evaluate changes in the measures employed across two time-points. The main 
advantage of this analysis was the separation of individual variations in responses from  
random error, so resulting in a more powerful design (Howell, 1985). Ideally, a profile 
analysis of repeated measures design (Tabachnick and Fidell, 1989) would allow  
several dependent variables to be assessed within one analysis. Unfortunately, the 
variables used within this study had different ranges of scores and could not be included 
within a single analysis. Consequently, eight single repeated measure analyses were  
carried out for anxiety, the three decisional conflict sub-categories, the perceived  
advantages and disadvantages of prenatal testing, knowledge and the usefulness of 
information. As the study numbers for the repeated measures only represented the  
wom en who completed the follow-up questionnaire, the sam e co-variates were used in 
these analyses as those included within the analyses of the T2 measures: level of 
education, consultation length and optimism. The criteria assessing homogeneity of 
variance were met for each analysis (table 6:28).
T a b le  6 :28  te s ts  fo r  h o m o g e n e ity  o f  v a r ia n c e  (re p e a te d  m e a s u re s ).
Bartlett-Box’s M d.f. Chi2 Sig.
a n x ie ty 10.7 6 10.2 0 .12
u n c e rta in ty  -  d e c is io n a l c o n flic t 4.5 3 4.0 0 .26
in fo rm e d  - d e c is io n a l c o n flic t 1.5 3 1.4 0 .69
e ffic a c y  -  d e c is io n a l c o n flic t 14.4 3 13.9 0 .0 03
a d v a n ta g e s  te s tin g 2.7 3 2.6 0.46
d is a d v a n ta g e s  te s tin g 1.1 3 1.1 0 .79
k n o w le d g e  (p ro -ra te d  to  20) 0.1 3 0.1 0 .99
u s e fu ln e s s  in fo rm a tio n 4.8 3 4.6 0 .20
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T a b le  6 :29  re p e a te d -m e a s u re s  a n a ly s e s  fo r  d e c is io n  q u a lity  b y  s tu d y  g ro u p .
G ro u p  A llo c a tio n
(n = 68)
T im e
(n = 68)
G ro u p  x T im e
(n = 68)
F S ig . F S ig . F S ig .
a n x ie ty 0.2 0 .66 97.2 <0.0001 0.3 0.8
u n c e rta in ty -  decisional conflict 4.3 0 .04 8.0 0 .006 3.5 0.07
in fo rm e d - decisional conflict 0.3 0 .60 0.02 0 .89 8.8 0 .0 0 4
e ffic a c y  -  decisional conflict 3.5 0 .07 0.3 0 .60 6.5 0.01
a d v a n ta g e s  te s tin g 5.2 0 .03 2.1 0 .15 0.2 0.63
d is a d v a n ta g e s  te s tin g 2.9 0 .10 0.1 0.71 0.01 0 .9 4
k n o w le d g e  (pro-rated to 20) 0.3 0 .58 1.3 0.25 0.03 0 .87
u s e fu ln e s s  in fo rm a tio n 1.2 0 .20 11.0 0.001 1.5 0 .22
T a b le  6 :30  rev is e d  m ean  s co re s  fo r  d e c is io n  q u a lity  by s tu d y  g ro u p .
R o u tin e  g ro u p  sco re s  
(n =  39)
D e c is io n  a n a ly s is  g ro u p  s c o re s  
(n =  29)
B e fo re  T1 
x (s .d .)
T1
x (s .d .)
T2
x (s .d .)
B e fo re  T1 
x (s .d .)
T1
x (s .d .)
T 2
x  (s .d .)
a n x ie ty 62.3
(12.8)
59.4
(14.1)
34.7
(14.5)
60.3
(14.6)
57.6
(15.4)
35.3
(11.8)
d e c is io n a l c o n flic t-
uncertainty
8.4
(3.0)
8.1
(3.5)
8.0
(2.8)
6.6
(2.7)
d e c is io n a l c o n flic t-
informed
6.8
(1.7)
7.5
(2.2)
7.2
(1.7)
6.4
(2.1)
d e c is io n a l c o n flic t-
efficacy
7.6
(2.4)
8.6
(2.9)
7.4
(1.7)
6.8
(2.1)
a d v a n ta g e s  o f  
te s tin g
1.9
(0.9)
2.1
(1.0)
1.5
(0.8)
1.7
(0.9)
d is a d v a n ta g e s  o f  
te s tin g
1.7
(1.0)
1.7
(1.1)
1.4
(0.9)
1.4
(0.9)
k n o w le d g e
(pro-rated 0-20)
14.6
(3.5)
15.0
(3.2)
14.8
(3.6)
15.4
(3.0)
u s e fu ln e s s  o f  
in fo rm a tio n
5.2
(1.1)
4.5
(1.4)
4.8
(1.1)
4.4
(1.4)
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Two significant main effects and one trend towards significance were observed by study 
group allocation for the decisional conflict sub-category ‘uncertainty’, perceived 
advantages of testing and the decisional conflict sub-category ‘efficacy’ (table 6:29). 
Those in the routine group perceived more advantages to testing, had less certainty 
with the decision and a tendency towards less efficacy with the decision than those in 
the decision analysis group (table 6:29). The scores for the following measures were 
found to differ significantly from before the results of the diagnostic test or fetal anomaly 
scan to after this information had been received: anxiety; the decisional conflict sub­
category; perceived usefulness of information (table 6:30). The women rated their 
anxiety as lower, uncertainty with the decision as lower and the usefulness of the 
consultation information as lower after receiving the ‘good news' (table 6:30). For all 
three sub-categories of the decisional conflict scale, interactions were observed 
between the time of completing the questionnaire and of the study group allocation 
(table 6:30). The mean decisional conflict scores of women in the decision analysis 
group decreased by over 1.5 points for each sub-category from T1 to T2, i.e. a 
reduction in decisional conflict over time (table 6:30). For the women in the routine 
group, only the uncertainty sub-category decreased by a smaller number of points (0.3) 
from T1 to T2. The mean scores of the remaining two categories increased by over 0.8 
points each, i.e. a constant or increased level of decisional conflict. These findings 
suggest that, at follow-up, there was an increase in decisional certainty amongst women 
in the decision analysis consultation, whereas the evaluation of decisional certainty 
amongst women in the routine consultation either remained at the same level or 
decreased at follow-up.
6.3 D iscussion.
The purpose of this study was to evaluate the effectiveness of decision analysis to 
facilitate women’s informed decision making about prenatal diagnosis upon receipt of a 
screen positive triple test result. Few, if any, studies have compared the quality of 
decisions made in routine health care consultations with consultations structured using 
the decision analytic technique. Proponents of decision analysis maintain that the 
quality of decision making improves following application of the technique to real-world 
decisions, whereas critics argue the opposite. In essence, a better decision would 
include: a more accurate evaluation of the information; integration of probability and 
value information; more reasoned decisions; less confusion surrounding the decision; 
greater satisfaction with the final decision (see chapter six, introduction). In the study 
described in this chapter, four types of measures were used to evaluate whether or not 
decision analysis facilitated women’s prenatal diagnosis decision making: behaviour;
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affect; cognitive processes; clinical quality. Assessments were made during the decision 
making process, immediately after the decision was made (T1) and four weeks after the 
decision was made (T2). Measures were both questionnaire-based and derived from the 
transcripts of audio tape-recorded consultations.
All women participating in the study had received a screen positive triple test result and 
were offered the opportunity to have, or not have, a diagnostic test. Over the fifteen- 
month study period, 106 women participated in the study, a participation rate of 84%. 
Six women were not sent follow-up questionnaires because they had either miscarried 
the pregnancy or received a positive diagnostic test result for Down’s syndrome. One 
hundred women with a negative diagnostic test result and/or ‘normal’ nineteen week 
fetal anomaly scan were sent follow-up questionnaires (T2). The return rate of the T2 
questionnaire was 68% (68/100).
The following discussion of findings is divided into four sections: a summary of the main 
results by category of measure (behaviour, affect, cognitive processes and clinical 
quality); an assessment of the internal validity of the results; an evaluation of the 
external validity or generalisability of results; the effectiveness of decision analysis to 
facilitate women’s decision making.
6.3.1 Summary of main findings.
Decision behaviour was not influenced by the differences between the information 
giving consultations. The women in the decision analysis consultation were as likely to 
have, or not have, further testing than those in the routine group (table 6:8). The 
moderate sample size meant the study was under-powered in order to draw conclusions 
about non-significant associations, for example, that there was no relationship between 
the decision to have or not have testing with the decision analytic technique. However, 
it is unlikely that a consultation structured by the decision analytic technique would have 
an immediate impact on behaviour. Evidence suggests a number of factors are 
predictive of prenatal testing behaviour such as attitudes, perception of social norms 
and past behaviour (see chapter one). It is more likely that the evaluation of information 
is associated with a change in attitude rather than a behaviour change (see Eagly and 
Chaiken, 1993; Baron, 1994; Garnham and Oakhill, 1994).
The three measures o f affect were: general anxiety as assessed by the short-form 
STAI; the number of positively and negatively emotional-laden words utilised by the 
women during the prenatal diagnosis consultation and analysed using the SLIWC; the
176
measure of decisional affect assessed by the decisional conflict scale. The findings 
suggested that there was an association between the consultation group and the 
women’s experience of decisional affect but no such association with general affect. To 
explain further, anxiety levels did reduce dramatically over time from scores 
comparable with clinical significance before and after the decision making consultation 
(T1) to those considered normal for pregnant women upon receipt of 'good news' (T2). 
No differences by study group were observed for levels of anxiety at any time point 
(tables 6:9, 6:19 and 6:29). However, differences in findings by study group were 
observed for measures of affect associated with the decision making process both 
during the consultation and at follow-up (T2). First, the number of positive and negative 
words expressed during the information consultation differed by group allocation (table 
6:6). The women in the decision analysis group were less likely to use words associated 
with positive emotions and a trend towards significance suggested that they were more 
likely to use words associated with negative emotions than those in the routine 
information group. Second, the results of the repeated measures analyses found there 
to be differences in the decisional conflict scores by group allocation (table 6:29). Those 
in the decision analysis group were more confident about their prenatal choice than 
those women receiving the routine consultation. In addition, the results of the repeated 
measures analyses suggested that there was an interaction between study group 
allocation and time of completion of measures (table 6:29). The women in the routine 
group reported an increase in decisional conflict upon receipt of ‘good news’ (T2), 
whereas women in the decision analysis group reported a decrease in decisional conflict 
(table 6:30). The pattern of decisional affect illustrated by these findings is that the 
women in the decision analysis group expressed greater decisional affect whilst making 
their decision, about the same decisional affect immediately after the consultation (T1) 
and less decisional affect at follow-up (T2) than those in the routine consultation.
The measures assessing cognitive mechanisms fell broadly into two categories, 
informed decision making and perception of the decision information.
Informed decision making: The findings suggest that the women in the decision analysis 
group were making more informed decisions than those in the routine group (table 6:3). 
During the consultation, the women in the decision analysis consultation appeared to 
reason more with the decision information than the women in the routine consultation 
(table 6:3). That is to say, women in the decision analysis group were able to generate 
more reasons for and against an option than those in the routine group. In addition, the 
results of the SLIWC analysis showed that the women in the decision analysis
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consultation made reference to more words associated with thinking than those in the 
routine group (table 6:5). However, neither information-seeking within the consultation 
(table 6:3) nor the questionnaire-based measure of knowledge (tables 6:10, 6:20 and 
6:29) differed by study group allocation. It is feasible to suggest from these findings that
(a) the decision analysis consultation was associated with the facilitation of informed 
decision making and not information-seeking and (b), as previously discussed in 
chapters one and two, knowledge is not an adequate measure of informed decision 
making.
Perception of decision making: The measures assessing differences in the perception of 
decision information by study group allocation were mixed. There was no difference in 
the perception of the triple test risk by group allocation at either T1 or T2 (tables 6:11 
and 6:21). The perception of perceived social norm differed significantly by group 
allocation at follow-up (T2) only. At follow-up (T2), the women in the decision analysis 
group were more likely than the women in the routine consultation to perceive others as 
being in favour of prenatal testing (table 5.12, 5.24). This finding may lend support to 
the idea that the women in the decision analysis group were more confident with their 
testing choice than women in the routine group, as suggested by the decisional conflict 
results. In addition, the women in the routine group were likely to generate more 
perceived advantages to prenatal testing than those in the decision analysis group 
(tables 6:10 and 6:20). Although not significantly different, those in the routine group 
also generated more disadvantages to testing than those in the decision analysis group 
(tables 6:10 and 6:20). One interpretation of this finding is that those in the decision 
analysis group had a more neutral perception of the prenatal testing process and were 
cautious in labelling the consequences of testing as an advantage or disadvantage. An 
alternative interpretation is that the difference in completion of these items suggests 
that the women in the decision analysis group were less satisfied with the decision 
analysis consultation than the women in the routine group. In support of this latter 
explanation were the findings that the women in the decision analysis group expressed 
more negative emotions during the consultation (table 6:5) and perceived the 
usefulness of the consultation information to be lower immediately after the decision 
was made (table 6:15) than those in the routine group. These two explanations are not 
necessarily mutually exclusive and may indicate that those in the decision analysis 
consultation were less 'falsely reassured’ by the consultation information and/or 
evaluated the consultation information more objectively than the women in the routine 
group.
178
The measures assessing rational or accurate decision making were not associated 
with any consistent pattern by study group allocation. That is to say, the decision 
analysis consultation did not encourage women to make decisions more rationally or in 
accord with EUT than women in the routine information group. To explain further, one of 
the axioms of EUT is the ability to rank order the consequences of prenatal testing. 
There was no association between study group allocation and the women’s ability to 
rank order the five consequences of prenatal testing at either T1 or T2 (tables 6:14 and 
6:24). However, on exploring differences in the women's allocation of EUVs to the 
consequences of prenatal diagnosis, one difference by study group was observed for 
the consequences of 'terminating for child with Down's syndrome’. The women in the 
decision analysis group had a greater expected-utility score than the routine 
consultation women at both T1 and T2 (tables 6:12 and 6:22). One explanation for this 
finding is that, within decision analysis, the lottery method for utility extraction 
encourages women to focus on their attitudes towards termination for Down's syndrome. 
As mentioned previously (see chapters four and five), the routine information giving 
consultation does not provide women with an adequate opportunity to discuss their 
attitudes towards termination. In essence, the decision analysis consultation in this 
health context appears to be associated with an increase in informed decision making 
but not an increase in accurate, rational or optimum decisions.
The three measures o f clinical quality were perceived usefulness of information, 
perceived directiveness of information and length of consultation. There was a main 
effect of time on perceived usefulness of information following the repeated measures 
analyses (tables 6:29 and 6:30). That is to say, regardless of group allocation, the 
women found the consultation information to be useful but their perception of the 
usefulness of information was lower than upon receipt of good news (T2) than when 
having made a decision (T1). Although the repeated measures analysis found no 
association between the study group allocation and consultation usefulness, women in 
the decision analysis group were significantly less enthusiastic about the consultation 
information at T1 than women in the routine group. There was no association between 
group allocation and perceived directiveness of health professionals at either T1 or T2 
(tables 6:16, 6:17; 6:26 and 6:27). However, a total of 8% of the women perceived the 
information about prenatal diagnosis to be directive. Only the measure of consultation 
length differed significantly by group allocation; the decision analysis consultation was 
approximately six minutes longer than the routine information consultation (table 6:15). 
Pauker and Pauker (1987) suggested that consultations structured by decision analysis 
would increase the consultation length by about ten minutes. It is likely that the
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increased consultation length is mainly attributable to the ‘lottery’ question, i.e. the 
elicitation of a woman’s utility about the termination of pregnancy for Down's syndrome.
6.3.2 Internal validity.
As there is little a priori evidence evaluating the decision analytic technique in this or 
other areas, it is difficult to assert that the findings of this study are valid. However, the 
measures used to evaluate this study suggest some confidence with the results and 
their subsequent interpretation. A number of measures were standardised: the SLIWC 
categories; the short-form STAI; the decisional conflict sub-categories. Most measures 
were developed from questionnaire items used in previous studies of prenatal and 
genetic testing: attitudes towards testing; perception of risk; knowledge; elicitation 
utilities; usefulness of information. The remaining measures, perceived directiveness of 
information (section 6.1.2) and the informed decision making variables (see chapter 
five), were developed with reference to the decision making literature and appropriately 
piloted. In addition, although few studies have employed a randomised control trial 
design to evaluate the effectiveness of decision analysis, there is a large body of 
empirical work describing the experience and decision making processes of women in 
the context of prenatal diagnosis (see chapter one). There were at least five findings 
within the current analyses that replicated some of the dominant themes observed in 
previous empirical research. These similarities in findings increase confidence in the 
interpretation of this chapter's results and in the validity of the study’s measures. The 
findings are described in more detail below:
• The number of the women choosing to have the diagnostic test result was 84%, a 
figure consistent with observed clinical practice in this area (Ward, 1991; Marteau, 
Kidd, Cook, Michie, Johnston, Slack and Shaw, 1992).
• The pattern of anxiety from receipt of a screen positive triple test result to the four 
week follow-up was the same as in previous research: clinical levels of anxiety upon 
receipt of a screen positive reducing to levels considered normal for a female and 
pregnant population (Beeson and Golbus, 1979; Burton, Dillard and Clark, 1985; 
Marteau, Kidd, Cook, Michie, Johnston, Slack and Shaw, 1992: Thornton, Hewison, 
Lilford and Vail, 1997).
• The reasons provided by women for choosing an alternative, such as the risk of 
miscarriage, timing of the tests, beliefs about termination and evaluation of the 
consequence of the unselected option have been described previously in 
questionnaire and interview-based studies (Farrant, 1985; Lippman, Perry, Mandel 
and Cartier, 1985; McGovern, Goldberg and Desnick, 1986; Sjorgen and
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Uddenberg, 1988; Julian-Reynier, MacQuart-Moulin, Moatte, Aurran, Chabal and 
Ayme, 1994).
• When listing the perceived advantages and disadvantages of testing in pregnancy 
(table 6:6), 37% of the women stated that making informed decisions was an 
advantage whereas 27% identified taking responsibility for making the decision as a 
disadvantage. This apparent ambiguity towards prenatal diagnosis is supportive of 
the evidence suggesting that women want to be informed about the decision 
alternatives but do not necessarily want to take responsibility for their final 
treatment choice (Fallowfield, 1997).
• Forty-five per cent of the women were able to rank order the utilities associated with 
the consequences of testing in this study. Of those studies that have assessed the 
degree to which women made prenatal diagnosis test choices consistent with the 
‘optimum’ or ‘accurate’ choice, about half of the women were able to do so (Pauker 
and Pauker, 1978; Heckerling and Verp, 1994).
6.3.3 External validity.
The sample representativeness, participation rates and questionnaire response rate of 
this study suggest that the findings have good external validity and are generalisable to 
a wider field of interest (Bowling, 1997). To explain further, over the fifteen month study 
period, all the women who received a screen positive triple test result were assessed for 
their eligibility to participate in the trial. Sixteen per cent (28/178) of the women were not 
invited to participate because they did not fulfil the study criteria. That is to say, they did 
not speak English, the test result was a screen positive for Spina Bifida or Edward’s 
syndrome, another health professional informed the woman of her triple test result or 
the woman was a private patient. A further ten per cent (18/178) were excluded 
because they made their test decision over the phone. As stated, controlling the amount 
of information these women received, defining the decision context and assessing the 
decision making processes was compromised in all of these situations. In an effort to 
assess the representativeness of the sample invited to participate, the demographic 
characteristics, diagnostic test decisions and reasons for inclusion or exclusion were 
analysed. Those women invited to participate did not differ from those excluded from 
participation on any demographic and reproductive characteristics (Appendix XIV). 
However, the women making their test decision over the telephone were more likely to 
chose to have no further diagnostic testing. In consequence, it is likely that the women 
invited to participate in the study were more inclined to consider having a diagnostic 
test, i.e. the study sample under-represented those choosing to have no further 
diagnostic testing. The remaining 132 women were invited to participate in the study
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and asked to complete a consent form. Fifteen women declined to participate and a 
further seven women were excluded post-randomisation because their test result was 
recalculated as a screen negative. There was no difference in anxiety, reproductive 
variables and demographic characteristics between those agreeing or those declining to 
participate (Appendix XIV). It was beyond the boundaries of the study’s resources to 
explore what impact those women not included in the study sample might have had on 
subsequent results. Suffice it to say that, as there were few differences between those 
included in the study from those not included, the final sample of women were fairly 
representative of women offered prenatal diagnosis upon receipt of a screen positive 
triple test result at the LGI.
The participation rate of the women invited to participate was excellent (84%) (Bowling, 
1997). The simple randomisation technique provided an effective method for the 
allocation of the women to study groups. Apart from gestation, the demographic and 
reproductive characteristics were equally represented between groups (Appendix XIV). 
In addition, one of the measures for individual differences, optimism (LOT), was also 
found to differ significantly between study groups. One explanation for these errant 
findings is chance. That is to say, those in the routine group had a later gestation and 
were less optimistic than those in the decision analysis group. Certainly, this is the most 
likely explanation for the differences in gestation which was noted before the women 
had been contacted about their triple test result. However, there is a second explanation 
for the differences observed in the measure of optimism. Theoretically, there should 
have been no association between this trait, individual or personality measure with the 
experimental intervention. As this measure was completed after the information giving 
consultation (T1), it is feasible to suggest that the intervention did influence the 
perception of optimism and, perhaps that the measure assessed state rather than trait 
optimism. To explain further, there was evidence to suggest that those in the decision 
analysis group were less satisfied with the consultation information (table 6:15). In 
addition, fewer women in the decision analysis group did not return their T2 
questionnaires than women in the routine group (table 1, Appendix XV). Although this 
difference did not reach significance, it may be a further indication that women in the 
decision analysis group were less satisfied with the information giving consultation than 
women in the routine group as increased satisfaction is associated with greater 
compliance (Ley, 1988; Ley and Llewelyn, 1995). In consequence, it is feasible to 
suggest that the optimism measure may have assessed a mood state associated with 
consultation satisfaction. However, it was beyond the scope of this study to pursue this 
assertion further, subsequent analyses included gestation and optimism as co-variates
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to adjust for the systematic differences observed at this preliminary stage of 
randomisation. In essence, women in each study group were generally representative of 
those women agreeing to participate in the study.
The response rate from the follow-up questionnaire was satisfactory (68%). Analyses 
were carried out on all the T1 and information giving consultation measures to assess 
the representativeness of those women returning the T2 questionnaire compared with 
those that did not (Appendix XV). Five variables differed significantly between those 
that did and did not complete the T2 questionnaire: level of education; family history of 
abnormality; optimism; length of consultation; perceived directiveness of consultation. 
Those that completed the questionnaire were more likely to have 'A' level or degree 
qualifications, less likely to have had a family history of abnormality, to have had 
shorter information giving consultations, were less optimistic and perceived the 
information giving consultation to be less directive than those that did not return the T2 
questionnaire. Again, explaining these significant differences between those returning 
and not returning the questionnaire would have been difficult to pursue without further 
investigation. Suffice it to say, the women completing the T2 questionnaire were not as 
representative of the Leeds screen positive triple test population as those completing 
T1. In consequence, statistical steps were taken to counteract the impact that this less 
representative sample may have had on the generalisability of findings. Preliminary 
correlations were carried out between the variables that differed by completion of the T2 
with the quality of decision measures at T1. Variables that were significantly associated 
with the measures of decision quality were entered as co-variates in the subsequent 
analysis of the women’s T2 responses. It is feasible to suggest that these statistical 
adjustments would be sufficient to ensure confidence in the findings evaluating the 
effectiveness of decision analysis at T2.
There were at least three factors beyond the control of the author that may be 
associated with the interpretation of the current findings. The first concerns the study 
sample size. As previously stated, power calculations using the anxiety score to 
estimate sample size suggested that approximately 52 women were required for each 
study group. After fifteen months, the final sample included 56 women allocated to the 
routine group and 50 women to the decision analysis consultation. Although just under 
the approximate sample size, this final figure was in part a compromise with the 
demands of the clinical setting. On recalculating the sample size using the observed 
differences on the anxiety score (two point difference, s.d. = 16), about 1000 women 
would be required in each study group to achieve an acceptable level of power. This re­
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analysis suggests that the study may have been under-powered. However, in retrospect, 
it could be argued that anxiety was not an appropriate measure with which to evaluate 
the decision quality. Perhaps subsequent power calculations will use the measure of 
decisional conflict. As the study may have benefited from having a larger sample size, 
conservative estimates of significance were employed suggesting that some type II 
errors may have occurred.
Two other factors of note concern the generalisability of the study outside the Leeds 
health authority: the uptake of the triple test by women at the LGI and the offer of the 
triple test to women by the Leeds health authority. The figures supplied by the LGI for 
the uptake rate of the triple test two years before and during the study period was 58% 
(3600/6253), one of the lowest rates within the country. In addition, Leeds only offered 
the triple test to women aged 29+ years at estimated date of delivery (EDD); some 
health authorities offer the triple test to all pregnant women regardless of age. One 
study has documented factors associated with the uptake rate of the triple test within 
Leeds and Bradford (Thornton, Hewison, Lilford and Vail, 1997) and found that older, 
Caucasian women in higher social classes with healthy children were more likely to 
have the triple test. This set of profile characteristics suggests that, within the triple test 
and prenatal diagnosis context, these findings of the effectiveness of decision analysis 
are generalisable. However, this evaluation of the decision analytic technique has been 
carried out on a sample of female, predominantly white, moderately well-educated and 
‘older’ reproductive-age population. In consequence, it remains an empirical question as 
to whether the same findings would be observed within a different clinical and socio­
demographic population.
6.3.4 The effectiveness of the decision analytic technique.
As summarised earlier in the discussion, a number of differences were found for both 
consultation and questionnaire measures of decision quality by study group. These 
findings are discussed below with specific focus on the efficacy of decision analysis to 
facilitate the quality of individuals' decision making.
Decision analysis is a technique or aid derived from EUT. It has been well established 
that individuals do not make decisions in accord with EUT (chapter one). However, an 
aim of the application of decision analysis is to encourage individuals to make decisions 
in accord with EUT. There was little evidence to suggest that the women in the decision 
analysis group made more optimum decisions. Most of the women were not able to rank 
order the utilities associated with the consequences of prenatal testing. Furthermore,
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the women in the decision analysis group were no more or less likely to be able to rank 
order the utilities than the women in the routine group (tables 6.14 and 6.24). Although it 
is possible that with a larger sample, decision analysis may be seen to facilitate 
optimum decision making, no such association was established in this study.
Although decision analysis has not been associated with an increase in the accuracy of 
decisions, the women in the decision analysis group made more informed decisions 
about prenatal diagnosis than the women in the routine group (table 6:3). To explain 
further, the results of the theme-based coding frame suggest that the women in the 
decision analysis group evaluated more reasons for and against alternatives than the 
women allocated to the routine consultation group (table 6:3). In addition, the women in 
the decision analysis group were more likely to use words associated with cognition than 
those in the routine group (table 6:5). It is fair to say that the women in the decision 
analysis group made a more reasoned evaluation of the information during the 
consultation than those in the routine consultation. It was beyond the scope of this 
chapter’s analysis to explore other group allocation differences in the strategies 
employed by women when making the decision to have or not have prenatal diagnosis; 
for example, whether or not women in the routine group employed more ‘heuristic’ 
information processing strategies than those in the decision analysis consultation. 
However, the frequency table summarising the information utilised by the women during 
the consultation indicates that the women in both consultations appeared to refer 
equally to the themes associated with a more heuristic appraisal of information (themes 
13-20, table 6:1). In other words, it seems feasible to suggest that decision analysis was 
associated with facilitating the utilisation of the decision specific information rather than 
all the information referred to in the consultation.
Another advantage of applying a decision aid to a real-world decision is to reduce the 
degree of decisional conflict experienced by an individual when making a difficult 
decision (O’Connor, 1995). The women in the decision analysis consultation reported 
less decisional conflict at follow-up than those in the routine group (tables 6:29 and 
6:30). In other words, decision analysis was associated with greater confidence in the 
decision made. However, during the consultation, the women in the decision analysis 
group were less likely to use positive emotion words and more likely to use negative 
emotion words than those in the routine group, i.e. greater expressed affect (tables 6:1 
and 6:4). This finding supports the observation that the decision analysis technique 
may encourage women to confront difficult issues during the consultation, as suggested 
by Pauker and Pauker (1977). In particular, the decision analysis consultation may
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provide women with a more effective forum to express how they feel about the 
diagnostic test decision than the routine consultation. After the decision was made, 
there were no differences in measures of anxiety by study group (tables 6:9 and 6:19). 
This finding may support the latter assertion. Alternatively, this lack of association 
between anxiety and study group allocation may reflect the idea that anxiety is not an 
appropriate measure of decisional affect. It is possible that a larger sample or more 
sensitive assessment of anxiety might have been able to establish a link between 
decision analysis and a global measure of affect.
Some of the concerns regarding the application of decision analysis to the real-world 
health care setting are those pertaining to clinical quality. The following measures were 
used to assess changes in the perceived clinical quality of the information giving 
consultation: satisfaction with the consultation information; length of consultation; 
perceived directiveness of information. The women did not perceive the decision 
analysis consultation to be any more or less directive than those in the routine group 
(tables 6:16, 6:17, 6:26 and 6:27). After making the decision (T1), the women in the 
routine group rated the usefulness of information as higher than those in the decision 
analysis group (table 6:15). However, the repeated measures analysis using the smaller 
sample size did not replicate this finding (tables 6:29 and 6:30). The decision analysis 
consultation did take, on average, six minutes longer than the routine consultation. 
Although this has implications for health care resources and return rates of follow-up 
questionnaires, it is unlikely that the women were unduly affected by the consultation 
length. On the contrary, as individuals are more likely to apply heuristic processes in 
time-pressured situations, it is likely that longer consultation lengths may be associated 
with more informed decisions.
As discussed, the main purpose of this study was to evaluate the effectiveness of 
decision analysis to facilitate women’s informed decision making in the context of 
prenatal diagnosis. The randomised control trial compared decisions made following the 
application of decision analysis to the consultation with those made unaided. The 
findings suggested that (a) women's informed decision making can be facilitated and 
that (b) women in the decision analysis consultation made more informed decisions 
than women receiving routine information. However, the decision analytic technique 
requires the application of both information and decision aids to structure the decision 
information, elicit utilities, integrate utilities with appraisals of risk and proffer a decision 
based on expected-utility (see section 6.1). It is unclear from the evidence reported in 
this chapter what aspect of the decision analytic technique was associated with the
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facilitation of informed decision making. For example, it is feasible to suggest that 
women’s informed decision making was facilitated with reference to the decision tree 
representation of the prenatal diagnosis decision alone. In essence, the decision tree 
component of the decision analytic technique is an information aid. To explain further, 
the decision tree may have acted as a visual prompt for both the health professional 
and woman decision maker, thus enabling the health professional to provide sufficient 
information about the decision alternatives and/or encouraging woman to appraise 
equally all the decision information. Alternatively, it is as likely that the ensuing 
discussions of the lottery question, the threshold graph and/or the proffered decision 
between the health professional and woman were the stages of decision analytic 
technique that were associated with the facilitation of informed decision making. 
Although a more in-depth analysis of the health professional’ and women’s transcripts 
would provide some evidence to address these issues, further randomised control trials 
comparing decisions made with reference to information aids, decision aids or unaided 
would be required to ascertain what aspect of the decision analysis consultation was 
associated with women's increase in the utilisation of decision information.
6.3.5 Chapter summary.
The study discussed in this chapter was one of the first to evaluate the effectiveness of 
decision analysis to facilitate individuals’ decision making. The study employed both 
information-tracing techniques and questionnaire measures to assess the quality of the 
prenatal diagnosis decision made following a routine information giving or decision 
analysis consultation. The study sample was representative of women having the triple 
test at Leeds General Infirmary. The decision analysis consultation was associated with 
the making of a more informed decision, with lower decisional conflict about the final 
decision and with greater confidence in others attitude to undergoing prenatal testing. 
Those in the decision analysis group were less likely to report the perceived advantages 
of prenatal testing and the usefulness of information following the making of the 
prenatal diagnosis decision. These findings may indicate that the women in the decision 
analysis consultation were less likely than those in the routine group to be falsely 
reassured by the diagnostic test information. During the consultation women in the 
routine group expressed more positive words and those in the decision analysis group 
expressed more negative words suggesting that either the decision analysis consultation 
was more confrontational than the routine information or that the decision analysis 
consultation provided a better forum for women to express how they felt about the 
consequences and alternatives of the prenatal diagnosis decision. The women did not 
perceive the decision analysis consultation to be more directive or to engender more
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anxiety than the women in the routine consultation. The decision analytic technique was 
not associated with the making of more optimum decisions, with differences in the 
decision made, nor with knowledge and perception of individual risk.
As one of the primary goals of prenatal testing is to ensure informed decision making, 
implementing a technique demonstrated to facilitate informed decision making within 
routine clinical practice would seem appropriate. The decision analytic technique was 
associated with positive changes in informed decision making and with the experience 
of being offered prenatal diagnosis. The nature of the technique ensures women are (a) 
exposed to the information considered necessary to enable reasoned or informed 
decisions and (b) provided with the opportunity to integrate this information with their 
beliefs and values concerning the consequences of prenatal diagnosis. The findings 
suggest that knowledge is an inadequate measure of informed decision making and that 
the assessment of anxiety is an unsatisfactory measure of decisional affect. It remains 
an empirical question as to whether or not informed decision making can be adequately 
assessed using a pre- or post-decision questionnaire. The decision analytic technique 
has been found to facilitate informed decision making within the prenatal diagnosis 
consultation. However, this decision context is well defined and lends itself to such a 
formal technique (Pauker and Pauker, 1987; Ubel and Loewenstein, 1997). It remains 
an empirical question whether or not decision analysis facilitates decision making in 
other decision contexts.
188
7. Predicting women’s prenatal diagnosis decisions.
This final, empirical chapter focuses on identifying those psychological factors 
associated with the decision to have or not have a prenatal diagnostic test. Describing 
the psychological factors associated with women’s prenatal diagnosis decisions has 
been one of the main research questions of empirical studies carried out in the prenatal 
testing context (see chapter one). The following factors have been identified as 
predictive of women's prenatal diagnosis behaviour: age (Sjorgen and Uddenberg, 
1988; Evans, Pryde, Evans and Johnson, 1993; Julian-Reynier, Macquart-Moulin, 
Moatti, Aurran, Chabal and Ayme, 1994); parity (Sjorgen and Uddenberg, 1988; 
Halliday, Lumley and Watson, 1995); reproductive history (Sjorgen and Uddenberg, 
1988); level of education (Sjorgen and Uddenberg, 1988; Julian-Reynier, Macquart- 
Moulin, Moatti, Aurran, Chabal and Ayme, 1994; Halliday, Lumley and Watson, 1995); 
attitudes towards abnormality (Sjorgen and Uddenberg, 1988; French, Kurczynski, 
Weaver and Pituch, 1992; Evans, Pryde, Evans and Johnson, 1993; Julian-Reynier, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994); termination (Volodkevich 
and Huether, 1981; French, Kurczynski, Weaver and Pituch, 1992; Heckerling and 
Verp, 1994); prenatal testing (French, Kurczynski, Weaver and Pituch, 1992; Lippman, 
Perry, Mandel and Cartier, 1985; McGovern, Goldberg and Desnick, 1986) and 
pregnancy (Burke and Kolker, 1993; Heckerling and Verp, 1994); the perception of 
others’ prenatal testing attitudes (Volodkevich and Huether, 1981; Julian-Reynier, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994); perceptions of risk 
(Volodkevich and Huether, 1981; Lippman, Perry, Mandel and Cartier, 1985; McGovern, 
Goldberg and Desnick, 1986; Kolker and Burke, 1993; Evans, Pryde, Evans and 
Johnson, 1993); affect (Fava, Trombini, Michelacci, Linder, Pathak and Bovicelli, 1983; 
Evans, Pryde, Evans and Johnson, 1993).
As described in more detail in chapter one, there are some methodological concerns 
pertaining to these studies that may limit the interpretation of subsequent findings 
(section 1.3.2.2). First, most studies employed a pro- or retrospective study design and 
did not describe the process of decision making. Second, few studies assessed the 
factors associated with the choice between having or not having prenatal diagnosis. A 
number of studies included a sample of women who were representative of those who 
had prenatal diagnosis or those who had not had prenatal diagnosis. In other words, 
these study samples only enabled the assessment of the decision making processes 
associated with one of the decision alternatives. Finally, few studies were designed with 
reference to established models of behaviour from either the decision making or social
189
cognition literature. In consequence, it is difficult to ascertain whether or not the 
psychological processes underpinning women’s prenatal decision making have been 
adequately assessed or described. However, understanding the factors associated with 
women’s prenatal diagnosis decision making may be useful to either inform subsequent 
interventions aimed at facilitating decision making or to provide a more comprehensive 
explanation as to why the decision analysis intervention was not associated with 
behaviour change.
The purpose of this chapter is to carry out further analyses of the data collected from 
the randomised control trial (RCT) described in chapter six in order to identify the 
psychological factors associated with women’s prenatal diagnosis decision making. In 
this sample of women, 17 chose to have no further diagnostic testing and 89 decided to 
have a diagnostic test. As no association was observed between the women’s test 
behaviour and allocation to the RCT's study groups, the women randomised to each 
trial arm were integrated to form one data source.
7.1 Methodology.
7.1.1 Sample, Design, Measures and Procedure.
The data used in this chapter's analyses were collected from the 106 women who 
participated in the randomised control trial reported in chapter six. As this chapter is 
concerned with psychological factors associated with the decision to have or not have 
prenatal diagnosis, only the data from the information giving consultation and T1 
questionnaire will be analysed in more detail. The study sample, design, measures and 
procedure have been fully described in chapter six.
7.1.2 Analysis.
The aim of the following analyses is to identify the psychological factors associated with 
women’s decisions to have or not have prenatal diagnosis. The purpose of the RCT 
described in chapter six was to evaluate the effectiveness of decision analysis to 
facilitate women’s decision making. The study was not designed to operationalise or test 
a particular model of decision making. However, the measures used to evaluate the 
RCT were informed by theories of and empirical research from both the social cognition 
and decision making literature. In consequence, data were obtained for the following 
measures1:
1 Categorical variables were only included in the analyses if the sample distribution was 
at least 25:75% between levels (Tabachnick and Fidell, 1989).
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• demographic characteristics and reproductive history - age, gestation, number of 
children, number of miscarriages, level of education and religious activity;
• individual differences - need for cognition and optimism (LOT);
• cognitive processes - informed decision making variables, cognitive content of 
women’s utterances, perception of risk, perceived advantages and disadvantages of 
prenatal testing, expected-utility values for the five consequences of testing, rank 
ordering of the values of the consequences of testing and knowledge;
• affect - anxiety (STAI) before and after the consultation, decisional conflict 
variables and emotional content of women’s utterances;
• clinical quality - consultation length, usefulness of information and perceived 
directiveness of study and other professionals.
To establish the factors associated with women’s decisions to have or not have prenatal 
diagnosis, a discriminant function analysis was applied to the data set. In a suitably 
powered study, all of the above variables could be included in an analysis. However, 
sample size is a consideration when selecting the number of variables to be included in 
a discriminant function analysis (Tabachnick and Fidell, 1989). Fewer variables than 
cases in the smallest group should be selected. In a study with a small sample size (n = 
20 in one group), only a few variables should be entered. There is no correct way to 
select variables for inclusion within a discriminant function analysis (Tabachnick and 
Fidell, 1989). Certainly, the aim of the research is a factor in selecting the type of 
variables for inclusion in the analysis. The study reported in this chapter was particularly 
concerned with identifying the psychological factors associated with women’s decision 
making. In consequence, the cognitive mechanisms identified in previous research and 
theories of individual's decision behaviour received particular consideration (see 
chapter one). In addition, items can be omitted from the analysis if there are several 
measures assessing a similar construct. In this instance, preliminary univariate and 
multivariate analyses should be carried out to identify the item showing the greatest 
association with the dependent variable. Finally, if no specific model is being tested or 
there are no a priori reasons for including one variable over another, a statistical or 
stepwise discriminant function can be used to select the variables that best classify the 
pattern of responses between groups. In consequence, the analyses in this section were 
carried out in two stages:
• Chi square tests, Mann-Whitney tests and MANOVA were carried out to assess 
differences between the test decision and the following: demographic 
characteristics, reproductive history and individual differences; cognition and clinical 
outcomes; affect.
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• a stepwise discriminant function analysis was carried out to find the variables that 
best predicted group membership. A more detailed explanation for the inclusion of 
the nine variables included within this discriminant function analysis is described 
below.
Nine items were selected from the available measures for further analysis, either 
because they were found to differ significantly by test decision in the preliminary 
analysis or because there was an indication from other research and theory that they 
would be predictors of health behaviour. Items that were selected following the 
preliminary analyses of variables were: anxiety before and after consultation; informed 
decision making, reasons for an option; the expected utility values for the consequences 
of having a healthy baby, a baby with Down’s syndrome and terminating for Down’s 
syndrome; perception of the triple test risk; perceived social norm. Most of these eight 
variables selected on the basis of the preliminary analyses would also have been 
included in the discriminate function analysis for prior empirical or theoretical reasons. 
An additional variable included in the discriminant function analysis on the basis of prior 
research was the measure of knowledge. One variable, usefulness of information, was 
found to be associated with the test decision following the preliminary analyses. 
However, usefulness of information was omitted from the discriminant function analysis 
because it did not assess a process measure of decision making. In essence, 
usefulness of the information received was an outcome measure, an assessment of 
satisfaction. As there was little a priori evidence to suggest which variables would 
discriminate between the two behaviours, a stepwise discriminant function analysis was 
used to statistically select the most appropriate items from this list. No variables were 
transformed for this analysis as the discriminant function analysis is considered robust 
enough to accommodate variables with skewed distributions.
7.2 Results.
As mentioned, complete data were available for 106 women, 17 of whom decided to 
have no further testing and 89 to have either amniocentesis or chorionic villus sampling. 
The following results are presented in four sections. The first three parts summarise the 
preliminary analyses carried out to ascertain whether there were significant differences 
in scores by decision behaviour for the following variables: demographic characteristics, 
reproductive history and individual differences; affect; cognitive processes and clinical 
outcomes. The final section of the results describes the stepwise discriminant function 
analysis carried out to identify the variables that were the best predictors of the 
women’s decision to have or not have prenatal diagnosis.
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7.2.1 Demographic characteristics, reproductive history and individual 
differences.
None of the analyses carried out between test decision and any of the demographic 
characteristics, reproductive variables or measures of individual differences for 
information processing had a significance level of less than 0.05 (tables 7:1, 7:2 and 
7:3). There was a trend towards significance indicating that a higher level of education 
was attained by those choosing to have no further testing (table 7:3).
Table 7:1 demographic characteristics and individual differences by decision 
behaviour.
Total
n = 106
No Test
n = 17
Test
n = 89
MANOVA
d.f. = 1, 104
X (s.d.) x (S.d.) x (S.d.) f value sig.
age 35.2 (3.0) 34.8 (3.8) 35.3 (2.9) 0.3 0.57
gestation 14.8 (1.0) 14.7 (10) 14.8 (10) 0.04 0.83
life orientation test (LOT) 21.0 (6.5) 19.8 (7.3) 21.3 (6.3) 0.7 0.41
need for cognition (NFC) 81.7 (20.8) 84.3 (24.2) 81.4 (20.2) 0.3 0.58
Table 7:2 reproductive history and presence companion in consultation by test 
decision.
Total
n = 106
Test
n = 17
No Test
n = 89
Chi* A
d.f. = 1
nalysis
n % n % n % Chi* Sig.
have children 68 64% 10 59% 58 65% 0.3 0.61
miscarried 27 25% 3 18% 24 27% 0.7 0.41
family history abnormality 24 23% 3 18% 21 24% 0.3 0.59
companion present 78 74% 10 59% 68 76% 2.3 0.13
Table 7:3 level of education and religious activity by test decision.
Total
n = 106
No Test
n = 17
Test
n = 89
Chi* Analysis
d.f. = 2
Level n % n % n % Chi* Sig.
Education:
up to GCSE 46 44% 6 35% 40 45%
‘A ’ level equiv. 33 31% 3 18% 30 34%
degree + 27 25% 8 47% 19 21% 5.2 0.07
Religious activity:
not active 66 63% 10 59% 56 63%
occasional attendance 31 29% 5 29% 26 29%
frequent attendance 9 8% 2 12% 7 8% 0.3 0.86
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7.2.2 Affect.
Apart from the anxiety scores (see below table 7:4), all the affect measures from the 
consultation transcripts and post-decision questionnaire were entered into a MANOVA. 
There was no significant association between the test decision with the measures of 
decisional conflict or expressed emotion during the consultation (table 7:4).
Table 7:4 measures of affect by test decision.
Total
n = 106
No Test
n = 17
Test
n = 89
MAN
( V
OVA
04)
X (s.d.) X (s.d.) X (S.d.) f Sig.
anxiety before consultation 62.2 (13.6) 53.9 (13.5) 63.8 (13.1) NA NA
anxiety after consultation 60.1 (14.8) 44.1 (14.9) 63.2 (12.8) NA NA
conflict - uncertainty 8.4 (2.8) 9.1 (3.0) 8.3 (2.7) 1.3 0.26
conflict - informed 6.8 (1.7) 6.7 (1.7) 6.8 (1.7) 0.1 0.78
conflict - efficacy 7.5 (2.2) 8.0 (2.3) 7.4 (2.2) 0.9 0.35
positive emotion (SLIWC) 1.9 (0.7) 2.1 (0.7) 1.9 (0.7) 1.8 0.19
negative emotion (SLIWC) 0.9 (0.5) 0.8 (0.4) 0.9 (0.5) 0.9 0.35
Anxiety was the only measure of affect to be assessed before the consultation and at T1 
(post-decision). In consequence, a separate, repeated measures analysis was applied to 
the two anxiety scores. The repeated measures analysis enabled both a between- 
subject and within-subject comparison of the data (table 7:5).
Table 7:5 repeated measures analysis for anxiety over time by test decision.
f Sig.
effect of test decision 21.1 < 0.0001
effect of time 12.3 0.001
effect of test decision by time 9.6 0.002
Significant differences in anxiety were observed by time, test decision and an 
interaction between time and test decision (table 7:5). Univariate analyses indicated that 
those women choosing to have no further testing had significantly lower anxiety both 
before and after the consultation than those choosing to have a diagnostic test 
(respectively: t = -2.83, d.f .= 104, p = 0.006; t = -5.49, d.f .= 104, p < 0.0001). In 
addition, the anxiety of the women choosing to have no further testing was significantly 
lower after the consultation than before with no change in the anxiety of women
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choosing to have a test (respectively: t = -3.13 d.f. = 14, p = 0.007; t = -0.52, d.f. = 88, p 
= 0.60).
7.2.3 Cognitive processes and consultation quality.
The measures included in the consultation transcripts and T1 questionnaire (post­
decision) to assess cognitive measures were: informed decision making variables, 
information seeking, reasons for and reasons against; expressed cognitions or ‘thinking 
words’ as measured by SLIWC; perceived advantages and disadvantages of testing; 
expected utility values for the consequences of testing; ability to rank order the 
consequences of testing; perceived social norm; perception of triple test risk. The 
variables assessing consultation quality were: directiveness of consultation information; 
length of consultation; usefulness of information. Only about half of these were interval 
measures with normal distributions, a few interval measures had skewed distributions 
and the remainder were essentially categorical measures (see chapter six). All the 
interval measures with normal distributions were included in a single MANOVA (tables 
7:6 and 7:11), a non-parametric test applied to the interval measures with skewed 
distributions (table 7:7), and Chi square analyses to the remaining categorical variables 
(tables 7:8, 7:9, 7:10, 7:12, 7:13 and 7:14). The findings pertaining to the cognitive 
processes are discussed first, followed by a summary of clinical quality results.
Table 7:6 cognitive processes and consultation quality by test decision
Total
n = 106
No Test
n = 17
Test
n = 89
MANOVA
d.f. = 1,104
X (s.d.) x (s.d.) x (s.d.) f sig.
informed decision making - 
information seeking (IDM-I) 2.8 (1.1) 3.0 (0.9) 2.8 (1.1) 0.5 0.48
informed decision making • 
reasons for option (IDM-F) 2.3 (1.0) 2.8 (11) 2.2 (1.0) 5.8 0.02
informed decision making - 
reasons against (IDM-A) 2.1 (1.1) 2.4 (1.1) 2.1 (1.1) 1.3 0.26
cognitive mechanism 
(SLIWC) 11.3 (17) 11.6 (1.9) 11.2 (1.7) 0.5 0.47
advantages testing 1.6 (0.9) 1.8 (10) 1.6 (0.9) 0.9 0.36
disadvantages testing 1.5 (1.0) 1.9 (11) 1.4 (0.9) 3.0 0.09
knowledge 14.5 (3.0) 14.5 (4.1) 14.5 (2.8) 0.0 0.98
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A number of findings suggested that the cognitive processes underlying the decision to 
have a diagnostic test were different from those associated with choosing to have no 
further testing. The ‘test’ women generated fewer reasons for choosing an option than 
'no test’ women (table 7:6), ‘test’ women had greater perceived social norm scores than 
the 'no test' women, i.e. more likely to agree with the statement ‘people who are 
important to me think I should have a diagnostic test’ (table 7:7), ‘test’ women had lower 
expected-utility values for having a baby without Down’s syndrome and having a baby 
with Down’s syndrome (table 7:7) and a greater expected-utility value for terminating a 
baby with Down s syndrome than ‘no test' women (tables 7:7 and 7:8), and more ‘test’ 
women perceived their triple test risk figure to be a high risk than ‘no test’ women (table 
7:10). In addition, there was a trend towards significance suggesting that the ‘test’ 
women were less likely to be able to rank order the consequences associated with the 
prenatal diagnosis decision than ‘no test' women (table 7:9). However, the actual ranked 
order of each of the expected utility values remained the same for both those choosing 
to have and not have a diagnostic test: having a healthy baby; terminating for Down’s 
syndrome; miscarrying a baby with Down’s syndrome; having a baby with Down’s 
syndrome; miscarrying a healthy baby (table 7:7).
Table 7:7 expected-utility values and perception social norm by test decision.
Total
n = 106
No Test
n = 17
Test
n = 89
Mann-Whitney
NA = no analysis
x (s.d.) X (s.d.) X (s.d.) U z Sig.
EUT1 - healthy baby 39.5 (10.9) 46.1 (9.3) 38.2 (10.7) 451 -2.6 0.008
EUT2 - miscarry DS 13.0 (11.1) 8.6 (7.6) 13.8 (11.5) 558 -1.7 0.09
EUT3 - terminate DS 28.7 (21.7) 17.7 (19.9) 30.8 (21.6) NA NA NA*
EUT4 - have baby DS 3.5 (6.6) 6.5 (8.2) 2.9 (6.1) 389 -3.2 0.002
EUT5 - miscarry baby 1.2 (2.1) 1.6 (3.3) 1.1 (1.8) 719 -0.3 0.75
perception social norm 
(should have test) 1.5 (1.7) 3.7 (1.7) 1.1 (1.3) 178 -5.1 >0.001
* means only reported as a bi-modal distribution (see chapter six).
Table 7:8 expected-utility for termination Down’s syndrome by test decision.
Total
n = 106
No Test
n = 17
Test
n = 89
Chi* (d.f. = 1)
Fisher’s Exact
n % n % n % Chi * Sig.
EUT value <30 58 55% 13 76% 45 51%
EUT value >30 48 45% 4 24% 44 49% 3.9 0.04
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Table 7:9 rank ordering of expected utilities by test decision.
Total
n = 106
No Test
n = 17
Test
n = 89
Chi * (d.f. = 1)
Fisher’s Exact
n % n % n % C h i' Sig.
ranked 48 45% 11 65% 37 42% 3.1 0.07
not ranked 58 55% 6 35% 52 58%
Table 7:10 perception triple test risk by test decision.
Total
n = 106
No Test
n=  17
Test
n = 89
Mann-Whitney
n % n % n % U z Sig.
low 13 12% 4 24% 9 10%
medium 43 43% 12 70% 31 35%
high 50 50% 1 6% 49 55% 376.5 -3.6 0.003
With regard to the quality of consultation measures, the women choosing to have no 
further testing perceived the information to be useful but not as useful as those deciding 
to have a diagnostic test (table 7:11). There was a trend towards significance to suggest 
that the ‘no test’ women had longer consultations than ‘test’ women (table 7:11). A small 
percentage of the women (8%) found the information or advice provided by the 
researcher, other health professionals and their friends and family to be directive (tables 
7:11, 7:12 and 7:13). This perceived directiveness did not differ significantly by test 
decision.
Table 7:11 clinical quality by test decision.
Total
n = 106
No Test
n = 17
Test
n = 89
MANOVA
d.f. = 1,104
length consultation 29.0 (12.2) 34.2 (11.9) 28.1 (12.1) 3.8 0.06
usefulness information 5.2 (1.1) 4.7 (1.7) 5.3 (0.9) 4.6 0.04
Table 7:12 directiveness of study health professional information by test 
decision.
Total
n = 106
No Test
n = 17
Test
n = 89
C h i1 
d. f .  (2)
n % n % n % C h i1 Sig.
not discussed 10 9% 1 6% 9 10%
neutral 88 83% 13 76% 75 84%
directive 8 8% 3 18% 5 6% 3.1 0.21
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Table 7:13 directiveness of other health professionals’ information by test 
decision.
Total
n = 106
No Test
n = 17
Test
n = 89
C h i2
d.f. (2)
n % n % n % Chi 2 Sig.
not discussed 54 51% 11 64% 43 48%
neutral 43 41% 4 24% 39 44%
encouraged 9 8% 2 12% 7 8% 2.5 0.29
7.2.4 Predicting test behaviour from cognitive processes and affect.
A stepwise discriminant function analysis was carried out to establish which cognitive 
processes and affect best predicted testing behaviour. As mentioned in section 7.1.2, 
variables were selected for entry in the analysis because they were either important 
components of theories explaining behaviour and/or had been found to differ 
significantly by test decision during the preceding preliminary analyses. The following 
nine variables were entered into the stepwise discriminant function command: the 
expected utility values for the consequences of having a healthy baby, a baby with 
Down's syndrome, and terminating for Down’s syndrome; perception of the triple test 
risk; perceived social norm; the informed decision making reasons for an alternative 
sub-category; knowledge of testing; anxiety before and after the consultation. The 
pattern of responses for four variables were selected by the stepwise discriminant 
function analysis for inclusion in the final equation as predictors of testing behaviour: 
perceived social norm; the expected utility value for the consequence of having a 
healthy baby; the expected utility value for the consequence of having a baby with 
Down’s syndrome; post-consultation anxiety (table 7:14).
Table 7:14 discriminant function analysis for test decision.
Between-group 
Corr. with Fctn.
Univariate 
F (1,104)
Wilks
lamda
Sig.
post-consultation anxiety -0.52 13.6 0.55 <0.001
perceived social norm: should have test 
expected utility value: healthy baby 
expected utility value: Down’s baby
0.70
0.27
0.20
48.6
8.0
5.5
0.71
0.52
0.51
<0.001
<0.001
<0.001
Canonical R (R2) 0.72 (52%)
Eigenvalue 1.07
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The discriminant function accounted for 52% of the variance in testing behaviour (X2 = 
74.4, d.f. = 4, p < 0.00001). The function correctly classified 94.3% of cases; 94.1% of 
women in the no test decision group and 94.4% in the test decision group. The Bartlett 
box M test for homogeneity of variance was not significant (Box’s M = 19.4, d.f .= 10, 
3583.1, p = 0.06) suggesting there was little threat to the interpretation of the 
multivariate analysis.
Bi-variate analyses showed no significant relationship between the cognitive processes 
found to predict test behaviour, i.e. the EUVs and perceived social norms (table 7:15). 
However, affect was significantly associated with both perceived social norm and the 
expected-utility value for the consequence of having a healthy baby (table 7:15). That is 
to say, women who had greater anxiety scores at T1 were more likely to perceive others 
as encouraging them to have a test and less likely to perceive themselves as having a 
healthy baby.
Table 7:15 correlation matrix between predictors of testing behaviour.
Anxiety Social Norm EUT 1
r Sig. r Sig. r Sig.
perceived social norm -0.27 0.006
expected utility for healthy baby (EUT1) -0.30 0.002 -0.05 0.60
expected utility for Down’s baby (EUT4) 0.03 0.71 0.08 0.40 0.01 0.93
Figure 7:1 perceived social norm by test decision.
0  ^ 5
s h o u l d  have d i a g n o s t i c  tes t  ( shou Id
I i l l  no test  
I I test
To provide a clearer understanding of the pattern of responses by group, bar charts of 
the responses to the perception of norm item (figure 7:1) and the two perception of risk 
components for the expected-utility values (figures 7:2 and 7:3) were constructed. The
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pattern of responses suggests the following interpretation (tables 7:3 and 7:4; figures 
7:1 - 7:3): the ‘test' women had higher anxiety at T1 than the ‘no test’ women; the 'test' 
women perceived their likelihood of having a healthy child as slightly lower than the 'no 
test’ women; the 'test' women perceived their likelihood of having a child with Down's 
syndrome as slightly higher than the ‘no test' women; the ‘test’ women were more likely 
to perceive others as having expectations about them having prenatal diagnosis, 
whereas the 'no test’ perceived others as having a more neutral attitude towards them 
having a diagnostic test.
Figure 7:2 perceived likelihood of healthy baby by test decision.
1 0 .
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Figure 7:3 perceived likelihood of baby having Down’s syndrome by test 
decision.
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7.3 Discussion.
The purpose of these additional analyses was to describe the psychological 
mechanisms associated with women's decisions to have or not have prenatal diagnostic 
tests. To identify these mechanisms, a stepwise discriminant function was applied to the 
data. However, preliminary analyses were carried out on the following variables to 
select measures for inclusion in the discriminant function analysis: demographic 
characteristics, reproductive history and individual differences; affect; clinical quality 
and cognitive measures. The findings from these preliminary analyses are summarised 
briefly below:
• No significant differences by test decision were observed for the demographic 
characteristics, reproductive history or individual difference measures (tables 7:1, 
7:2 and 7:3);
• The preliminary analyses assessed differences for three measures of affect by test 
decision: affect expressed during the consultation (SLIWC); decisional conflict 
measured after the decision was made (T1); anxiety measured before and after the 
decision making consultation (STAI - consent form and T1). Significant differences 
were observed for measures of anxiety only, both before and after the information 
giving consultation (tables 7:4 and 7:5). The women choosing to have no further 
testing had lower anxiety before and after the consultation than the women deciding 
to have a diagnostic test. Further, the anxiety of the 'no test’ women was 
significantly lower after the consultation, whereas that of the ‘test’ women remained 
consistently high;
• The women deciding to have a diagnostic test had shorter consultations and 
perceived the information to be more useful than the ‘no test’ women (tables 7:11). 
Perceived directiveness of consultation information was not associated with test 
decision (tables 7:12 and 7:13);
• There were several measures assessing cognitive mechanisms: informed decision 
making assessed during the consultation; expressed cognitive or ‘thinking’ words 
during the consultation (SLIWC); knowledge; perceived advantages and 
disadvantages of testing; perception of risk; expected-utility values associated with 
the consequences of testing; ability to rank order the EUVs. The preliminary 
analyses suggested a number of significant differences in these measures by test 
decision (tables 7:6 - 7:10). The 'no test’ women provided more reasons for 
choosing an alternative, were more likely to be able to rank order the EUVs, more 
likely to view their triple test risk as a medium risk, less likely to perceive others as 
having an expectation towards them having diagnostic test, more likely to perceive
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that they would have a healthy baby, less likely to perceive that they would have a 
child with Down's syndrome and less likely to perceive that they would terminate for 
Down's syndrome than the 'test' women. No significant differences by test decision 
were observed for measures of knowledge.
Following these preliminary analyses, nine variables were selected for inclusion in the 
stepwise discriminant function analysis. From these variables, the discriminant function 
analysis selected four items for inclusion in the final equation predicting the women’s 
testing behaviour, three assessing cognitive mechanisms and one measure assessing 
affect. The pattern of responses elicited from the following items contributed to the one 
function accounting for 52% of the variance in women’s prenatal diagnostic testing 
behaviour: perception of others’ attitude to testing; expected-utility of having a healthy 
baby; expected-utility of having a baby with Down's syndrome; post-consultation 
anxiety.
As previously discussed, the main advantages of this study were (a) the assessment of 
both the decision to have and the decision to not have prenatal diagnosis, (b) the 
inclusion of measures to assess cognitive mechanisms concurrently with and 
retrospectively to the making of the prenatal diagnosis decision, and (c) the use of 
decision making theories to inform the development of measures. In addition, the 
women participating in this study were making the prenatal diagnosis decision following 
receipt of a screen positive triple test result, i.e. the same reason for being offered 
prenatal diagnosis. The methodological rigour of this study is an important consideration 
when interpreting the findings. For example, although this study found no association 
between the test decision and demographic characteristics, reproductive history and 
individual differences, prior empirical research has observed such associations (Sjorgen 
and Uddenberg, 1988; Evans, Pryde, Evans and Johnson, 1993; Julian-Reynier, 
Macquart-Moulin, Moatti, Aurran, Chabal and Ayme, 1994; Halliday, Lumley and 
Watson, 1995). In addition, the discriminant function analysis applied to this data set 
accounted for about twice as much of the variance in women’s behaviour as that of 
previous studies (Marteau, Johnston, Kidd, Michie and Cook, 1992). It is likely that 
methodological limitations, such as assessing the factors associated with only one of 
the decision alternatives and/or the reasons for being offered prenatal testing, 
contributed to discrepancies in the findings between prior research and the results of 
this chapter. However, the following section of this discussion focuses on describing the 
similarities between the findings of this study with those previously reported from 
empirical investigations of women’s prenatal testing behaviour.
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Most empirical research in this health context has reported the high levels of anxiety 
experienced by women when undergoing prenatal diagnosis (Beeson and Golbus, 1979; 
Verjaal, Leschot and Treffers, 1982; Burton, Dillard and Clark 1985; Marteau, Kidd, 
Cook, Michie, Johnston, Slack and Shaw, 1992; Green, Stratham and Snowdon, 1992; 
Evans, Pryde, Evans and Johnson, 1993). In addition, anxiety has been previously 
identified as a factor in predicting prenatal screening test behaviour: women refusing 
serum screening had lower anxiety levels than those accepting screening (Marteau, 
Johnston, Kidd, Michie and Cook, 1992). Anxiety has been identified as one of four 
predictor variables discriminating women's decision to have or not have prenatal 
diagnosis in this chapter’s study (section 7.2.4). In particular, the discriminant function 
analysis identified post-decision anxiety (T1) as the only measure of affect to predict 
group membership for this data set (table 7:14). Further, the ‘no test’ women did have 
lower anxiety than those deciding to have a diagnostic test (table 7:4). However, the ‘no 
test’ women also had lower anxiety than the ‘test’ women before the information giving 
consultation. A number of explanations to account for these findings in anxiety are 
described in more detail below.
First, it is likely that anxiety assesses affect associated with the procedure rather than 
the difficulty in making the prenatal diagnosis decision (Marteau, Kidd, Cook, Michie, 
Johnstone, Slack and Shaw, 1992). This explanation is supported by (a) the finding that 
it was the post-decision measure of anxiety that distinguished the two test behaviours, 
i.e. after the decision was reached and before the test procedure was carried out, and 
(b) the finding that no measures of decisional affect differed significantly by test 
decision, i.e. both those choosing to have or not have the test found the decision 
making equally difficult (table 7:4). In other words, the 'no test’ women’s anxiety 
decreased after the receipt of a screen positive triple test result and information giving 
consultation because they were not going to have an invasive procedure. The ‘test’ 
women were as anxious after the information giving consultation as upon receipt of their 
screen positive triple test result because they were going to have an invasive 
procedure.
Second, there is some evidence to suggest that women may come to the information 
giving consultation with an idea of whether or not they want to have further testing 
(Verjaal, Leschot and Treffers, 1982; Sjorgen Uddenberg, 1988). Indeed, the findings 
reported in chapters five and six suggest that about a third of women discussed the 
prenatal diagnosis decision before the consultation. If anxiety is associated with the
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diagnostic test procedure, then it is likely that the 'no test' women would have lower 
anxiety before the information giving consultation than the 'test' women. However, as 
the assessments of affect and cognitive mechanisms are cross-sectional, there is at 
least one more explanation for these findings.
The third explanation suggests that there is a relationship between affect, decision 
making processes and decision behaviour (Bell, 1982; Loomes and Sugden, 1982; 
Tymstra, 1989; Van der Pligt, 1998). The 'no test’ women had a high level of anxiety but 
lower than that of the ‘test’ women (table 7:4). The relationship between anxiety and 
decision making is indirect, with anxiety being associated with differences in information 
processing; raised levels of anxiety result in a more systematic or vigilant evaluation of 
the information but high levels result in a more heuristic, less exhaustive appraisal of 
the information (Janis and Mann, 1977). It is feasible to suggest that anxiety was 
indirectly associated with the final decision through differences in the underlying 
cognitive processes. Certainly, the correlations earned out following the discriminant 
function analysis indicated an association between anxiety and measures of cognitive 
mechanisms (table 7:15). In addition, the findings from the preliminary analyses suggest 
that the 'no test' women tended to make more rational (table 7:9) and informed 
decisions (table 7:6) than the test’ women; more ‘no test' women were able to rank 
order the consequences of prenatal testing and provide reasons for alternatives than the 
‘test’ women. It is likely that, in part, all the explanations provided for differences in 
anxiety by test decision are correct. However, the cross-sectional design of this study 
does not lend itself to a more comprehensive exploration of the nature of these 
relationships In other words, it is beyond the scope of this thesis to provide a more 
detailed explanation of the association between anxiety and women’s prenatal testing 
behaviour.
The remaining predictor variables selected by the discriminant function analysis were 
items assessing cognitive mechanisms: perceived social norm; EUV associated with 
having a healthy baby; EUV associated with having a baby with Down's syndrome (table 
7:14). In previous empirical research, perceived importance of others’ attitudes to 
serum screening has been associated with the women's test decisions (Sikkink, 1990). 
In this study, the 'no test' women had higher perceived social norm scores than the ‘test’ 
women. That is to say, the ‘test’ women were more inclined to agree with the statement 
‘those who are important to me think I should have prenatal diagnosis’ (figure 7:1). 
There is some debate as to what the concept of perceived social norm is assessing (see 
Trafimow, 1998). Recurrent in a number of theories is the idea that the individual’s
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perception of others’ attitudes to the behaviour and their evaluation of their own beliefs 
about the consequences of an action are conceptually distinct, with both concepts being 
independent predictors of the behaviour. The counter-argument suggests that perceived 
social norms and evaluations of individual beliefs are measures of the same underlying 
construct, both being measures of attitude. Although it was beyond the remit of this 
study design to adequately address this issue, the correlation matrix carried out after the 
discriminant function analysis suggests that perceived social norm was independent of 
the other cognitive mechanisms and, therefore, an independent predictor variable (table 
7:16). More detailed explanations for the findings pertaining to the cognitive predictor 
variables following the discriminant function analysis are described below.
Previous empirical research provides at least one explanation for why women choosing 
to have a diagnostic test perceive others’ attitudes to testing differently from those 
women deciding to have no further testing. It has been argued that women find it 
difficult to refuse a medical technology, such as prenatal diagnosis, when it is offered to 
them (Tymstra, 1989; Clark, 1990; Marteau, Johnston, Kidd, Michie and Cook, 1992; 
Gregg, 1993 Lippman, 1994). To explain further, it is feasible to suggest that health 
professionals are the 'experts’ in the context of health care. Therefore, if a health 
professional offers prenatal diagnosis then this technology is endorsed by the act of 
offering it. In other words, having a prenatal test is perceived as the normative 
behaviour. There is some evidence to suggest that health professionals do perceive the 
‘correct’ decision to be that of having a diagnostic test (Farrant, 1985; Marteau, 
Johnston, Kidd, Michie and Cook, 1992; Marteau, Plenicar and Kidd, 1993; findings in 
chapter four). There is also evidence to suggest that women are aware of this health 
professionals’ attitude (Sjorgren and Uddenberg, 1988). In consequence, choosing to 
have no further testing requires a more proactive refusal or ‘opting out’ by the woman. 
The findings from this chapter’s analyses support this idea of women pro-actively 
refusing prenatal diagnosis rather then choosing the no test alternative. The analysis of 
the transcripts described in this chapter found that the ‘no test’ women generated more 
reasons not to have testing than the ‘test’ women did to have a test.
The two final predictive variables identified by the discriminant function analysis were 
the EUVs associated with the consequences of having a healthy baby and having a 
baby with Down's syndrome (table 7:14). The EUVs associated with both having a baby 
with Down's syndrome or having a healthy baby were higher in the ‘no test’ women than 
those of the ‘test’ women (table 7:7). To provide a clearer understanding of these 
findings, the perception of risk component of these EUVs was looked at independently.
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The pattern of responses described in figures 7:2 and 7:3 suggested that the ‘no test’ 
women perceived their risk of having a healthy child as higher and their risk of having a 
baby with Down's syndrome as lower than the ‘test’ women both the ‘test’ and ‘no test’ 
women. These results support prior empirical evidence describing differences in 
women’s perception of risk by test decision (Volodkevich and Huether, 1981; Verjaal, 
Leschot and Treffers, 1982; French, Kurczynski, Weaver and Pituch, 1992; Marteau, 
Johnston, Kidd, Michie and Cook, 1992; Julian-Reynier, Macquart-Moulin, Moatti, 
Aurran, Chabal and Ayme, 1994). It is likely that on evaluating the decision information, 
the ‘test’ women minimised their likelihood of having a healthy baby and augmented the 
risk of having a baby with Down's syndrome (Croyle, Sun and Mart, 1997), i.e. 
augmenting the Down's syndrome risk and decreasing their likelihood of having a 
healthy baby. This interpretation is further supported by the finding that the ‘test’ women 
were more likely to rate their triple test risk as high, whereas the ‘not test’ women were 
more likely to perceive their risk as medium (table 7:10). These findings are consistent 
with the previous assertion that women choosing to have no further testing were making 
more informed decisions about the test decision. The ‘no test’ women were more likely 
to generate reasons for an alternative, rank order the EUVs associated with the 
consequences of testing and had a more ‘accurate’ perception of their triple test risk 
than ‘test’ women.
Finally, this chapter’s results provide some empirical support for the explanation 
provided in chapter six to understand the lack of association between the decision 
analysis intervention and women's prenatal diagnosis decisions. As mentioned in 
chapter six, decision analysis is predominantly an information manipulation intervention. 
The aim of applying the decision analytic technique to a real-world decision is to 
encourage a more balanced appraisal of the decision information, a more accurate 
perception of the information and the opportunity to integrate this information with 
existing attitudes and beliefs. In the long-term, an information giving consultation 
structured by decision analysis may lead to a more accurate or complete representation 
of the decision information. The empirical findings described in this chapter suggest that 
the main predictors of women’s testing behaviour identified by the discriminant function 
analysis were EUVs, i.e. a combination of attitudes and evaluations of risk. It is likely 
that the systematic evaluation of decision information may lead to the development of 
stable attitudes that are, in the long-term, associated with decision behaviour (see Eagly 
and Chaiken, 1993; Olson and Zanna, 1993; Stroebe and Stroebe, 1995). In other 
words, it is possible that decision analysis may be indirectly associated with decision 
behaviour through mechanisms associated with attitude change and development.
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However, it is beyond the remit of this thesis to explore this ascertain and it remains, 
therefore, an empirical question.
7.4 Chapter summary.
In summary, the findings from this study support those of previous empirical research 
that suggest that perceptions of risk and attitudes were predictive of women's prenatal 
diagnosis decisions. More specifically, the discriminant function analysis applied to this 
data set identified four predictor variables of women's behaviour: post-decision anxiety 
(T2); perceived social norm; EUV associated with the consequence of having a healthy 
baby; EUV associated with having a baby with Down's syndrome. In general, the 
empirical evidence suggests that women choosing to have no further testing were 
making more informed decision about prenatal diagnosis than women choosing to have 
a diagnostic test. There was no association between demographic characteristics, 
reproductive history, individual difference measures, decisional affect and knowledge, 
and women's decision to have or not have prenatal diagnosis.
207
8. Discussion.
The focus of this thesis has been on understanding women’s decision making in the 
context of prenatal diagnosis for Down's syndrome. One of the main objectives for 
those offering prenatal diagnosis is to ensure women make informed choices about 
testing (Royal College of Physicians, 1989). Over the last twenty years, empirical 
research has described women’s prenatal diagnostic test experiences and the factors 
associated with the decision to have or not have testing (see chapter one). Few, if any, 
studies have defined and operationalised informed decision making (Marteau, 1995b; 
Bekker et al, 1999). Further, most studies in this health context have employed pro- or 
retrospective designs to address their research questions (section 1.3.2.2). Assessing 
informed decision making requires an evaluation of the decision making process, i.e. 
the information utilised when making the decision (section 1.1.5). In this health context, 
the most appropriate method to access the process of decision making is to use an 
information tracing technique (chapter five). In other words, studies assessing informed 
decision making should employ an observational design.
As mentioned, the previous empirical research has focused on describing the factors 
associated with women’s prenatal testing behaviour (section 1.3.2.1). The findings 
suggest that women make decisions by weighing up the advantages and disadvantages 
of the testing alternatives. In particular, it has been observed that women's attitudes 
towards and risk perceptions of the testing consequences are associated with the 
decision to have or not have prenatal diagnosis. In addition, there was evidence that the 
final decision about testing was influenced by characteristics of the health professional 
(Verjaal and Treffers, 1982; Sjorgren and Uddenberg, 1988; Julian-Reynier, Macquart- 
Moulin, Moatti, Aurran, Chabal and Ayme, 1994). This finding and those describing 
women’s varied and often incomplete knowledge of testing (Volodkevich and Huether, 
1981; Farrant, 1985; French, Kurczynski, Weaver and Pituch, 1992) have been used to 
support the assertion that not all women were making fully informed decisions about 
prenatal diagnosis. To explain further, as women's knowledge of testing was poor and 
health professionals’ characteristics were associated with the prenatal diagnostic choice, 
it was unlikely women had sufficient information to make an informed choice and likely 
that their autonomy to reach a decision was compromised. However, there were a 
number of methodological concerns that may restrict the interpretation of these 
previous findings (section 1.3.2.2): few studies assessed the decision making process; 
most studies employed a retrospective design, i.e. after women have made the prenatal
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diagnosis decision; some study samples included women who had either had or not had 
the test, i.e. factors associated with the choice of one test alternative only; the study 
sample included women offered prenatal diagnosis for a number of different reasons 
such as increased maternal age, genetic predisposition, MSAFP screening or triple test 
screening, i.e. a heterogeneous sample. In essence, these studies may not have 
adequately defined the decision context, the responses of women are likely to be 
affected by issues of recall bias and the psychological processes described may not be 
representative of women choosing to have and not have prenatal diagnosis.
The empirical studies described in this thesis were designed to address some of the 
methodological limitations of prior research that assessed women’s prenatal diagnosis 
decision making upon receipt of a screen positive triple test result. The research 
questions clustered around two main themes (chapter three), describing the conditions 
and criteria associated with women’s informed decision making about prenatal diagnosis 
and understanding the psychological mechanisms associated with women’s risky 
decision making. Both observational and questionnaire based designs were employed 
to assess decision making factors concurrently with and retrospectively to the women’s 
testing choice. The empirical research was summarised in four chapters of this thesis 
(chapters four to seven). Within the following sections of this chapter, the findings from 
these studies are discussed with reference to the research questions outlined in chapter 
three. First, the conditions enabling women to make informed prenatal diagnosis 
decisions and the criteria of informed decision making are explored (originally 
mentioned in chapters four and five). Second, the effectiveness of decision analysis to 
facilitate informed decision making is assessed (chapter six). Third, the effectiveness of 
decision analysis to facilitate better decision making is discussed with reference to 
measures of behaviour, affect, cognitive mechanisms and clinical quality (chapter six). 
Fourth, the psychological strategies and factors associated with women’s decision 
making are described (chapters five and seven). The final section of this thesis 
summarises the limitations of the analyses carried out in chapters four to seven, the 
directions for subsequent empirical work and the clinical application of these findings to 
the prenatal testing context.
8.1 Describing informed decision making: provision and utilisation.
The conditions to enable women to make informed prenatal decisions have been well 
documented in a number of clinical guidelines and texts (Emery, 1984; Royal College of 
Physicians, 1989; Royal College of Obstetricians and Gynaecologists, 1993; Clarke, 
1994). In essence, it is the responsibility of the health professional to provide women
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with sufficient information to be able to make the decision; this information should be 
neutrally communicated to encourage women’s assimilation of the information without 
undue pressure from the health professional (section 1.2). As discussed in chapter one, 
there was no one definitive set of guidelines describing the information considered 
sufficient for women making the prenatal diagnosis decision upon receipt of a screen 
positive triple test result (section 1.3.1). In consequence, guidelines for both serum 
screening and prenatal and genetic testing were referred to when outlining the 
information considered sufficient for women’s decision making in this health context. In 
brief, the consultation content should include (sections 1.3.1 and 4.1.3.2): a description 
of the abnormality being tested for; an explanation of the triple test result; an 
explanation of the consequences associated with having no further testing; an 
explanation of the consequences associated with having a diagnostic test; an 
exploration of the decision to terminate or not for Down's syndrome. This information 
should be imparted non-directively, i.e. without the health professional explicitly stating 
or subtly implying a desirable course of action. Few, if any, prior empirical studies had 
assessed whether or not the information provided during the prenatal diagnosis decision 
following a screen positive triple test result was sufficient and neutrally communicated.
A structured, observational design was employed to ascertain whether or not the 
conditions enabling women's informed decision had been met in the study described in 
chapter four. Twenty-two1 routine information giving consultations between the health 
professional and woman receiving a screen positive triple test result were audio tape- 
recorded. The audio tape-recordings were transcribed by a third party at a later date. To 
assess whether or not sufficient information had been provided, the health 
professional’s utterances of the transcribed consultations were coded. A checklist was 
developed to classify the health professional’s utterances (section 4.1.3.2). The 
checklist was informed by the literature on the criteria for sufficient and neutrally 
communicated information. Each of the 22 health professional’s transcripts was coded 
with reference to this checklist.
In brief, the findings were as follows. The information communicated during each 
consultation was fairly consistent. That is to say, the health professional provided
1 Data from 128 prenatal diagnosis information giving consultations were used within this thesis. 
The study in chapter four audio tape-recorded 22 consultations between the health professional 
and women receiving a screen positive triple test result; the health professional’s utterances were 
analysed. For the RCT reported in chapter six, 106 consultations were audio tape-recorded. 
Chapter five included the analyses of women’s utterances; 22 from the chapter four study and 22 
from the RCT. Chapters six and seven analysed the data from the 106 women who participated 
in the RCT.
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different women with similar information. Most women received information about the 
triple test result, the risks and benefits associated with the diagnostic test alternatives, 
the option to have no further testing and miscarriage. However, as in associated 
research (Marteau et al, 1993; Bernhardt et al, 1998), this study observed that 
termination and Down's syndrome were not discussed with all women (table 4:1). in 
addition, the health professional provided some misinformation in most of the 
consultations (table 4:1). In other words, not all women received sufficient or accurate 
information to enable an informed choice between having and not having prenatal 
diagnosis. Further, there was evidence that some of the information provided was not 
neutrally communicated. It was suggested that this information may imply a correct or 
normative choice regarding the test decision. To explain further, from these directive 
statements it might be inferred that a woman having the triple test should have a 
diagnostic test upon receipt of a screen positive result which should be followed by a 
decision to terminate for Down's syndrome if it too was positive. In consequence, it is 
likely that for some women the autonomy to choose between having and not having a 
diagnostic test was compromised.
As mentioned, one of the main objectives of offering prenatal diagnosis is to ensure 
women make informed decisions to have or not have a diagnostic test. Within the 
applied medical literature, few, if any, studies have defined the criteria associated with 
an informed decision (Marteau 1995b; Bekker et al, 1999). In an attempt to address this 
dearth of research operationalising informed decision making, criteria for an informed 
decision were developed with reference to both reason-based models of decision 
making and medical guidelines for making informed decisions (section 1.2.2). 
Proponents of reason-based models of decision making are concerned with evaluating 
the quality of the process of reaching a decision rather than assessing the decision 
outcome (Zey, 1992; 1998). Two previously defined sets of criteria for making an ‘ideal’ 
decision were referred to when operationalising informed decision making for this 
thesis: Janis and Mann’s (1977) seven stage approach to ensuring ‘vigilant’ decision 
making; Frisch and Clemen’s (1994) three point standard forming the basis of making a 
‘good’ decision (section 1.2.2 and chapter five). In essence, an informed decision 
requires an evaluation of the consequences of the different options, an accurate 
assessment of the consequences and evidence that the decision was made following a 
'trade-off between the consequences of the decision alternatives.
An observational study design was employed to assess whether or not women were 
making an informed decision to have or not have prenatal diagnosis (chapter five).
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Forty-four routine information giving consultations between the health professional and 
woman receiving a screen positive triple test result were audio tape-recorded. The 
audio tape-recordings were transcribed by a third party at a later date. To assess 
whether or not women were making informed decisions, the information utilised by 
women during the information giving consultation was coded, i.e. an information tracing 
technique was employed. In consequence, all utterances made by women during the 
consultation were transcribed and classified. A coding frame was developed to 
categorise women's utterances (section 5.1.4). The coding frame was informed by 
theories of individual's decision making, findings from prior empirical research 
assessing women’s prenatal diagnosis decision making and categories developed 
specifically to classify information generated during this health context. From the 
classification of information utilised by women during the information giving 
consultation, four measures of informed decision making were created (section 5.1.5): a 
global measure of informed decision making based on the utilisation of information 
about the two alternatives and three 'negative’ consequences associated with prenatal 
diagnosis (IDM-T); a variable coding information-seeking utterances about the 
consequences of testing utterances (IDM-I); a variable coding the generation of reasons 
for selecting a decision alternative (IDM-F); a variable coding the generation of reasons 
against selecting a decision alternative (IDM-A).
In brief, the findings suggested that few women utilised all the information considered 
necessary to make an informed decision. Only 5% (2/44) of women utilised information 
pertaining to all five themes included within of the IDM-T measure; most women (63%) 
utilised information from just two or three of the themes (table 5:3). The pattern of 
results suggested that women were using the consultation to search for further 
information about the decision alternatives and to make trade-offs between the 
consequences (table 5:4). However, the findings indicated that not all the information 
considered necessary to make an informed decision was surveyed, evaluated and 
utilised during the consultation. In particular, a significant minority of women did not 
refer to the ‘no test’ alternative, miscarriage or the condition of Down's syndrome.
These findings lend support to the assertion from previous questionnaire-based studies 
that women were not making informed prenatal diagnosis decisions. Certainly, there 
was evidence to suggest that the conditions required to enable informed decision 
making were not met during every information giving consultation; not all women 
received sufficient information to enable informed decision making and aspects of the 
information provided were directively communicated. In addition, the process tracing
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technique illustrated that not all women utilised the information considered sufficient to 
ensure the final decision was based on an evaluation of all the consequences of the 
decision alternatives. In consequence, it is feasible to suggest that the objective of 
ensuring women make informed decisions about prenatal diagnosis is not being fulfilled.
8.2 Facilitating informed decision making.
The evidence reported in both this thesis and previous empirical research indicated that 
some women were not making fully informed decisions about testing. In research 
published to date, few studies have adequately operationalised informed decision 
making. In consequence, whether or not informed decision making can be facilitated 
has remained an empirical question (O'Connor, Llewellyn-Thomas and Drake, 1995; 
Bekker et al, 1999). Decision analysis is a decision aid based on EUT that targets both 
the provision of information and the assimilation of information by the decision maker. 
Although decision analysis has been applied in the context of prenatal diagnosis 
decision making (Pauker and Pauker, 1977; 1978; 1987), there is little evidence to 
suggest that a decision structured by decision analysis leads to a better or more 
informed decision than one made unaided (O’Connor, Llewellyn-Thomas and Drake, 
1995; Bekker et al, 1999).
A randomised control trial was carried out to assess the effectiveness of decision 
analysis to facilitate women's decision making. All women receiving a screen positive 
triple test result over a fifteen month period were considered for inclusion in the study 
(section 6.1). Upon opening a previously numbered, sealed, opaque envelope, women 
agreeing to participate in the study were randomised to one of two information giving 
consultations: an information giving consultation providing routine care for the LGI; an 
information consultation structured by decision analysis. In total, 106 women were 
randomised to either the routine consultation (n = 56) or the decision analysis 
consultation (n = 50). All women completed a consent form before the information 
giving consultation, the consultations were audio tape-recorded and transcribed by a 
third party at a later date and all women completed a post-decision questionnaire (T1) 
upon making their prenatal diagnosis decision. Women were sent a follow-up 
questionnaire (T2) if they received a negative diagnostic test result, a ‘normal’ scan 
result and did not miscarry within four weeks of the information giving consultation. In 
total, 100 women were sent a were sent a follow-up questionnaire (T2) and 68 were 
returned. Informed decision making was assessed by applying the coding frame 
developed in chapter five to the transcripts of women’s utterances recorded during the 
information giving consultation. Three of the informed decision making variables
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created from the categorisation of women’s utterances were used in between group 
differences: IDM-I, information seeking; IDM-F, generation of reasons for alternatives; 
IDM-A, generation of reasons against alternatives.
The findings from the RCT suggest that women randomised to the information giving 
consultation structured by decision analysis did make more informed decisions than 
those receiving the routine information (section 6.2.3.2). To explain further, the process 
tracing technique and subsequent coding frame enabled the classification of information 
utilised by women when making the prenatal diagnosis decisions. The informed decision 
making measures were summaries of the frequencies of women’s utterances 
categorised by the coding frame. The results of the MANCOVA (table 6:3) indicated that 
women in the decision analysis group were more likely to search for both reasons for (f 
= 5.24; d.f. = 1, 103; p = 0.02) and against (f = 5.33; d.f. = 1, 103; p = 0.02) the 
decision alternatives than women in the routine consultation. There was no difference 
by information giving consultation for the information searched during the decision 
making period (f = 0.08; d.f. = 1, 103; p = 0.78). In other words, women in both 
consultations were as likely to ask for additional information about the decision 
alternatives and consequences. In retrospect, this finding is not surprising as the two 
consultations were designed to provide the same information content. However, the 
utilisation of information when reasoning about the decision alternatives and 
consequences did differ by group allocation. That is to say, decision analysis was 
associated with a more reasoned or informed decision than women in the routine 
consultation. From the frequencies described in table 6:1, it is feasible to suggest that 
the decision analysis consultation provided women with more opportunity to discuss the 
consequences of miscarriage and termination than was available during the routine 
information giving consultations. In summary, these findings suggest that the decision 
analysis technique does enable women to make a more informed prenatal diagnosis 
decision.
8.3 Evaluating decision analysis.
Few studies have evaluated the quality of decisions made following the application of 
decision analysis compared with those made unaided (O'Connor et al, 1995; Bekker et 
al, 1999). In consequence, there is little evidence to indicate whether or not the decision 
analysis technique does facilitate decision making (section 1.2.1.3 and chapter six). 
Proponents of decision analysis suggest that the application of decision analysis to real- 
world decisions will influence the following aspects of decision quality (chapter six): 
facilitate rational decision making; encourage more accurate evaluations of the decision
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information; reduce the amount of affect associated with making the decision; enable 
the individual to make decisions independent of the other’s advice. However, critics 
suggest that decision analysis will have a detrimental affect on the quality of real-world 
decision making including: an increase in negative affect as the individual is confronted 
with unusual and difficult hypothetical questions to elicit utilities; greater decisional 
conflict as the individual is encouraged to make rational decisions rather than employ 
more ’natural' information processing strategies; a reduction in the ‘personal’ or ‘human’ 
aspect of the consultation; a needless increase in consultation time; a decrease in the 
individual’s autonomy to make the decision.
There are numerous measures to evaluate the quality of decisions which can be broadly 
divided into those that assess behaviour, affect, cognitive mechanisms and clinical 
quality (Llewellyn-Thomas, 1995). In addition to measures of informed decision making, 
the randomised control trial described in the previous section incorporated measures to 
assess each of these aspects of decision quality (section 6.1.2). The findings from the 
RCT are summarised in brief below (see section 6.2 for a more in-depth account):
• behaviour - no difference was observed for the decision to have or not have 
prenatal diagnosis by group allocation. Eighteen per cent (10/56) of women in the 
routine group and fourteen per cent (7/50) of women in the decision analysis group 
had no further testing (table 6:8).
• affect - during the consultation women in the decision analysis group expressed 
fewer positive emotion words (f = 4.7; d.f. = 1, 102; p = 0.03) but tended to express 
more negative emotion words (f = 2.8; d.f. = 1, 102; p = 0.09) than women in the 
routine consultation group (table 6:5). A repeated measures analysis of decisional 
conflict indicated that women in the decision analysis group had decreased 
decisional conflict scores at follow-up, whereas women in the routine group had 
increased decisional conflict scores (tables 6:29 and 6:30). There was no difference 
in measures of anxiety by group allocation (tables 6;29 and 6:30).
• cognitive mechanisms - as mentioned in section 8.2, women in the decision 
analysis group made more informed prenatal diagnosis decisions. In addition, 
women in the decision analysis group referred to more ‘cognitive’ words during the 
consultation than women in the routine group (table 6:5). A repeated measures 
analysis found there to be little difference in knowledge scores by group allocation 
(tables 6:29 and 6:30). However, those in the routine group were likely to generate 
more advantages to prenatal testing than those in the decision analysis group. The 
expected utility values associated with the consequence of terminating for Down's 
syndrome were significantly different by group allocation at both T1 (table 6:12) and
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T2 (table 6:24). Women in the decision analysis group had higher EUV scores 
associated with the termination consequence. There was no difference by group 
allocation in the ability of women to rank order the five consequences associated 
with the prenatal diagnosis decision (tables 6:14 and 6:25). There was no difference 
in women's perception of their triple test risk by group allocation (tables 6:11 and 
6 :21).
• clinical quality - the decision analysis consultation was approximately six minutes 
longer than the routine information giving consultation (table 6:15). Also, women in 
the decision analysis group were less satisfied with the decision information than 
women in the routine information giving consultation immediately after making the 
prenatal diagnosis decision (table 6:15). However, this association was not 
supported by the findings of the repeated measures analysis (tables 6:29 and 6:30). 
There was no difference in perceived directiveness of the consultation information 
by study group (tables 6;16 and 6:26).
One interpretation of these findings is that the application of decision analysis to real- 
world decisions is associated with positive changes in the quality of the decisions made. 
To explain further, women randomised to the decision analysis group had higher 
measures of informed decision making than women in the routine information giving 
consultation, i.e. the ‘decision analysis’ women utilised more of the decision information 
during the information giving consultation than the ‘routine’ women. In addition, the 
'decision analysis' women expressed less decisional conflict about their diagnostic test 
choice than women in the routine information consultation. There were no differences in 
the experience of anxiety or women’s perceived directiveness of the consultation 
information by group allocation. In other words, women’s decision making experience 
was not adversely affected following the application of decision analysis. Indeed, the 
application of decision analysis may be associated with the facilitation of decision 
quality.
Alternatively, some of the findings from this study's evaluation of decision analysis may 
be interpreted as detrimental to women’s experience of the prenatal diagnosis decision. 
Women allocated to the decision analysis consultation did have longer consultations, 
were less likely to use positive emotion words during the consultation, were less likely to 
generate advantages for prenatal testing and rated the usefulness of information as 
lower than that of women receiving the routine information. However, whether or not 
these particular differences by group allocation are negatively perceived is one of 
interpretation (section 6.3). For example, a health professional providing this
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information may perceive these findings as illustrating the inadequacies of decision 
analysis; the consultation takes longer, women express fewer positive aspects to the 
process of prenatal testing and women appear to be less enthusiastic about the 
information offered than those receiving the routine hospital care. On the other hand, a 
health professional concerned with ensuring women make informed choices about 
prenatal diagnosis may infer that these findings support the use of decision analysis in 
this health context; the longer consultation length may indicate a more informed process 
of decision making and the less favourable expressions pertaining to the experience of 
prenatal testing experience may reflect a more accurate evaluation of the decision 
information. It is feasible to suggest that as informed decision was facilitated and affect 
associated with the making of a difficult decision reduced, the explanation for these 
findings is consistent with the latter interpretation.
There is little evidence from this study to suggest that the application of decision 
analysis to a real-world decision was associated with the making of a more accurate or 
correct decision. Women’s appraisal of their triple test risk was not associated with 
group allocation. Most evaluations of the attitudes towards the decision consequences 
and likelihood of a consequence occurring did not differ by group allocation. Further, 
women in the decision analysis group were no more or less likely to rank order the 
consequences of the test alternatives than those in the decision analysis group. In 
addition, the structure of the decision analysis consultation was not associated with a 
greater recall in knowledge of prenatal testing. It is likely that as the study was under 
powered, type II errors may account for some of the ‘none significant' findings. An 
alternative explanation may be that as this decision context is a particularly well 
structured risky-decision with serious consequences, women are likely to evaluate the 
decision information systematically (Ubel and Loewenstein, 1997). In consequence, 
decision analysis is unable to encourage women to employ a more accurate strategy 
with which to appraise the decision information. A final interpretation may be that the 
beneficial effects of the decision analytic technique are long term. That is to say, 
women’s recall of information or evaluation of the decision consequences may be 
maintained for longer as a result of the elicitation of utilities and/or the structure of the 
consultation information. However, it was beyond the scope of this thesis to provide 
evidence to confirm or counteract these explanations.
8.4 Factors associated with women’s decision making.
Most, if not all, published studies have assessed factors associated with women’s 
prenatal diagnosis decision making pro- or retrospectively to women’s decision making.
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Few studies have employed a process tracing technique to describe the strategies 
employed by women concurrently with the making of the prenatal diagnosis decision. In 
consequence, it is unclear whether or not the strategies employed by women when 
making their prenatal diagnosis decisions have been accurately and comprehensively 
identified. As mentioned, chapter five summarises the findings from a study employing 
an information tracing technique to describe the information utilised by women when 
making their decision to have or not have prenatal diagnosis. The pattern of information 
utilised by women is an indirect measure of the psychological processes employed by 
women when making the decision (section 5.1.2). The purpose of summarising the 
information utilised by women during the consultation was to describe the type of 
information and psychological mechanisms employed by women when making the 
prenatal diagnosis decision. It was outside the remit of this thesis to operationalise a 
naturalistic or shared decision making model.
In brief, the results suggested that most (over 70%) women utilised information 
pertaining to the consequences and alternatives of the prenatal choice (table 5:1). In 
particular, most women weighed up the advantages and disadvantages of choosing 
between the two diagnostic tests. Both actual risks associated with the consequences of 
the alternatives and their evaluations were referred to by most women. Women tended 
not to verbalise attitudes towards the consequences of testing during the consultation 
but used reasons for and against alternatives when weighing up the decision 
information. These findings suggest that women employed systematic strategies when 
processing the decision information. However, most women also referred to information 
outside that provided by the health professional during the consultation. To explain 
further, most women mentioned their own and other’s experience of prenatal testing, 
pregnancy and abnormality. As this information is peripheral to that of the prenatal 
diagnosis decision, these findings suggest that women also employed heuristic 
strategies to assimilate information during the consultation. In addition, about 40% of 
the sample appeared to screen out the ‘no test’ alternative so reducing the amount of 
information to be appraised. The previously reported finding that not all women were 
making informed decisions is probably attributable to women employing this screening 
technique.
The theoretical review described in chapter one summarised the findings from 
published empirical research investigating women’s decision making in the context of 
prenatal diagnosis. A significant proportion of this prior research has been concerned 
with identifying the factors associated with the decision to have or not have prenatal
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diagnosis. Understanding the psychological processes involved in women’s decision 
making may be useful in either explaining women's responses to the testing experience 
or informing subsequent interventions aimed at the facilitation of informed decision 
making (Marteau, 1995a). As mentioned, there are a number of methodological issues 
pertaining to these studies that may adversely influence the interpretation of findings 
(section 1.3.2.2). Most of these methodological limitations were addressed by the study 
designs of the empirical research described in chapters four to seven of this thesis. For 
example, the study referred to in chapters six and seven included both concurrent and 
retrospective measures of factors associated with women’s decision making, and a 
sample of women representative of those choosing to have a diagnostic test and those 
choosing to have no further testing. The findings from these analyses are summarised 
below.
Unlike findings from previous research, there was no significant association between the 
decision behaviour and demographic characteristics, reproductive history or individual 
differences (tables 7:1, 7:2 and 7:3). Of the three measures of affect, decisional conflict, 
emotional content consultation and anxiety, only anxiety differed significantly by test 
decision. Those women choosing not to have a diagnostic test had lower anxiety than 
those having a diagnostic test (table 7:4). The results from the application of the coding 
frame to the consultation transcripts suggested that women choosing to have no further 
testing were making more informed decisions than those having a diagnostic test (table 
7:6). This result was observed in both analyses of the consultation transcripts described 
in chapters five and seven. From the frequency table summarising women’s utterances 
during the consultation (table 5:2), it is feasible to suggest that women choosing to have 
a diagnostic test were more likely to screen out the information associated with the 'no 
test’ alternative; whereas women deciding to have no further invasive testing 
assimilated information about both test alternatives. There was a trend towards 
significance for an item within the questionnaire (T1) assessing a similar construct (f = 
3.0; d.f. = 1, 104; p = 0.09; table 7:6); 'no test' women tended to generate more 
perceived disadvantages to prenatal testing than 'test' women. Knowledge of testing 
was equally high in women choosing to have or not have testing (table 7:6). Apart from 
the consequence of miscarrying, all EUVs associated with the consequences of testing 
differed significantly by decision behaviour (tables 7:7 and 7:8). The ‘no test' women 
had higher EUVs associated with having a healthy baby and a baby with Down's 
syndrome and lower EUVs associated with miscarrying or terminating a baby with 
Down's syndrome. In addition, there was a trend towards significance (Chi2 = 3.1, d.f. =
1, p = 0.07; table 7:9) suggesting that the 'no test' women were more likely to rank order
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the consequences of testing than the ‘test’ women, i.e. more likely to be making rational 
or accurate decisions. Women choosing to have a diagnostic test perceived their triple 
test risk as higher than the ‘no test’ women (z = 3.6, p = 0.003; table 7:10). The 
perceived social norm of others’ attitude towards testing differed by decision behaviour 
(z = 5.1, p < 0.001; table 7:7); ‘test’ women perceived there to greater external pressure 
from others to have a diagnostic test, whereas the ‘no test’ women perceived there to be 
a more neutral attitude from others to have a diagnostic test. Women’s perceived 
directiveness of the consultation information did not differ by group allocation (tables 
7:12 and 7:13). Finally, ‘no test’ women tended to have longer consultations but found 
the information to be less useful than ‘test’ women (table 7:11). From those variables 
described above, a stepwise discriminant function analysis identified four predictor 
variables accounting for 52% of the variance in women’s decision behaviour (table 
7:14): the measure of perceived social norm; anxiety at T1; EUV associated with having 
a healthy baby; EUV associated with having a Down's syndrome baby.
A number of these results support those found in previous research (see chapters one 
and seven). First, anxiety has been observed to be higher in women undergoing 
prenatal diagnosis than those choosing to have no further testing. This finding supports 
the assertion that anxiety is experienced in anticipation of undergoing an invasive, 
diagnostic test rather than as a consequence of making a difficult decision (Marteau, 
Kidd, Cook, Michie, Johnston, Slack and Shaw, 1992). Second, previous empirical 
evidence described differences in the attitudes and perceptions of risk by decision 
behaviour (section 1.3.2.1). This pattern of results was observed in the analyses carried 
out in chapter seven; the ‘no test’ women were making more informed, rational and 
accurate decisions than those having a diagnostic test. Further, these differences in 
attitudes and perception of risk were predictive of women’s decision behaviour (see 
section 7:3 for some explanations of these findings). Although the ‘no test’ women were 
making more informed and accurate decisions, they found the decision information less 
useful than the test women. As discussed in section 8.3, it is likely that the more 
informed decision is associated with a more accurate appraisal of the decision 
information. That is to say, women making more informed decisions appear to be 
satisfied with the information but less so than women employing a screening out 
information processing strategy. However, this finding may indicate that a more 
informed decision is a less falsely reassured one. Third, the findings pertaining to 
women’s reasoning during the consultation support the assertion that the ‘no test’ 
women are ‘opting out’ of having a test rather than choosing to have no further testing. 
A final observation is that although knowledge has been found to differ by test decision
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in previous research, the analysis reported in chapter seven found no such association. 
One explanation for this discrepant result is that this sample of women were well 
informed about prenatal diagnosis. Two results support this explanation: women's mean 
knowledge score in both groups was equally high ( a mean score of 14.5 from a 
measure ranging between 0-20); the provision of test information was good if not 
sufficient to ensure a fully informed decision (chapter four).
8.5 Critique of methods.
The main strengths of the empirical studies described in this thesis were (chapters four 
to seven): the observational study design; the representativeness of the study sample; 
the well defined clinical context; the use of psychological models of decision making to 
enable the operationalisation of informed decision making and inform measures 
evaluating the decision quality. Below is a discussion outlining some of the 
methodological strengths of these studies with reference to the empirical research 
described in this thesis.
1. The application of an observational study design enabled the accurate appraisal of 
whether or not the conditions and criteria of informed decision making had been 
met. To explain further, from the information search techniques it was possible to 
describe the information provided by health professionals and utilised by women 
during the prenatal diagnosis decision consultation. Both the checklist (chapter 
4.1.3.2) and coding frame (section 5.1.4) were informed by psychological theories 
of decision making and evidence from prior empirical research. It is likely that the 
good inter-rater reliability of both instruments was, in part, attributable to their 
thorough development and grounding within the literature.
2. The decision context was well-defined. The information provided to women was 
consistent between consultations. All women included within the analyses of this 
thesis were offered prenatal diagnosis as a consequence of receiving a screen 
positive triple test result. In other words, the reasons for being offered prenatal 
diagnosis were the same for each woman. All women invited to attend the 
information giving consultation were choosing either to have or not have prenatal 
diagnosis. To explain further, the final sample of women were representative of 
those making the choice between having or not having prenatal diagnosis.
3. The study evaluating decision analysis employed a randomised control trial design 
with a low risk of bias. The items included within the questionnaires were designed 
with reference to psychological models of decision making and standardised 
measures of women's prenatal testing experience (section 6.1.2). The
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questionnaires were piloted before inclusion in the main RCT. It is feasible to 
suggest that this rigorous methodology and well-defined decision context 
contributed to the validity of the difference in findings observed between the 
decision analysis and routine care study groups (Bowling, 1997). In addition, it is 
feasible to suggest that the well-defined decision context and the theoretically 
driven measures were in part responsible for achieving a function accounting for 
52% of the variance in women’s decision behaviour (chapter seven). The four 
predictor variables identified by the stepwise discriminant function analysis (chapter 
seven) accounted for about twice as much of the variance in women’s prenatal 
testing behaviour than previously published empirical research;
4. The study was carried out in a real-world setting and a concerted effort was made to 
integrate the research into the routine ante-natal care of the LGI. Women's rate of 
participation in the study was excellent (84%) and the return rate of follow-up 
questionnaires (T2) good (68%) (chapter six). These factors suggest that the study 
sample of women were representative of women making the triple test decision in 
Leeds.
The combination of study designs and measures employed in this thesis have provided 
some unique empirical findings for the area of women’s decision making in the context 
of prenatal diagnosis. First, it is likely that informed decision making requires the 
assessment of the decision making process. Questionnaire-based measures assessing 
knowledge did not access the information utilised by women when making a decision. 
However, there was some evidence to suggest that an open-ended question 
encouraging women to identify perceived advantages and disadvantages of testing 
might be associated with the process of making the decision. Future empirical research 
of informed decision making may benefit from developing a questionnaire-based 
measure of informed decision making. Second, women’s informed decision making was 
facilitated by application of the decision analytic technique to the information giving 
consultation. In other words, it is possible to operationalise and facilitate informed 
decision making. Third, women employed both systematic and heuristic strategies when 
assimilating information to make a decision about prenatal diagnosis. Fourth, women 
utilised both risk information and evaluations of risk during the prenatal diagnosis 
decision consultation. Retrospective assessments of the factors associated with 
women’s decision making have implied that only risk perceptions were predictive of 
women’s decision behaviour. Fifth, individual differences in preferences for information 
and perceived optimism did not appear to be associated with either women’s informed 
decision making or factors predicting their decision behaviour. Sixth, measures of
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decisional conflict and anxiety assessed different aspects of affect. It seems feasible to 
suggest that decisional conflict assessed the difficulty with making the decision, 
whereas anxiety measured the general affect associated with undergoing clinical 
procedures. Seventh, more informed decisions were associated with lower satisfaction 
scores. As the majority of women still perceived the information to be useful, it is 
possible that this score reflected a decrease in 'false reassurance'. Finally, women 
choosing to have or not have prenatal diagnosis had different perceptions of others' 
attitude to prenatal testing. The ‘test’ women perceived there to be more pressure from 
others to have a diagnostic test, whereas the ‘no test’ women’s response to the 
perceived social norm question suggested that there was a more neutral attitude from 
others to have a diagnostic test. As perceived social norm was measured 
retrospectively to the decision behaviour, it is feasible to suggest that the response to 
this item was subject to a cognitive readjustment (section 1.3.2.2). That is to say, 
women’s perceptions of risk and attitudes were, or were being, re-aligned in order to be 
congruent with their behaviour. To explain further, it might be adaptive for women 
undergoing the invasive procedure to perceive their choice as being the ‘norm’ and 
dependent on others’ opinions; acknowledging that the invasive, risky choice was their 
responsibility alone may be a dissonant cognition. In contrast, it might be adaptive for 
women choosing the non-invasive alternative to acknowledge their responsbility in 
selecting the ‘non-medical’ alterniative. It is possible that knowingly ‘going against a 
norm’ is difficult, which might account for the lower perceived satisfaction scores of the 
‘no test' women.
There were a few limitations of the methods employed in this thesis. First, the 
randomised control trial mentioned in chapter six was under-powered. As the sample 
size of this study was small, it suggests that some type II errors may have occurred. For 
example, it is possible that decision analysis was associated with changes in women’s 
decision behaviour or knowledge despite the analyses in this thesis being unable to 
establish such a relationship. Second, few studies have evaluated decision analysis to 
assess its efficacy in the facilitation of informed decision making. In consequence, a 
large number of measures were employed to evaluate changes in affect, behaviour, 
cognition and clinical quality. As several measures were analysed, it is possible that 
some type I errors may have occurred. For example, the results suggested that decision 
analysis was associated with a decrease in decisional conflict but this finding may have 
been attributable to chance. Third, although chapter six reported the results of a 
randomised control trial with a low risk of bias, the study compared only decision 
analysis with a routine information giving consultation. In consequence, it is unclear
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whether or not the facilitation of informed decision making was attributable to decision 
analysis as a complete package or an attribute of the technique, such as the decision 
tree visual prompt. Finally, there are some issues concerning the generalisability of the 
findings described in the empirical chapters of this thesis and the analyses applied to 
the studies’ data. These concerns are discussed in more detail below.
1. The study sample were representative of those women choosing to have a triple 
test at the LGI; the majority of women were Caucasian and had a moderate level of 
education (60% had ‘A ’ level qualifications or higher). It is unclear whether or not 
the findings reported in this thesis would be replicated in a more demographically 
varied sample of women. In addition, the LGI triple test uptake rate is modest 
compared with rates of other hospitals nationally. In consequence, it is possible that 
the decision making processes of women at the LGI might differ from those of 
women at other UK hospitals.
2. The analyses applied to the data were consistent with the research aims of the 
thesis. In essence, to describe the factors associated with women’s informed 
decision making about prenatal diagnosis. As mentioned, an observational study 
design generates a rich source of data. In consequence, more in-depth qualitative 
analyses might have been useful in trying to understand the relationship between 
the provision of consultation information by the health professional and women’s 
subsequent utilisation of information when making the prenatal diagnosis decision. 
At present, it is unclear to what extent the woman discussed information pertaining 
to the health professional’s agenda or vice versa.
3. Ensuring informed decision making is an objective of prenatal testing programmes. 
The implicit assumption, then, is that informed decision making is desirable or 
’good’. In consequence, the analyses of both the consultation and questionnaire- 
based measures focused on assessing the quality of the decisions made, i.e. 
whether or not the decisions were informed. However, no analyses were carried out 
to establish the relationships between measures. For example, ascertaining whether 
or not informed decision making is always ‘good’ by assessing the relationship 
between informed decisions and affect or satisfaction. In addition, these analyses 
may be useful in addressing more specific research questions about factors 
associated with the decision making process, such as the relationship between 
raised anxiety and vigilant information processing (Janis and Mann, 1977). Although 
the evidence to test these associations exists within the current data set, it was 
beyond the remit of this thesis to carry out the appropriate analyses.
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4. The randomised control trial study was carried out to evaluate the effectiveness of 
decision analysis to facilitate decision making. The findings suggested that women 
in the decision analysis consultation did make more informed decisions than women 
in the routine care consultation. However, the decision analysis consultation was not 
associated with changes in rational or accurate decision making. One interpretation 
of these findings was that decision analysis facilitates informed decision making but 
not rational decision making. Another explanation may be that the decision analytic 
technique was inappropriately carried out. To explain further, the lottery question 
that is used to elicit utilities within the prenatal testing context provides a global 
value or utility figure. It is possible that the use of an alternative elicitation method 
may provide individual utility values. An association between the application of the 
decision analytic technique and more accurate or rational decision making may be 
associated with this different elicitation of utilities.
5. As mentioned, informed decision making was facilitated in women randomised to 
the decision analysis consultation. However, the randomised control trial compared 
only the decision analysis consultation with a routine care consultation. It is unclear 
whether or not women’s informed decision making would be facilitated by a 
consultation structured by an alternative information intervention. For example, 
genetic counselling research suggests that the use of scenarios to structure the 
decision information is a useful technique (Clarke, 1994). It remains an empirical 
question, then, whether or not a decision aid is more likely to facilitate informed 
decision making than an information aid.
Although some of these methodological concerns and new empirical questions may be 
addressed by secondary analyses of the data collected for this thesis, additional 
empirical research is required to adequately respond to its limitations. Further studies 
might focus on a number of issues raised from the findings in this thesis including: 
carrying out the research in a more varied sample of pregnant women; developing a 
questionnaire-based measure of informed decision making; evaluating decision analysis 
in a different health context; assessing whether or not informed decision making can be 
facilitated by the use of an information aid.
8.6 Clinical recommendations.
The empirical evidence reported in this thesis suggested that (a) the information 
provided by health professionals is not sufficient to enable informed decision making,
(b) the women were not utilising sufficient information to ensure their final decision was 
informed, and (c) the application of decision analysis to the prenatal diagnosis
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consultation was associated with an increase in informed decision making. In addition, 
the randomised control trial evaluating decision analysis found that the women in the 
decision analysis group experienced less decisional conflict about their prenatal 
diagnosis choice than those the routine group. There was also some evidence to 
suggest that the women in the decision analysis group were less falsely reassured by 
the consultation information than those in the routine consultation. The two adverse 
consequences of applying decision analysis to the prenatal diagnosis consultation were 
that the decision analysis consultations were approximately six minutes longer than 
routine consultations and the women were less satisfied with the consultation 
information than those in the routine group.
One of the main objectives of prenatal diagnosis programmes is to encourage women 
to make informed decisions. As decision analysis was associated with an increase in 
informed decision making, it is reasonable to suggest that the decision analytic 
technique be applied to the prenatal diagnosis information giving consultation. However, 
there are a number of issues that are likely to impede the implementation of this 
technique to the real-world context. First, health professionals would have to receive 
additional training to be able to structure a consultation by decision analysis. Second, 
the application of the decision analytic technique requires more time than routine 
information giving. Third, women are less satisfied with the decision analysis 
consultation. It is unlikely that health professionals would adopt a technique that 
requires re-training, is more time-consuming and is perceived as less useful by the 
woman, on the basis that it facilitates informed decision making. In consequence, 
further research is required to establish what aspect of the decision analysis ‘package’ 
facilitates informed decision making. To explain further, decision analysis may have 
increased informed decision making for the following reasons: the decision tree visual 
aid encouraged the health professional to provide sufficient information; the decision 
tree visual aid reduced the cognitive demands of the decision and/or prompted the 
woman to utilise sufficient information during the consultation; the lottery question 
provided women with an opportunity to discuss termination; the threshold graph enabled 
women to assimilate information about attitudes and evaluations of risk. The first three 
reasons suggest that an information aid is sufficient to enable informed decision 
making. The final reason suggests that a decision aid is necessary to facilitate informed 
decision making. Before recommendations for changes to clinical practice can be 
confidently asserted, further empirical investigation is required to assess which of these 
interventions or combinations of interventions might be associated with the facilitation 
of women’s informed decision making.
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Informed decision making: an annotated bibliography and 
systematic review - executive summary.
Objectives
To provide an unbiased bibliography of controlled studies evaluating interventions 
that may affect informed patient decision making.
To classify studies by research design, decision-making theory, type of intervention 
and health setting.
To describe the measures of informed patient decision making and other outcomes 
reported.
To identify under-reported areas and direct future research.
Conducting the review
Study selection: Studies were included if they reported the results of a controlled 
study of any intervention using real patients making a health decision. Specifically, 
randomised controlled trials (RCT), non-randomised concurrent studies, historical 
studies, and same subject “before and after” studies were included. Health decisions 
were defined to include any reported health behaviour change as well as explicit 
decisions. Interventions were defined broadly to include any that could reasonably be 
expected to affect informed decision making, such as changes in information 
provision, cost, or service provision. Patients were defined as any individual making 
a decision about health care. Experimental studies on healthy student volunteers, 
studies of health professionals making decisions about another individual's care and 
articles not published in English were excluded.
Data classification: Articles were classified by study quality according to the hierarchy 
of evidence, underlying theory, the domain of health care, and the health decision. 
The comparison groups, other factors associated with the decision making process, 
reported measures, and a summary of the findings were recorded.
Data sources: The electronic databases Medline, BIDS (social science), and Psychlit 
were searched for 1991-1996. The journals Medical Decision Making, Patient 
Education and Counselling, and Preventive Medicine were hand searched for 1986- 
1996.
Article identification: Abstracts were assessed by the first author and articles retrieved 
if the review criteria were met. Final inclusion decisions was made by the first author 
and verified by another member of the project group.
Data extraction: This was performed by a member of the project group and checked 
by the first author with disagreements resolved by discussion.
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Data synthesis: Descriptive summaries and qualitative analysis were performed. 
The health domains and decisions were too diverse for meaningful quantitative 
meta-analysis.
Review findings
Following hand-searching and abstract evaluation 825 articles were distributed to the 
project group members and 547 were subsequently included within the bibliography. 
Study quality: There were 336 RCTs, 114 non-randomised concurrent studies, 34 
historical, and 63 before and after same sample studies. Only 51 of the RCTs were 
classified as having a low risk of bias. 267 studies claimed to have approached a 
representative sample of participants, but only 243 reported the number invited to 
take part. Few studies provided adequate descriptions of the intervention materials. 
Theoretical context: 206 studies referred to an underlying theory. Of these, 101 
referred to theories explaining decision making such as expected utility theory, 
prospect theory or social cognition models.
Health domain and the decision: 251 studies were in general medicine, 114 cancer, 
108 genitourinary medicine, 61 primary care, 31 paediatrics; 15 mental health, 10 
dentistry, 11 surgery, 7 genetics, and 31 OBGYN and midwifery. The decision was 
classified as a life-style change in 357 studies, a screening decision in 114, a 
treatment decision in 107, a decision to participate in the consultation in 51, and as 
another type of decision in 26.
Interventions: 301 interventions were of information provision itself, 273 varied the 
delivery of information, 208 provided patient feedback, 94 manipulated information 
in some other way, 55 prompted active patient participation, and 89 of another 
intervention altogether.
Decision making factors: 512 studies assessed actual rather than hypothetical 
decisions, 476 involved decisions affecting the participant rather than a third party 
and in 525 studies the decision was made without time pressure. Only 26 studies 
explicitly made patients aware of their involvement in the decision making process. 
Measures assessed: demographic details were recorded in 515 studies, knowledge 
in 181, decision making measures in 169, measures of affect in 69, satisfaction in
60, self efficacy in 75, personality trait in 20 and other variables in 111 studies. 
Trajectory of knowledge: The annual number of included studies increased by 
approximately 50 percent over the five years 1991-96 but the proportion of better 
quality remained unchanged.
Summary result: Only five studies were theory driven, assessed measures 
associated with informed decision making and used a low risk of bias design. 
Although of disparate design these five studies suggest that information and 
education are relatively ineffective ways of facilitating informed decision-making, 
compared with the context and social influences. Studies reporting manipulation of 
information, and provision of feedback, were the most likely to report an effect.
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Conclusions
There is a paucity of well designed, theoretically driven and adequately 
operationalised research assessing informed patient decision-making. Although 
additional information does not necessarily lead to more informed decisions, this was 
the most frequently coded intervention. Less than a fifth of studies assessed 
information manipulation or active patient participation. Informed patient decision 
making was under-evaluated with less than a third of studies assessing any measure 
associated with the process of informed decision making. No broad conclusions 
could be drawn from the five ‘good quality’ studies as the theoretical context, health 
domain, decision and measures were disparate. Given the small number of high 
quality studies and the relatively slow increase in research in this area there is no 
need for the NHS to revisit this topic as a review for five years. Resources should 
be concentrated on better primary research.
Recommendations
1. Future primary research should work under an explicit theory of decision making, 
record process measures to permit evaluation of whether the decision was informed 
and if evaluating experimental interventions use randomised trials with a low risk of 
bias.
2. The HTA programme should develop a booklet describing the main decision 
making theories, and an inventory of suitable outcome measures, to help clinical 
researchers design appropriate studies.
3. Three complementary systematic reviews should be commissioned.
The effect of interventions on patient preferences. At least 50 trials were excluded 
from the present bibliography because no behaviour change was recorded. 
Observational studies of real patient decision-making. Studies using tape-recorded 
consultations, verbal “thinking aloud” protocols, and other written or computer based 
“process tracing” methods will predominate.
Assessing the effect of additional information, manipulation of information, provision 
of feedback, and group delivery of information on informed patient decision making.
4. Primary research is a priority such areas as genetics, prenatal diagnosis and 
where decisions are often made by proxy such as paediatrics and mental health.
5. Primary research is required to evaluate the following types of interventions 
Decision aids, such as graphical and computer based devices.
Information manipulation, such as decision analysis, prompts, and feedback.
Coding form to extract article information: IPDM review.
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Appendix II
Article Identification Details (reference details from electronic data-base - idealist - review database)
Field Details
Article review number 
number studies 
project number 
number of duplicate
Authors | ............................................................................................................................................
Title ! ............................................................................................................................................
Journal Details 
{name,year,vol., pages}
------------------------------------------------------------------------------------------------------------------------
Code 1-6
(reasons exclude) [ ]
Database medline □ psychlit □ BIDS □ handsearch □
Date downloaded /
Date sent to reviewer /
Date returned reviewer /
Initials Reviewer
MA □ HB □ JC □ JH □ JM □ MM □ SM □ AP 0 MR □ JT □
Summary decision/health behaviour
Location research:
unknown □ UK □ North America □ 
S.Africa □ Australia/ NZ □ 
other □ (please w rite .............................
................................................................ )
Participants:
adult □ well □ 
pregnant □ physically impaired □ 
elderly (>65) □ mentally impaired □ 
child (<17) □ non-English speaking □ 
unknown □
The nature of the decision is:
A) Real □ Intended 0 Hypothetical □
B) Implicit □ Explicit □
C) affects - Participant □ other □
D) made at - time intervention □ later □
Domain of Health Care:
Write in the type of illness or health 
domain that the research located 
within (eg. cervical cancer, breast 
cancer, asthma, general health 
promotion, cardiovascular risk factors, 
HIV/condom use, smoking cessation, 
drug use, tuberculoses, maleria, etc.)
Defining type of health decision:
Write in the type of therapy decision 
below (eg. screening, diagnostic 
testing, medication/drug therapy, 
surgical treatment, behavioural therapy, 
willingness to pay for..., donating ..., 
taking part in research, cessation, etc.,)
Authors Awareness theory:
Decision making theory:
0 = no theory referred to 
Write in the name of theory referred to in 
the introduction or methods section
Quality of Study:
Design of study:
randomised (RCT) a □ b □ c □ 
non randomised concurrent □ 
before/after different sample □ 
before/after same sample □
Other (eg. matched case-controlled,) □
Quality of Study Continued...
Level of intervention:
patient level □ other level □ not rec.D 
Sample invited to participate: 
total ‘population’ available □ 
stratified/ systematic sample □ 
volunteer/ non-systematic sample □ 
not adequately described □
Quality of Study Continued...
Sample size:
total number available not rec. □ 
total number invited not rec. □ 
number DarticiDated not rec. □ 
number excluded not rec. □ 
number in final analysis not rec.D
Quality study continued...
Causes for concern:
no/ not obvious causes for concern □ 
yes (please state any concerns 
including study poorly designed, 
sample not representative, bias, etc) □
Quality study continued... 
Development intervention materials: 
piloted some aspect of intervention: 
no □ yes □ in part □ 
piloted some aspect measures 
no □ yes □ in part □ 
applied a readability score:
no □ yes □ in part □
Reference to be accessed . . .
Description Intervention Groups
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Nature Intervention: explicit information □ change in service □ other □
Comparative Group Description of Intervention (write . . . ) Code (see box 1) number in 
group(n)
Group 1 [ ] [ ] 
[ ] [ ] 
r i [ ]
Group 2 [ ] [ ] 
[ ] [ ] 
[ ] [ ]
Group 3 [ ] [ ] 
[ ] [ ] 
r i r l
Group 4 [ ] [ ] 
[ ] [ ] 
[ ] [ ]
Other Independent, Moderator or Mediator Variables
Variable Code Descriptives Main Effect Analysis Interaction Analysis
age 101
gender 102
level education 103
social class/ income 104
marital status 105
ethnicity 107
anxiety 151
depression 153
other affect 158
knowledge 159
attitudes/ utilities 160
perception risk/ severity 161
other variables (write) . .
Main Decision Making Outcomes Assessed
Description (write & code - box 3) Continuous/
Categorical
Validated, Piloted or 
Study Specific
Description validated I Code val. 
measure (write): j measure
val □ pil □ study □
val □ pil □ study □
val □ pilO study □
valD pil □ study □
val □ pil □ study 0
Results of Intervention on Main Outcome variables
Code
variable
Categorical onlv 
level / group (box 5)
eg adhere 1 
not adhere 2
Group 1
not available or 
'n' or 
mean (sd) n
Group 2
not available or 
‘n ’ or 
mean (sd) n
Group 3
not available or 
•n’ or 
mean (sd) n
Group 4
not available or 
'n' or 
mean (sd) n
Group 5
not available or 
'n' or 
mean (sd) n
Summarise the results and main outcome measures of the study if different from the review outcome 
measures.
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Summary extracted information from articles: IPDM review.
T ab le  1: A u th o rs , t i t le  and  s o u rc e  o f  d e c is io n  a id  o r  p rena ta l te s tin g  a rtic le s  
(IPDMRN is  th e  in fo rm e d  p a tie n t d e c is io n  m a k in g  rev iew  num be r).
Binstock, M.A. and Wolde-Tsadik, G. (1995) Alternative prenatal care: impact of reduced visit frequency, 
focused visits and continuity of care. The Journal of Reproductive Medicine. 40: 507-512. (IPDMRN: 83) *
Brennan, P.F., Moore, S.M. and Smyth, K.A. (1995) The effects of a special computer network on caregivers
of persons with Alzheimer’s disease. Nursing Research. 44:166-172. (IPDMRN: 493)______________________
Butow, P.N., Dunn, S.M., Tattersall, M.H.N. and Jones Q.J. (1994) Patient participation in the cancer
consultation: evaluation of a question prompt sheet. Annals of Oncology. 5:199-204. (IPDMRN: 700)________
Katon, W., Von Korff, M.V., Lin, E., Walker, E., Simon, G.E., Bush, T., Robinson, P. and Russo, J. (1995) 
Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA.
273:1026-1031. (IPDMRN: 794)___________________________________________________________________
Maisiak, R., Austin J. and Heck, L. (1996) Health outcomes of two telephone interventions for patients with
rheumatoid arthritis or osteoarthritis. Arthritis and Rheumatism. 39:1391-1399. (IPDMRN: 27)______________
McCann, S. and Weinman, J. (1996) Empowering the patient in the consultation: a pilot study. Patient
Education and Counseling. 27:227-234. (IPDMRN: 387)_______________________________________________
Richardson, J.L., Mondros, G.T., Danley, K., Deapen, D. and Mack, T. (1996) Impact of a mailed 
intervention on annual mammography and physician breast examinations among women at high risk of
breast cancer. Cancer Epidemiology: Biomarkers and Prevention. 5:71-76. (IPDMRN: 154)_________________
Rost, K.M., Flavin, K.S., Cole, K. and McGill, J.B. (1991) Change in metabolic control and functional status 
after hospitalisation: impact of patient activation intervention in diabetic patients. Diabetes Care. 14:881-889.
(IPDMRN: 472)__________________________________________________________________________________
Rowley, M.J., Hensley, M.J., Brinsmead, M.W. and Wlodarczyk, J.H. (1995) Continuity of care by a midwife 
team versus routine care during pregnancy and birth: a randomised trial. The medical Journal of Australia.
163:289-293. (IPDMRN: 678) *____________________________________________________________________
Rutten, G.E.H.M., Beek, M.M.L. and van Eijk, J.T.M. (1993) Effects of systematic patient education about 
cough on the consulting behaviour of a general practice population. Patient Education and Counseling.
22:127-132. (IPDMRN: 337)______________________________________________________________________
Sachs, G.A., Stocking, C.B. and Miles, S.H. (1992) Empowerment of the older patient? A randomised, 
controlled trial to increase discussion and use of advance directives. Journal o f American Geriatrics Society.
41:928-930. (IPDMRN: 343)______________________________________________________________________
Sander, R.W., Holloway, R.L., Eliason, C., Marbella, A.M., Murphy, B. and Yuen, S. (1996) Patient-initiated 
prevention discussions: two interventions to stimulate patients to initiate preventive discussions. Journal of
Family Practice. 43:468-474. (IPDMRN: 601)________________________________________________________
Shepperd, S., Coulter, A. and Farmer, A. (1995) Using interactive videos in general practice to inform
patients about treatment choices: a pilot study. Family Practice. 12:443-447. (IPDMRN: 594)_______________
Shiloh, S., Reznik, H., Bat-Miriam-Katznelson, M. and Goldman, B. (1995) Pre-marital genetic counselling to 
consanguineous couples: attitudes, beliefs and decisions among counselled, noncounselled and unrelated
couples in Israel. Social Science and Medicine. 41: 1301-1310. (IPDMRN: 430)*_________________________
Sikorski, J., Wilson, J., Clement, S., Das, S. and Smeton, N. (1996) A randomised controlled trial comparing 
two schedules of antenatal visits: the antenatal care project. British Medical Journal. 312: 546-553. (IPDMRN:
425)*________________________________________ ________________________________________________
Tabak, E.R. (1988) Encouraging patient question asking: a clinical trial. Patient Education and Counseling.
12: 37-49. (IPDMRN: 506)________________________________________________________________________
Thornton, J.G., Hewison, J., Lilford, R.J. and Vail, A. (1995) A randomised trial of three methods of giving
information about prenatal testing. British Medical Journal. 311: 1127-1130. (IPDMRN: 778) *______________
Whelan, T.J., Levine, M.N., Gafni, A., Lukka, H., Mohide, E.A., Patel, M. and Streiner, D.L. (1995) Breast 
irradiation postlumpectomy: development and evaluation of a decision instrument. Journal o f Clinical 
Oncology. 13: 847-853. (IPDMRN: 691)____________________________________________________________
* Articles selected fo r inclusion by health care context: obstetrics, gynaecology and  
m idwifery; and, genetics.
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Table 2: Description of article’s health context and type of decision.
First Author Health Area Decision
Binstock obstetrics and midwifery adherence with antenatal care schedule
Brennan mental health - Alzheimer's utilisation of health services
Butow cancer question asking
Katon mental health - depression adherence with medication levels
Maisiak arthritis utilisation of health services
McCann primary care - general question asking
Richardson cancer adherence with screening appointment
Rost diabetes question asking
Rowley obstetrics and midwifery utilisation of health services
Rutten primary care - coughs utilisation of health services
Sachs geriatric making of living wills
Sander primary care - general question asking / information seeking
Shepperd primary care - hypertension treatment decisions
Shiloh genetics reproductive decision making
Sikorski obstetrics and midwifery utilisation of health service
Tabak primary care - general question asking
Thornton obstetrics and midwifery attendance antenatal clinic
Whelan cancer treatment decision
Table 3: Design and intervention group descriptions by article.
First Author Design Intervention (sample size)
Binstock RCTc group 1 - assigned 13 visits (n=259) 
group 2 - assigned 8 visits (n=320)
Brennan RCTb group 1 - computer + training + decision & information aid
programme (n=51)
group 2 - questionnaire only (n=51)
Butow RCTb group 1 - leaflet prompting question asking 
group 2 - leaflet about cancer services (n=142 total)
Katon RCTc group 1 - leaflet about depression & therapy techniques +
video + prompt (n=108)
group 2 - routine care by physician (n=109)
Maisiak RCTb group 1 - routine care + questionnaire (n=127)
group 2 - symptom monitoring counseling sessions (n=124)
group 3 - treatment counseling (n=128)
McCann RCTa group 1 - leaflet prompting question asking (n=59) 
group 2 - information about ‘health eating’ (n=61)
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Table 3 continued.
First Author Design Intervention (sample size)
Richardson RCTc group 1 - routine letter of invitation (n=195) 
group 2 - leaflet + video information about breast cancer & 
breast self examination & reasons for attending 
mammography & procedure mammography (n=172)
Rost RCTc group 1 - nurse consultation before discharge + written self­
completion exercise + information on skill acquisition (n=30) 
group 2 - routine care + questionnaire (n=31)
Rowley RCTa group 1 - midwife team planning continuity of care (n=405) 
group 2 - routine care (n=409)
Rutten RCTc group 1 - ‘cough’ education during consultation + leaflet on 
causes, symptoms & treatments for coughs (n=1 1 1 2 0 ) 
group 2 - routine care for coughs (n=9511)
Sachs RCTc group 1 - information interview + copies of forms + reminder 
cards & patient prompts (n=52) 
group 2 - routine care (n=85)
Sander RCTc controll - questionnaire before and after consultation (n=42) 
group 1 - patient prompt about health risk behaviours (n=87) 
control2 - questionnaire before and after consultation (n=59) 
group 2 - nurse talked about health risk behaviours (104)
Shepperd same sample 
before & 
after
group 1 - interactive video: adjust patient risk estimates 
based on responses + lifestyle change + hypertension 
information + types of treatment (n=77)
Shiloh comparative group 1 - adult cousins + genetic counseling (n=58) 
group 2 - adult cousins (n=40) 
group 3 - unrelated adults (125)
Sikorski RCTa group 1 - routine care: thirteen visits (n=1416) 
group 2 - new style: six / seven visits (n=1378)
Tabak RCTa group 1 - ’readable’ leaflet listing type of questions to ask 
(n=35)
group 2 - ‘readable’ leaflet listing services available (n=32)
Thornton RCTc group 1 - routine booking in information (n=567)
group 2 - group 1 + extra visit & information + leaflet
(n=561)
group 3 - group 1 + extra class + leaflet (n=563)
Whelan RCTc group 1 - routine + questionnaire (n=23) 
group 2 - physician prompt consultation (n=29) 
group 3 - decision board based consultation (n=30)
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Table 4: Description theory and measures by article.
First Author Theory Measures
Binstock no theory reproductive history, number of antenatal visits, 
antenatal care required, patient satisfaction
Brennan EUT age, sex, utilisation health services by carer & patient, 
decision making confidence & skill, social support, 
burden of care, depression, patient functional status
Butow Doctor-patient
communication
age, sex, medical history, disease status, anxiety, tape- 
recorded consultation, satisfaction, information recall, 
information preferences, decision making involvement
Katon no theory age, sex, level education, marital status, employment, 
medical history, satisfaction, depression, neuroticism, 
adherence to medication
Maisiak Doctor-patient
communication
age, sex, ethnicity, education level, medical history, 
disease status, affect, pain, utilisation health services
McCann Doctor-patient
communication
age, sex, employment, readability leaflet, self-efficacy, 
health locus of control, satisfaction, consultation length, 
question asking, health professional measures
Richardson no theory age, level education, marital status, medical history, 
family history, attendance mammography, risk 
perception, perceived susceptibility & efficacy, screening
Rost Doctor-patient
communication
age, sex, level education, employment, medical history, 
disease status, question asking, information preference
Rowley no theory age, ethnicity, marital status, employment, reproductive 
history, preventive behaviours, pregnancy complications, 
breast feeding, attendance antenatal classes & 
appointments, satisfaction, consultation participation
Rutten no theory age, sex, health insurance, attendance
Sachs no theory age, sex, ethnicity, level education, marital status, health 
insurance, disease status, knowledge, living wills
Sander Doctor-patient
communication
age, sex, request for information, decision participation, 
behaviour change, recall information, sources of 
information, satisfaction
Shepperd Doctor-patient
communication
age, sex, level education, employment, disease status, 
decision preference and autonomy, usefulness video
Shiloh no theory age, sex, ethnicity, marital status, beliefs, counseling 
reasons, perception risk, reproductive behaviour
Sikorski no theory age, ethnicity, level education, marital status, 
accommodation, reproductive history, preventive 
behaviours, disease status, pregnancy complications, 
affect, attitudes, satisfaction, utilisation services, social 
support
Tabak Doctor-patient
communication
age, level education, employment, question asking, 
satisfaction with physician care
Thornton no theory age, ethnicity, employment, reproductive history, 
attendance antenatal classes, uptake tests, affect, 
satisfaction, knowledge
Whelan Doctor-patient
communication
age, level of education, marital status, diseases status, 
knowledge, treatment choice, usefulness information, 
decision autonomy, directiveness information
257
Table 5: Description main findings by article.
First Author Results
Binstock Attendance for antenatal visits, antenatal care and pregnancy outcomes 
did not differ by intervention group. Satisfaction was greater in group 1 .
Brennan There was no difference in use of health care services by group. 
Decision confidence but not decision skill increased in group 1.
Butow There was no difference in the number of questions asked and duration 
of question asking by group. Those in group 1 were more likely to ask 
questions about disease prognosis. Results discuss differences in 
preference for information and involvement in decision making.
Katon Adherence to medication was greater in group 1 than the routine care 
group (88% vs. 57% major depression; 76% vs. 50% minor depression).
Maisiak There was no difference in service utilisation by group. However, when 
analysed by disease status, group 3 was associated with fewer visits 
amongst osteoarthritis patients but not rheumatoid arthritis patients.
McCann Group 1 had longer consultations and a trend towards significance for 
asking more questions (p=0.07). There was no difference in satisfaction 
by group.
Richardson Group 2 associated with greater attendance than routine care (40% vs. 
30%). No differences between groups for perception risk, severity and 
perceived efficacy mammography.
Rost Group 1 associated with greater question asking and longer 
consultations than routine care patients. There was no difference in 
preference for information seeking or satisfaction by group.
Rowley Group 1 were less likely to attend antenatal classes and more likely to 
ask questions than the routine group. No difference for breast feeding 
was observed.
Rutten Intervention associated with an increase in attendance for coughs.
Sachs No association between number of living wills made and group.
Sander Group 1 requested more information than contrail, no other differences 
observed. Group 2 requested more information, recalled more, more 
likely to change behaviour than control2. No differences in perceived 
decision participation by intervention groups.
Shepperd The video was associated with changes in choices of treatment and 
confidence with choice. There was no increase in consultation length.
Shiloh Group 1 had fewer children, greater perceived risk and severity genetic 
diseases than group 2 or 3.
Sikorski Group 1 received more ultrasounds, had more day admissions, and had 
more positive attitudes than group 2. There was no difference in the 
number of inpatient admissions, night admissions, and attending 
antenatal classes.
Tabak No significant difference by group was observed for question asking. No 
association between question asking and satisfaction.
Thornton Group 2 associated with a greater uptake Down syndrome screening; 
group 1 associated greater uptake cystic fibrosis carrier testing; and, 
group 3 associated lower attendance at extra class.
Whelan There was no association between group and treatment decision. Group 
3 associated with an increase in autonomy decision making and a 
reduction in perceived directiveness consultation.
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Appendix IV
TEST REPORT
Check carefully and 1? 0113 234 4013 
with corrections or updated information
L e e d s
A n t e n a t a l
Sc r e e n in g
S e r v ic e
Consultant Not Known 22-Apr-99
c/o Sister, Antenatal Clinic
Leeds General Infirmary
Clarendon Wing
Belmont Grove
Leeds
LS2 9NS
PATIENT
Name :
DOB :
Sample # :
PREGNANCY DETAILS
Age @ EDD :
LMP :
Dating Scan Details : 
Sample Date :
Gestation @ Sample : 
W eight:
MARKER LEVELS
AFP : 
uE3 :
free-beta h C G :
INTERPRETATION
Down's Syndrome Result : 
Down's Syndrome Risk : 
Edwards’ Syndrome Result 
Edwards' Syndrome Risk : 
NTD &AW D Result:
Patient SAMPLE 
24-Aug-5 8 
C,99.0000000.X
40 years 11 months (age-related Down's syndrome risk 1 in 100) 
04-Nov-98
14 weeks 3 days @ 15-Feb-99 
15-Feb-99
14 weeks 5 days (by LMP); 14 weeks 3 days (by scan)
75 Kg
0.46 MoM
0.20 MoM 
1.38 MoM
*** SCREEN POSITIVE *** (risk > or = 1 in 250)
1 in 10
Screen Negative 
1 in 60
Uninterpretable (AFP measured < 15  weeks gestation)
•  MoMs calculated using gestation by scan
•  Risks calculated at term
260
Describing women’s decision making process: item list.
P1 Comments/ Questions about the triple test
p1.1 understanding the cutoff (1 in 250) for a screen positive
p1 .2 what causes a screen positive triple test result (age, family, previous test)
p1.3 what does a screen positive mean (not having a child with Down syndrome)
p1 .4 what does a screen negative mean (having a child with Down syndrome)
p1.5 could have screened positive in previous pregnancies
p1 .6 is the tt risk specific to this pregnancy/ screen positive in future pregnancies
p1 .7 what is an average risk figure (is ours high/low)
p1 .8 triple test is inaccurate/ is the risk figure accurate
p1.9 would I get a different triple test result if had it again
p1 . 1 1  does the triple test result affect health baby (high hormones, etc)
p1 .12 does a screen positive mean there is something wrong with parents
p1.13 age risk not associated with triple test figure
p1.14 what does triple test test for/ not heard of Edward’s
p1.15 why triple test called the triple test (hormones, scan/blood/urine)
p1.16 is gestation based on scan/ what is figure based on Imp
p1.17 how long has the triple test been around
p1.18 why does this figure differ so much from previous triple test figure/ Imp/ age
p1.19 is age risk more accurate
p1 .20 edwards was mentioned
p1 .21 is raised tt familial (sister had screen positive tt)
P2 Comments/ questions about ‘no diagnostic test’ option
p2.1 what would nuchal pad tell me
p2.2 what does a (nineteen week) scan tell me
p2.3 can more be known further on in pregnancy
p2.4 is there a non-invasive alternative
p2.5 can the child be tested at birth
p2.6 can the child be adopted
p2.7 triple test provides reassurance (can do/ has done)
P3 Comments/ questions about diagnostic tests
p3.1 are they diagnostic/ tell for certain
p3.2 are there limb defects with cvs
p3.3 are there limb defects with amnio
p3.4 what are tests (cvs/amnio) testing for
p3.5 which test is more reliable/ accurate
p3.6 which test is more common
p3.7 test might give a negative result
p3.8 how likely is mosaic Down's/ inconclusive test results
p3.9
p3.10 who is offered amnio/ are tests offered to everyone
p4 Planning for tests
p4.1 when can the test be carried out (hospital limitations)
p4.2 what gestational age can the test be done (medical limitations)
p4.3 does the test hurt/ do they anaesthetise/ how test done
p4.4 do they scan the fetus ( and needle) during the procedure
p4.5 what happens after the test (rest, antiobiotics, stay in hospital)
p4.6 how long does test take
p4.7 is the consultant proficient/ risk of miscarriage minimised
p4.8 how do you get results of diagnostic
p4.9 what happens if scan screens positive/ would they tell us after 19 week scan
p4.10 can test damage the baby in other ways
P5 Comments/ questions about the consequences of testing/ not testing
p5.1 what is the risk of miscarriage
p5.2 are the risk figures quoted for the hospital or national/has anyone miscarried
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p5.4 what is the background risk of miscarriage/ could miscarry for other reasons
p5.5 when would a miscarriage occur
p5.6 why would a miscarry occur
p5.7 what would a miscarriage involve
p5.8 does a recent miscarriage affect test miscarriage
p5.9 what is the legal limit for termination
p5 . 1 1 what does termination involve
p5.12  is there counselling after termination
p5.13 when would termination take place
p5.14 if have a Down syndrome child, will it affect other pregnancies
p5.15 what information do you have about Down's syndrome
p5.16 what services do you provide for Down's syndrome
p5.17 how long do the diagnostic test results take/ can this time be reduced
p5.18 the diagnostic test result could be wrong/ inconclusive result
p5.19 differences in time between test result and scan are close
p5.20 would risk miscarriage reduce later in pregnancy
p5.21 what percentage of people have a diagnositic test and Down's syndrome kid
p5.22 even if scan +ve, still be normal
P6 Comments/ questions about Down Sydrome
p6.1 what are the causes Down syndrome
p6.2 there are different severities in Down syndrome/ can tests detect severity
p6.3 Down's syndrome child would be OK
p6.4 would want to hear parents view of Down's syndrome
p6.5 would want more information about Down's syndrome before made a
decision to terminate
p6.6 what information do you have about Down’s syndrome
P7 Comments/ questions about the decision
p7.1 do we have to decide now/ let you know later
p7.2 what do other people do
p7.3 what did you do
p7.4 what should we do/ what do you recommend
p7.5 difficult to take information in/ need to discuss it/ what does partner think
p7.6 need to go home and discuss my decision with family
p7.7 have all the information and know what want
P8 Use of risk
p8.1 used age-related risk when talking
p8.2 used triple test risk figure when talking
p8.3 used ‘other’ reference figure (previous triple test, cut-off figure)
p8.4 used amniocentesis risk figure when talking
p8.5 used CVS risk figure when talking
p8.6 used background miscarriage risk figure when talking
p8.7 used combined background and diagnostic miscarriage rates
p8.8 compared risk figures for triple test result and diagnostic
p8.9 compared risk figures for CVS and amniocentesis
p8.10 compared previous triple test figure with current risk
p8.11 compared population/age risk with own risk
p8.12 compared risk to cut-off limit
p8.13 misrepresented/ misunderstood risk figure
P9 Perception of risk
p9.1 triple test risk figure is a high risk
p9.2 triple test risk figure is an acceptable risk/ good odds
p9.3 diagnostic miscarriage rates are high
p9.4 diagnostic miscarriage rates are low
p9.5 I am more likely to get a screen positive
p9.6 I am more likely to have an Down syndrome child/ could be the one 
p9.7 I am more likely to miscarry
p9.8 compared with other risks Down syndrome figure is low/ miscarriage high 
p9.9 compared with other risks miscarriage figure is lowI others high 
p9.10 I am unlikely to miscarry
p9.11 I am unlikely to have Down syndrome baby (baby moves)
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p9.12 risk sounds better as a percentage
p9.13 risk Down’s syndrome outwieghs risk miscarriage
p9.14 this risk is more certain because (previous result...)
p9.15 scan reduces risk
P10 Comments about triple test and result
p1 0.1 regret having triple test/ not have triple test again
p1 0.2 triple test result affects pregnancy/ worry not normal
p10.3 triple test creates uncertainty
p10.4 getting the result was a shock/ is upsetting
p10.5 tt might reassure/ thought I would get a negative result/ didn’t cross my mind
p10.6 if I had a negative result/ was younger I would be none the wiser / happier
p10.7 didn't think hard about having triple test (HCP, family, had it before)
p10.8 thought hard about having triple test (reasons given for having it)
p10.9 had triple test because of age-ds link
p1 0.10 had the test and know I am at risk now
p1 0.11 wanted triple test for knowledge
p10. 12  thought positive meant good
p10.13 not heard tt before
p10.14 concerned that it has come back positive again
p10.15 friend/ relative had a screen positive triple and everything OK
p10.16 worrying that the triple test is still being researched
p10.17 screen negative still at risk
P11 Reasons for not having a diagnostic test
p11.1 did not have triple test last time (everything OK)
p11.2 had triple test last time (everything OK)
p11.3 not had diagnostic tests before (other kids healthy)
p11.4 Down syndrome not in the family
p11.5 risk of miscarriage/ worry of losing the baby
p1 1.6 worried about the procedure (needles)
p11.7 this is the last pregnancy
p1 1.8 problems getting pregnant/ miscarried before
p11.9 would not terminate even if it had Down syndrome/ emoationally hard
p1 1 . 1 1  prenatal testing interfering with nature
p11.12 other conditions more severe/ DS not such a bad condition
p11.13 scan reassuring
p11.14 won’t disrupt family/ other children
p11.15 practically a developed child (not terminate)
p11.16 want a baby no matter what
p11.17 want to take the Down's syndrome risk (not have a test)
p11.18 don’t want to know whether Down's syndrome
p11.19 friend had amnio and lost baby
P12 reasons for having a diagnostic test
p1 2.1 decided to have the diagnostic test before consultation
p12.2 had the triple test to find out, therefore have diagnostic test
p12.3 had diagnostic test before
p12.4 friend/ HCP/ relative had diagnostic test (and baby was fine)
p12.5 do not want to regret not having a diagnostic test
p12.6 did not realise had a choice
p12.7 to have the scan, to check baby alive
p12.8 have to know whether an abnormality (set mind at rest)
p12.9 can’t wait until term, live with uncertainty
p1 2.10
p12.11 do not want a Down syndrome child (can't take the risk)
p12.13 to be prepared (for the birth of a child with DS/ self & family)
p12.14 to terminate if result positive
p12.15 other children to consider/ we have one normal
p12.16 if had other children would be different
p12.17 woman/ partner would not cope with Down syndrome child
p12.18 woman would be the one to look after Down syndrome child
p12.19 have a family history of Down syndrome/ abnormality
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p12.21  no problems getting pregnant
p12.22 miscarry for other reasons
p12.23 still an embryo, not a child
p12.24 heard of amniocentesis
p12.25 not heard of chorionic villus sampling
p12.26 heard of chorionic villus sampling
p12.27 get to know sex
p12.28 scan not a certain result
p12.29 19 weeks scan too far on in pregnancy
p12.30 friend had abnormal child (bad effect on her and family)
p12.31 friend had diagnostic and everything OK
P13 Reason to choose one diagnostic test over another
p13.1 want to have a test but don't know which one
p13.2 there is a risk with both tests/ might as well have CVS
p13.3 still have to go through labour no matter which test (amnio, time not adv.)
p13.4 CVS get a result in 24 hours
p13.5 worth the risk to get a result in 24 hours
p13.6 CVS have to wait three weeks for a follow up result
p13.7 amniocentesis takes three weeks to get a result (affect...hard)
p13.8 not worth the risk to get a result in 24 hours
p13.9 amniocentesis has a lower rate of miscarriage
p13.11 CVS has a higher rate of miscarriage
p13.12 CVS get limb defects
p13.13 CVS get more inconclusive results (md)
p13.14 cvs same risk as amnio
p13.15 find out sooner in pregnancy (before kicking)
p13.16 three weeks better than term
p13.17 have both tests
P14 Reference to Down Syndrome
p14.1 a child with Down syndrome never grows up/ child in adult body
p14.2 a child with Down syndrome will be unusual in the world/ freaks
p14.3 child with Down syndrome will not have a full life/ feel sorry for them
p14.4 Down syndrome is life-threatening
p14.5 it's for life/ what happens when we're not here
p14.6 condition 'x' less severe than Down syndrome
p14.7 had positive experiences of Down syndrome
p14.8
p14.9 more severe Down's syndrome picked up on scan 
p14.10 knew someone with Down's syndrome 
p14.11 Down's syndrome time consuming 
p14.12 worked with Down’s syndrome
p14.13 knowledge that Down's syndrome has physical problems 
p14.14 if it is Down's syndrome, there now 
P15 Causes of Down syndrome 
p15.1 Down syndrome related to age
p15.2 there is a mental disability in the family/ inherited/ familial 
p15.3 mental disability not in family 
P16 Conflict in decision making
p16.1 it is a difficult decision/ don't know what to do/ don't want to make a decision 
p16.2 want to make a decision today
p16.3 uncertain whether terminate, depends result/ know for sure/ one step at time
p16.4 will make a decision after the nineteen week scan
p16.5 if a positive result will seek more information about Down syndrome
p16.6 don’t know how I would feel about a Down syndrome child until born
p16.7 my attitudes appear cruel/ heartless
p16.8 my decision is against the norm - most terminate
p16.9 my decision against norm - some people cope with Down syndrome
p16.11 decision to have diagnostic test goes against beliefs
p16.12 decision to terminate emotionally difficult/ against beliefs self/ family
p16.13 want test now
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p16.14 don’t want test now
p16.15 don’t want to make a decision now/ need more time
p16.16 my decision against norm - should have test
p17 Health Professional Advice/ Comments
p17.1 ‘s/he’ said don't have test unless consider termination
p17.2 ‘s/he’ advice good/ talked through all alternatives
p17.3 ‘s/he’ expressed said triple test unaccurate/ unreliable
p17.4 ‘s/he’ encouraged me to have triple
p17.5 ‘s/he’ encouraged me to have diagnostic
p17.6 HCP said at scan baby healthy, active/ OK
p17.7 s/he discouraged me to have tt
p17.8 s/he discouraged me to have diagnostic
p17.9 HCP gave contrary advise to HB
p17.10 HCP said amnio was the better test
p17.11 HCP said chorionic villus sampling was the better test
p18 Experience
p18.1 had a recent bleed
p18.2 had a screen positive before
p18.3 had a diagnostic test before
p18.4 had a termination before/ know about termination (work) 
p18.5 (related) baby ill/ abnormality 
p18.6 experience infertility/ waited to have a baby 
p18.7 miscarried before
p18.8 saw baby on scan and brings a new perspective
p18.9 genetic risk in family/ had genetic tests before/ know about risk
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Appendix VII
Coding frame for women’s decision making.
Woman ID: Group: Risk: Decision:
Theme Number Observations
1. No Test Option (non invasive/ scan)
1 . 1  information seeking / planning
1.2 reasons for
1.3 reasons against
2. Test Option
2.1 information seeking / planning
2.2 reasons for
2.3 reasons against
3. Choice between tests - neutral comment
4. Chorionic villus sampling choice
4.1 information seeking / planning
4.2 reasons for
4.3 reasons against
5. Amniocentesis choice
5.1 information seeking planning
5.2 reasons for
5.3 reasons against
6 . Down syndrome consequence
6.1 information seeking/ planning
6.2 neutral-positive reference
6.3 negative reference
7. Miscarriage consequence
7.1 information seeking/ planning
7.2 neutral - positive reference
7.3 negative reference
8 . Termination consequence
8.1 information seeking/ planning
8.2 neutral - positive comment
8.3 negative reference
9. Risk figure reference
9.1 single risk Down syndrome
9.2 single risk miscarriage
9.3 comparison risks
10. Perception of risk reference
10.1 minimised Down syndrome risk
10.2 maximised Down syndrome risk
10.3 minimised miscarriage risk
10.4 maximised miscarriage risk
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Theme Number Observations
11. Expressed Affect
1 1 . 1  triple test (shock)
1 1 .2  diagnostic test (hard) - conflict
11.3 termination (hard) - conflict
11.4 reassurance testing
11.5 anticipated regret
12. Decision Making
12. 1  triple test
12.2 diagnostic test made before consultation
12.3 termination / stage at a time
12.4 delay in making decision - uncertainty
12.5 confidence with decision - certainty
12.6 consultation / disucssion final decision
13. Triple test - further explanation
13.2 Nuchal pad
14. Confidence with screening results
15. Comparison norms (others / you do)
15.1 what would you suggest
15.2 what do others do / general percentages
16. Personal experiences
16.1 physical aspects pregnancy (scan/ move)
16.2 complications with pregnancy (misc.)
16.3 prior testing / pregnancies
16.4 abnormalities / genetics
16.5 not telling others about pregnancy
17. Others experience
17.1 prenatal testing
17.2 abnormalities / genetics
18. Preparation pregnancy (birth, telling others)
19. Health professionals’ advice
19.1 neutral / positive comments
19.2 dissatisfaction / directive
19.3 inaccurate / conflicting consultation
20. Other sources information
Modified coding frame categories aggregating themes.
Aggregated themes women
(n=44)
%
(2) All test options - calculated from themes 2, 3, 4 & 5.
information seeking about testing (from 2.1, 3, 4.1 & 5.1) 43 98 %
reasons for having a test (from 2.2, 4.2 & 5.2) 41 93 %
reasons against having a test (from 2.3, 4.3 & 5.3) 37 84 %
(11) Total negative affect - calculated from 11.1 & 11.2 25 57 %
(16) Personal experiences - calculated from all sub groups 29 66 %
(17) Others experience - calculated from all sub groups 17 39 %
(19) Health professionals’ advice - calculated from all sub groups 18 41 %
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Visual prompts used during the decision analysis consultation: 
decision tree: lottery question: threshold graph.
Decision tree prompt.
healthy baby (at birth)
■© miscarriage
^  baby with Down’s syndrome (at birth) 
Decision
healthy baby (at 20 weeks)
.© miscarriage
---------------------------------------------O continue pregnancy
. | baby with Down’s syndrome (at 20 weeks) + Decision 
___________________________q  terminate pregnancy
Prompt for extraction of utilities.
What is the value of
Appendix VIII
% risk of termination % risk of Down's syndrome
diagnostic test
no diagnostic test
------ a
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Consent from for the randomised control trial.
LEEDS GENERAL INFIRMARY ANTE-NATAL STUDY
Making Decisions in Pregnancy
During pregnancy, women are asked to make many decisions that affect the well-being of either 
themselves or their fetus. For example, women can choose to have a test, or not, that will tell 
them the likelihood of their fetus having a disease or abnormality. Some decisions during 
pregnancy are more difficult to make than others.
This study is looking at two ways of giving information to women who are deciding to have 
further tests in pregnancy or not. Your views and experiences will further our understanding of 
what information women find most useful when making these decisions. For example, do women 
find the information easier to understand and more helpful if it is presented in one way rather 
than another.
Taking part in the study.
Hilary Bekker is the clinical researcher for this project. Hilary will be talking with you about your 
triple test result and giving you information about the options available at this stage in your 
pregnancy.
Agreeing to take part in the study involves being randomised to one of two information-giving 
groups. The only difference between the two groups is the way the information is presented. The 
consultations will be tape-recorded and you will be asked to complete a questionnaire after the 
consultation and in four weeks time. The questionnaire takes about fifteen minutes to complete. 
Your responses during the consultation and from the questionnaires are confidential. You will 
be given a 'study number' so only Hilary can match your name with the study information. Hilary 
will be happy to answer any questions you may have about this study.
If you decide not to take part in the study, you will still receive the routine care provided by the 
ante-natal clinic at this hospital.
Consent
Name (in block letters)..........................................................................................
Please answer yes or no
a) I have read the information sheet: yes/ no b) I agree to take part in the study: 
yes/ no
Signature:...................................................................................................................................
Appendix IX
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We are interested about how you are feeling now. There are no right or wrong 
answers to these questions. Please circle one number for each question.
A number of statements which people have used to describe themselves are given 
below. Read each statement and then circle the most appropriate number to the right of 
the statement to indicate how you feel right now, at this moment. There are no right or 
wrong answers. Do not spend too much time on any one statement but give the answer 
which seems to describe your present feelings best.
not at all somewhat moderately very much
1 . I feel calm..... 1 2 3 4
2 . I feel tense .... 1 2 3 4
3. I am upset....  1 2 3 4
4. I feel relaxed . 1 2 3 4
5. I feel content. 1 2 3 4
6 . I am worried ...1 2 3 4
7. How likely do you think you are to: not at all likely
have a healthy child 
have a child with Down syndrome 
miscarry a fetus without Down syndrome 
miscarry a fetus with Down syndrome
0
0 -
0 -
0 -
-1 ------2 ------
- 1 ---------------2 —
„ 1 -----------2 —
_ 1 ---------------2 —
3 — 
3 — 
3 — 
3 —
-4 ...
.4 -
_4 ...
.4 ...
very likely
— 5 -------6
— 5 ------6
—5 ------6
—5 ------6
8 . What concerns, if any, do you have at the moment about your: 
a) health (please list):
b) pregnancy (please list):
c) baby (please list):
Thank you for answering all the questions.
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Linguistic Inquiry and Word Count: II (SLIWC)
Appendix X
James W. Pennebaker and Martha E. Francis
Correspondence should be addressed to James W. Pennebaker, Department of Psychology, 
Mezes Hall, The University of Texas, Austin, TX 78712 (e-mail: Pennebaker@psy.utexas.edu).
Dimension Examples
1. STANDARD LINGUISTIC DIMENSIONS
Word Count
Words per sentence
Sentences ending with ?
Unique words (type/token ratio)
% dictionary words captured
% words longer than 6 letters
Total pronouns I, our, they, you're
1 s person singular I, my, me
1 st person plural we, our, us
Total first person I, we, me
Total second person you, you'll
Total third person she, their, them
Negations no, never, not
Assents yes, OK, mmhmm
Articles a, an, the
Prepositions on, to, from
Numbers one, thirty, million
II. PSYCHOLOGICAL PROCESSES
Affect: Emotional Processes happy, ugly, bitter
Positive Emotions happy, pretty, good
Positive feelings happy, joy, love
Optimism and energy certainty, pride, win
Negative Emotions hate, worthless, enemy
Anxiety or fear nervous, afraid, tense
Anger hate, kill, pissed
Sadness or depression grief, cry, sad
Cognitive Processes cause, know, ought
Causation because, effect, hence
Insight think, know, consider
Discrepancy should, would, could
Inhibition block, constrain
Tentative maybe, perhaps, guess
Certainty always, never
Sensory and Perceptual Processes see, touch, listen
Seeing view, saw, look
Hearing heard, listen, sound
Feeling touch, hold, felt
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Dimension Examples
III. PSYCHOLOGICAL PROCESSES
Social Processes talk, us, friend
Communication talk, share, converse
Other references to people 1st pi, 2"a, 3rd per pms
Friends pal, buddy, coworker
Family mom, brother, cousin
Humans boy, woman, group
Time hour, day, oclock
Past tense verb walked, were, had
Present tense verb walk, is, be
Future tense verb will, might, shall
Space around, over, up
Up up, above, over
Down down, below, under
Inclusive with, and, include
Exclusive but, except, without
Motion walk, move, go
IV. PERSONAL CONCERNS
Occupation work, class, boss
School class, student, college
Job or work employ, boss, career
Achievement try, goal, win
Leisure activity house, TV, music
Home house, kitchen, lawn
Sports football, game, play
Television / movies TV, sitcom, cinema
Music tunes, song, cd
Financial issues cash, taxes, income
Metaphysical issues God, heaven, coffin
Religion God, church, rabbi
Death and dying dead, burial, coffin
Physical functions ache, breast, sleep
Body states ache, heart, cough
Sex and sexuality lust, penis, fuck
Eating / drinking eat, swallow, taste
Sleeping / dreaming asleep, bed, dreams
Grooming wash, bath, clean
APPENDIX: EXPERIMENTAL TERMS
Swear words damn, fuck, piss
Nonfluencies uh, rr*
Fillers youknow, Imean
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Post-Decision Questionnaire (T1): facilitating informed decision making. 
LEEDS GENERAL INFIRMARY ANTE-NATAL STUDY =~
Prenatal Testing Questionnaire (T1)
Study Number ....................  Group 1 r / 2 ( d a )  t t / age
The following questionnaire is part of the project looking at how women 
make decisions during pregnancy. The questionnaire takes about fifteen 
minutes to complete. Filling in the questionnaire will not interfere with the 
care you receive from this clinic.
Your experiences and views of making decisions in pregnancy are 
important to this study. The results of this study will provide us with a better 
understanding of what information women find useful at this stage in their 
pregnancies.
If you have any questions about the study, or the questionnaire, please tell 
Hilary Bekker. The answers you give in this questionnaire are confidential 
and anonymous. Only Hilary can match your study number with your name.
Thank you for your time.
Appendix XI
Hilary Bekker
Clinical Researcher, 
University of Leeds.
Mr Jim Thornton
Consultant in Obstetrics and 
Gynaecology, Leeds General Infirmary.
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The following questions ask for details about you.
1. What is your marital status:
married □ living as married □ single □ other (.............................. )
2. What is the highest level of education you have received (please tick the highest)
no formal level of education □ GCSE equivalent ('O' level/ 'CSE1) □
apprenticeship (Btec/ HND/ city & guilds)□ 'A' level equivalent (highers etc.) □ 
Degree or more □
3. Do you follow a religion: yes, it is ............................................................. /no
If yes, how often do attend religious gatherings (please tick one box):
not at all □ a few times a yearn once a month □ once a week or more □
4. How would you describe your ethnic origin:
White □ Black - Caribbean □ Black - African □ Black - Other □
Indian □ Pakistani □ Bangladeshi □ Chinese □ Other □
5. Your increased risk figure for having a baby with Down syndrome is 1 in _______
Would you describe this risk as: low □ medium □ high □
6. Have you had any contact with people with Down syndrome?
no □ no, just seen someone in village/ street □ no, only on TV □
yes, family historyD yes, friend of the family □ yes, through work □
7. Was this pregnancy planned: yes/ no
8. What tests have you had or are about to have in:
a ) th is  p re g n a n c y  a n d  b ) y o u r  la s t  p re g n a n c y :
u ltra s o u n d  s c a n n u c h a l p ad tr ip le  te s t a m n io c e n te s is CVS
THIS p re g n a n c y
LAST p re g n a n c y
A number of statements which people have used to describe themselves are given below. Read 
each statement and then circle the most appropriate number to the right of the statement to 
indicate how you feel right now, at this moment. There are no right or wrong answers. Do not 
spend too much time on any one statement but give the answer which seems to describe your 
present feelings best.
n o t  a t a s o m e w h a t  m o d e ra te ly  v e ry  m u c h
9. I feel calm........................... 1 2 3 4
1 0 . I feel tense.......................... 1 2 3 4
1 1 . I am upset........................... 1 2 3 4
1 2 . I feel relaxed...................... 1 2 3 4
13. I feel content...................... 1 2 3 4
14. I am worried.......................... 1 2 3 4
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The following question asks for your views and feelings about prenatal testing in general.
15. Some people think there are both advantages and disadvantages to having tests 
in pregnancy. In the box below, please list the advantages and disadvantages that are 
important to you and rate how much of an advantage or disadvantage it is (no more than 
six of each).
Advantaqes
small advantage 1 2 3 5 great advantage
small advantage 1 2 3 5 great advantage
small advantage 1 2 3 5 great advantage
small advantage 1 2 3 5 great advantage
small advantage 1 2 3 5 great advantage
small advantage 1 2 3 5 great advantage
Disadvantages
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
The following questions ask how you feel about the decision you made to have, or not have, 
amniocentesis or chorionic villus sampling (CVS). There are no wrong or right answers (please 
circle one number).
16. Before this consultation had you made a decision to have or not have a test:
yes □ no □ If yes, please state which test..................................................................................
17. Before this consultation did you intend to have a diagnostic test:
definitely did not definitely did
0 1 2 3 4 5 6
18. How much time did you spend thinking about the decision to have/not have 
amniocentesis?
very little time a lot of time
0 1 2 3 4 5 6
After reading the following statements, please circle a number that reflects how you much you 
agree with them
19. The decision to have/ not have a test was hard to
strongly agree neither agree
agree nor disagree
1 2 3
20. I was unsure whether to have/ not have a test:
strongly agree neither agree
agree nor disagree
1 2 3
21. It was clear what the best choice was for me:
strongly agree neither agree
agree nor disagree
1 2 3
make:
disagree
4
strongly
disagree
5
disagree
4
disagree
4
strongly
disagree
5
strongly
disagree
5
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22. I was aware of the choices I had based on my triple test result:
23.
24.
25.
26.
strongly agree neither agree
agree nor disagree
1 2 3
I feel I know what the benefits of having a test are: 
strongly agree neither agree 
agree nor disagree
1 2 3
I feel I know what the risks of having a test are:
strongly agree neither agree
agree nor disagree
1 2 3
disagree strongly 
disagree 
4 5
disagree strongly 
disagree 
4 5
disagree strongly 
disagree 
4 5
I feel I have made an informed choice about whether to have a test or not:
disagree strongly 
disagree 
4 5
strongly agree neither agree
agree nor disagree 
1 2 3 
My decision shows what is most important for me:
strongly agree neither agree
agree nor disagree 
1 2 3
disagree
27. The decision to have or not have a test was entirely up to me
strongly agree neither agree disagree
agree nor disagree
1 2  3 4
28. I am satisfied with my decision
strongly agree neither agree disagree
agree nor disagree
1 2  3 4
29. I expect to stick with my decision
strongly agree neither agree disagree
agree nor disagree
1 2  3 4
strongly
disagree
5
strongly
disagree
5
strongly
disagree
5
strongly
disagree
5
The following question is about the five consequences health professionals mention when talking 
about prenatal testing:
30. When health professionals talk about tests in pregnancy they mention five 
consequences of the tests (listed below). The consequences differ in importance for each 
person. Please place a mark along the dotted scale to show how 'bad' or 'good' each 
consequence is for you:
bad good
having a normal baby ................................................................................................
miscarrying a baby with Down syndrome
terminating a fetus with Down syndrome
having a baby with Down syndrome
miscarrying a normal baby
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31. Imagine a close friend has the same risk of having a baby with Down syndrome as 
you and she asks you for some advice about amniocentesis (CVS). Would you encourage 
her to have amniocentesis (CVS) (please circle one response)?
strongly encourage neither encourage/ discourage strongly
encourage nor discourage discourage
1 2 3 4 5
The following questions ask you how useful the information about amniocentesis (CVS) was to 
you.
32. Was there anything you wanted more information about? yes/ no
if yes please state...............................................................................................................
33. Please write below what bits of information were helpful and unhelpful to you 
when making the decision to have, or not have, amniocentesis (CVS): __________
Helpful information Unhelpful information
34. Overall, how useful was the information given during this consultation (please 
circle one number): not at all useful very useful
0 ------  1 ------2 --------  3 ------  4 ------  5 ------  6
35. Do you feel the following people encouraged you to have amniocentesis (CVS).
S).
discouraged
Please circle one response for each person that you spoke to about amniocentesis (CV ).
did not strongly encouraged neither encouraged strongly i
discuss encouraged nor discouraged discouraged
a midwives □ 1 2 3 4 5
b obstetrician □ 1 2 3 4 5
c general practitioner □ 1 2 3 4 5
d the researcher □ 1 2 3 4 5
e husband / partner □ 1 2 3 4 5
f other □ 1 2 3 4 5
The following questions ask you about a previous decision you made: the decision to have the 
triple test. Again, these questions ask for your views so there are no right or wrong answers.
36. How much time did you spend thinking about the decision to have the triple test?
very little time a lot of time
0 ------  1 ------ 2 ------ 3 ------ 4 ------  5 ------  6
37. There are many reasons why women have the triple test. What reason made up 
your mind to have the triple test?
38. Do you regret having had the triple test at all (please circle one response):
no regret regret very much
0 ------  1 ------2 --------  3 ------  4 ------ 5 ------  6
39. Imagine a close friend the same age as you asks for advice about the triple test. 
Would you encourage her to have the triple test (please circle one response)?
strongly encourage neither encourage/ discourage strongly
encourage nor discourage discourage
1 2 3 4 5
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40. Do you feel the following people encouraged you to have the triple test. Please 
circle one response for each person that you spoke to about the triple test.
did not strongly encourage neither encouraged strongly discouraged
discuss encouraged nor discouraged discouraged
a midwives □ 1 2 3 4 5
b obstetrician □ 1 2 3 4 5
c general practitioner □ 1 2 3 4 5
d husband / partner □ 1 2 3 4 5
e other D 1 2 3 4 5
Some women find pregnancy a worrying time. The following questions ask you how worried you 
a re .
41. How worried are you that the following harm the fetus (please circle one number 
for each item):
not at all worried very worried
(a) ultrasound scan 0 ------  1 ------ 2 ------ 3 -----  4 ------ 5 ------ 6
(b) emotional upset 0 ------  1 ------ 2 ------ 3 -----  4 ------ 5 ------ 6
(c) triple test 0 ------  1 ------ 2 ------ 3 -----  4 —  5 — 6
(d) amniocentesis 0 ------ 1 ------  2 ------  3 -----  4 ------ 5 ------ 6
(e) taking medication 0 ------  1 ------ 2 ------ 3 -----  4 ------  5 ------ 6
(f) chorionic villus sampling 0 ------  1 ------ 2 ------ 3 -----  4 —  5 — 6
42. How worried are you about the baby having (please circle one number for each
item):
not at all worried very worried
(a) a physical disability 0 ------  1 ------ 2 ------ 3 -----  4 ------ 5 ------ 6
(b) a mental disability 0 ------ 1 ------ 2 ------ 3 -----  4 ------ 5 ------ 6
(c) a serious health problem 0 ------  1 ------ 2 ------  3 -----  4 ------ 5 ------ 6
43. 1 need to know for certain whether or not this baby has Down syndrome
not at all very much
p ----- 1 --------  2 ------ 3 ------ 4 ------ 5 ------ 6
The following questions are about your views on disability and how likely you think the possible 
consequences of testing are to happen to you (please circle one number for each question)
44. Do you feel a child's life would be affected by the following: (please circle a
response for each item)_____________________________________________________________________
Condition how affected not at all greatly
____________________________________ affected_________________________affected
cleft palate/lip quality of life 0 ------1 -------2 -------3 -------4 -------5 -------6
__________________ amount of care________ 0 ----- 1 -------2 -------3 -------4 -------5 -------6
Down syndrome quality of life 0 ------1 -------2 -------3 -------4 -------5 -------6
__________________ amount of care________ 0 ------1 -------2 ------ 3 -------4 -------5 -------6
spina bifida quality of life 0 ------1 -------2 -------3 -------4 -------5 -------6
amount of care 0 ------1 -------2 ------ 3 -------4 -------5 -------6
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45. How likely do you think you are to: 
have a healthy child 
have a child with Down syndrome 
miscarry a fetus without Down syndrome 
miscarry a fetus with Down syndrome 
terminate a pregnancy for spina bifida 
terminate a pregnancy for a cleft palate 
terminate pregnancy for Down syndrome
not at all likely
0 -
0 -
0 -
O'
0
0
0
------2
------2 •
------2 •
----- 2
------ 2
------2
------2
very likely
-3 ------4 ------5 ------6
-3 ------4 ------5 ------6
-3 ------4 ------5 ------6
-3 ----- 4 ------5 ------6
- 3 ------4 ------5 ------6
. 3 ------4 ------5 ------6
-3 ----- 4 ------5 ------6
46. Most people who are important to me should should not 
think I should:
have had the triple test for Down syndrome 0 ----- 1 ------2 ------3 ------4 ------5 ------6
have a diagnostic test 0 ----- 1 ------2 ------3 ------4 ------5 ------6
terminate a pregnancy for Down syndrome 0 ----- 1 ------2 ------3 ------4 ------5 ------6
47. Is there anything that you think may increase or decrease the likelihood of having 
a child with Down syndrome (please list your response in the space below)
48. Compared with women your age: less likely about the same more likely
how healthy would you say you were 0 --------1 ------2 ------3 ------4 ------5 ------6
how likely to develop a health problem 0 --------1 ------2 ------3 ------4 ------5 ------6
how likely to have a healthy child 0 --------1 ------2 ------3 ------4 ------5 ------6
how likely have a child with Down syndrome 0 ------- 1 ------2 ------3 ------4 ------5 ------6
how likely to miscarry a pregnancy 0 --------1 ------2 ------3 ------4 ------5 ------6
The next part of the questionnaire asks your opinions about the purpose of tests in pregnancy. 
How much do you agree with the following statements (please circle one number for each 
question).
49. Tests during pregnancy are necessary for my well-being:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
50. Tests during pregnancy improve my chance of having a healthy baby:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
51. Tests during pregnancy are necessary for the well-being of the fetus:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
52. Tests during pregnancy decrease my chance of miscarrying:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
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The following questions are about your knowledge of tests in pregnancy. Please answer the 
questions for all three tests. Do not worry if you do not know all the answers:
53. To whom are the following tests routinely offered, in this hospital (please tick aU
all
women
women 
over 29
women 
over 35
family history 
Down’s syndrome
screen positive 
triple test result
don’t
know
triple test
amniocentesis
CVS
54. The following are tests for (please tick all boxes that apply for each test)?
all health 
abnormalities
Down ‘s 
syndrome
all known chromosomal 
abnormalities
spina bifida none of 
these
don’t
know
triple test
amniocentesis
CVS
55. The following three tests use what type of sample (please tick one box for each 
test)?
your blood your urine your baby’s 
blood
fluid from around 
the baby
cells from 
the placenta
don’t
know
triple test
amniocentesis
CVS
56. Are the following screening procedures (telling you whether you are more or less 
likely to have a baby with a disability), diagnostic procedures (give you as definite a 'yes’ 
or 'no' answer as medicine can) or neither (e.g. routine checks) (please tick one response 
for each test).
(a)
(b)
(c)
(d) 
(e)
57.
woman s age 
triple test 
amniocentesis 
ultrasound scan
screening test □ diagnostic test □ neither □ don't know □ 
screening test □ diagnostic test □ neither □ don't know □ 
screening test □ diagnostic test □ neither □ don't know □ 
screening test □ diagnostic test □ neither □ don't know □ 
diagnostic test □ neither □ don't know □chorionic villus sampling: screening test □
A negative test result for the following tests usually means (please tick one item only
the baby definitely 
does not have Down's
it is unlikely the 
baby has Down's
the baby might 
have Down's
the baby definitely 
does have Down's
don'
knov
triple test
amniocentesis
CVS
58. A positive test result for the following tests usually means (please tick one item only
the baby definitely 
does not have Down's
it is unlikely the 
baby has Down's
the baby miqht 
have Down's
the baby definitely 
does have Down's
don'
knov
triple test
amniocentesis
CVS
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59. How long does it take for the results from each test to come back (please tick one 
box for each test)"?
1 to 2  days 1 to 2 weeks 3 to 4 weeks don’t know
triple test
amniocentesis
CVS
60. The extra risk of miscarriage after having the following three tests is (please tick one box 
for each test)?
no extra 
risk
greater 
than 1 in 50
1 in 50
( 2%)
1 in 100 
( 1 1 )
1 in 150 
(0.7%)
1 in 200 
(0.5%)
less than 
1 in 200
don't
know
triple test
amniocentesis
CVS
61. The average population risk of a baby being born with Down syndrome is (please 
tick a box)?
a) 1 in 5 (20%) □ d) 1 in 600 (0.002%) □
b) 1 in 60 ( 2%) □ e) 1 in 1000 (0.001%) □
c) 1 in 100 ( 1  %) □ f) don't know □
62. The overall population risk of a woman miscarrying in pregnancy is (please tick 
one box)?
a) 1 in 5 (20%) □ d) 1 in 600 (0.002%) □
b) 1 in 60 ( 2%) □ e) 1 in 1000 (0.001%) □
c) 1 in 100 ( 1 %) □ f) don't know □
This is the final set of questions. Different people have different ways of thinking about problems. 
The following questions ask about how you feel towards solving problems. Please circle one 
number for each item.
strongly agree 1
63. I hardly ever expect things to go my way strongly agree 1
64. Thinking is not my idea of fun strongly agree 1
65. I would rather do something that requires little thought strongly agree 1 
than something that will challenge my thinking abilities
66. The idea of relying on thought to make my way to the 
top appeals to me
67. The notion of thinking abstractly is appealing to me strongly agree 1
68. I like to have the responsibility of handling a situation strongly agree 1 
that requires a lot of thinking
69. I really enjoy a task that involves coming up with new strongly agree 1 
solutions to problems
70. It's enough for me that something gets the job done: strongly agree 1 
I don’t care how or why it works
71. Learning new ways to think doesn't excite me very strongly agree 1 
much
72. I always look on the bright side strongly agree 1
2 3 4 5 strongly 
2 3 4 5 strongly
disagree
disagree
disagree2 3 4 5 strongly
2 3 4 5 strongly disagree
2 3 4 5 strongly disagree
2 3 4 5 strongly disagree
2 3 4 5 strongly disagree
2 3 4 5 strongly disagree
2 3 4 5 strongly disagree
2 3 4 5 strongly disagree
Thank you for answering all these questions.
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Development of the short-form Need for Cognition Scale (NFC).
Background: "Need for cognition refers to an individual's tendency to engage in and 
enjoy effortful cognitive endeavours" (p.306; Cacioppo, Petty and Kao, 1984). The 
'short-form' questionnaire developed by Cacioppo et al includes eighteen items to 
measure this one construct. As the eighteen items aim to measure one construct, 
participants comment on the repetitive nature of the items. Certainly, an eighteen item 
measure is long when a variety of constructs are being assessed. The following analysis 
was carried out to produce a shorter 'need for cognition' (NFC) scale on a British 
sample.
Sample: 160 psychology undergraduates at a university in the UK.
Analysis: a) principal components analysis to extract items
b) Chronenbach's alpha correlation to assess internal reliability
c) Pearson's correlation to assess the relationship between the 
short form questionnaires with the eighteen item questionnaire
Results: eighteen items were entered into the principal components analysis. 
Factors with Eigen values of greater than 1.00 were included and items with loadings of 
.55 were considered for further analysis. Six factors were extracted, accounting for 62% 
of the total variance (factor 1, factor 2, factor 3, factor 4, factor 5, factor 6 accounted for 
26%, 11%, 7%, 6%, 6%, 6% respectively of the variance). As the NFC has been 
developed to measure one construct, only the results of factor one are reported.
Appendix XII
Table 1:______ loadings of items on factor 1 (>.55)
Factor 1 
26% variance
Thinking is not my idea of fun .74
1 would rather do something that requires little thought then something that is 
sure to challenge my thinking abilities
.73
The idea of relying on thought to make my way to the top appeals to me .65
The notion of thinking abstractly is appealing to me .61
It's enough for me that something gets the job done, 1 don't care how or why 
it works
.60
1 try to anticipate and avoid situations where there is a likely chance 1 will 
have to think in depth about something
.59
1 like to have the responsibility of handling a situation that requires a lot of 
thinking
.58
Learning new ways to think doesn't excite me very much .58
1 really enjoy a task that involves coming up with new solutions to problems .55
Reverse scoring of items in italics.
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The internal reliability of nine measures of the NFC scale were considered: 18 item, and 
nine to two item questionnaires. In order to select items for inclusion in the short-form 
questionnaires, individual items were correlated with the sum of the eighteen-item 
questionnaire. These correlations were ranked and those items with the lowest 
correlations were systematically removed to form the short-forms.
Table 2: items loading greater than .55 on factor 1 correlated with the sum of all
eighteen items (reverse scoring of items in italics.)
sum 18 item correlations
Thinking is not my idea of fun 0.70
1 would rather do something that requires little thought then something 
that is sure to challenge my thinking abilities
0.66
The idea of relying on thought to make my way to the top appeals to me 0.60
The notion of thinking abstractly is appealing to me 0.57
1 like to have the responsibility of handling a situation that requires a lot 
of thinking
0.56
1 really enjoy a task that involves coming up with new solutions to 
problems
0.56
It's enough for me that something gets the job done, 1 don't care how or 
why it works
0.54
Learning new ways to think doesn't excite me very much 0.54
1 try to anticipate and avoid situations where there is a likely chance 1 will 
have to think in depth about something
0.52
Table 3: Chronenbach's alpha coefficients for nine short-form questionnaires
Alpha coefficient
18 items 0.81
9 items 0.83
8 items 0.81
7 items 0.79
6 items 0.77
5 items 0.76
4 items 0.76
3 items 0.74
2 items 0.72
Table 4: short-form and 18 item questionnaire correlations
Eighteen item questionnaire
9 items 0.90
8 items 0.90
7 items 0.89
6 items 0.89
5 items 0.86
4 items 0.83
3 items 0.81
2 items 0.77
Summary: the first factor extracted by the principal component analysis accounted for 
26% of the variance which is comparable with Cacioppo et al's original 34 item 
questionnaire. All the short-form questionnaires had satisfactory internal reliability
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scores (>0.70). Following the correlation of the short-form questionnaires with the 
eighteen item scale, only two scales had correlation coefficients of greater than 0.90, 
the eight and nine item scales. In summary, the eight item short-form appears to be as 
reliable as the nine item and is comparable with the eighteen item.
Items to be included in the short-form need for cognition scale (reverse scoring 
of items in italics).
Thinking is not my idea of fun
I would rather do something that requires little thought then something that is sure to challenge my 
thinking abilities
The idea of relying on thought to make my way to the top appeals to me 
The notion of thinking abstractly is appealing to me
I like to have the responsibility of handling a situation that requires a lot of thinking 
I really enjoy a task that involves coming up with new solutions to problems 
It's enough for me that something gets the job done, I don't care how or why it works 
Learning new ways to think doesn't excite me very much
Hilary Bekker, Department of Psychology, University of Leeds, LS2 9JT 
Mark Conner, Department of Psychology, University of Leeds, LS2 9JT 
(November, 1995)
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Follow-up Questionnaire (T2): facilitating informed decision making.
Appendix XIII
LEEDS GENERAL INFIRMARY ANTE-NATAL STUDY
Prenatal Testing Questionnaire (T2)
Study Number ...................  Group: 1 (r) I 2 (da) tt I age
The following questionnaire is the final part of the project looking at 
how women make decisions during pregnancy. The questionnaire 
takes about fifteen minutes to complete. Filling in the questionnaire 
will not interfere with the care you receive from this clinic.
Your experiences and views of making decisions in pregnancy are 
important to this study. The results of this study will provide us with a 
better understanding of what information women find useful at this 
stage in their pregnancies.
If you have any questions about the study, or the questionnaire, 
please contact Hilary Bekker (0113 233 6696). The answers you give 
in this questionnaire are confidential and anonymous. Only Hilary can 
match your study number with your name.
Please return the questionnaire in the stamped-addressed envelope 
provided.
Thank you for your time.
Hilary Bekker
Clinical Researcher, 
University of Leeds.
Mr Jim Thornton
Consultant in Obstetrics and 
Gynaecology, Leeds General Infirmary.
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Study num ber......................
The following questions ask you for some details about tests you had during this 
pregnancy.
1. Your increased risk figure for Down syndrome was 1 in _______
Would you describe this risk as a low □ medium □ high □
A number of statements which people have used to describe themselves are given below. 
Read each statement and then circle the most appropriate number to the right of the 
statement to indicate how you feel right now, at this moment. There are no right or wrong 
answers. Do not spend too much time on any one statement but give the answer which 
seems to describe your present feelings best.
not at all
2.
3.
4.
5.
6. 
7.
I feel calm....
I feel tense ....
I am upset....
I feel relaxed.
I feel content
I am worried ..
somewhat
2
2
2
2
2
2
moderately
3
3
3
3
3
3
very much
4
4
4
4
4
4
The following question asks for your views and feelings about prenatal testing in general.
8 . Some people think there are both advantages and disadvantages to having 
tests in pregnancy. In the box below, please list the advantages and 
disadvantages that are important to you and rate how much of an advantage or 
disadvantage it is (no more than six of each).
Advantaqes
small advantage 1 2 3 4 5 great advantage
small advantage 1 2 3 4 5 great advantage
small advantage 1 2 3 4 5 great advantage
small advantage 1 2 3 4 5 great advantage
small advantage 1 2 3 4 5 great advantage
Disadvantages
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
small disadvantage 1 2 3 4 5 great disadvantage
The following questions are about how you feel about the decision to have or not to have 
amniocentesis or chorionic villus sampling (CVS).After reading the following statements, 
please circle a number that reflects how much you agree with them
9. The decision to have (not to have) a test was hard to make:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
1 0 . I was unsure whether to have/ not have a test:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
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1 1 . It was clear what the best choice was for me:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
1 2 . I was aware of the choices I had based on my triple test result: 
strongly agree neither agree disagree strongly 
agree nor disagree disagree
1 2 3 4 5
13. I feel I know what the benefits of having a test are:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
14. I feel I know what the risks of having a test are:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
15. I feel I made an informed choice about whether to have a test or not: 
strongly agree neither agree disagree strongly 
agree nor disagree disagree
1 2 3 4 5
16. My decision shows what is most important for me:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
17. The decision to have or not have a test was entirely up to me: 
strongly agree neither agree disagree strongly 
agree nor disagree disagree
1 2 3 4 5
18. I am satisfied with my decision:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
19. I expected to stick with my decision:
strongly agree neither agree disagree strongly
agree nor disagree disagree
1 2 3 4 5
The following questions ask how useful the information about amniocentesis (CVS) was 
to you.
20. Was there anything you wanted more information about? yes/ no
if yes please state.
21. Please write below what bits of information were helpful and unhelpful to 
you when making the decision to have amniocentesis (chorionic villus sampling) 
or not:
Helpful information Unhelpful information
22. Overall, how useful was the information given when making this decision:
not at all useful very useful
0   1 ------  2 ------ 3 ------ 4 ------ 5 ------  6
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23. Since having the amniocentesis (CVS) test, or not, have you looked for 
information about the following topics (please tick one response for each topic)
I looked for information: Someone gave me
information:
(a) triple test no □ yes □ no □ yes □
(b) amniocentesis no □ yes □ no □ yes □
(c) chorionic villus sampling no □ yes □ no □ yes □
(d) Down’s syndrome no □ yes □ no □ yes □
(e) other diseases/ disabilities no □ yes □ no □ yes □
(f) termination of pregnancy no □ yes □ no □ yes □
(g) other (please state)................
24. Do you regret having had the triple test at all (please circle one response):
no regret regret very much
0 ------ 1 ------ 2 ------ 3 ------ 4 -----  5 ------ 6
25. Do you regret the decision to have, or not have, amniocentesis (chorionic 
villus sampling) (please circle one response):
no regret regret very much
0 ------ 1 ------ 2 ------ 3 -----  4 ------ 5 ------ 6
26. Imagine a close friend the same risk of having a baby with Down syndrome 
as you and she asks you for advice about amniocentesis (chorionic villus 
sampling). Would you encourage her to have amniocentesis (chorionic villus 
sampling) (please circle one response)?
strongly encourage neither encourage/ discourage strongly
encourage nor discourage discourage
1 2 3 4 5
27. Do you feel the following people encouraged you to have or not have 
amniocentesis (chorionic villus sampling). Please circle one response for each 
person.
did not strongly encouraged neither encouraged discouraged strongly
discuss encouraged nor discouraged discourag
a midwives □ 1 2 3 4 5
b obstetrician □ 1 2 3 4 5
c general practitioner □ 1 2 3 4 5
d the research □ 1 2 3 4 5
e husband / partner □ 1 2 3 4 5
f other □ 1 2 3 4 5
Some women find pregnancy a worrying time, how worried you are about the following?
28. How worried are you that the following harm the fetus (please circle one 
number for each item):
not at all worried very worried
(a) ultrasound scan 0 ------ 1 ------ ? — ... 3 — . . .  4 ----- 5 — ... R
(b) emotional upset 0 ----- 1 ------ 2 —-... 3 —.... 4 ----- 5 —--  6
(c) triple test 0 ------ 1 ------ . . .  3 — ... 4 ----- 5 —-. . .  fi
(d) amniocentesis 0 ------ 1 ------ — 3 —-... 4 ----- 5 —-. . .  6
(e) taking medication 0 ----- 1 ------ ? — ... 3 ....... 4 ----- 5 —-... 6
(f) chorionic villus sampling 0 ------ 1 ------ 2 — ... 3 —.... 4 ----- 5 —-. . .  fi
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Condition_________ how affected_______not at all affected_______________ greatly affected
cleft palate/lip quality of life 0 ------1 -------2 -------3 -------4 -------5 -------6
_________________ amount of care______ Q----- 1 -------2 -------3 -------4 -------5 -------6
Down syndrome quality of life 0 ------1 -------2 -------3 -------4 ------ 5 -------6
_________________ amount of care______ 0 ----- 1 -------2 -------3 -------4 ------ 5 -------6
spina bifida quality of life 0 ------1 -------2 -------3 -------4 ------ 5 -------6
amount of care 0 ------1 -------2 -------3 -------4 -------5 -------6
29. How worried are you about the baby having (please circle one number for 
each item):
not at ail worried very worried
(a) a physical disability 0 ------ 1 ------ ? — -  3 —-... 4 — ... 5 .— - 6
(b) a mental disability 0 ------ 1 ------ 2 —.... 3 ....... 4 ....... 5 .— - fi
(c) a serious health problem 0 ------1 ------- 2 —.... 3 ....... 4_...... 5 .— -  f i
30. How reassured were you about the health of the baby when you received 
the following test results (please circle one response for each test):
not at all reassured very reassured
(a) ultrasound screening 0 ------ 1 ------ 2 ------ 3 ------ 4 ------ 5 ------ 6
(b) triple test 0 ------ 1 ------ 2 ------ 3 ------ 4 ------ 5 ------ 6
(c) amniocentesis (CVS) 0 ------ 1 ------ 2 ------ 3 ------ 4 ------ 5 ------ 6
The following questions are about your views on disability and how likely you think the 
possible consequences of testing are to happen to you (please circle one number for 
each question)
31. Do you feel a child's life would be affected by the following: (please circle a 
response for each item)
32. How likely do you think you are to: 
have a healthy child 
have a child with Down syndrome 
miscarry a fetus without Down syndrome 
miscarry a fetus with Down syndrome 
terminate a pregnancy for spina bifida 
terminate a pregnancy for a cleft palate
not at all likely
p ------1 ------2 ------3 ------4 -----
p ------1 ------2 ------3 ------4 -----
p ------1 ------2 ------3 ------4 -----
p ------1 ------2 ------3 ------4 -----
p ------1 ------2 ------3 ------4 -----
p ------1 ------2 ------3 ------4 -----
p ------1 ------ 2 ------3 ------4 -—
33. Most people who are important to me 
think I should:
have had the triple test for Down syndrome
have had a diagnostic test
terminate a pregnancy if the fetus has Down
syndrome
34. Compared with other women your age: 
how healthy would you say you were
how likely to develop a health problem 
how likely to have a healthy child 
how likely have a child with Down syndrome 
how likely to miscarry a pregnancy
ry likely
5 ----- 6
5 ----- 6
5 ----- 6
5 ----- 6
•5----- 6
5 ----- 6
5 ----- 6
should should not
p ------1 ------2 ------3 ------4 ------5 ------6
p ------1 ------2 ------3 ------4 ------5 ------6
p ------1 ------2 ------3 ------4 ------5 ------6
less likely about the same more likeh
p ------1 ------2 ------3 ------4 ------5 ------6
p ------1 ------ 2 ------3 ------4 ------5 ------6
p ------1 ------2 ------3 ------4 ------5 ------6
p ------1 ------2 ------3 ------4 ------5 ------6
p ------1 ------2 ------3 ------4 ------5 ------6
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The next part of the questionnaire asks about your opinions towards pregnancy and 
disease. How much do you agree with the following statements (please circle one number 
for each question).
35. Tests during pregnancy are necessary for my well-being:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
36. Tests during pregnancy improve my chance of having a healthy baby:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
37. Tests during pregnancy are necessary for the well-being of the fetus:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
38. Tests during pregnancy decrease my chance of miscarrying:
strongly disagree neither agree agree agree
disagree nor disagree strongly
1 2 3 4 5
The following questions are about your knowledge of tests in pregnancy. Do not worry if 
you do not know all the answers:
39. The following are tests for (please tick all boxes that apply for each test)?
all health 
abnormalities
Down
syndrome
all known chromosomal 
abnormalities
spina
bifida
none of 
these
don’t
know
triple test
amniocentesis
CVS
40. The following three tests use what type of sample (please tick one box for 
each test)?_______________________________________________________________
your
blood
your
urine
your baby’s 
blood
fluid from around 
the baby
cells from 
the placenta
don’t
know
trip le  test
am niocentesis
CVS
41. Are the following screening procedures (telling you whether you are more 
or less likely to have a baby with a disability), diagnostic procedures (give you as 
definite a 'yes' or 'no' answer as medicine can) or neither (e.g. routine checks) 
(please tick one response for each test).
(a) woman's age screening test □
(b) triple test screening test □
(c) amniocentesis screening test □
(d) ultrasound scan screening test □
(e) cvs: screening test □
diagnostic test □ 
diagnostic test □ 
diagnostic test □ 
diagnostic test □ 
diagnostic test □
neither □ 
neither □ 
neither □ 
neither □ 
neither □
don't know □ 
don't know □ 
dont know □ 
don't know □ 
don't know □
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42. A negative test result for the following tests usually  means (please tick one 
item only for each test)?
the baby
definitely does not 
have Down's
it is unlikely the 
baby has Down's
the baby might 
have Down's
the baby definitely 
does have Down's
don
knc
trip le  test
am niocentesis
CVS
43. A positive test result for the following tests usually  means (please tick one 
item only for each test)?_______________________________________________________________
the baby
definitely does not 
have Down's
it is unlikely the 
baby has Down's
the baby might 
have Down's
the baby definitely 
does have Down's
don
kno
trip le test
am niocentesis
CVS
44. How long does it take for the results from each test to come back (please 
tick one box for each test)?
1 to 2 days 1 to 2 weeks 3 to 4 weeks don’t know
triple test
amniocentesis
CVS
45. The extra risk of miscarriage after having the following three tests is (please tick 
one box for each test)?
no extra 
risk
greater 
than 1 in 50
1 in 50 
( 2%)
o o 1 in 150 
(0.7%)
1 in 200 
(0.5%)
less than 
1 in 200
don't
know
trip le test
am niocentesis
CVS
Thank you for answering all the questions and returning 
the questionnaire in the stamped addressed envelope.
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Study sample representativeness: facilitating informed decision making.
The data summarised in the following tables summarise the analyses carried out to assess the 
representativeness of the sample and comparability of women within the randomised control trial 
study groups (section 5.2.1 and 5.2.2).
Appendix XIV
Table 1: women receiving a screen positive triple test result by participation (n=178).
Frequency %
participated: invited, participated, completed T1 questionnaire 106 60%
excluded random: invited, participated, did not complete T1 4 2 %
excluded random: invited, participated, screened negative 7 4%
declined: invited, declined participation 15 8 %
excluded telephone: no invite, decision made before consultation by 
telephone
18 10 %
excluded criteria: no invite, study criteria not met 28 16 %
Table 2: Reproductive history by study participation (n=173; 5 missing values).
Participated Excluded:
Random
Declined Excluded:
Telephone
Excluded:
Criteria
Total
n=106 % n=11 % n=15 % =3 II 00 % n=23 % n=173 %
had children 68 64 7 64 9 60 13 72 14 61 1 1 1 64
miscarried 27 25 3 27 4 27 7 39 7 30 48 28
terminated 3 3 0 0 2 13 3 17 2 9 10 6
family history 
abnormality
24 23 2 18 2 13 2 1 1 7 30 37 21
Table 3: Age and gestation by study participation (n=173; 5 missing values).
Participated Random: Declined Excluded: Excluded: Total
Excluded Telephone Criteria
n=106 n=11 n=15 n=18 n=26/25 n=176 /175
x (sd) x (sd) x (sd) x (sd) x (sd) X (sd)
age 35.2 (3.0) 35.3 (3.1) 35.3 (4.3) 35.6 (2.8) 35.7 (3.5) 35.3 (3.2)
gestation 14.8 (1.0) 14.8 (1.2) 15.0 (1.4) 14.9 (1.1) 14.5 (1.2) 14.7 (1 .1 )
Table 4: Diagnostic test decision by study participation (n=169; 9 missing values).
Participated Random:
Excluded
Declined Telephone:
Excluded
Criteria:
Excluded
Total
no test 17 16% 5 45% 1 7% 5 28% 6 NA 34 NA
test 89 84% 6 55% 14 93% 13 72% 13 NA 135 NA
NA: no analysis or percentages provided because there were 9 missing values.
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Table 5: Differences in demographics and reproductive history by participation (n=178).
Test F or Chi^ value d.f. Significance
had children Chi'* 0.7 4 0.95
miscarried Chi" 1.5 4 0.83
terminated NA NA NA NA*
family history abnormality NA NA NA NA*
test decision Chi" 9.4 4 0.05
age MANOVA 0.1 4,170 0.97
gestation MANOVA 0.7 4,170 0.60
*NA (no analysis) too little variation in responses to carry out meaningful analyses.
Table 6 : Pre-consultation anxiety by participation (n=131; 1 missing value)
Total 
n=131
Participated
n=106
Excluded: 
-ve result 
n=5
Excluded: 
no T1 
n=5
Declined
n=15
X (s.d.) X (s.d.) x (s.d.) X (s.d.) X (s.d.)
pre-
consultation
anxiety
62.6 (13.9) 62.1 (13.6) 53.3 (14.3) 60.7 (23.4) 69.6 (10 .2)
Table 7: Socio-demographic characteristics by study group (n=106)
Total
n=106
Routine
n=56
Decision Analysis 
n=50
Pearson Coefficient
Level n % n % n % d.f. Chi" Sig.
Ethnic origin:
white
other
103 97% 
3 3%
54 96%
2 4%
49 98%
1 2% NA NA NA
Marital status:
married
living as married 
single
81 76%
22 2 1 % 
3 3%
40 71% 
13 23%
3 6%
41 82% 
9 18%
0 0% 2 3.4 0.18
Education:
up to GCSE 
‘A’ level equiv. 
degree +
46 44%
33 31% 
27 25%
25 44% 
16 29% 
15 27%
21 42% 
17 34% 
12 24% 2 0.4 0.83
Religious Activity:
not active
occasional
frequent
66 63% 
31 29% 
9 8%
35 63% 
17 30% 
4 7%
31 62% 
14 28% 
5 10% 2 0.3 0.86
'NA = no analysis carried out, too little variation responses
Table 8 : Experience of prenatal testing by study group (n=81)
Total
n=81
Routine
n=40
Decision Analysis 
n=41
Pearson
Coefficient
n % n % n % d.f. Chi" Sig.
last pregnancy: scan 61 75% 27 68% 34 83% 1 2.6 0.11
last pregnancy: triple test 31 38% 13 33% 18 44% 1 1.1 0.29
last pregnancy: diagnostic 4 5% 1 3% 3 7% NA NA NA*
*NA = no analysis carried out too little variation in responses
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Table 9: Reproductive history by study group (n=106)
Total
n=106
Routine
n=56
Decision Analysis 
n=50
Pearson Coefficient
n % n % n % d.f. Chi' Sig.
have children 68 64% 32 57% 36 72% 1 2.5 0.11
miscarried 27 25% 15 27% 12 24% 1 0.1 0.74
terminated 3 5% 1 2 % 2 4% NA NA NA*
family history abnormality 24 23% 16 29% 8 16% 1 2.4 0.12
companion present 78 74% 41 73% 37 74% 1 0.01 0.93
*NA = no analysis carried out, too little variation responses
Table 10: Age, gestation, anxiety, optimism & need for cognition by study group (n=106).
Total
n=106
Routine
n=56
Decision
Analysis
n=50
MANOVA 
d.f. 1, 104
x (s.d.) x (s.d.) X (s.d.) f
value
sig.
age 35.2 (3.0) 34.9 (2.9) 35.6 (3.2) 1.5 0.2
gestation 14.8 (1 .0) 15.0 (1 .0) 14.5 (0.9) 6.0 0.02
pre-consultation anxiety 62.2 (13.6) 62.3 (12.9) 62.0 (14.4) 0.01 0.9
life orientation test (LOT) 21 .0 (6.5) 22.3 (6.4) 19.5 (6 .2) 5.2 0.03
need for cognition (NFC) 81.7 (20.8) 81.2 (19.1) 82.3 (22.7) 0.0 0.8
295
Representativeness of sample returning follow-up questionnaires (T2): 
facilitating informed decision making.
The data summarised in the following tables summarises the analyses carried out to assess the 
representativeness of those women that returned the follow-up questionnaire (T2) (section 5.
Appendix XV
Table 1: Study group allocation by completion T2.
Total (100) T1Q only (32) T1&T2Q (68) Chi* (d.f. = 1)
n n % n % Chi* Sig.
routine 52 13 25% 39 75%
decision analysis 48 19 40% 29 60% 2.4 0.12
Table 2: Socio-demographic characteristics and reproductive history by completion T2.
Total (100) T1Q
(32)
only T1&T2Q (68) Pearson Chi^
n n % n % d.f Chi2 Sig.
had children 63 24 38% 39 62%
no children 37 8 2 2 % 29 78% 1 2.9 0.09
had miscarried 25 7 28% 18 72%
no miscarriage 75 25 33% 50 67% 1 0.2 0.62
had family history abnormality 22 11 50% 1 1 50%
no family history abnormality 78 21 27% 57 73% 1 4.2 0.04
Education:
up to GCSE 42 20 48% 22 52%
‘A’ level equiv. 33 9 27% 24 73%
degree + 25 3 1 2 % 22 88% 2 9.6 0.008
Religious attendance:
not active 64 21 33% 43 67%
occasional 27 9 33% 18 67%
frequent 9 2 2 2 % 7 88% 2 0.4 0.80
Table 3: Socio-demographic characteristics and individual differences by completion T2.
Total
n=100
T1 only 
n=32
T1 &T2 
n=68
MANOVA 
d.f. = 1,98
X (s.d.) X (s.d.) X (s.d.) f Sig.
age 35.2 (3.1) 36.0 (2.7) 34.9 (3.2) 3.0 0.09
gestation 14.8 (1 .0) 14.6 (1 .1 ) 14.8 (0.9) 1.7 0.20
optimism (LOT) 2 1 . 2 (6.5) 23.1 (6.7) 20.3 (6.3) 4.3 0.04
need for cognition 81.6 (2 1 .2) 82.8 (23.3) 81.1 (20.4) 0.1 0.72
Table 4: Test decision by completion T2.
Total (100) T1Q only (32) T1&T2Q (68) Pearson Chi*
n n % n % R Sig.
no test 17 4 24% 13 76%
test 83 28 34% 55 66% 0.67 0.41
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Table 5: Measures of affect, cognitive processes and clinical quality by completion T2.
Total
n=100
T1 only 
n=32
T1 &T2 
n=68
MANOVA 
d.f. = 1,98
x (s.d.) X (s.d.) X (s.d.) f Sig.
anxiety-before consultation 62.1 (13.7) 63.5 (14.2) 61.5 (13.5) 0.49 0.40
anxiety (T1) 59.7 (15.0) 61.9 (16.0) 58.6 (14.6) 1.0 0.32
conflict - uncertainty 8.5 (2.8) 9.0 (2.5) 8.2 (2.9) 1.5 0.22
conflict - informed 6.9 (1.7) 6.7 (1.5) 7.0 (1.7) 0.5 0.48
conflict - efficacy 7.6 (2.3) 7.8 (2.3) 7.5 (2.2) 0.2 0.63
IDM: information seeking 2.8 (1.0) 2.9 (1.2) 2.8 (1.0) 0.3 0.58
IDM: reasons for 2.3 (1.0) 2.5 (1.1) 2.2 (1.0) 1.6 0.20
IDM: reasons against 2.1 (1.1) 2.3 (1.2) 2.0 (1.0) 1.5 0.23
advantages testing 1.7 (0.9) 1.5 (0.8) 1.8 (0.9) 2.3 0.13
disadvantages testing 1.5 (1.0) 1.5 (1.0) 1.5 (1.0) 0.004 0.95
knowledge 14.6 (3.1) 14.3 (2.0) 14.7 (3.5) 0.4 0.54
useful information 5.1 (1.1) 5.3 (1.1) 5.1 (1.1) 0.9 0.36
length consultation 28.9 (12.3) 32.4 (15.9) 27.3 (9.8) 3.9 0.05
Table 6: SLIWC variables of decision making process by completion T2 (covariate 
consultation length).
Total
n=100
T1Q
n=32
T1 &T2Q 
n=68
MANCOVA 
d.f. = 1,97
x (s.d.) x (s.d.) X (s.d.) f Sig.
SLIWC: word count 1121 (916) 1419 (1310) 982 (618) 1.3 0.26
SLIWC: positive emotion 1.0 (0.7) 2.1 (0.8) 1.9 (0.7) 1.5 0.23
SLIWC: negative emotion 0.9 (0.5) 1.0 (0.5) 0.8 (0.5) 2.6 0.11
SLIWC: cognitive 11.2 (1.8) 11.4 (1.7) 11.2 (1.8) 0.2 0.69
SLIWC: social 9.5 (2.2) 9.8 (2.3) 9.3 (2.1) 0.2 0.65
Table 7: EUVs for the consequences of prenatal testing and perceived social norm by 
completion T2.
Total (100) T1Q only (32) T1 &T2Q (68) Mann-Whitney
X (s.d.) X (s.d.) X (s.d.) U z Sig.
EUT1 -
have healthy baby 39.5 (10.7) 40.6 (11.9) 39.0 (10.1) 997.0 -0.7 0.47
EUT2-
misc. Downs baby 12.7 (10.5) 12.5 (10.8) 12.8 (10.5) 1073.5 -0.1 0.88
EUT3-
term. Downs baby 27.8 (21.4) 27.8 (22.2) 27.9 (21.2) NA NA NA
EUT4-
have Downs baby 3.6 (6.7) 3.9 (8.8) 3.4 (5.4) 994.5 -0.7 0.75
EUT5-
misc. normal baby 1.2 (2.1) 0.9 (1.8) 1.3 (2.3) 1046.5 -0.3 0.13
perceived social 
norm 1.5 (1.7) 1.3 (1.6) 1 .6 (1.7) 1017.5 -0.5 0.59
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Table 8: EUV for termination Down syndrome by completion T2.
Total (100) T1Q only (32) T1&T2Q (68) Chi  ^(d,f.= 2)
n n % n % Chi^ Sig.
EUT value <30 56 19 34% 37 66%
EUT value >30 44 13 30% 31 70% 0.2 0.64
Table 9: Ability to rank order the consequences prenatal testing by completion T2.
Total (100) T1Q only (32) T1&T2Q (68) Chi' (d.f.= 2)
n n % n % Chi* Sig.
ranked 47 16 34% 31 66%
not ranked 53 16 30% 37 70% 0.17 0.68
Table 10: Perception triple test risk by completion T2.
Total (100) T1Q only (32) T1&T2Q (68) Chi' (d.f.= 2)
n n % n % Chi2 Sig.
low risk 12 5 42% 7 58%
medium risk 41 13 32% 28 68%
high risk 47 14 30% 33 70% 0.6 0.73
Table 11: Perceived encouragement health professionals’ information by completion T2.
Total (100) T1Q only (32) T1 &T2Q (68) Chij (d.f.= 2)
n n % n % Chi' Sig.
not discussed 51 18 35% 33 65%
neutral 40 9 23% 31 77%
encouraged 9 5 16% 4 6% 4.21 0.12
Table 12: Perceived encouragement researcher information by completion T2.
Total (100) T1Q only (32) T1&T2Q (68) Chi' (d.f.= 2)
n n % n % Chi' Sig.
not discussed 9 5 56% 4 44%
neutral 83 22 27% 61 73%
encouraged 8 5 63% 3 37% 6.87 0.03
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Table 13: Correlations between level education, family history and optimism with T2 
measures of decision quality (n=68).
EDUCAT
EDUCAT 
1.0000 
P= .
NFAMHIS TOPTIM EUT1.T2 EUT2.T2 EUT4.T2
NFAMHIS -.0205 
P= .868
1.0000 
P= .
TOPTIM -.1749 
P= .154
-.0176 1.0000 
P= .887 P= .
EUT1 ,T2 .0956 
P= .438
.0076 -.2621 1.0000 
P= .951 P= .031 P= .
EUT2.T2 -.0273 
P= .825
-.0737 .1584 -.2423 1.0000 
P= .550 P= .197 P= .047 P=
EUT4.T2 -.1622 
P= .186
-.1054 .3848 -.0645 .1680 
P= .392 P= .001 P= .601 P=
1.0000 
171 P=
EUT5.T2 .0604 
P= .625
.0895 -.0125 -.1417 .0959 
P= .468 P= .920 P= .249 P=
.0582 
.437 P= .637
SHOLD2.2 -.0081 
P= .947
-.1198 .1429 -.0706 .1979 
P= .331 P= .245 P= .568 P=
.3546 
.106 P= .003
TADVT2 .2300 
P= .059
.0876 -.1314 .4506 -.2846 
P= .478 P= .286 P= .000 P=
-.2824 
.019 P= .020
TDIST2 .2256 
P= .064
.0592 -.0958 .3254 -.3750 
P= .632 P= .437 P= .007 P=
-.2364 
.002 P= .052
TKNOWT2 .3296 
P= .006
.1116 -.3427 .2300 -.2150 
P= .365 P= .004 P= .059 P=
-.1296 
.078 P= .292
USEFULT2 -.2033 
P= .096
.0293 -.1782 .2831 -.4098 
P= .813 P= .146 P= .019 P=
-.2004 
.001 P= .101
T2DECEFF .0501 
P= .685
.0165 .3246 .0648 .0489 
P =  .894 P= .007 P= .599 P=
.2641 
.692 P= .030
T2DECINF -.0891 - 
P= .470
.0469 .2983 -.0004 .2068 
P= .704 P= .013 P= .997 P=
.2492 
.091 P= .040
T2DECUNC -.0035 
P= .977
.0826 -.0016 .1071 -.0467 
P= .503 P= .989 P= .385 P=
.0724 
.706 P= .557
TANXT2 -.0694 -.0629 .3784 -.1348 .2146 
P= .574 P= .610 P=.001 P= .273 P=
.2343 
.079 P= .055
RISKPER2 -.1444 - 
P= .240
.0645 .0759 -.1226 -.1301 -.3434 
P= .601 P= .539 P= .319 P= .290 P= 004
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Table 14: Correlations between consultation length and T2 quality of decision measures.
EUT1.T2 EUT2.T2 EUT3.T2 EUT4.T2 EUT5.T2 RISKPER2
LENCONS .1323 - 0671 -.0552 .1550 -.0887 -.1009
P= .282 P= .586 P= .655 P= 207 P= .472 P= .413
SHOLD2.2 TADVT2 TDIST2 TANXT2 TKNOWT2 T2DECUNC
LENCONS .2077 - 0474 .0363 .0156 .1369 .2651
P= .089 P= .701 P= .769 P= 900 P= .266 P= .029
T2DECINF T2DECEFF USEFULT2 LENCONS
LENCONS .0738 1368 -.2191 1.0000
P= .550 P= .266 P= .073 P=
Table 15: Correlations between researcher information and T2 quality of decision 
measures.
DIRRES EUT1.T2 EUT2.T2 EUT3.T2 EUT4.T2 EUT5.T2 
DIRRES 1.000 -.0928 -.1562 -.0002 .1630 .0814
P= . P= .452 P= .203 P= .998 P= .184 P= .509
RISKPER2 SHOLD2.2 TADVT2 TDIST2 TANXT2 TKNOWT2 
DIRRES -.1127 .0179 -.0992 -.0183 .0403 .0608
P= .360 P= .885 P= .421 P= .882 P= .744 P= .622
T2DECUNC T2DECINF T2DECEFF USEFULT2 
DIRRES .0354 .0876 -.1239 -.1892
P= .774 P= .477 P= .314 P= .122
Table 16: Correlations between gestation and T2 quality of decision measures.
EUT1.T2 EUT2.T2 EUT3.T2 EUT4.T2 EUT5.T2 RISKPER2 
GESTAT -.1946 .2087 -.0026 .1812 .0181 .0826
P= .112 P= .088 P= .983 P= .139 P= .883 P= .503
SHOLD2.2 TADVT2 TDIST2 TANXT2 TKNOWT2 T2DECUNC
GESTAT .1977 -.1975 -.0880 .0307 -.1330 .0510
P= .106 P= .107 P= .475 P= .804 P= .280 P= .680
T2DECINF T2DECEFF USEFULT2 GESTAT 
GESTAT .1598 .2272 -.1939 1.0000
P= .193 P= .062 P= .113 P=.
